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5ALA Delta Aminolevulinic Acid
A600 Absorbance at 600 nm
AA Amino acid (see Appendix D)
ABTS 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid
AFM Atomic Force Microscopy
BCA Bicinchoninic acid
bp Base-pair
BSA Bovine serum albumin
BHA Benzhydroxamic Acid
cAMP cyclic AMP
C50 Half Inactivation Concentration
CD Circular Dichroism
CIP Calf Intestinal Phosphatase
CO Carbon Monoxide
Cone. Concentration
CRP cyclic AMP receptor protein
DAB 3,3 ’-Diaminobenzidine T etrahydro chloride
DET Direct Electron Transfer
dH20 Deionised water
dNTPs Nucleotide mix
DMSO Dimethyl sulphoxide
DNA Deoxyribonucleic acid
DnaK/DnaJ Co-expression chaperones
DsbA,B,C Folding accessory proteins
DTT Dithiothreitol
EC Enzyme commission
EDTA Ethylenediaminetetra acetic acid
ELISA Enzyme Linked Immunosorbant Assay
ET Electron Transfer
FRET Fluorescence Resonance Energy Transfer
HRP Horseradish Peroxidase
HRP A2 Horseradish Peroxidase, Iso form A2
HRPc Horseradish Peroxidase, Iso form C
Ill
H R P I - V Horseradish Peroxidase, Compounds One to Five
H2O2 Hydrogen Peroxide
AG Gibbs free energy
IMAC Immobilised metal affinity chromatography
IPTG Isopropyl-|3-D-thiogalactopyranoside
ISH In situ hybridisation
k3 Apparent peroxidase kcat
K ’m Apparent peroxidase Km
LB Luria Bertani
MCS Multiple cloning site
MOPS 3-(N-Morpholino)propanesulfonic acid
mRNA Messenger RNA
NT A Nitrilotriacetic acid
NMR Nuclear magnetic resonance
OD Optical density
OPD 1,2-Diaminobenzene
ORF Open reading frame
PAGE Polyacrylamide gel electrophoresis
PANI Polyanaline
PEG Polyethylene Glycol
Pt Platinum
RBS Ribosome binding site
rHRP Recombinant HRP
RNA Ribonucleic acid
RZ Reinheitzahl
SAM Self Assembled Monolayer
SBP Soyabean Peroxidase
SDM Site Directed Mutagenesis
SDS Sodium dodecyl sulphate
SEM Scanning Electron Microscopy
STET Sucrose/ Triton X I00/ EDTA/ Tris
t\a Apparent half-life.
TAE Tris Acetate EDTA
TEMED N, N, N, V ’-tetramethyl ethylenediamine
IV
TMB 3,3’,5’5-Tetramethyl Benzidine
TNBS 2,4,6-trinitrobenzenesulfonic acid
Tris Tris (hydroxymethyl) amino methane
tRNA Transfer RNA
UV Ultraviolet light
Vmax Maximum reaction velo city
v/v Volume per volume
w/v Weight per volume
X-Gal 5-bromo-4-chloro-3-indolyl-/3-D-galactopyranoside
% SD Percentage Standard Deviation
Units
A Ampere
A Angstrom (1.0 x 10'10 metres)
°C Degrees celcius
Da Dalton
g Gram
g g-force (relative centrifugal force - ref)
hr Hour
kb Kilo base
L Litre
m Metre
M Molar
min Minute
mol mole
s Second
pH Logarithm of reciprocal hydrogen-ion concentration
pi Isoelectric point
rpm Revolutions per minute
V Volts
W Watts
V
Prefixes
k kilo (IO3)
c centi (IO'2)
m milli (IO'3)
micro (IO'6)
n nano ( 10'9)
P pico (IO'12)
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Abstract
The peroxidases are a ubiquitous subset o f enzymes found in both the animal and plant 
kingdoms. Of all the peroxidases, the majority o f research has focussed on the Class III 
Horseradish Peroxidase (E.C. 1.11.1.7). The basic form, HRP-C, is the most common 
and is utilised in this study. Recombinant HRP-C was first expressed over fifteen years 
ago; however, its production has been plagued by the formation o f inclusion bodies and 
low yields. In this present study, the HRP gene and a PelB leader sequence were 
directionally cloned to form a fusion protein, expressed to the bacterial periplasmic 
envelope. By manipulating subsequent expression conditions, fully functional HRP was 
successfully produced, with the inclusion of a poly-Histidine tag permitting single step 
purification.
Site directed mutagenesis was utilised to probe the stability o f the recombinant enzyme. 
Two methodologies were employed to select residues for mutation, initially a rational 
approach, based on previous knowledge proposed 16 mutations. The second method 
based on a peroxidase sequence alignment utilising novel bioinformatic software, 
proposed 6 mutations. These mutants were generated, expressed and purified via 
optimised conditions. All mutants were characterised based on thermal, solvent and 
H2O2 stabilities, as well as kinetic analysis. Important stabilising roles for Glutamic 
Acid 238, Glutamine 106 and the helical secondary structure within the HRP protein 
were noted. Peroxidase structure evolution could be followed via a novel archetype 
peroxidase sequence generated. Mutations, which increased hydrogen bonding in the 
Lysine 232/Lysine 241 axis, improved stability.
Genetic engineering was also employed to generate a recombinant HRP-C that 
permitted simple directed immobilisation (one triple mutant and one pentuple mutant), 
allowing maximal accessibility to the enzymes’ active site. Improved immobilisation 
capacity was achieved, however, at the cost of free and immobilised stability. 
Application o f wildtype recombinant HRP-C to screen-printed and etched platinum 
electrode biosensors was investigated. Improved direct electron transfer was noted for 
recombinant HRP over plant HRP for both configurations.
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Chapter One. 
Introduction.
1.1 Introduction to Peroxidases.
The peroxidases are a ubiquitous subset of enzymes found in both the animal and plant 
kingdoms. This extensive distribution suggests that these enzymes maintain a pivotal 
role in the growth and development of living systems. Horseradish peroxidase is the 
most widely studied of all the peroxidases, due mainly to its ability to fulfil many 
diverse roles in biotechnology and associated research areas such as medicine, genetics, 
and histochemistry (Dunford, 1991 and Ryan et al., 2006).
1.1.1 Heme Peroxidase Classification
All heme peroxidases have a heme-based prosthetic group located at the active site. In 
most plant peroxidases this is ferriprotoporphyrin IX, which is composed of four pyrrole 
rings joined by methene bridges with iron centering the molecule (Dunford, 1999). 
Several attempts to classify this unique set o f enzymes have been made, based mainly 
on the HRP amino acid sequencing work of Welinder (1979) and crystal structure 
(Gajhede et al., 1997). Welinder developed a classification based on structural 
homology, sequence homology and posttranslational modifications that divided the 
peroxidase superfamily into three distinct groups, as outlined in Table 1.1.
Recently, Welinder has vindicated her classification via a more bioinformatic approach 
focussing on the evolutionary diversity of a Class III secretory plant peroxidase, 
Arabidopsis thaliana. The phylogenetic and molecular evolution approaches developed 
to characterise the chosen related peroxidases yielded similar results to the earlier 
classification based on structure, sequence and post-translational modifications. Based 
on these findings, Duroux suggests that the Class III plant peroxidase gene family 
emerged when plants first colonised land, and that adaptive advantages were conferred 
through the presence o f peroxidase activity, such as in cell wall metabolism and plant 
defence mechanisms (Duroux and Welinder, 2003).
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Table 1.1: Description of Welinder’s classification of the peroxidase superfamily. The divisions are 
based on structural homology, sequence homology and post-translational modifications (Welinder, 1992).
Class I: Prokaryotic lineage
Intra cellular. Unique structural features such as distal Heme Helix B sequence.
No amino terminal signal peptides.
No disulfide bridges.
No glycosylation.
No structural calcium ions.
Conservation of Tryptophan residue.
Class II: Fungal Peroxidases
These are extracellular with amino terminal signal peptides.
Contain four disulfide bridges, located at different positions to other peroxidases.
Low glycosylation, normally 5%.
One structural calcium ion present.
Absence o f tyrosine residues.
Class III: Classical Secretory plant peroxidases.
These are secretory with amino terminal signal peptides.
Contain four disulfide bridges, located at different positions to other peroxidases 
High glycosylation, between 10 - 25%.
Two structural calcium ions present.
1.1,2 Horseradish Peroxidase Features and Crystal Structure.
Horseradish Peroxidase (HRP; E.C. 1.11.17, donor, hydrogen peroxide oxidoreductase), 
the most commonly studied Class III peroxidase isolated from the roots o f the 
horseradish plant (Armoracia msticana), is a “hardy perennial herb cultivated mainly in 
temperate regions o f  the world, prim arily for its roots” (Veitch, 2004). It is a heme 
peroxidase that catalyses the oxidation o f a wide range o f aromatic compounds, and also 
functions in the transfer of hydrogen peroxide from hydrogen donors (Gilabert et al.,
2004). Shannon and co-workers succeeded in isolating seven isoenzymes, three acidic, 
two neutral, and two basic, based on the pi of the purified isoenzyme (Shannon et al., 
1966). Continued studies revealed an increasing number o f iso forms (Aibara et al., 1981 
and Aibara et al., 1982), generating at least fifteen iso forms that can be purified by 
conventional techniques. However, up to forty-two iso forms can be identified via 
isoelectric focussing o f the crude root lysate (Hoyle, 1977). Several explanations have 
been forwarded as to the reason behind the large number of isoforms, including
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posttranslational modification by non-specific C-terminal cleavage to yield peroxidase 
variants (Welinder, 1979). HRP-C, a neutral isoenzyme, is the single most-studied 
iso form, and is also the most abundant iso form in the horseradish root.
HRP-C consists of 308 amino acid residues, four disulphide bridges (between cysteines 
11-91, 44-49, 97-301, 177-209) and a single buried salt bridge, between Asp99 and 
Argl23. The N-terminal residue is blocked by pyroglutamate and the C-terminal is 
heterologous, with some molecules lacking the terminal Ser308 (Welinder, 1979). As a 
member of the Class III secretary peroxidases, HRP has a tendency to be highly 
glycosylated. There are nine potential N-glycosylation sites, with only eight o f them 
being occupied by a sugar moiety (Wuhrer et al., 2005). Branched heptasaccharides 
account for up to 80% of the molecule’s sugar content, with the remaining 20% formed 
by a variety o f heterogeneous glycans. Ultimately the total glycosylation depends on the 
source of the enzyme, and can range from 18-22% total mass typically (Veitch, 2004). It 
appears that glycosylation has an important effect on the stability o f the enzyme and this 
will be discussed later (Section 1.2.3).
The heme prosthetic group attaches to the apoprotein via the side chain o f the proximal 
Hisl70 (Newmyer, et al., 1996a). The second axial co-ordination site remains 
unoccupied during the resting phase of enzyme catalysis. It is, however, available for 
hydrogen peroxide binding during enzyme catalysis. Small inactive molecules such as 
carbon monoxide and cyanide can replace a water molecule at the second co-ordination 
site and yield a six co-ordinate peroxidase complex (Meunier et al., 1995). The presence 
of the two calcium ions was confirmed by atomic absorption spectroscopy and removal 
of these caused a dramatic decrease in HRP-C thermostabililty, probably due to 
structural deterioration. Removal o f the calcium ions also causes decreased enzymatic 
activity, indicating that Ca plays an indirect role in catalytic activity (Haschke and 
Friedhoff 1978). Removal o f the calcium ions causes a perturbation in the heme 
microenvironment; however, this can be reversed by restoration o f calcium which 
causes a conformational change in the apoprotein around the single tryptophan residue 
in HRP, altering the region towards a more hydrophobic environment, elongating the 
heme-Trp distance by 9 A, and changing the accessibility of the heme residue (Coates et 
al., 1998). Howes and co-workers revealed that the proximal calcium ion is dominant in 
influencing catalytic activity and structure (Howes, et al., 2001a).
The total molecular weight of HRP-C is a combination of all the factors outlined above. 
The amino acid residues contribute 33,890 Da, the ferric heme 550 Da, the two
3
calciums 80 Da and the carbohydrate sidechains (at 18%) account for 7,580 Da, 
yielding a total in vivo molecular weight of 44,100 Da. Gajhede and co-workers (1997) 
solved the crystal structure for recombinant HRP-C to 2.5 Ä only in the last decade; the 
delay in crystallisation was mainly due to the difficulty in expressing recombinant HRP- 
C in bacterial cell lines (see Section 1.1.4). The results yielded a protein structure with 
similar folding patterns, heme content and calcium composition to other peroxidases, as 
proposed previously by Welinder (Welinder, 1979).
Figure 1.1: Schematic relationship between the proximal (bottom) and distal (top) calcium ions and the 
heme group. The calcium linkage to the heme region is also described by the various hydrogen bonds to 
neighbouring oxygen donor ligands, provided by amino acid side chains such as carboxylates (Asp) and 
hydroxyl groups (Ser and Thr), The attachment of the apoprotein to the heme moiety is also outlined at 
Hisl70 (Howes, et al., 2001 b).
1.1.3 Recombinant HRP Expression.
The gene coding for the HRP protein was first synthesised by Smith and co-workers 
(1990) based on the protein sequence published by Welinder (Welinder, 1979). This 
synthetic gene was 940 basepairs in length and was designed utilising codons 
commonly used in E. coli in order to minimise protein truncation due to codon bias 
(Gustafasson et al., 2004). It was constructed by combining twenty-three separate forty 
basepair oligonucleotide sequences in the correct order. The synthetic gene was then 
subcloned into the pGC517 expression vector and recombinant HRP was overexpressed
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by induction via isopropyl-B-D-thiogalactoside (IPTG) addition. However, 
overexpression led to the formation o f misfolded apoprotein and necessitated disrupting 
these protein aggregates, refolding the protein correctly and addition o f the heme centre. 
The disruption process involved addition of EDTA to chelate ions, lysozyme and 
DNAse to reduce viscosity of bacterial cell lysate, urea to solubilise the protein, and 
dithiothreitol (DTT) to break disulphide bonds. The refolding procedure required slow 
exchange of disrupting reagents with folding reagents such as calcium (to provide 
structural integrity), oxidized glutathione (to reform disulphide bridges) and bovine 
hemin (to form the holoprotein active site; Smith et al., 1990).
Initially E. coli was chosen as the recombinant HRP expression system (Table 1.2); 
however, expression in this system is plagued by inclusion body formation, as described 
above. Additional problems with recombinant HRP expression in bacterial cell lines 
include the reducing nature o f the host cytoplasm, which does not allow the oxidation of 
cysteine residues to form disulphide bonds (Teilum et al., 1999). Several other 
peroxidases have been cloned and expressed in E. coli, for example, soybean peroxidase 
(Chen and Vierleng, 2000), lignin peroxidase (Doyle and Smith, 1996), Neutral 
Horseradish Peroxidase (Bartonek-Roxa and Eriksson, 1994) and Bacillus 
stearothermophilus Peroxidase Gene (Loprasert et al., 1989).
Further studies have developed other expression hosts, such as Pichia and 
Saccharomyces, insect cell lines (such as Spodoperta and Trichoplusia), mammalian 
and plant cell lines. The main advantage of expressing in a eukaryotic system is that 
posttranslational modifications can be carried out on the recombinant protein; however, 
some insect systems can hyper-glycosylate proteins and purification from animal and 
plant cell lines can be difficult (Morton and Potter, 2000). Several o f these have been 
utilised in the expression o f recombinant HRP (Table 1.3).
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Table 1.2: Characteristics of E.coli expressed recombinant HRP.
Comment Reference
Apoprotein overexpressed as inclusion bodies 
Non glycosylated, 2-3% total protein 
Refolding protocol required
Smith et al., 1990.
Strain of E.coli affects expression levels. Egorov et al., 1991.
Low temperature expression with added hemin. 
Low level expression, 0.5 U/ml.
Reverted to refolding protocol to increase yield.
Egorov et al., 1994.
Overexpressed holoprotein as inclusion bodies Grigorenko et al.,
Non-glycosylated, periplasmic expression.
PelB leader sequence for periplasmic location C-terminal His tag for purification 
8-10 mg/L cell culture
1999.
PelB leader sequence for periplasmic location. Induced with IPTG, no ABTS activity Zhanglin et al.,
Weak activity in absence o f IPTG. 1999
Coexpression of foldases with HRP. Kurokawa et al.,
Active HRP located in periplasm 2 0 0 0 .
Table 1.3: Eukaryotic expression hosts of recombinant HRP.
Expression Host Comment Reference
Baculovirus High level expression
Soluble, active and glycosylated HRP
Identical catalytic activity to wildtype HRP
Hartmann & Ortiz 
de Montellano, 
1992
S. cerevisiase Hyperglycosylated HRP produced 
Enzymatically treated to remove excess sugars
Vlamis-Gardikas et 
al., 1992
S. cerevisiae Directed evolution towards increased expression. 
40 fold activity increase in culture supernatant. 
260 U/L culture supernatant.
Morawski et al., 
2 0 0 0  a
P. postons Directed evolution towards increased expression. 
85 fold activity increase in culture supernatant. 
600 U/L culture supernatant.
Morawski et al., 
2 0 0 0  b
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Table 1.3 (Cont.): Eukaryotic expression hosts of recombinant HRP.
Expression Host Comment Reference
P. pastoris Active HRP expressed.
Continuous induction with methanol
Morawski et al., 
2001
Peak HRP activity after 90 hours induced growth
N. tobaccum CaMV-35s or Light inducible promoter. 
10 fold overexpression ofrHRP 
Natural N-terminal sequence is essential.
Kis et al., 2004
Spodoperta HRP secreted into culture medium 
25 mg/L without hemin addition.
41 mg/L with hemin addition 
Ni2+ Affinity purification, RZ of 3.2
Segura et al., 2005.
Beta vulgaris 1.21 x 106  U/L, 20-day incubation.
Similar pH optimum to plant HRP.
Increased thermal stability compared to plant HRP.
Rudrappa et al.,
2005.
Peroxidase-specific methodologies have been developed to overcome the major 
problem of inclusion body formation during prokaryotic expression, including use of 
specific E. coli strains, inclusion of chaperones and use o f leader sequences. Teilum and 
co-workers developed a thioredoxin reductase-negative E. coli strain via selective 
pressure protocols. This E. coli strain allows for the formation o f disulphide bonds, and 
hence a fifty-fold increase in the formation of active recombinant peroxidase was noted 
(Teilum et al., 1999). Kondo and co-workers (2000) co-expressed Dsb folding 
accessory proteins and molecular chaperones with recombinant HRP and noted an 
increase in HRP production and activity. The foldases utilised in this study included 
Dsb, which aids in the transportation of proteins to the periplasm, DsbA, which 
catalyses disulphide bond formation, and DsbC, which initiates disulphide bond 
isomérisation if abnormal cysteine bonds are formed. DsbD, in conjunction with Dsb, is 
thought to maintain DsbA and DsbC. Active HRP production increased with 
coexpression o f these foldases, even at high inducer concentrations, which normally 
caused cell death due to toxic effects. Co-expression of molecular chaperones, such as 
DnaK, DnaJ and GrpE, had no effect on HRP production or activity (Kondo et al., 2000; 
Kurokawa, et al., 2000). Gene fusion technology has also been used to ameliorate the 
inclusion body formation problem (Zhang et al., 1998). Leader sequences were fused in­
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frame with the HRP gene to direct the protein to the periplasm where it can fold 
correctly in the oxidising environment (Zhanglin et al., 1999; see also Table 1.2).
Another major obstacle in the recombinant expression o f HRP is the limited availabilty 
of heme and iron within a bacterial cell. Bacterial cells each contain 105 to 106 iron ions 
that are essential for many metabolic pathways. The low solubility o f iron (III) salts at 
physiological pH in the presence of oxygen is a serious obstacle to any method of 
introducing extra iron to a bacterial system (Wandersman and Stojiljkovic, 2000). 
Recombinant expression o f hemoproteins is often hindered by the fact that the protein 
produced lacks the heme prosthetic group due, in part, to the increased rate of 
recombinant protein biosynthesis compared with the rate of heme biosynthesis 
(Vamado and Goodwin, 2004). Recently, Arnold and Lin (2000) noted poor RZ 
(Reinheitzahl; ratio o f holoprotein to apoprotein, see Section 2.29) values (between 1.2- 
1.9) for recombinantly-expressed HRP. Again, simple suggestions have been put 
forward to alleviate the problem, including slower cultivation to allow the heme 
biosynthesis rate equilibrate with the protein synthesis rate; however, this reduces the 
total yield. An alternative approach is to supplement the cells with 5-aminolevulinic 
acid, synthesis o f  which is the rate-limiting step in heme biosynthesis in bacterial cells, 
but this is expensive on a large scale (Woodard and Dailey 1995). Direct addition of 
heme to the culture broth during recombinant protein expression has been proposed as a 
cost effective alternative to o-aminolevulinic acid addition but problems remain in the 
ability o f most laboratory E. coli strains to use exogenous heme as an iron source. In an 
effort to increase the ability of E. coli to utilise exogenous heme, certain strains have 
been genetically modified to express successfully a membrane heme receptor (Perry et 
al., 2003). Vamado and Goodwin (2004) cited another approach to this problem where a 
series o f co-expression plasmids contain the genes for a heme receptor protein which, 
once transformed with the gene o f interest, allow the host cell to utilise heme in the 
surrounding growth medium. The heme that is bound by the host cells can then be 
directly incorporated into the recombinant hemoprotein without affecting the rate o f 
protein expression (Vamado and Goodwin, 2004).
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1.1.4 Horseradish Peroxidase Catalytic Activity.
HRP is classified as an oxidoreductase (E.C. 1.11.17, donor: hydrogen peroxide) and as 
such it functions in the transfer of hydrogen peroxide from hydrogen donors. Inherent to 
this transferal ability is the catalytic cycle it undertakes. Theorell noted the formation of 
a green solution that rapidly turned red (reviewed in Theorell, 1957), which puzzled 
peroxidase scientists for decades until the work of Chance and George elucidated the 
existence o f Compounds I and II in the HRP catalytic cycle (Chance and George, 1949). 
Their work allowed for the formulation of the widely accepted reaction scheme:
HRP + H2O2 = Compound I + H2O
Compound I + AH2 = Compound II + AH*
Compound II + AH? = HRP + AH*+ HzO 
Reaction Sum: H2O2 + 2 AH2 = 2 H2O + 2AH*
Figure 1.2: Basic HRP reaction scheme showing the formation of Compounds I and II. AH2  is a reducing 
substrate, whilst AH* is the oxidised form of the substrate. (Dunford, 1999).
Continued studies concluded that the catalytic cycle o f HRP is initiated by a rapid two- 
electron oxidation of the enzyme by hydrogen (or a similar) peroxide to yield the first 
intermediate, Compound I (Hiner et al., 2002) At this point, the heme iron is oxidised to 
its oxyferryl state [Fe(IV)=0] and a rc-cation radical is located on the porphyrin ring 
(see Figure 1.3; Rodriguez-Lopez et al, 2000). To complete the cycle, HRPC-I is 
converted back to the resting enzyme via two successive single-electron reducing steps, 
the first yielding HRPC-Compound II, the second enzyme intermediate. HRPC-II 
retains the oxyferryl group but not the porphyrin cation radical. Compounds I and II are 
powerful oxidants, with redox potentials estimated to be close to +1.0 volts (Dunford,
1999). The site o f oxidation has been investigated through the use o f enzyme 
inactivation assays, with substrates such as cyclopropanol hydrate, nitromethane, 
alkylhydrazine, phenylhydrazine and sodium azide. The free radicals generated from the 
inactivating molecule remain in the region o f activity and act as indicators to the site o f 
oxidation. Hence, it was concluded that HRP oxidation took place at the exposed heme 
edge, which is composed of the Cl 8 and C20 meso protons (Veitch and Smith, 2000). 
The rate o f peroxidation catalysis depends on the nature o f the reducing substrate, with 
conversion o f Compound II to resting-state HRP being the rate-limiting step in the 
cycle. This is probably due to the longer electron transfer distance between the iron
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atom of the heme group and the substrate, compared with the corresponding distance 
from the n-cation radical to the substrate in Compound I (Folkes and Candeias, 1997). 
Dunford and co-workers reported for horseradish peroxidase that Compound I 
formation is independent of viscosity in aqueous glycerol solutions. However, 
Compound I formation was a function of diffusion, influenced by such phenomena as 
size o f the substrate and electrostatic interactions between charged reactants and the 
enzyme (Dunford and Hewson, 1977). Sato and co-workers described the effect o f 
solvents on the oxidation of Compound II. Methanol and ethylene glycol (up to 50% 
v/v) were examined and oxidation was dramatically reduced, explained by the 
interaction of the hydroxy group of the solvent with the heme iron (Sato et al., 1995). 
Dead-end compounds, which lead to inactive enzyme, can also be formed in the 
presence of inhibitors. With Compound III formation a red colouration is observed, 
whilst with Compound IV formation a green colouration is noted (see Figure 1.3; Ryan 
et al., 1994). Dunford describes the Horseradish peroxidase catalytic pathway as a 
“peroxidase ping-pong'’ mechanism, in which the cycle is irreversible. This; combined 
with the fact that “true” peroxidase saturation cannot be achieved, prevents Km value 
calculation (Dunford. 1999). However, much debate continues to surround this topic, 
with other mechanistic theories postulated, including van Haandels “ping-pong-pang” 
theory in which compound I formation is reversible (van Haandel et al., 1998).
h 2o 2
Peroxide
£
H R P C
Resting
HRPC III, 
HRPC IV
II R P C -II H UPC-1
AH
Figure 1.3: Schematic of HRP catalytic cycle, indicating the two intermediates (Compound I and II), the 
reaction rates k¡, k2 and kf, and the products of the reaction, two radicals (A') and two water molecules. 
Compounds III and IV are inactive forms of HRP, often referred to as dead-end coumpounds.
There are several possible fates for the free radicals produced during catalysis. The 
radical may dimerise, react with another substrate molecule or attack another species 
causing co-oxidation. The radical may also reduce molecular oxygen to superoxide 
(O2*), or it may be scavenged by molecular oxygen to form a peroxyl radical (HO2’; 
Dunford, 1991). The catalytic cycle o f HRP continues to stimulate active research, 
including the observation o f a transient intermediate Compound 0 (prior to the 
formation of Compound I) occurring at low temperatures in reactions between HRP and 
H2O2 (Filizola and Loew, 2000). In 2002 the catalytic cycle o f horseradish peroxidase 
was solved by crystallography. Berglund and co-workers describe high-resolution 
crystal structures o f the oxidation states of HRP (Resting State and HRP I-IV, as 
outlined in Figure 1.3); continued related studies will provide direct structural insights 
into redox chemistry at poryphyrin-based iron centres (Berglund et al., 2002).
1.1.5 HRP Substrates.
Peroxidases are capable of catalysing the oxidation o f a wide range o f substrates. 
Fundamentally, HRP catalyses the decomposition of H2O2, its natural substrate, into 
oxygen and water, via a two-electron transfer procedure, as outlined previously. The 
two-electron step requires that the HRP molecule be returned to its resting state, and this 
regeneration is aided by the presence of a hydrogen donor. The hydrogen donor is 
oxidised as the HRP molecule returns to its native state, and hence the term 
“oxidation/reduction reaction” is often used to describe the catalytic activity o f HRP 
(Dunford, 1999).
Several types o f hydrogen donor exist and many of these also serve as indicators for 
HRP activity. Indicator molecules encompass colorimetric, luminescent and 
fluorimetric methods of detection (Conyers and Kidwell, 1991). Not only do these 
molecules detect the presence of HRP, but they also indicate the rate o f catalytic 
activity. Examples o f colorimetric HRP substrates include TMB (3,3',5,5'- 
Tetramethylbenzidine), OPD (1,2-Diaminobenzene) and DAB (3,3'-Diaminobenzidine). 
However, to quantify the enzyme’s catalytic activity ABTS (2,2'-Azino-bis(3- 
ethylbenzothiazoline-6-sulfonic acid) is a commonly cited substrate. One ABTS unit 
will oxidize 1 (imol of ABTS per minute at 25°C at pH 5.0 (Sigma Aldrich, 2005).
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Figure 1.4: Reaction mechanism of ABTS with peroxidase results in the generation of two water 
molecules and a green coloured product, which can be read spectrophotometrically.
HRP can also oxidise certain chemiluminescent substrates, most commonly luminol, 
yielding light (Lu et al., 2004). This light emission can be measured and used to 
quantify HRP activity. Enhancers, such as luciferin, can be incorporated into assays to 
increase light emission from a flash signal to a more steady-state output and, hence, 
chemiluminsecent techniques offer greater sensitivity compared with colorimetric 
assays (Azevedo et al., 2003 and Bonfils et al., 1996). Tanaka and co-workers 
unsuccessfully attempted to increase the active site accessibility o f a recombinant HRP 
molecule to a luminol-based substrate to by site-directed mutagenesis as outlined Table
1.8 (Tanaka et al., 1999). HRP can also react with certain fluorimetric substrates such as 
10-Acetyl-3,7-dihydroxyphenoxazine, known commercially as Amplex Red™. HRP 
reacts with Amplex Red™, in the presence of H2O2, in a 1:1 stoichiometry, to form 
resorfin, the fluorescent product. However, resorufin also has strong absorption, and 
hence it can be detected either fluorometrically (573 and 590 nm for absorption and 
emission respectively) or spectrophotometrically (575nm). The fluorometric assay is, 
however, the more sensitive method (Endo et al., 2005).
HRP can also participate in electrochemical reactions due to the inherent redox 
properties associated with its catalytic cycle. Here, HRP utilises a hydrogen donor that 
can be monitored voltametrically upon reduction. Electron donors that act as electron 
mediators and can be easily monitored voltametrically are essential (Sanchez et al., 
1990). Electron donors employed in such situations include hydroquinone, o-toluidine, 
resorcinol and catechol. If reduction of the hydrogen donor can be measured, the 
concentration of hydrogen peroxide involved in the reaction can also be examined (Anh 
et al., 2003; Luo et al., 1997). Application of this is examined in more detail in Section
HRP can also function as a catalyst in a number of other arrangements, most notably in 
the one-electron oxidation o f phenols. Phenols such as p-hydroxyphenylacetate and p-
1.1.9.
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cresol can be converted into phenol radicals, which in turn spontaneously form 
polymers. The main application of this catalysis is the bioremediation o f wastewater 
(Wanger and Nicell, 2002) as outlined in Table 1.4.
Iodine also reacts with HRP: in the presence of hydrogen peroxide, horseradish 
peroxidase and iodine, a simple enzyme-catalysed clock reaction occurs. In this 
reaction, hypoiodous acid, HOI, is reduced to form I"; however, in the absence of 
hydrogen peroxide, the remaining HOI reacts with the excess I to form the chromogen 
I3 . The length of time to the appearance of I3 is proportional to the concentration of 
H2O2 (Dunford, 1999)
HRP maintains the ability to carry out catalysis, including hydroxylations, N- 
demethylations and sulphoxidations, in the presence of organic solvents. Activity is 
maintained in organic solvents due to tightly bound nature o f the water molecules 
within the enzyme structure (Azevedo et al., 2001). This is advantageous, as the enzyme 
can be used in detection systems where analytes must be dissolved in organic solvents 
(van de Velde et al 2001).
As can be seen, most reactions catalysed by HRPC utilise reducing substrates, typically 
aromatic phenols, phenolic acids, indoles, amines and sulfonates (Veitch, 2004). The 
substrates and their products, most notably aromatic amines, can be carcinogenic and 
care should be taken in substrate choice (Dunford, 1991).
Substrate oxidation occurs at the exposed heme edge of the ferriprotoporphyrin IX, at 
the region comprising the heme methyl Cl 8 and heme meso C20 protons (Smith and 
Veitch, 1998, and Adak et al., 1996).
Figure 1.5: Diagrammatical representation of the exposed heme edge of the ferriprotoporphyrin DC, 
adapted from Veitch (2004).
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Recall that the rate-limiting step in HRP catalysis is the oxidation of the donor hydrogen 
molecule and the conversion of Compound II back to resting state HRP (Section 1.1.5). 
However, different rates of compound II conversion to resting state can be caused by 
substrate choice: van Haandel and co-workers (1999) noted a 3-fold difference between 
phenol and aniline oxidation, which was further proven by studies by Gilabert and co­
workers. (Gilabert et al, 2004)
1.1.6 HRP Inhibitors.
In addition to the native substrate, phenols and aromatic amines, HRP can also bind a 
wide range of structurally related substrate analogs or inhibitors. Elegant suicide 
inhibitors have been developed that can bind to the exposed heme edge and 
competitively inhibit the peroxidase catalytic activity. One example o f such an inhibitor 
is Benzhydroxamic Acid, BHA, which was utilised to elucidate the binding region of 
the HRP molecule, and demonstrated a hydrophobic aromatic binding pocket generated 
by His42, Phe68, Gly69, A lai40, Prol41 and Phel79 (Henriksen et al., 1998).
Other competitive inhibitors include 2-amino-4-nitrophenol (ANP), gallic acid (GA), 
4,4'-dihydroxydiphenylsulfone (DDS) and their polydisulfides poly(ADSNP), 
poly(DSGA), poly(DSDDS). Metelitza and co-workers (2004) demonstrated that the 
most effective competitive inhibitor, when TMB is utilised as a secondary hydrogen 
donor, is poly(DSGA); however, this may be due to the apparent peroxidase preference 
for phenol substrates. Interestingly, the polymer phenols were significantly more active 
inhibitors than their monomer analogs, indicating that size of the polymer phenol does 
not affect its binding capacity to HRP (Metelitza et al., 2004).
Zaton and de Aspum (1995) demonstrated that all uracils bind non-competitively to the 
active site of HRP; however, only thiolated uracils inhibit peroxidase activity. This 
inhibition could be due to the thiol residues interacting with the apoprotein, causing 
structural perturbation and thereby affecting activity (Zaton and de Aspuru, 1995). 
Keyhani and co-workers (2003) established the inhibition o f HRP by cadmium, noted as 
a noncompetitive or mixed inhibitor of HRP depending on the duration of incubation
o i 9 #
with HRP and on Cd concentration. Three cadmium ions bound per HRP molecule, 
causing large conformational changes and a decrease in HRP activity (Keyhani et al., 
2003). Similar results were noted when HRP was incubated with nickel. Four nickel 
ions bound to the HRP molecule, again causing structural perturbation and a dramatic 
decrease in activity The enzyme remained active only over a limited metal
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concentration range. Data indicated that binding of one Ni affected the substrate 
binding site, binding of a second Ni2+ affected both substrate and peroxide binding sites, 
and binding of more than 2 Ni2+ per HRP molecule led to complete loss o f enzymatic 
activity (Keyhani et al., 2005). Other methods of HRP inactivation, such as H2O2 
poisoning, will be discussed in the section on protein stability (Section 1.2.3).
1.1.7 HRP Roles and Applications.
Interestingly, despite its many in vitro roles (Table 1.4), HRP’s actual in vivo role has 
never been elucidated. Several suggestions have been based on the known roles o f other 
plant peroxidases. Plant peroxidases are usually found in the cell wall, vacuoles, 
transport organelles and the rough endoplasmic reticulum, and have noted roles in 
lignification (Mader and Fussel, 1982), wound healing (Kerby and Sommerville, 1996) 
and auxin catabolism (Gazaryan et al., 1998). However, due to its intrinsic generation o f 
free radical species during its catalysis, HRP offers a wide range of in vzYroapplications, 
as outlined in Table 1.4.
Table 1 .4 : S u m m a ry  o f  H R P  a p p lic a t io n s ,  w ith  r e fe re n c e s  to  p u b l is h e d  w o rk  in  th e  r e le v a n t  a rea .
Application. Reference.
Biosensor: This can be defined as an analytical device in which a specific biological 
interaction is transduced into an electrical signal. HRP is currently one of the most 
common biological components.
Li et al., 2004. 
Tang et al., 2003,
Immunoassay: Immunoassays are typically used to identify and quantify antigens 
and antibodies. HRP-based conjugates are commonly used in ELISA, immuno histo­
chemistry and Western blotting immunoassays.
Dotsikas & 
Loukas, 2004. 
Shrivastav, 2003.
DNA Detection: In situ hybridisation (ISH) techniques are used to localise specific 
nucleic acid sequences within tissues or chromosomal preparations. HRP-based signal 
systems remain pivotal to ISH technology.
Ishii et al., 2004. 
van Gijlswijk et al., 
2000
Bioremediation: From a variety of aromatic pollutants HRP can generate free 
radicals, which spontaneously polymerise and aid in the bioremediation of wastewater 
effluent.
Singh & Singh 
2002. Wanger & 
Nicell, 2002.
Organic Synthesis: Peroxidases can catalyse oxidative transformations of organic 
reactants, utilising peroxide as the oxidant. Examples include sulfoxidations, N- and 
O-dealkylations and epoxidations.
van de Veide et al., 
2001 
Colonna et al., 
1999.
Gene Therapy: HRP has been successfully used in gene-directed enzyme/prodrug 
therapy. An inactive precursor of the therapeutic agent is activated by the presence of 
HRP at specific location in the body.
Tupper et al., 2004 
Greco et al., 2001.
Biomedical: Diagnostic test kits perform rapid analysis, sometimes at the bedside / 
point of care patient, with many containing HRP as an active component. Glucose 
sensors are the most common type of HRP-based diagnostic test.
Azevedo et al., 
2003 
Jamnicky et al., 
1988.
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1.1.8 HRP Applications: Direct electrochemical biosensors, a case study.
One of the fundamental areas o f applied HRP research is biosensor innovation. A 
biosensor was recently stringently defined as “a se lf  contained integrated device which 
is capable o f  providing specific quantitative (or semi-quantitative) analytical 
information using a biological recognition element, which is in direct spatial contact 
with a transducer elem enf’ (Thevenot et al., 1999). In theory, a biosensor can be 
tailored to match any individual analytical demand, provided the target molecule 
interacts selectively with a biological system. Electrochemical enzyme-based biosensors 
are of special interest owing to their practical advantages such as operational simplicity, 
low-cost fabrication, portability, potential for miniaturisation, high sensitivity and 
suitability for real time detection (Xu et al., 2004). In this configuration, an enzyme 
provides the “biological recognition element”, the output o f which is converted to a 
measurable signal by electrochemical transduction. Currently, amperometric 
electrochemical transduction is most popular, as it offers high sensitivity in conjunction 
with a wide linear range (Freire et al., 2003).
Amperometric enzyme based biosensors can be classified into first, second and third 
generation devices. First generation biosensors relied on the electro activity o f the 
enzyme substrate or product. Second generation biosensors required a conducting 
molecule to shuttle the electrons generated at the enzyme’s active site to the electrode 
surface. Third generation biosensors do not require such mediators, with electrons 
''hopping” directly from the active site to the electrode surface. The area o f HRP-based 
electrochemical sensors is too vast to review here; however, third generation, direct 
electrochemistry based biosensors will be summarised.
Direct enzyme-electrode electron transfer offers superior sensitivity, as it occurs during 
the catalytic conversion of the substrate to product. Selectivity is also increased by 
operating the biosensor in a potential range closer to the enzyme’s redox potential, thus 
reducing interfering reactions. Despite the many advantages o f direct electron transfer 
(DET) in biosensor configurations, very few biomolecules are capable o f interacting 
with an electrode whilst catalysing the corresponding enzymatic reaction. Typically, 
plant horseradish peroxidase has very slow DET, presumably due to heavy 
glycosylation (~20%) and the buried nature o f the active site heme moiety (Ruzgas et 
al., 1996). Although there are reports o f plant HRP-driven DET (Xu et al., 2004), these 
are mostly associated with carbon-based electrodes (Ferapontova, 2004a). However, 
DET for recombinant HRP has been noted with several electrode configurations,
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including graphite rotating disk electrodes, with the improved DET being attributed to 
the lack of glycosylation (Lindgren et al., 1998). Marcus and Sutin (1985) postulate that 
electron transfer kinetics are governed by the potential difference (between the active 
site and the electrode), the structural rigidity o f the redox species and the distance the 
electron has to travel (Marcus and Sutin, 1985). Mayo and co-workers (1986) further 
postulated that the rate of electron transfer (k) is exponentially proportional to the 
distance (d) the electron has to travel, and a constant (a), as given by:
k  oc e~ad
In extreme cases, when the distance from the electron donor to acceptor is greater than 
10 A, the electron transfer rate drops by a factor of 104 (Cassidy et al., 1998). It appears 
that electron transfer occurs through “electron transfer channels” in the enzyme 
structure, as opposed to direct contact between the active site and the electrode 
(Lindgren et al., 1998). The pH at which the electrochemical catalysis is performed can 
also affect the rate of direct electron transfer. Ferapontova and Gorton (2002a) 
demonstrated that by decreasing the reaction pH from 8.0 to 6.0 DET is enhanced, 
possibly due to the involvement o f a proton in the rate-determining step o f electron 
transfer. Ferapontova (2004) recently reviewed peroxidase DET on a variety o f 
electrode materials and concluded that DET is substantially more evident with 
recombinant than with plant HRP. In general, the specific catalytic requirements o f 
HRP dictate the optimisation of bioelectrocatalysis on different electrode 
configurations. Adsorption is a particularly common immobilisation method for carbon- 
based electrodes, whilst the intrinsic structural features of the enzyme and o f the 
electrode are crucial for metal based electrode immobilisation (Ferapontova, 2004b). 
Several examples o f rHRP-based amperometric DET sensors are available in the 
literature (Ferapontova 2001, Ferapontova 2004a and references within) along with 
some reports o f plant HRP DET sensors (Sun et al., 2004). Recombinant HRP was 
utilised in the movement towards bi-enzyme biosensors in work carried out by 
Shipovskov and co-workers (2004). In this work, a two-electrode system, comprising 
immobilised rHRP and cytochrome c, was established to detect superoxide radicals. In 
this arrangement, superoxide radicals (CV) and H2O2 were simultaneously detected. A 
coupled bi-enzyme biosensor, in which the product of the first enzymatic reaction 
provides the substrate for the second, sensing, reaction is currently a vibrant area o f 
research (Yang et al., 2004). Other peroxidases, both recombinant and native, are the
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subject o f DET research, including enzymes from tobacco, peanut and sweet pea 
(Lindgren et al., 2000, and Castillo et al., 2006).
Recent research has focussed on controlled deposition and orientation of immobilised 
recombinant oxidoreductases for optimal DET. As alluded to earlier, the shorter the 
electron transfer distance the greater the chance of DET occurring; hence, controlled 
directional immobilisation of enzymes is critical for the progression of third generation 
biosensors. Recombinant HRP demonstrates a higher percentage o f correctly orientated 
molecules for DET in graphite rotating disk system than plant HRP; this has been 
ascribed to the absence of glycosylation. (Lindgren et al., 1999). Recently, Ferapontova 
and Dominguez (2004) demonstrated that DET could be improved by strategic 
manipulation of the electrode and surface charge of a recombinant HRP, presumably 
due to improved immobilisation. Typically, physical adsorption is utilised for 
peroxidase immobilisation onto a metal electrode; however, other methods such as 
entrapment (Yang et al., 2004) and direct covalent attachment (Castillo et al., 2005) are 
regularly employed.
Often, these methods lead to the formation of a randomly orientated layer, either on the 
surface o f the electrode (metal) or within cavities (carbon). Physical adsorption may 
result in enzyme denaturation, due to multiple contacts with the solid phase. Binding of 
ligands, or substrate / product access and egress, may also be hindered, all resulting in 
poor bioelectrocatalytic activity (Freire et al., 2003). Self-assembled monolayers (SAM) 
are an attractive alternative for controlled, directed enzyme immobilisation. SAMs are 
highly organised monomolecular layers that form spontaneously upon submersion of a 
solid phase into a solution containing amphifunctional molecules. The lengthy 
hydrophobic chain o f the SAM can be altered and terminated with a functional group 
that will interact only with a specific residue on an enzyme backbone (Gilardi and 
Fantuzzi, 2001). In this instance, a site-directed mutation could be utilised to dictate the 
location o f the specific residue and, hence, control the orientation of the molecule (e.g 
additional Cys residue for thiol immobilisation; Ferapontova et al., 2002). Addition o f 
chemically modifiable residues, preferably at the C-terminus o f a protein, can 
simultaneously allow for improved immobilisation and DET. Ferapontova and co­
workers (2002) introduced an additional Cys residue at the C-terminus of HRP, which 
leads to simple thiol-based immobilisation to a gold electrode and also improved DET. 
Redox proteins are not evolved, nor optimised, for bioelectrocatalysis. In Nature, 
random electron transfer is not permitted, as it would be wasteful to the organism. Also,
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toxic metabolites, such as H2O2, are not naturally produced in high concentrations. 
Further control is implemented by embedding redox-active centres deep within the 
insulating folds o f the enzyme’s backbone, and by regulating electron transfer through 
sophisticated control mechanisms (Wong and Schwaneberg, 2003). Protein engineering 
can be utilised to increase electron transfer rates and also to tailor redox proteins for 
specific requirements.
Researchers are faced with several challenges when attempting to optimise a redox 
protein for bioelectrocatalysis (see Tablel.5); however, several approaches are currently 
being pursued. Molecular wiring of redox proteins is an emerging field, in which 
electron-conductive chains can be used to link the redox centre o f an enzyme to a 
electrode, thus providing an efficient electronic conjugation. Mutagenesis has been 
utilised to alter the protein backbone of azurin protein, in which a His residue was 
replaced with a smaller Gly, permitting direct molecular access to a buried copper ion 7 
A below the protein surface (Gilardi et al., 1994). Residues close to the active site can 
be mutated to allow for quicker product dissociation (lower Km), as outlined by 
Davidson (2003) who replaced a bulky Phe residue in the substrate access channel o f 
methylamine dehydrogenase with a smaller Ala; this decreased the Km but also opened 
up the active site entrance. Removal o f excess amino acids, not critical for structure or 
function, can increase access to the active site. Gelo-Pujic and co-workers (1999) 
removed 11 C-terminal amino acids from the Laccase protein, which improved access 
to the copper ion at the active site. Directed evolution also offers the potential o f 
evolving an enzyme with a non-natural function, increased DET or long-term stability 
(Wong and Schwaneberg, 2003).
HRP dominates biosensor research, from the traditional voltammetric- and 
amperometric-based methods of detection, to nano-sized devices. Real-time 
quantification o f hydrogen peroxide continues to be one o f the main reasons for sensor 
development (T0nning et al., 2005), although other diverse applications include the 
detection o f glucose (Alonso Lomillo et al., 2005), ethanol (Azevedo et al., 2005) and 
tumour markers in vivo (Lin and Ju, 2005). While a detailed account o f the current 
applications o f HRP-based sensors is beyond the scope of this review, some of the 
emerging trends in HRP-based biosensor development, including organic solvent 
compatible sensors and nano-sized sensors are highlighted.
Biosensors, including immunosensors (Penalva et al., 1999) and electrosensors 
(Campanella et al., 2001), incorporating organic solvents have developed as an
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expanding area of peroxidase research, primarily due to insolubility o f many analytes in 
aqueous solutions. Recently, Konash and Magner (2006) developed a HRP- 
immobilised, mediated H2O2 sensor which demonstrated good catalytic activity in 2- 
butanone and ethyl acetate. Organic-solvent compatible bi-enzyme peroxidase sensors 
have also been cited in the literature (Castillo et al., 2003). Size reduction remains a 
pivotal area in sensor research. The use o f nanoparticles offers increased surface area 
for enzyme immobilisation, whilst simultaneously reducing apparatus size (Liu et al.,
2005). Currently, HRP-based nano-sensors are at the forefront o f biosensor research 
(Ryan et al., 2006)
Table 1.5: Challenges in redox protein optimisation for bioelectrocatalysis.
Problem Explanation.
Field Conditions Enzymes tend to have a narrow optimal operation range, which may 
not suit test conditions.
Cofactor Requirement Cofactors can be expensive and difficult to regenerate.
Enzyme Stability Operation time can be reduced due to enzyme dénaturation.
Enzyme Pretreatment Many pre-treatment procedures (e.g. deglycosylation) can reduce 
enzyme activity.
Enzyme Immobilisation Selection of suitable immobilisation technique can be an empirical 
process.
ET Control Processes Naturally occurring ET control processes can be difficult to reverse.
1.2 Introduction to Protein Stability:
Protein stability is defined as “the persistence o f  molecular integrity or biological 
function despite adverse influences or conditions, such as heat or other deleterious 
conditions” (O Fagain, 1997). Protein stability can be measured in many ways 
including conformational stability (which comprises monitoring protein unfolding due 
to deleterious conditions) and kinetic stability (which involves measuring the 
persistence o f biological activity with time under stressful conditions; O Fagain, 1997). 
In Nature, enzymes are not optimised towards stability; they are just stable enough not 
to be limiting for an organism (Lee and Vasmatzis, 1997). Indeed, most enzymes 
display a marginal stability profile regardless o f size or function, and forcing the 
stability equilibrium towards instability is easily achieved (Tavema and Goldstein, 
2002a) although sometimes apparently contradictory reports on enzyme robustness are
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cited (Tavema and Goldstein, 2002b). It is clear, however, that the in vitro use o f 
enzymes in biotechnological applications requires a degree of enzyme stabilisation to 
allow optimal enzyme function in non-natural environmental conditions (O Fagain, 
2003). Several methodologies have been developed to overcome the problems presented 
by protein instability, including chemical modification and genetic manipulation.
1.2.1 Chemical Modification.
Chemical modification of protein residues is a commonly utilised method in protein 
stabilisation. In this procedure, certain reactive amino acid R-groups are suitably 
changed to reduce the instability. At least eight amino acids (Cys, Lys, Asp, Glu, Arg, 
His, Tyr and Met) can react with specific chemical modifying reagents to form new 
“chemically-stabilised” proteins. These modifying reactions include crosslinking by 
bifunctional reagents, strengthening of hydrophobic interactions by non polar reagents, 
introduction o f novel groups to aid in additional hydrogen bond formation, or 
hydrophilisation of the protein surface to reduce unfavourable surface hydrophobic 
contacts with water (O Fagain, 1997). A recent example o f such work includes 
Yoshitsune and co-workers (2005) laccase modification by use o f an amphiphilic 
copolymer, polyalkyleneoxide-co-maleic anhydride. This strengthened the hydrophobic 
interactions o f the enzyme, resulting in increased stability (Yoshitsune et al., 2005). A 
succinic anhydride modification of the lysine residues o f papain reversed the charge of 
the lysine residue and yielded an increase in stability as well as a pH optimum shift 
(Roy et al., 2005). This methodology follows from the hydrophilization o f protein 
surface concept postulated by Mozhaev and co workers (Mozhaev et al., 1988). 
Although chemical modification is a step above simple addition of stabilising additives, 
it does have many drawbacks including accessibility and the limited number of 
modifiable R-groups. This has led protein scientists to recombinant protein expression 
and genetic modification in an attempt to increase protein stability.
1.2.2 Genetic Modification.
Stable enzymes maintain features that allow the protein to function in non-optimal 
environments. Identifying and understanding the contributing factors to stability has 
been a long-standing problem. As research into protein stability continues, several 
attributes involved in the molecular basis o f protein stability have been cited in the 
literature (Sterner and Liebl, 2001). The reasons for increased stability o f particular
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enzymes include optimal protein core packing and increased helical content, both o f 
which increases the enzymes rigidity and reduce the risk o f protein denaturation during 
environmental stress. Greater protein hydrophobicity allows for optimal folding of a 
protein structure and maintenance of this tertiary structure (Vlassi et al., 1999). The 
deletion or shortening o f loop residues often helps increase stability. Loops are often 
considered the “Achilles heel” of protein structure and thermozymes often have shorter 
loops than their mesozyme counterparts (Kumar et al., 2000). The effect o f increased 
hydrogen bonding is akin to locking the protein in position and, hence, increases protein 
stability; however, only certain amino acid residues can hydrogen bond (Pace et al.,
2001). It has also been suggested that intramolecular salt bridges can stabilise proteins, 
even in a highly polar solvent. Salt bridges can also stabilise protein structure by 
enhancing structure rigidity (Elcock, 1998). In recent years the role o f long-range 
electrostatic interactions in protein stabilisation has become clear (Spector et al., 2000; 
Sanchez-Ruiz and Makhatadze 2001; Vendruscolo 2002 and Torrez et al., 2003), 
contradicting previous ideas (Matthews, 1993). At a simple comparison level, 
thermophiles differ from mesophiles in their specific amino acid sequences, with each 
thermozyme capable o f stabilisation by a unique combination of the attributes listed 
above (Sterner and Liebl, 2001). These differences, in conjunction with other 
biochemical studies, helped to identify certain labile amino acid residues as outlined in 
Table 1.6.
Table 1.6: Description of common labile amino acid residues and possible fate of each residue. (Fersht 
and Serrano, 1993 and Veille and Zeikus, 1996)
Asn and Gin Deamination of amino acid residues.
Asp/Pro and Asn/Gly dipeptides Susceptible to peptide bond hydrolysis.
Cys /3-elimination of disulphide bridges.
Cys Oxidation of amino acid residue.
Methionine Oxidation to sulphoxide component
Asp and Ser Amino acids can be racemized to their D-form.
Lys Can react with reducing sugars via Maillard reaction
Other specific amino acid residues, or patterns, were identified as labile and, as such, 
certain guidelines could be developed to select suitable amino acid replacements for 
increased stability. Statistical analysis indicates trends towards Gly—>Ala and Lys—>Arg 
substitutions. High Ala content is reflective o f a high protein helical content, which, as 
discussed previously, leads to improved protein rigidity. There is also a notable
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decrease in Val and Thr content, residues not compatible with helix formation. 
Hyperthermophilic proteins have a high hydrophobic and aromatic residues content, 
which aids packing, as does the presence of lie: its high conformational flexibility, 
allows it to occupy any voids in the protein structure. In conjunction with this, 
Lys—»Met mutants are often noted, as the bulkier side chain of Met (and lie) aid in 
occupying voids in the protein core. A high Arg content is noted in hyperthermophiles: 
it readily forms ion pairs and hydrogen bonds with carboxylic acid residues close by. 
Increased Pro content is also typical o f hyperthermophiles: as Pro can adopt only a few 
configurations, a low conformational entropy is achieved by its presence. The opposite 
is true for Gly the most flexible amino acid, and hence Gly—>Xaa or Xaa—»Pro are 
common substitutions in hyperthermophiles. Ultimately, these tendencies should allow 
rational selection of key residues for protein design, as outlined in Section 1.3 (Veille 
and Zeikus 2001).
10 -
Figure 1.6: Relative amino acid compositions of mesophilic (white columns) and hyperthermophilic 
proteins (black columns). Sample mesophilic proteins taken from the genome sequences of; B. subtilis, C. 
jejuni, E. coli, Haemophilus influenzae, Helicobacter pylori, Neisseria meningitidis, Rickettsia 
prowazekii and Synechocystis. Hyperthermophilic proteins taken from the genome sequences of 
Archaeglobus fulfidus, Aquifex aeolicus, Aeropyrum pernix, Methanococcus jannaschii, Pyrococcus 
abyssi, Pyrococcus horikoshii and Thermus maritime (adapted from Veille and Zeikus, 2001. Single letter 
amino acid nomenclature used throughout.).
1.2.3 Horseradish Peroxidase Stability.
As outlined in Section 1.1.7, HRP has a wide and varied role within the life sciences 
and, as such, any increase in stability would afford new applications and functions for 
this “analyst’s friend’’ (Ryan et al., 1994). As with all proteins, the stability o f HRP is
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affected by a number o f parameters including temperature (Pina et al., 2001; 
Chattopadhyay and Mazumdar 2000; Kaposi et al., 1999), calcium content (Kaposi et 
al., 1999), glycosylation (Tams and Welinder, 1998), pressure (Smeller and Fidy, 2002), 
irradiation (Orlaova et al., 2000), pH (Priori et al., 2000), hydrogen peroxide (Schmidt 
et al 2002; Nicell and Wright 1997; Amao et al., 1990), urea (Moosavi-Movahedi and 
Nazari, 1994; Haque et al., 1999), guanidinium chloride (Chakrabarti and Basak, 1996) 
and various solvents including dimethyl sulfoxide (Santucci et al., 2002) and 
dimethylformamide (Machado and Saraiva, 2002). Thermal dénaturation o f horseradish 
peroxidase does not follow simple first- or second-order kinetics; instead, it tends 
towards a 1.5-order as outlined by Chang and co-workers (1998). Unfolding o f both the 
apo- and holo-protein has been studied in detail, with refolding of the holo-protein 
proving particularly difficult. In these studies it was discovered that the protein 
backbone forms first, followed by calcium ion incorporation and finally by heme moiety 
inclusion (Pappa and Cass, 1993). Recent developments in the refolding o f denatured 
holo-protein include the use of anti-peroxidase antibodies, which increases the refolding 
yield 100-fold over traditional refolding methods (Ermolenko et al., 2002).
Several attempts have been made to chemically increase the stability o f this enzyme 
including addition o f stabilising reagents (Kuhlmeyer and Klein 2003; Eremin et al.,
2002), crosslinking (Liu et al, 2006; Gonera et al., 2004; O’Brien et al., 2001; Miland 
et al., 1996a; Ryan et al., 1994a), surface modification (Hassani et al., 2006; O'Brien et 
al., 2003; Liu et al., 2002; Miland et al., 1996b,), attachment o f PEG (Garcia et al., 
1998) and carbohydrate residues modification (Bonnaffe et al., 1993). Immobilisation of 
the enzyme has also yielded good increases in stability, as outlined by Fishman and co­
workers (Fishman et al., 2002; also Azevedo et al, 2001).
To date, only one attempt has been made to genetically alter the stability o f HRP by 
Arnold and Lin (2000), as outlined in Section 1.3.8.2. No attempt has been made to alter 
the stability o f HRP rationally via site directed mutagenesis; however, it is clear that 
there is potential for this method. Wells (1990) noted that single mutational effects can 
have small effects on protein stability and that several small mutations can give a large 
cumulative increase in stability. This theory was applied when selecting suitable amino 
acids for HRP site-directed mutagenesis in conjunction with previous knowledge o f the 
protein from chemical modifications, as outlined in Chapter 4.
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1.3. Protein Mutagenesis
1.3.1 Site directed Mutagenesis.
Site-directed mutagenesis has become a routine laboratory technique and has since been 
commercialised by several biotechnology companies, for example: Transformer1 M Site 
Directed Mutagenesis Kit (CLONTECH Laboratories, Palo Alto, CA, USA), Altered 
Site® II in vitro Site directed Mutagenesis Systems (Promega, Madison, WI, USA) and 
Quick Change1 M Site-directed Mutagenesis (Stratagene, La Jolla, CA, USA). The key 
technique that allowed the rapid development o f these site-specific mutagenesis kits was 
the Polymerase Chain Reaction, PCR (Mullis and Faloona, 1987). PCR methodology 
can be used in simple recombination mutagenesis (Jones and Winistorfer, 1997) or 
megaprimer-based mutagenesis (Barik, 1997). Current mutagenesis kits utilise a 
supercoiled vector containing the gene of interest and two synthetic oligonucleotide 
primers that contain the desired mutation. The oligonucleotide primers are 
complementary to opposite strands o f the vector and are extended around the vector by 
a proofreading polymerase during PCR. Incorporation o f the primers generates a 
mutated nicked plasmid which is subsequently treated with Dpn I restriction 
endonuclease to digest the parental wild type vector. The mutated plasmid is then 
transformed into an E. coli cell line lacking mismatch repair ability, where it is 
propagated and the gene expressed (Boms et al., 2000). The use o f site directed 
mutation has grown exponentially due mainly to its ease of application, the vast 
amounts o f data mutants can generate and the expansion of protein engineering, a field 
dedicated to developing superior enzymes through mutagenesis (Brannigan and 
Wilkinson, 2002).
1.3.2 Random Mutagenesis.
Initially, protein engineering and design were based on the rational and semi-rational 
methods outlined previously. It soon became apparent, however, that knowledge of 
protein structure-function relationships was insufficient to generate a consistent, robust, 
engineering approach; also, crystal structures had not been solved for many enzymes, 
thus rendering their rational design impossible (Chen, 2001). Hence, directed protein 
evolution has developed as an alternative mutational strategy, as it does not require 
precise structural information. In brief, the approach utilises accelerated protein 
evolution to develop the protein o f interest, based on a strong selection pressure 
(Mossner and Pluckthun, 2001; Jermutus and Pelletier, 2001). Directed evolution
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implements a simple iterative Darwinian optimisation approach, i.e. an improved 
mutant is used as the “parent” for the next round of evolution (Farinas et al., 2001; 
Petrounia and Arnold, 2000).
Directed evolution can be divided into two general approaches. Non-recombinative 
methods include error prone PCR, in which a small number o f mutations are introduced 
randomly in the gene during PCR. The mutations occur due to variation in the PCR 
constituents, for example nucleotide concentration. The mutation frequency must be 
finely tuned, as beneficial mutations are rare compared to deleterious ones. This 
approach is limited to a small number o f mutations and only mutations in the parental 
clone can be brought forward to the next round of mutagenesis. Recombinative methods 
(e.g. DNA shuffling and staggered extension process) overcome this problem. DNA 
shuffling involves the random fragmentation of several mutant DNA molecules 
followed by their reassembly by PCR into full-length molecules. This process is akin to 
sexual recombination; it enables mutations that are truly random and, in addition, allows 
for the formation of chimeric molecules. Strong selective pressure must be maintained 
to isolate improved mutants and evolve away from deleterious mutations. Desirable 
clones may be bred iteratively, thus creating offspring that contain multiple beneficial 
mutations (Shigeaki, 1998). DNA shuffling evolution has proven to be an especially 
powerful tool for the rapid functional evolution of single gene products with enhanced 
activity, altered substrate specificity, improved protein folding and biological pathways 
with improved function (Tobin et al., 2000). Other methods of library generation 
include the STep Process (Zhao et al., 1998) and Iterative Somatic Hypermutation 
(Wang et al., 2004). The single most popular use of directed evolution is in the increase 
o f enzyme stability and activity in non-natural environments. Improvements in these 
two enzymatic properties were often thought to be mutually incompatible. However, 
Miyazaki and co-workers (2000) enhanced both properties in a single directionally 
evolved mutant. Ultimately, the outcome of directed evolution is critically dependent on 
how a mutant library can be screened or a superior mutant selected for (Olsen et al,
2000). A system of high-throughput screening is essential for any successful random 
mutagenesis protocol. Current conventional methodologies (Jestin and Kaminski, 2004) 
compete alongside state-of-the art concepts o f phage display (Verheart et al., 2002), 
lipid vesicles display (Tawfik and Wells, 1999) and whole cell display (Daugherty et 
al., 2000).
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1.3.3 Combination Mutagenesis: Site Directed Mutagenesis and Directed Evolution
The two methodologies discussed above are complementary (see Figure 1.8), with many 
groups demonstrating that directed evolution effectively augmented a site-directed 
mutant (Cherry et al., 1999; and Alltamirano et al., 2000). Recent publications suggest 
that targeted, “semi-rational”, evolution o f enzymes might yield superior mutants in less 
time (Kazlauskas, 2005).
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Figure 1.7: Comparison of rational (site directed mutagenesis based) and directed evolution methods for 
enhancing protein characteristics. The role of combination mutagenesis is also outlined (Bomscheuer and 
Pohl, 2001).
1.3.4 Rational and Semi-Rational Design.
Most rationally designed enzymes fail to reach their expected catalytic performances 
because of our limited knowledge of protein folding, dynamics and stability (van 
Regenmortel, 2000) e.g. subtle changes in the geometry of an active site can generate
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unpredicted consequences for enzyme function (Cedrone et al., 2000). Examples o f 
rationally based design are sequence comparison of high and low temperature-stable 
proteins, entropic stabilisation, sequence dipeptide composition and the 
“Tanford/Kirkwood-Bashford/Karplus” method. Examples o f semi-rational protein 
design include the homology-based consensus approach, the canonical sequence 
approximation, SCOPE (Structure based Combinatorial Protein Engineering) and 
bioinformatic based approaches, all detailed with references below.
1.3.4.1 Sequence Comparison.
One strategy for identifying thermo stabilising mutations involves the comparison of 
stable proteins with less stable ones, with the aim of identifying amino acid sequence 
patterns that correlate with thermostability (Lehmann and Wyss, 2001). In this 
approach, statistical analysis identifies recurring amino acid replacement trends that are 
linked with thermal adaptation, as opposed to random genetic drift. However, there are 
several limitations to this methodology, including availability o f sequence data and its 
skewed nature (Haney et al., 1999).
1.3.4.2 Entropic Stabilisation.
This approach selects regions where entropic forces within a protein molecule are sub- 
optimal. It is hoped that the designed mutation will influence the AG of unfolding by 
reducing the entropy of the protein in question. Unfortunately, the forces that govern 
protein unfolding are not completely understood and, hence, selection o f critical 
residues is still arbitrary (van den Berg and Eijsink, 2002)
1.3.4.3 Sequence Dipeptide Composition.
Here the protein primary sequence is analysed for arrangements o f certain sets o f amino 
acids, in a specific order, that are known to degrade rapidly in vivo. Pro line, methionine, 
glutamine, glutamic acid and serine occur regularly in unstable proteins and 
juxtaposition o f these residues may lead to instability. The main disadvantage with this 
approach is that other factors influencing protein stability, such as disulphide bridges, 
ligand binding etc., are not taken into consideration (Guruprasad et al., 1990).
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1.3.4.4 Tanford/Kirkwood-Bashford/Karplus. (TK-BK). Method.
This methodology is based on optimisation o f long-range charge-charge interactions. 
The interaction energies between unit positive charges placed on the protonation sites o f 
ionisable groups are estimated using the Tanford/Kirkwood model and, subsequently, 
the pairwise charge-charge interaction energies are calculated as averages over the 
protonation states of native protein based on the Bashford/Karplus “reduced set o f sites 
approximation”. The results yield a W\ value (TK-BK Energy value), which is positive 
for groups involved in destabilising interactions and negative for groups involved in 
stabilising interactions. Hence, certain groups can be selected for charge deletion or 
charge reversal to optimise the protein’s overall Wx value (Loladze et al., 1999).
1.3.4.5 Consensus Approach.
This is based on the comparison of amino acid sequences o f homologous proteins and 
subsequent calculation o f a consensus amino acid sequence using a suitable 
bioinformatic package. Amino acid residues in the target protein are then mutated to the 
corresponding consensus residue. Utilising this approach, Lehmann and co-workers 
increased the thermostability of a recombinant fungal phytase by 34°C, whilst 
maintaining catalytic activity. Another key point to emerge from these studies was the 
concerted effect of single mutations, with numerous mutations yielding cumulative 
small stabilising effects (Lehmann et al., 2002). Success primarily relies on sufficient 
utilisation of non-biased sequence data sets. Also, once the regions have been selected, 
the labour-intensive nature of site-directed mutagenesis and the quantity o f regions to be 
mutated may be prohibitive.
1.3.4.6 Canonical Sequence Approximation.
This approach has been primarily utilised for immunoglobulin stabilisation; however, its 
rationale can be generalised to any protein molecule. The hypothesis is that closely 
homologous proteins are derived from a common evolutionary relation, and evolved via 
accelerated independent local evolution. It is postulated that a protein is marginally 
stable and is in a state of equilibrium with respect to sequence alteration. Hence, any 
destabilising mutations will be neutralised so long as the overall domain stability does 
not fall below a certain threshold. The most probable distribution of a given amino acid 
at a specific position can also be statistically determined, and thus a statistical free
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energy can be calculated from its frequency of occurrence. This free energy value 
quantitates the amino acid selection at a given position (Steipe et al., 1994).
1.3.4.7 SCOPE: Structure-based Combinatorial Protein Engineering.
SCOPE is an example o f a semi-rational combinatorial approach that combines rational 
and random engineering. This idea is based on the naturally occurring “exon shuffling” 
in which proteins are constructed by assembling blocks o f coding sequences, mediated 
by recombination between non-coding regions o f genes, introns. SCOPE utilises 
structural information from two proteins to design coding segments o f genes that 
correspond to elements present in both proteins. In a series o f PCR reactions, hybrid 
oligonucleotides act as surrogate introns to direct the assembly of coding segments to 
create hybrid genes, with iteration of this process enabling the synthesis o f  all desired 
combinations o f structural elements (O’Maille et al., 2002).
1.3.5 Mutation Selection Software.
Bioinformatics is an emerging science in which biology, computer science and 
information technology converge into a single discipline. It allows vast sets o f data to be 
analysed and predictions to be made through powerful algorithms. Examples o f 
bioinformatic approaches to mutation region selection include homology modelling, 
complex algorithms such as the “PoPMuSiC” algorithm (Kwasigroch, et al., 2002) and 
specific computer programs such as “WHAT IF” (Vriend, 1990) (Section 1.3.5.2 and
1.3.5.3 respectively). In silico design methods combine the structure-based rational 
approach with the high throughput of random protein design, by utilising computational 
models to generate and screen sequences against mathematically defined criteria in 
order to identify mutant proteins with optimal folding energies (Dahiyat, 1999). 
Regarding the use o f computer algorithms and programmes, it should be noted that 
protein engineering is a non polynomial-complete problem. This means that the 
problem scales non-polynomially with increasing complexity, and hence, no known 
algorithm can guarantee determining the optimal solution without evaluating all 
possible solutions. This also means that empirical random protein engineering relies on 
screening massive numbers of possible beneficial mutations, as outlined in Section 
1.3.2, to approximate towards evaluating all possible solutions to the problem 
(Gustafsson, et al., 2003).
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1.3.5.1 Homology Modelling.
Homology modelling utilises the same sequence alignments as in the sequence 
comparison approach. However, computer generated structural models are then 
developed for both thermophile and mesophile sequences, and regions for increased 
stability are then inferred from structure comparison. Modelling allows for specific 
regions, such as solvent-exposed loops and salt bridges, to be studied in detail and, 
hence, selection of key residues for this particular region is optimised (Chakravarty and 
Varadarajan, 2002)
1.3.5.2 Prediction Of Protein Mutation Stability Changes. “POPMuSiC”. algorithm.
A powerful algorithm is utilised in this bioinformatic package to perform in silico all 
possible point mutations in a given protein or protein region. The programme then 
estimates the stability changes with linear combinations o f database-derived potentials, 
the coefficients o f which depend on the solvent accessibility o f the mutated residues. 
The results generated are presented in the form of stabilising, destabilising and neutral 
mutations (Kwasigroch et al, 2002).
1.3.5.3 “WHAT IF” Computer Program.
This is a much-cited (Eijsink et al., 2004 and references therein) computer programme 
designed for macromolecular modelling and drug design, with the added ability to 
mutate specific residues and ascertain the effect on the protein in silico. Within the 
programme there are two mutational methods, the first being a database comparison 
approach, while the second is an algorithm procedure. This algorithm employs 
statistically significant correlations between observed frequencies o f occurrence o f side 
chain torsion angles to predict the optimal mutation. A conformational search can be 
completed to minimise the spatial overlap with neighbouring residues, whilst a fragment 
search can be implemented to asertain potentially beneficial deletions, insertions or loop 
transplantations (Vriend, 1990).
1.3.6 Horseradish Peroxidase Mutagenesis.
Mutagenesis studies on Horseradish Peroxidase began with the successful cloning of a 
synthetic HRP gene and its subsequent expression, purification and refolding to yield an 
active recombinant HRP molecule (Smith et al., 1990). Prior to the elucidation o f the
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crystal structure in 1997, (Gajhede et al., 1997) the majority o f the mutants focused on 
ascertaining the key residues in the active site.
1.3.6.1 Site Specific Horseradish Peroxidase Mutants.
Before solution of the HRP crystal structure, researchers based their assumptions on the 
structures of closely related peroxidases (such as cytochrome c peroxidase), which 
suggested residues 38 through 42 as key catalytic residues. Primarily, mutants focussed 
on Arginine 38, Phenylalanine 41 and Histidine 42, with all mutants revealing a 
dramatic decrease in peroxidase catalytic activity (see Table 1.7). However, some Phe 
41 mutants revealed an augmented thioester sulfoxidation activity, due to increased 
access channel area (see Table 1.8; Ozaki and Ortiz de Montellano, 1994).
Through continued studies, asparagine 70 was also noted as being an important residue 
in HRP catalysis, although it was not located in the active site. Mutations in this region 
also caused decreased HRP activity and a re-orientation of active site residues. 
Phenylalanine 221 was also mutated and was shown to alter the resting state o f enzyme 
to a quantum mechanically mixed-spin heme species. Tryptophan 117 mutations 
revealed the role of this residue in protein folding and electron transfer within the 
enzyme. Mutations within the active site entrance revealed the key role o f Phe 142 in 
binding aromatic molecules, whilst mutations within the proximal region of the enzyme 
disclosed the role of Phe 179 in aromatic molecule binding and the role o f His 170 in 
heme group anchorage. From the site directed mutation studies the roles o f the various 
catalytically important residues can be described (Veitch, 2004), as set out in Table 1.7.
Table 1.7: Summary table listing the critical role of catalytic residues in HRP as elucidated by site 
directed mutagenesis.
Residue Role
Arg 38
Formation and Stabilisation of Compound I.
Binding and stabilisation of ligands and aromatic molecules.
Phe 41 Prevents substrate access to the ferryl oxygen of compound I.
His 42
Formation of Compound I
Binding and stabilisation of ligands and aromatic molecules
Asn 70 Maintains basicity o f His 42 side chain through hydrogen bond network.
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AB
Figure 1.8: Part A illustrates the catalytically active residues in HRP; ■, Arg 38; ■, Phe 41; ",His 42. Part 
B shows the remaining residues dicussed in Table 1.8; 1, Asn 70; 2, Trp 117; 3, Phe 143; 4, His 170, 5, 
Thrl71; 6, Phe 172; 7, Phe 221. The proximal calcium is shown as a yellow sphere.
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Table 1.8: Detailed description of HRP site-specific mutants. The region of mutation, its effect, the 
expression host and purification methodology are also outlined. Expression host: 3>, E. coli; *, 
Spodoptera fruigiperda\ # ,  Trichoplusia ni. All mutants purified by refolding of inclusion bodies unless 
otherwise noted: 0 ,  S Fast Flow Q Fast Flow; O, Mono Q anion Exchange; Chelating Fast Flow 
Sepharose Thiophilic gel or Nickel Affinity.
Primary Author Mutation | Effect
Active Site Region
Asokan et al., 
2001
His 42 Ala. Wildtype NMR structure was indistinguishable from that of the solved 
crystal with the exception of Phe68 reorientation within the substrate- 
binding pocket. Adjacent residues Ile53 and Leul38, reoriented 
slightly in H42A mutatnt.
Howes et al., 
2001c
Phel79Ala, 
His42Glu, 
His42 Glu/ 
Arg38 Leu.
Mutation of His42 leads to an increase of 6-coordinate aquo heme 
forms at the expense of the 5-coordinate heme state. The 
His42Glu:Arg38Leu double mutant displays an enhanced proportion of 
the pentacoordinate heme state, similar to the single Arg38Leu mutant, 
whilst the Phel79 is unaffected. His 42 and Arg 38 play a more 
important role in BHA binding than Phel79.
^  Feis et al., 
(1998)
His 42 Leu, 
Arg 38 Leu.
Mutants do not have an effect on CO bound HRP structure at acid pH; 
however, Arg 38 Leu is less stable at alkaline pH, as CO is H-bound to 
the Arg residue in the wildtype CO bound structure.
Savenkova et 
al., (1998b)
His 42 Ala, 
Phe 41 His, 
Arg 38 His, 
Asn 70 Asp.
His 42 Ala mutation greatly reduces the peroxidase activity, as His 42 
deprotonates the H2 O2  and facilitates 0 -0  bond cleavage. Asn 70 is 
involved in hydrogen bonding to His 42 and locks it in position, Asn 
70 Asp cannot participate as a surrogate catalytic residue in His42 Ala, 
probably due to distance from the active site. His 42 Ala/Asn 70 Asp 
double mutant has a higher peroxidase activity than His 42 Ala.
Meunier et al., 
(1998)
His 42 Leu, 
His 42 Ala, 
Arg 38 Leu.
His 42, with its pK modulated by Arg 38, provides the protonation site 
on the reduced enzyme, which is reasonable for the pH dependencies 
of HRP. Mutants bind cyanide differently than wildtype and binding is 
affected by pH. However, His 42 Ala mutation binds cyanide similarly 
to wildtype. Mutants also affect access channel for carbon monoxide.
X Savenkova et 
al., (1998a)
Arg 38 Ala, 
Arg 38 His, 
Arg 38 His/ 
His 42 Val.
The rate of compound I formation for all the mutants was significantly 
decreased. Arg 38 mutant is reduced to its resting state without 
compound II formation. All mutants oxidise guaiacol and ABTS 
slower than the wildtype. Arg 38 Ala and Arg 38 His/His 42 Val are 
190 and 1400 times more efficient as sulfoxidation catalysts, and both 
are 25 times more efficient as styrene catalysts, than the wildtype. Arg 
38 is also important in compound I stabilisation.
^  Rodriguez- 
Lopez et al., 
(1997a)
His 42 Leu, 
His 42 Arg, 
Arg 38 Leu, 
Arg 38 Lys, 
Arg 38 Ser, 
Arg 38 Gly.
His 42 Leu and Arg increase the binding of dioxygen by less than one 
order of magnitude, His 42 Arg mutant increases binding of dioxygen 
by more than two orders of magnitude. All mutants, except Arg 38 Ser, 
had greater 0 2 dissociation than wild type. Arg 38 Ser had essentially 
irreversible binding. Provides evidence for the role o f Arg 38 and His 
42 as dioxygen-heterolytic cleavers. Also, both amino acids serve to 
decrease the lability of the ferric enzyme-dioxygen in order to suppress 
the formation of the inactive ferrous state.
Howes et al., 
(1997)
His 42 Leu, 
His 42 Arg, 
Arg 38 Gly, 
Arg 38 Glu.
The mutants displayed a diverse heme spin state, differentiated by the 
bonding of the iron bound water molecule and the Arg 38 or His 42 
residue. The mutants identify a concerted role of His 42 and Arg 38 in 
BHA binding, although Arg 38 plays the more critical role.
❖  Tanaka et al., 
(1997a)
His 42 Glu, 
His 42 Gin.
His 42 Glu compound I formation is greater than His 42 Gin, which 
suggests that the Glu residue could play a role as an acid base catalyst; 
however, both mutants are much less active than wildtype HRP. It was 
also noted that the basicity of the Glu mutant is lower than that of the 
wildtype and the Glu residue was not orientated correctly, both of 
which would destabilise the heme O2 distal Glu ternary intermediate. 
However, enhanced peroxygenase activity was noted in the Glu 
mutant.
34
Table 1.8: Continued.
Primary Author Mutation Effect
Active Site Region
^  Rodriguez- 
Lopez et al., 
(1996)
Arg 38 Leu. Mutation reveals pivotal roles o f Arg 38. It is involved in the rapid 
binding of H20 2 to HRP and the cleavage of O-O. It plays a role in 
the affinity of HRP for certain substrates, such as guaiacol, and it 
modulates the reactivity of HRP to compound I. Arg 38 serves as a 
charge stabiliser for the acid/base catalysis initiated by His 42.
<§> Newmyer et 
al., (1996a)
His 42 Ala. Mutant demonstrates acid/base catalysis role of His 42. Exogenous 
His can function as surrogates for the mutant, with similar formation 
of compound I as Native HRP. Neutral imidazoles serve this role 
best compared to protonated residues. Imidazole has a role in 
deprotonating H2 O2  and facilitates the formation of the Fe-OOH 
complex.
#§€ Savenkova et 
al., (1996)
His 42 Ala, Phe 
41 His,
His 42 Ala / Phe 
41 His.
His 42 Ala mutation greatly reduces the peroxidase activity, by a 
factor o f 105. Phe 41 His substitutes, slightly imperfectly, for His 42 
and allows for peroxidase catalytic activity. The Phe 41 His mutant 
does not H-bond in the same fashion as the wild type His, which 
causes Compound II instability. The double mutant, His 42 Ala/Phe 
41 His, is a considerably better thioanisole sulfoxidation and styrene 
epoxidation catalyst than wild type or the single His 42 Ala mutant.
^Tanaka et al., 
(1996)
His 42 Glu. Mutant can still carry out, at much lower levels, catalytic activity 
compared with other hydrophobic mutants. Possible role as acid- 
base catalyst for peroxidase reaction cycle if  the carboxyl group of 
Glu can be fixed in optimum position.
Gazaryan et al., 
(1995)
Phe 41 His, Phe 
143 Glu.
Mutants display a low specific activity. Phe 41 His destroys active 
site hydrophobicity. ABTS activity noted for Phe 143 Glu mutant. 
Role of Phe 41 and 143 is to form a hydrophobic pocket for the non- 
covalently bound heme and provide an entrapment mechanism for 
the heme.
X  © Ozaki and de
Montellano,
(1995)
Phe 41 Leu, 
Phe 41 Thr.
Both mutants have a higher Vmax for sulfoxidation of phenyl alkyl 
thioesters. Both catalyse the epoxidation of styrene and cis-j8- 
methylstyrene. Phe 41 Leu yields sulphoxides with higher 
enantioselectivity than native HRP. Both mutations greatly enhance 
the peroxygenase activity o f HRP.
®  Hiner et al., 
(1995)
Phe 143 Ala, 
Arg 38 Lys.
Both mutants were inactivated by H2 O2  quicker than native 
recombinant and wild type HRP. Inactivation by m- 
chloroperoxybenzoic acid was almost uniform across the mutants, 
native recombinant and wild type HRP. The affinity of Compound I 
for H20 2 leading to the formation of a transitory intermediate 
decreased in the order wild type HRP, native recombinant, Phe 143 
Ala, Arg 38 Lys.
Newmyer et 
al., (1995)
His 42 Ala, 
His 42 Val, 
Phe 41 Ala.
Mutants compromise the catalytic activity. His 42 Val destabilises 
compound II formation, due to breaking of hydrogen bonds with the 
ferryl oxygen. The Phe residue plays a role in shielding the ferryl 
species and also sterically hinders access to the active site. 
Peroxygenase activity noted for mutants due to increased access to 
active site.
Meunier et al., 
(1995)
His 42 Leu, 
His 42 Arg, 
Arg 38 Leu.
The His mutants allow for carbon monoxide recombination similar 
to wild type; however, Arg 38 Leu mutation increases the 
recombination rate by 103-fold. Cyanide could not bind to any of the 
mutants. This can be attributed to the charged anionic nature of 
cyanide compared to neutral carbon monoxide. Their differing distal 
heme pockets can, in part, explain differences between peroxidases 
and globins.
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Table 1.8: Continued.
Primary Author Mutation Effect
<§> Gazaryan et al., 
(1994)
Phe 41His, 
Phe 143 Glu.
Phe 41 and 143 have essential roles in the HRP catalytic mechanism. 
Phe 41 acts as a hydrophobic barrier between the two His in the 
active site and also provides a hydrophobic binding site for the 
porphyrin ring. Phe 143 is located at the entrance to the active site 
and mutations here generally cause steric hindrance for substrate 
entrance.
<$> Smulevich et 
al., (1994)
Phe 41 Val, 
Phe 41 Trp, 
Arg 38 Lys
Phe 41 Val and Trp show an increase in 6 coordinate high spin heme 
content, whilst Arg 38 Lys shows an increase in both 6 coordinate 
high and low spin. Results suggest that the distal heme pocket is 
different to cytochrome C peroxidase. Distal mutations affect ability 
to bind BHA, suggesting that BHA binds close to the distal region.
<$> Sanders et al., 
(1994)
Arg 38 Lys. Decrease in pH to 4 causes Arg 38 Lys mutant to display different 
enzyme intermediates, as compared to wildtype HRP.
it©  Ozaki and de
Montellano,
(1994)
Phe 41 Leu. Mutant increases the rate and enantioselectivity of thioester 
sulfoxidation, whilst maintaining catalytic activity. Increase in 
sulfoxidation is due to increased active site access and maintenance 
of active site hydrophobicity.
Veitch et al., 
(1992)
Phe 41 Val, 
Arg 38 Lys.
Phe 41 and Arg 38 have complex hydrogen bonding roles in the 
active site; binding of BHA affects the properties of the heme pocket 
as a whole.
Smith et al., 
(1992)
Phe 41 Val. Eight-fold decrease in activity for the formation of compound I, 2.5- 
fold for compound II and 1.3-fold for compound III with H2 O2 and 
para-aminobenzoic acid as substrates. A decrease in ABTS activity 
was also noted. Mutations in the distal region affect reactivity 
towards different reducing substrates.
<§> Tanaka et al., 
(1999)
Ser 35 Lys, Gin 
176 Glu, Ser 35 
Lys/
Gin 176 Glu.
The double Ser 35 Lys/Gln 176 Glu mutant, showed a decreased 
Vmax/Km for hydroquinone. However Ser 35 Lys showed an increase 
in ABTS Vmax/Km, while Gin 176 Glu showed a decrease and the 
double mutant showed no variation. The reduction potentials for 
compound II of Ser 35 Lys and Gin 176 Glu were higher than 
wildtype. Mutants did not bind luminol effectively, due to 
hydrophobic nature of binding pocket, steric hindrance from Phe 
residues and the orientation of the distal catalytic residues. Changes 
in NMR spectra revealed that luminol binds via electrostatic 
interactions in the binding cavity.
Veitch et al., 
(1995)
Phe 142 Ala, Phe 
143 Ala.
Phe 142 Ala, but not Phe 143 Ala, alters the aromatic donor 
molecule binding site. Phe 142 plays an important role in aromatic 
molecule binding in HRP as Phe 142 Ala binds BHA three times less 
effectively.
Mukai et al., 
(1997)
Asn 70 Val, Asn 
70 Asp.
Mutants demonstrated six co-cordinate high-spin structure, whilst 
wild type maintained a five co-ordinate high-spin structure. Asn 70 
serves as a hydrogen bond acceptor from His 42. Mutants have 
dramatically decreased activity. The pH range of the mutants is also 
decreased due to reduced pKa of the His residues lacking a hydrogen 
bond sink.
^Tanaka et al., 
(1997b)
Asn 70 Asp. Mutant displayed similar CD spectra and redox potential to that of 
the native enzyme. Paramagnetic NMR spectrum indicated lack of a 
hydrogen bond between His 42 and Asp 70. A H-bond did not form 
between the His 42 and the mutant Asp residue, despite the presence 
of a carboxy group on the Asp residue. The non-formation of the 
hydrogen bonds results in improper positioning of the distal His and 
causes cleavage of the other hydrogen bonds surronding the distal 
region, resulting in a substantial decrease in catalytic activity but 
without large structural alterations to the global structure of the 
enzyme.
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Table 1.8: Continued.
Primary Author Mutation Effect
Asparagine 70
<$> Nagano et al., 
(1996)
Asn 70 Val, 
Asn 70 Asp.
The mutants were spectroscopicaly similar to wildtype; however, 
compound I formation was decreased by 90%, as were the reduction 
rates of coumpound I and II due to decreased basicity o f the distal His. 
However, ABTS oxidation was substantially increased in the mutants 
due to higher-than-wildtype redox potentials of compound II caused 
by the altered hydrogen bond network.
^  Nagano et al., 
(1995)
Asn 70 Val. Disrupts hydrogen bond network to substrates. Compound I formation 
is reduced by two orders of magnitude. At neutral pH, Compound II 
formation is not noted in mutant; however, stable compound II is noted 
at alkaline pH. This pH effect may be due to the altered basicity o f the 
distal His caused by disrupted H-bonding.
Tryptophan 117
<$> Ignatenko et 
al., (2000)
Trp 117 Phe. Role of Trp 117 in ABTS and guaiacol oxidation, via electron transfer, 
elucidated with a decreased product dissociation constant noted for 
mutant. Trp 117 Phe mutation increased enzyme stability in acid media 
possibly due condensed heme region. However, Trp 117 plays a role in 
HRP folding and Trp 117 mutants required changes in refolding 
conditions as compared to wild type.
<§> Gazaryan et al., 
(1999)
Trp 117 Phe. Mutant is more acid (removal of a radical trap) and irradiation-stable 
(due to removal of irradiation-labile Trp residue). Trp 117 is noted to 
have a role in electron transfer pathways within the enzyme. Trp 117 is 
important in HRP folding but not in stability.
Threonine 171
Howes et al., 
(2005)
Thrl71Ser. Proximal structural alteration, affects proximal pocket hydrogen 
bonding. Methyl group of Thrl71 interacts with other core proximal 
residues, linking the proximal Ca2+ and the heme ligand. Significant 
change noted in the Fe2+/Fe3 + redox potential of the mutant.
Phenyalanine 221
Howes et al., 
(2001b)
Phe 221 Met. Changes resting state of enzyme to quantum mechanically mixed-spin 
heme species, decreases the enzymes pi, decreases enzyme stability in 
alkaline conditions.
<$> Morimoto et 
al., (1998)
Phe 221 Trp. Mutant is based on cytochrome c peroxidase. Trp mutant allows for the 
formation of Trp radical from Compound 1, as opposed to the ir-cation 
radical in native HRP. The Trp radical is unstable due to the amino 
acid environment in its vicinity and a cationic Ca2+ ion close by. The 
amino acid residues used to control radicals can be a key factor in 
discriminating the functions of peroxidases.
Proximal Region
Veitch et al., 
(1997)
Phe 179 Ala, 
Phe 179 His, 
Phe 179 Ser.
The mutants displayed an altered NMR spectrum, indicating that the 
Phe 179 side chain is in close proximity to the exposed heme edge. All 
mutants have decreased affinity for BHA, with Phe 179 having the 
lowest, followed successively by Phe 179 Ser and Phe 179 His, 
indicating that Phe 179 maintains a pivotal role in BHA binding, as 
opposed to other nearby by Phe residues (Phe 68, Phe 142). The 
mutants could be used to ascribe a reason for decreased BHA binding 
in other isoforms of HRP.
*36 Newmyer et 
al., (1996b)
His 170 Ala. Mutant is catalytically active in the presence of a reducing substrate. It 
is spectroscopically different to the wildtype, being hexacoordinate 
with a low-spin heme species. Mutant activity is lower than wildtype 
and is partially rescued by addition of exogenous imidazole. It is 
shown that the major function of the proximal His is to tether the heme 
iron, to maintain it in a pentacoordinated state and to prevent its 
coordination to the distal His.
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Table 1.8: Continued.
Primary Author Mutation Effect
#  Miller et al., 
(1995)
Phe 172 Tyr. Distal site not altered by this mutation. Compound I decays to a 
compound II state in the presence of H2 O2  and absence of any other 
reducing substrate. An electron radical is formed, located at the Tyr 
mutation, possibly due to Tyr being in a more oxidisable state.
1.3.6.2 Random Mutagenesis o f Horseradish Peroxidase.
As stated previously, the most common application o f random mutagenesis is 
enhancement o f protein characteristics such as thermostability, resistance to inactivation 
by inhibitors and stability in non-natural environments such as organic solvents. HRP 
has many biotechnological applications (see Table 1.5) and as such, increasing the 
stability has many potential benefits.
Arnold and Lin (2000) carried out directional evolution on native HRP with the aim of 
increasing activity and stability. Error-prone PCR, utilising an unbalanced concentration 
of nucleotides and a decreased concentration of MnCk, was used to generate random 
mutations, with many thousands of colonies screened for superior properties. The 
mutational protocol was optimised to produce approximately one mutation per gene. 
The parent gene, designated HRP1A6, was randomly mutated and expressed in 
Saccharomyces cerevisiae. Three rounds of random mutagenesis were carried out to 
improve expression o f the protein in the yeast host (see Table 1.9). One round of 
mutagenesis was also carried out to improve stability (see Table 1.10; Arnold and Lin, 
2000).
Table 1.9: Directed Evolution of the HRP protein towards increased activity. Error-Prone PCR was 
utilised to generate random mutants. ABTS, in standard assay conditions, was used as the reducing 
substrate. Silent mutations are also noted. The previous multiple mutant was utilised as the parent for 
subsequent round of mutagenesis in multi-round mutagenesis protocols.
Mutation(s) Name Effect
Round One Mutation: Selection or Increased Activity. Parent (HRP1A6)
L I3 IP, N135N, L223Q, T257T HRP1-117G4 Increased soluble activity to 147 U.L"1.
L37I HRP1-77E2 Greater ABTS activity than parent clone.
Round Two Mutation: Selection 'or Increased Activity. Parent (HRP1-117G4)
T102A, L131P, N135N, L223Q, 
P226Q, T257T.
HRP2-28D6 Increased soluble activity to 410 U.L-1.
Round Three Mutation: Selection for Increased Activity. Parent (HRP2-28D6)
N47S, T102A, G122G, L131P, 
N 135N, L223Q, P226Q, K241K, 
T257T.
HRP3-17E12 Increased soluble activity to 1080 U.L'1.
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Table 1.10: Directed Evolution of the IIRP protein towards increased thermal stability and H2 O2  
tolerance. Error-Prone PCR was utilised to generate random mutants. ABTS, in standard assay conditions, 
was used as the reducing substrate.
Mutation(s) Title Effect
Round One Mutation: Selection :or Increased Sta iility. Parent (HRP1-117G4)
L37I, K232M HRP1-4B6 6°C increase in T50 compared to parent.
L37I, F221L HRP1-28B11 Increased thcrmostabilty at 50°C 
compared to parent.
L37I, L I3 IP HRP1-24D11 Equally as thermostable as parent, 65% 
more stable in 25mM H 2 O2 .
After three rounds of directed evolution towards increased activity, a nine-position HRP 
mutant displayed an 85-fold increase in HRP activity over the original HRP1A6 parent. 
Additionally, after one round of random mutagenesis towards increased thermal 
stability and H2O2 tolerance, three mutants were produced that were more stable than 
the parental gene in relation to both temperature and H2O2 tolerance.
The mutants were then subcloned into an expression vector for Pichia pastoris  
expression. Recombinant protein expression in P. pastoris has several advantages: it has 
a strong, inducible promoter, it is capable o f generating post-translational modifications 
and isolation of foreign protein is facilitated by the fact that P. pastoris does not secrete 
its own proteins (Cregg et al., 1993) These advantages lead to a final mutated HRP yield 
of 6,500 U.L’1 after 55 hours growth, which was a 6.5 fold increase on expression in S. 
cerevisiae (Arnold and Lin, 2000).
1.4 Conclusions and Project Outline.
As outlined, HRP is a widely studied and very important oxidoreductase with many 
applications in the life sciences and beyond. In the quest to increase the scope o f HRP’s 
potential applications, it has been subjected to many stabilisation protocols. Chemical 
modifications have been effective in stabilising HRP activity against varying organic 
solvents, whilst both chemical and directed evolution have been successfully utilised to 
increase its thermostability (Arnold and Lin, 2000). Since the cloning of the HRP gene 
(Smith et al., 1990) a large body of work has been produced on site directed mutants of 
HRP. Initially, site specific mutants were produced with the aim o f elucidating the key 
residues involved in catalytic activity, while in more recent years researchers have 
utilised site directed mutagenesis to alter functions o f the HRP molecule (Tanaka et al., 
1999). Directed evolution has proven that the HRP molecule can be stabilised against 
thermal denaturation; however site specific, rationally designed, mutants aimed at
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increasing HRP thermostability have yet to be investigated. As alluded to previously, 
the selection of residues for site-specific mutation is the key step in any rational design 
experiment. Hence, previous knowledge from chemical stabilisation of HRP will 
provide candidate residues for mutation (O’Brien et al, 2001). Further residues will be 
selected utilising the consensus approach, which is simple to implement, yet has yielded 
large increases in the thermostability (Lehmann et al., 2001). It is hoped that judicious 
selection of residues for site directed mutagenesis will yield a more stable recombinant 
form of this classical enzyme. Stabilised, directionally-orientatable recombinant HRP 
would find many applications in the biosensor field. Direct electrochemistry afforded by 
the optimal use o f rHRP would aid further development o f third-generation biosensors, 
particularly in H2O2 sensing. Incorporation of rHRP into bi-enzyme sensors would 
extend its potential application and enhance its pivotal role in advancing biotechnology. 
This thesis describes the generation and characterisation of HRP mutants at residues 
identified (i) through chemical stabilisation, (ii) by consensus approach and (iii) for 
directional binding and immobilisation.
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Chapter Two. 
Materials and Methods.
2.0 Materials.
Alpha Technologies, The Leinster Technology Centre, Blessington Industrial Estate, 
Blessington, Co. Wicklow, Ireland.
Ethiduim Bromide Destaining Bags
Bioline, Allenwood Business Park, Naas, Kildare, Ireland.
DNAce Quick Clean.
Bio-sciences (Invitrogen), 3 Charlemount Tee, Dun Laoghaire Co. Dublin, Ireland.
T4 Ligase, Not I, Nco I.
Biomedics, Parque Technologico De Madrid, 28760 Tres Cantos, Madrid.
Nutrient Agar.
Cosmo Bio Company Ltd, Tokyo 135-0016, Japan. 
b-ALA (delta aminolevulic acid).
Fisher Chemicals, Slaney Close, Dublin Industrial Estate, Dublin 11, Ireland. 
Na2-EDTA, glacial acetic acid, glycerol, hydrogen peroxide, methanol, sodium chloride, 
sodium hydroxide, Tris buffer.
Fusion Antibodies Ltd, Queens University Belfast, Grosvenor Road, Belfast, BT12 
6BN, Northern Ireland.
Plasmid sequencing.
Isis (New England Biolabs), Boghall Road, Bray, Co. Wicklow Ireland.
BamH  I, BspH  I, Cla I, Dpn I, Ecor I, Hind III, Hpa I, Nae I, Pst I,
M elford Chemicals, Chelsworth, Ipswich, IP7 7LE, United Kingdom. 
Isopropyl-fi-D-thiogalactopyranoside.
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M edical Supply Company (Promega), Damastown, Mulhuddart, Dublin 15, Ireland. 
dNTP Mixture, Pierce Bicinchoninic Acid assay.
M W G  Biotech (Germany), Anzingerstr. 7a, 85560 Ebersberg, Germany.
All primers and some plasmid sequencing.
Oxoid, Basingstoke, Hampshire, RG24 8PW, England.
Tryptone, Yeast Extract
Sigma Aldrich, Airton Road, Tallaght, Dublin 24, Ireland.
ABTS (2,2’-Azino-bis(3-Ethylbenz-thialzoline-6-sulfonic acid), agarose, ammonium 
sulphate, ampicillin, 5-ALA, P-mercaptoethanol, bis-acrylamide, bromophenol blue, 
calcium chloride, chloramphenicol, dialysis tubing, diethylaminoethyl (DEAE) 
Sepharose™, ethidium bromide, GeneElute™ plasmid prep kit, glycine, lysozyme, 
MOPS, N-cn-acetyl-L-Lysine, Nickel-N-nitrotriacetic acid (Ni-NTA) resin, phenol 
phloroform isoamyalalcohol, phenyl Sepharose™, potassium acetate, ribonuclease A, 
rubidium chloride, Sephacryl™ S-300-HR, sodium acetate, sucrose, Taq polymerase 
and PCR buffers, tetracycline, 3,3’,5,5’-Tetramethylbenzidine dihydrochloride (TMB), 
2,4,6-trinitrobenzenesulphonic acid (TNBS), xylene cyanol.
Technopath (Stratagene), Rosse Centre, Holland Road, Plassey, Limerick, Ireland.
Dpn I, Quickchange™ Site directed Mutagenesis Kit, XL-10 Gold cell line.
Unitech (Eppendorff), Airton Road, Tallaght, Dublin 24, Ireland.
Perfect Prep Gel Clean up Kit.
VW R International (AGB scientific), Dublin Indusrial Estate, Glasnevin, Dublin 11, 
Ireland.
Macrosep centrifugal concentrators, Pall UltraBind1M US450 modified polyethersulfone 
affinity membranes.
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2.0.1 Instruments.
BioRad Powerpack 1000 (Alpha Technologies, Wicklow, Ireland),
Beckman J2-21 Centrifiige (VWR International, Dublin Ireland),
Corning 240 pH meter (VWR International, Dublin Ireland),
Enzfitter® Programme (Biosoft, Cambridge, CB2 INS, United Kingdom),
Eppendorff 5415D microfiige (Unitech, Dublin, Ireland.),
Labsystems multiscan MS platereader (Medical Supply Company Dublin, Ireland),
MT and C6CP Lauda water baths, (VWR International, Dublin Ireland)
ProteinParser consensus protein software, (This Study)
Unicam UV2 spectrophotometer (with Vision 1.3 software), (Brennan, Dublin Ireland), 
UV transilluminator (Pharmacia Biotech AB, Dublin, Ireland),
Vibra Cell Sonicator (Fisher Scientific, Dublin, Ireland),
660A CHi Potentiostat and CHi 660A software (CH Instruments, Texas, USA).
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2.1 E. coli strains, plasmids and cloning prim er sequences.
2.1.1 E. coli strains.
The E.coli strains utilised in this study are described in below:
Strain Phenotype/Genotype Source
NovaBlue endAl, hsdR\7(rKu,m Kl2+), supE44, thi-1, recAl, Novagen
gyrA96, relAl, lac[F’ pro A+B+
lacPZAM15 ::TnlO(tetR)]
JM109 el4(mcrA~), recAl, endAl, gyrA96, thi-1, hsdR\7(rK Stratagene
mK), supEAA, relA 1, X, A (lac-proAB), [F7raD36, 
proAB, lacVZA M l5].
Surell el 4'(mcrA'), A (mcrCB-hsdSMR-mrr) 171, endAl,
supE44, thi-1, gyrA96, relAl, lac, recB, recJ, sbcC, 
umuC\:Tn5(Kan1), uvrC, [F' proAB, lacfA M l5, 
TnlO(Tetr), Amy, Cam1].
Stratagene
TOP 10 F', mcrA, A(mrr-hsdRMS-mcrBC), 080/acZAM15 Invitrogen
A/acX74, deoR, recAl, araD139 A(ara-leu)l691 
galUgalK, rjP.vL(StrR), endAl, nupG
XL-1 Blue recAl, endAl, gyrA96, thi-1, A5,dR17(rK",mK+), Stratagene 
supEAA, relAl, X ', lac, [F1 proAB, laclqZA M l5,
TnlO(Tetr)].
XL 10-Gold TetR, A(pxpA) 183 A(mcrCB-hsdSMR-mrr)173, Stratagene
endAl, supE44, thi-1, recAl, gyrA96, relAl, lac 
Hte[F’ proAB lacfZAM  15 TnlO(tetR) Amy CamR]
ER2925 ara-14 leuB6 fhuA31 lacYl tsx78 glnV44 galK2 New England 
galT22 mcrA dcm-6 hisG4 rfbDl Bio labs
R(zgb210::Tnl0)TetS endAl rpsL136 daml3::Tn9 
xylA-5 mtl-1 thi-1 mcrBl hsdR2
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2.1.2 Plasmids.
The plasmids utilised in this study are outlined below:
Plasmid Description Source
pUC18 Cloning vector. Ampicillin resistant. LacZa. Amersham
pQE 60 High copy number expression vector. 
Ampicillin resistant. T5 promotor/lac 
operon. 6xHis sequence at 3’ end of MC S.
QIAgen
pQE 60 based plasmids.
pQEPelB
pQEPelBHRP
pQEPelBHRPHis
pQE_PelB_HRP_ AHis 
pBRI
pBR_I based site-directed
pBR_Kl 74A/E/N
pBR_K232A/E/N/Q/F 
pBR_E238Q 
pBR_E239N 
pBR_K241A/E/N/Q/F
pQE vector with PelB leader inserted via This Study 
Nco I -  BamH I directional cloning.
pQE PelB vector with HRP gene inserted This Study
via Not I -  Hind III directional cloning.
pQE vector with PelB -  HRP fusion This Study
construct inserted via BspH I -  BamH I
directional cloning in frame with C-terminal
His6 purification tag.
pQE vector with PelB -  HRP fusion This Study
construct inserted via BspH I -  Hind III 
directional cloning.
pQEPelBHRPHis vector with wildtype This Study 
HRP gene present. Generated via Pro 34 Ala 
mutation, 
mutagenesis plasmids.
pBR I plasmid with Lys 174 on the HRP This Study
gene replaced by an Ala/Glu/Asn..
pBR I plasmid with Lys 232 on the HRP This Study
gene replaced by an Ala/Glu/Asn/Gln/Phe.
pBR_I plasmid with glutamic acid 238 on This Study
the HRP gene replaced by a glutamine.
pBR I plasmid with glutamic acid 239 on This Study
the HRP gene replaced by an asparagine.
pBR_I plasmid with Lys 241 on the HRP This Study
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pBR_K232Q/241Q 
pBR_K232N/241N 
pBR_K232F/241N
pBR_T102A 
pBR_ Q106R 
pBR_ Q107D 
pBR_T110V 
pB R Il 80F
pBR_Rl 18K
pBR Rl 18K_159K 
( Velcro P lus K 283R ) 
pBRRl 18K_15 9KK232F 
_K241N
{Velcro M inus K 283R ) 
pBRRl 18K_159KR283K 
( Velcro P lus)
pBR Rl 18K_ 15 9K_R283K 
K232F_K241N 
( Velcro M inus)
gene replaced by an Ala/Glu/Asn/Gln/Phe.
pBR I plasmid with Lys 232 and 241 on the
HRP gene replaced by a Gin.
pBR_I plasmid with Lys 232 and 241 on the
HRP gene replaced by an Asn.
pBR I plasmid with Lys 232 and 241 on the
HRP gene replaced by Phe and Asp
respectively.
pBR_I plasmid with Thr 102 on the HRP
gene replaced by an Ala.
pBR I plasmid with Gin 106 on the HRP
gene replaced by an Arg.
pBR I plasmid with Gin 107 on the HRP
gene replaced by an Asp.
pBR_I plasmid with Thr 110 on the HRP
gene replaced by a Val.
pBR_I plasmid with lie 180 on the HRP
gene replaced by a Phe.
pBR_I plasmid with Arg 118 on the HRP
gene replaced by a Lys.
pBR_R118K plasmid with Arg 159 on the
HRP gene replaced by a Lys.
pBR Rl 18K_159K plasmid with Lys 232
and 241 on the HRP gene replaced by Phe
and Asn respectively.
pBR Rl 18K159K plasmid with Arg 283 
on the HRP gene replaced by a Lys. 
pBRRl 18K_159K R283 plasmid with Lys 
232 and 241 on the HRP gene replaced by 
Phe and Asnrespectively.
This Study 
This Study 
This Study
This Study 
This Study 
This Study 
This Study 
This Study
This Study 
This Study 
This Study
This Study 
This Study
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2.1.3 Cloning primers: design and sequences.
Primers were designed for amplification and final ligation o f PCR products into the 
QIAexpress type ATG vector construct pQE 60, commercially available from Qiagen. 
To amplify the specific regions (namely the PelB leader and the HRP gene) from the 
donated unknown vector, primers were designed based on the sequence determined 
from di-deoxy sequencing carried out commercially by MWG Biotech, Germany. The 
multiple cloning site o f pQE 60 contains three unique restriction sites: Nco I, BamH  I 
and Bgl II, with Nco I located closest to the Ribosomal Binding Site (RBS). The 
restriction site Hind III is located directly 3’ to the stop codon downstream o f the poly 
His tag. However, due to the nature of the cloning strategy, none o f these restriction 
sites could be utilised for HRP gene cloning, so judicious establishment o f unique 
restriction sites was required. Introduction of the PelB leader allowed for the 
development o f a unique restriction site, Not I. Therefore, the PelB leader sequence 
forward primer included the Nco I restriction sequence, while the Pel B reverse primer 
contained BamH I and 5’ Not I restriction sequences. Consequently the HRP forward 
primer contained Not I binding site sequence and the reverse primer contained a polyHis 
tag sequence and a 3’ Hind III binding site sequence. Forward primers were designed 
using the same bases found in the original sequence o f the required gene, whilst the 
reverse primers were designed using the complementary bases from the 3’ to the 5’ end 
of the bases. The amplification primers utilised in this study are listed in below:
pELB_For CATGCC ATGGATGAAAT ACCTGCTGCCG ACCGC
BspH I For ATATCATGAGCAAATACCTGCTGCCGACCG
pELBRev CGGGATCCGCGGCCGCGGCCATCGCCGGCTGGG
HRP_For: AAGGAAAAAAGCGGCCGCCATGCAGTTAACCCCTACATTCTACGAC
HRP His_Rev: CCAAGCTTAGTGATGGTGATGGTGATGAGAGTTGCTGTTGACCACTC
HRPAHis_Rev: CCCAAGCTT AG AGTTGCTGTTG ACC ACTCTGC AG
HRP Rev: CGCGGATCCGCTGTTGACCACTCTGCAG
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2.2 Preparation o f M icrobiological M edia.
2.2.1 Luria Bertani Broth. (LB Broth)
LB medium contained 10 g.L'1 tryptone, 10 g.L' 1 sodium chloride and 5 g.L' 1 yeast 
extract. Glassware was cleaned prior to addition o f media components, and distilled 
water (df^O) was used throughout. Once the components were reconstituted with 
dH2Û, the pH was adjusted to pH 7 and the medium was autoclaved immediately at 121 
°C and 1.5 bar for 15 min. No antibiotics were added prior to autoclaving, as these are 
heat labile. Filter-sterilised glucose, 2% w/v, was added to the LB to repress 
recombinant expression (after autoclaving, to avoid caramélisation o f the glucose).
2.2.2 SOB and SOC Media
SOB medium contained 20 g.L' 1 tryptone, 5 g.L' 1 yeast extract, 0.5 g.L' 1 sodium 
chloride, 2.5 mM potassium chloride and prepared as per 2.2.1 above. After making 
SOB medium (1 L as outlined above) and allowing it to cool to less than 50 °C, 50 (iL 
of sterile 2M MgC^ and 200 (J.L of sterile 1 M glucose were added, to give final 
concentrations o f 10 mM and 20 mM respectively.
2.2.3 Super Broth Medium and 50/5 Supplement.
Super broth medium contained 30 g.L'1 tryptone, 20 g.L'1 yeast extract and 10 g.L' 1 
MOPS and prepared as per 2.2.1 above. After making Super broth medium (outlined 
above) and allowing it to cool to less than 50 °C, sterile glycerol and glucose were 
added to final concentrations o f 50% v/v and 5% w/v, respectively. 2mM MgCl2 (final 
concentration) can also be added to increase cell density.
2.3 Antibiotic Preparation.
Antibiotics were prepared to the various concentrations outlined below and stored at -  
20 °C.
2.3.1 Ampicillin.
Ampicillin (100 mg.mL'1) was prepared in dHîO and was used in liquid broth and solid 
agar at a final concentration of 100 fj-g.mL'1.
2.3.2 Chloramphenicol.
Chloramphenicol (125 mg.mL'1) was prepared in 100% (v/v) ethanol and was used in 
liquid broth and solid agar at a final concentration of 125 (ig.mL"1.
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2.3.3 Tetracycline.
Tetracycline (125 rag.mL'1) was prepared in 50% (v/v) ethanol and was used in liquid 
broth and solid agar at a final concentration o f 125 fog.mL'1.
2.4 Preparation o f Buffers.
DNA Electrophoresis Buffers
5 OX TAE Buffer. 6X DNA Gel loading Dve.
EDTA 50 mM Bromophenol Blue 0.25% w/v
Glacial acetic acid 57 m l Xylene Cyanol 0.25% w/v
Tris 242 g Sterile Sucrose 20% w/v
dH20 to 1 L Made up in sterile dHzO, stored
pH 8.0 4°C.
Buffers One and Two for Competent Cell Production.
Buffer One (60mL):
Make up in UltraPure W ater 
Potassium Acetate 30 mM 
Calcium Chloride lOmM
Glycerol 15 % (v/v)
Rubidium Chloride 100 mM 
Adjust pH with dilute HC1 to 5.8. 
Manganese Chloride 50 mM
Filter sterilise into a sterile container. 
Store at 4°C.
Buffer Two (8mL):
Make up in UltraPure W ater 
Rubidium Chloride 10 mM
MOPS 10 mM
Calcium Chloride 75 mM
Glycerol 15 % (v/v)
Adjust pH with dilute KOH to 6 .8.
Filter sterilise into a sterile container. 
Store at 4°C.
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Buffers for 1.2,3 Plasmid Preparation.
Solution One: 
Glucose
Na2-EDTA (pH 8) 
Tris HCl (pH 8) 
dH20
1 mL 0.5 M 
ImLO.l M 
1 mL 1 M 
7 mL
TE Buffer
Tris-HCl (pH 8) lOmM
Na2-EDTA (pH 8) 1 mM
Solution Two: 
NaOH 
SDS 
dH20
2 mL 1 M 
1 mL 10% 
7 mL
Solution Three: 
Potassium acetate 
Glacial acetic acid 
dH20
60 mL 5 M
11.5 mL
28.5 mL
Buffers for Sodium  D odecyl Sulfate PolvA crvlam ide G el E lcctrophoresis
Buffer A
2M Tris/HCl, pH 8.8 750 ml
10% (w/v) SDS 40 ml
dH20 2 1 0  ml
Buffer B
1M Tris/HCL, pH 6.8 500 ml
10% (w/v) SDS 40 ml
cM 20 460 ml
4X Loading Buffer
dH20 20 mL
Tris/HCl, pH 6 .8, 0.5M 5 mL
Glycerol (neat) 4 mL
SDS (10% w/v) 8 mL
P-mercaptoethanol (neat) 2 mL
Bromophenol Blue (1% w/v) 1 ml
IPX Running Buffer 
Tris/HCl 30.25 g
Glycine 144 g
SDS 10% (w/v) 100 ml.
Make up to 1 litre with dH20. 
Dissolve in a waterbath set to 55°C.
Staining Solution: 
Acetic Acid (neat) 
Methanol (neat) 
dH20
Bromophenol Blue
Destaining Solution 
Acetic Acid (neat) 
Methanol (neat) 
dH20
100 mL 
250 mL 
250 mL 
2.5 g
10 mL 
450 mL 
450 mL
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The molecular weight standards used in SDSPAGE are:
Si&ma Wide Range Markers Amersham Rainbow Markers
Myosin, rabbit muscle 205 kDa Mr(X itf)
¡8  -Galactosidase, E, coli 116 kDa
Phosphorylase b, rabbit muscle 97 kDa 160
Fructose-6-phosphate Kinase 84 kDa -  105
Albumin, bovine serum. 66 kDa - -  . 75
Glutamic Dehydrogenase, bovine liver. 55 kDa i -  50
Ovalbumin, chicken egg. 45 kDa MfcN! «- 35
Glycer Phos Dehyd, rabbit muscle. 36 kDa m  -  *
Carbonic Anhydase, bovine erythrocytes. 29 kDa
25
Trypsinogen, bovine pancreas. 24 kDa
Trypsin Inhibitor, soybean. 20 kDa
•“  15
a  -Lactalbumin, bovine milk. 15 kDa
«- 10
Aprotinin, bovine lung. 6.5 kDa
Buffers for Non Denaturing Gel Electrophoresis
4x Buffer C
1.5M Tris/HCl, pH 8.8 100  ml
4x Buffer D
0.5M Tris/HCl, pH 6.8 100 ml
1 x Running Buffer (pH to 8.8). 
Tris/HCl 3.25 g
Glycine 14.4 g
Make up to 1 litre with dH2 0 .
4X Loading Buffer 
dH20
1M Tris/HCl,pH 6 .8, 
Glycerol (50% v/v)
15 mL 
5 mL 
4 mL
Bromophenol Blue (1% w/v) 1 ml
Staining Solution:
TMB Assay as outlined in Section 2.29
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Buffers for Western Blots.
lx  Transfer buffer TBS-Tween buffer (pH 7.5)
Tris-HCl 25 mM Tris-HCl 20 mM 
500 mM 
0.05% (v/v) 
0 .2 % (v/v)
Glycine
Methanol
150 mM NaCl
1 0 % (v/v) Tween 20
Triton X -100
TBS buffer (pH 7.5)
Tris-HCl
NaCl 150 mM
10 mM Blocking Buffer.
5% w/v Marvel™ milk powder in TBS
2.5 Storage and Culture o f Bacteria.
All bacterial strains were stored as 50% v/v glycerol stocks at -80 °C. The stocks were 
prepared by aseptically adding 0.5 mL of late log phase bacteria to 1.0 mL o f 80% 
(v/v) sterile glycerol in a sterile micro centrifuge tube. The contents were then mixed 
and the stock was stored at -80 °C for long-term storage, while an identical stock was 
also stored at -20 °C for medium term storage. Short-term storage was on agar plates 
containing the selective antibiotic, stored at 4 °C.
To culture bacteria from the medium- and long-term storage conditions, the uppermost 
layer o f the frozen cell mass was allowed to defrost and this was aseptically used to 
inoculate fresh LB broth supplemented with the correct antibiotic. The LB broth was 
then incubated at 37 °C, 220 rpm, overnight.
2.6 Standard Polymerase Chain Reaction.
Polymerase Chain Reaction was utilised to amplify the DNA for both the PelB leader 
and the HRP gene. A standard PCR reaction (stock concentrations indicated) was set 
up as follows:
1 [iL dNTP 10 mM mix
5 (4.L 1 Ox Red Taq PCR Buffer containing 500mM MgC^.
1 |iL Forward Primer (100 pMol)
1 |j.L Reverse Primer (100 pMol)
1 (iL Template DNA (varying concentration)
38.5 |o.L Sterile H2O
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The reaction tube contents were then gently mixed by flicking the tube repetitively. 
The solution was collected at the bottom of the tube by a short centrifugation. Finally,
2.5 |iL RedTaq© Polymerase
was added, and again the mixture was mixed and collected as outlined above. A 
negative control was also set up as above but without template DNA.
The following PCR cycle was utilised for DNA amplification:
Stage One: Denaturation.
95 °C 2 min 30 s 1 cycle
Stage Two: Cycling
95 ÜC 50 s
18 cyclesT anneal 50 s
72 °C 1 min/kb
Stage Three: Final Elongaltion
72 °C 5 min 1 cycle
If the optimum annealing temperature was to be determined, the Tanncai was varied 
based on the theoretical T a im e a i  calculation:
Tanneal= [2x (A/T content) + 4x (G/C content)] -  5 °C. (Maniatis et al., 1989)
2.7 Preparation o f PCR product for downstream processes.
Once the PCR was complete, the amplified DNA was cleaned for further downstream 
processes. This cleaning process removed the RedTaq, primers etc. from the amplified 
DNA. Two methods were used to purify the amplified DNA:
2.7.1 Phenol Chloroform Extraction.
The volume of the PCR reaction mixture was increased to 400 (iL by adding TE buffer. 
400 (iL of Phenol:Chloroform:Isoamyalalcohol [25:24:1] was then added to the 
reaction tube. The mixture was vortexed and centrifuged at 10,400 x g for 5min in a 
micro fuge. The aqueous layer was removed to a clean Eppendorf tube. One volume of 
ice-cold isopropanol was added to aqueous layer. One-tenth volume o f 3M sodium 
acetate (pH5.5) was added to the aqueous layer and alcohol. Repeated inversion o f the 
mixture led to homogeneity. The mixture was stood upright at -20 °C for 2 hours.
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Centrifugation at 10,400 x g for 15 min produced a pellet and supernatant, which latter 
was removed. The resultant pellet was washed with 400 jxL o f 70% v/v ethanol. This 
mixture was again centrifuged at 10,400 x g for 10 min and the supernatant removed. 
The pellet was resuspended in an appropriate volume o f TE buffer. A TAE agarose gel 
was run to confirm adequate cleaning o f PCR product and to estimate DNA 
concentration for further downstream applications.
2.7.2 Bioline DNAce Quick Clean®.
DNAce Quick Clean® is a commercially available size exclusion method for cleaning 
DNA used to concentrate double stranded DNA from PCR reactions and enzymatic 
reactions. The procedure was followed as per the manufacturer’s protocol. In short, 1 
volume of DNAce Quick Clean® was added to a sample o f DNA, mixed thoroughly by 
vortexing and statically incubated at room temperature for 5 min. The microcentrifuge 
tube containing the mixture was then centrifuged at 10,400 x g for 10 min and the 
supernatant discarded. The DNA pellet was then washed with 70% v/v ethanol to 
remove any residual salts etc., and again the microcentrifuge tube was centrifuged for 
10 min and the ethanol removed. The DNA pellet was then resuspended in the desired 
volume of TE buffer or molecular grade water for further downstream applications.
2.8 Plasmid Preparation.
2.8.1 Rapid Boiling Method.
This method is similar to that o f Holmes and Quigley (1981) and can be utilised to 
screen large number o f transformants. However, the resulting preparation is very crude 
and unsuitable for digestion experiments. A 1.5mL aliquot o f an overnight culture was 
centrifuged at 10,400 x g in a microfuge and the supernatant removed. The cell pellet 
was resuspended in 350fiL o f STET buffer. A 20 [iL aliquot o f a 10 mg.mL' 1 lysozyme 
solution (freshly prepared in STET buffer) was added and the micro fuge tube incubated 
at 30 °C for 10 min. The tube was then placed in boiling water for 30 s and 
immediately centrifuged at 10,400 x g for 10 min. The supernatant was removed to a 
fresh tube and an equal volume o f isopropanol was added to precipitate the DNA. The 
tube was left at room temperature for 10 min and the plasmid DNA was pelleted by 
centrifugation at 10,400 x g for 10 min. The pellet was dissolved in 70 % v/v ethanol, 
air dried and then dissolved in 50 [J.L o f TE buffer. This preparation was stored at 4 °C 
until required.
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I2.8.2 1,2,3 Plasmid Preparation Method.
This rapid and inexpensive method based on Bimboim and Doly (1979) produces a 
reasonably pure plasmid preparation. Cells from an overnight culture (4.5 mL) were 
pelleted via centrifugation at 10,400 x g. The LB was removed and the cells were 
resuspended in 100(iL of Solution One (Section 2.4) and statically incubated at room 
temperature for 5 min. Solution Two (200 (iL) was then added and the tube was mixed 
by inversion and stood on ice for 5 min. Solution Three (150 |aL) was then added and 
again mixed by inversion and stood on ice for 10 min. Chromosomal DNA precipitated 
out of solution and was pelleted by centrifugation at 10,400 x g. The supernatant was 
removed and placed into a clean eppendorff, 450jiL of 
phenol:chloroform:isoamylalcohol (25:24:1) was added and the solution mixed by 
vortexing. The mixed solution was then centrifuged for 5 min at 10,400 x g and the 
upper aqueous layer removed to a fresh tube. An equal volume of isopropanol was then 
added to the supernatant; the solution was mixed and incubated at room temperature for 
10 min. The mixture was again centrifuged at 10,400 x g for 10 min; this pelleted the 
plasmid DNA. The pellet was washed with 70% v/v ethanol and the ethanol was 
allowed to evaporate. The pellet was resuspended in 50 |iL of TE Buffer and 0.1 jaL 
RNAase (10 mg.mL'1) was added. The preparation was stored at -20 °C.
2.8.3 Sigma Gene Elute Plasmid Prep Mini Kit.
A single E.coli colony bearing the pQE 60 vector was picked from a LB agar plate 
containing 100 p.g.mL' 1 ampicillin and was grown overnight (16 hours) in 10 mL o f LB 
broth containing 100 jig mL'1 ampicillin at 37 °C, shaken at 220 rpm. The pQE 60 
vector was then purified via the Sigma Gene-Elute™ Kit as per manufacturer’s 
instructions. Briefly, 4.5 mL of cells from an overnight culture were pelleted via 
centrifugation at 10,400 x g. The LB was removed and the cells were resuspended in 
200 (iL of Resuspension Solution, containing RNase A. The cells were vortexed to 
ensure complete cell resuspension. Lysis solution (200 |iL) was added and the mixture 
was inverted 4-6 times to ensure correct mixing. The solution was allowed to clear for 
<5 min. Once the lysate had cleared, 350 p,L o f Neutralisation Buffer was added and 
the mixture inverted 4-6 times. The cell and chromosomal debris was then pelleted by 
centrifugation at 10,400 x g for 10 min. The spin-cup based Binding Column was
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prepared by adding 500(iL of Column Preparation Solution to the spin cup. The cup 
was spun at 10,400 x g for 1 min. The cleared lysate was then transferred to the 
prepared Binding Column and the contents were spun through the column at 10,400 x g 
for 1 min, with the flow-through being discarded. The Binding Column was then 
washed with 750 pL of Wash Solution, containing ethanol, and the column centrifuged 
for 1 min at 10,400 x g. The column was then spun for an additional minute to ensure 
dryness. The Binding Column was then transferred to a new collection microcentrifuge 
tube, and 100 (iL of Elution Buffer was added to the column. The column was spun at 
10,400 x g and the plasmid was eluted into the collection micro centrifuge tube. If  the 
plasmid preparation was not used immediately, it was stored at -20 °C.
2.9 Restriction Digest of the pQE60 V ector and the PC R  insert.
A restriction digest was typically carried out on the pQE 60 vector and the relevant 
insert, for directional cloning or mutant screening purposes. The restriction enzymes 
utilised depended on the insert, and ultimately on the primers, as outlined in Section
A standard double digest (stock concentrations noted) of the pQE 60 vector to prepare 
for PelB insertion is outlined below:
A standard double digest (stock concentrations noted) o f the pQE60_PelB vector to 
prepare for HRP insertion was as follows:
The inserts were also digested with the appropriate restriction enzyme, Nco I and 
BamH  I for the PelB insert and Not I and Hind III for the HRP insert, in a similar set-up 
to those above. Once the reaction mixture had been prepared the contents were gently
2.1.3.
20 pL
2.25 pL
1.25 [iL
1.25 pL
Freshly prepared pQE 60 vector. 
lOx Restriction Enzyme Reaction Buffer. 
Nco I Restriction Enzyme (10,000 U.mL'1) 
BamH I Restriction Enzyme (10,000 U.mL'1)
20 |jL
2.25 pL
1.25 |iL
1.25 nL
Freshly prepared pQE60_PelB vector.
1 Ox Restriction Enzyme Reaction Buffer.
Not I Restriction Enzyme (10,000 U.mL'1) 
Hind III Restriction Enzyme (10,000 U.mL'1)
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mixed and centrifuged. All digestions were carried out at 37 °C for 3.5 hours to ensure 
complete restriction. The restricted DNA fragment (vector or insert) was then gel 
purified (Section 2.10) for further processing or visualised to ensure correct restriction.
2.10 Agarose Gel Electrophoresis for DNA characterisation.
DNA was analysed by running on agarose gels in a horizontal gel apparatus. Agarose 
gels were prepared by dissolving low melting point agarose (typically 0.7% to 1.2% 
w/v) in 1 X TAE buffer and boiling until the solution became translucent. The 1 X 
TAE buffer was also utilised as the running buffer. Once the boiled agarose had cooled 
sufficiently, the gel was poured into the mould and the comb added to form loading 
wells for the DNA. A tracker dye was also incorporated into the DNA samples to aid 
loading into the wells and to estimate migration rate of DNA through the gel. On a 1% 
agarose gel, bromophenol blue and xylene cyanol migrate approximately with the 300 
bp and 4000 bp fragments respectively. However, where Sigma RedTaq® was used, no 
tracking dye was added, as this was included in the Redlag® mixture. Mini gels were 
frequently run at 100 Volts for 1 hour or until the tracker dye reached the end o f the 
gel. Gels were stained by immersion in a bath o f ethidium bromide (Section 2.12) for 
20min. Gels were then visualised on a UV transilluminator and photographed using a 
UV image analyser.
2.11 Preparation o f RNase.
Ribonuclease A (DNase free) was dissolved at a concentration o f 10 mg.mL"1in 10 mM 
Tris-HCl (pH 7.5) and 15 mM NaCl. The solution was aliquoted and stored at -20 °C.
2.12 Preparation o f Ethidium  Bromide.
A 10 mg.mL' 1 stock solution of ethidium bromide was prepared by dissolution in 
dH2 0 . This stock solution was stored in the dark at 4 °C. A 100 pL aliquot o f the stock 
solution was added to 1 L of dHzO for TAE gel staining. Gloves, lab coat and glasses 
were worn at all times when handling solutions o f ethidium bromide. Once the staining 
capacity o f the ethidium bromide solution had degenerated, one ethidium bromide 
destaining bag (Alpha Technologies, Wicklow), was added to the bath and allowed to 
absorb the ethidium bromide overnight. The clear solution was then disposed of
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normally and the solids contained in the ethidium bromide destaining bag were 
incinerated.
2.13 Purification o f DNA from an agarose gel.
DNA was purified from agarose gels using a DNA Gel Purification Kit (PerfectPrep, 
Eppendorff), utilised as per manufacturer’s instructions. After electrophoresis, the gel 
of interest was stained in ethidium bromide for 20 min and viewed under 70% UV 
illumination. As with the preparation of ethidium bromide (Section 2.12), gloves, 
glasses and lab coat were worn at all times during agarose manipulation. The time o f 
exposure was minimised as UV light is a known DNA mutagen. The DNA band o f 
interest was excised utilising a sterile scalpel blade, and the agarose slice was 
transferred to a sterile 1.5 mL micro centrifuge tube. Three volumes o f solubilising 
buffer were added and the tube was incubated at 55 °C with regular gentle vortexing 
until the gel slice had completely dissolved. One volume of isopropanol was added to 
the tube and mixed thoroughly. Eight hundred microlitres o f this solution was 
transferred into a spin cup and spun at 10,400 x g for 1 min. The flow-through was 
discarded and 750 (J.L of Washing Solution (containing ethanol) was added and 
centrifuged for a further minute at 10,400 x g. The flow-through was discarded and the 
cup was centrifuged for a further minute to ensure it was completely dry. The spin cup 
was then transferred to a fresh microfuge tube and 50 (J.L of TE was added to the cup. 
The cup was then centrifuged for one minute at 10,400 x g to elute the DNA. A ligation 
reaction was set up immediately.
2.14 Ligation Reactions.
In this project directional cloning was utilised and, hence, a cohesive ligation strategy 
was implemented. A typical reaction was carried out as outlined below:
9 |iL Gel Purified Restricted Insert
3 (J.L Gel Purified Restricted Vector
4 \iL T4 Ligase Buffer (5 X)
3 jjL  Sterile dl^O
1 jiL T4 Ligase (IU.ijL'1)
Generally, a 3:1 Insert:Vector ratio was implemented, as suggested by T4 Ligase 
manufacturer (Invitrogen). The ratio was judged from a 1% TAE gel. The ligation was
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allowed to proceed overnight at -17 °C. Once the reaction was completed, the ligated 
products were stored at -20 °C until transformation was carried out.
2.15 Preparation of High Efficiency Competent Cells.
The calcium chloride method was utilised for competent cell preparation as described 
by Inoue and co-workers (1990). A frozen stock of E.coli strain XL-10 Gold was 
slowly defrosted and streaked onto an LB agar plate containing 12.5 pg.mL'1 
tetracycline and 10 jig.mL-1 of chloramphenicol. The plate was incubated overnight at 
37 °C. One colony was picked from this plate and was used to inoculate 10 mL o f LB 
broth, again containing 12.5 ja.g.mL'1 tetracycline and 10 (a.g.mL'1 of chloramphenicol. 
This culture was grown overnight at 37 °C, 220 rpm. Two millilitres o f  overnight 
culture was taken and used to inoculate 200 mL of sterile LB broth without any 
antibiotics present. This culture was grown at 37 °C, 220 rpm. The growth was 
monitored carefully and once the ODfioonm reached 0.475 (approximately 2-3hrs), the 
flask was removed, placed on ice and gently swirled for 5 min. The culture was then 
transfered to a chilled sterile centrifuge tube and the cells were collected by 
centrifugation at low speed (5 min, 800 x g) in a previously cooled (4 °C) centrifuge, 
(Beckman J2-21). After centrifugation, the supernatant was carefully discarded, as per 
Class I licence standards, whilst maintaining the cells continuously on ice. The cell 
pellet was carefully resuspended in 60mL o f ice cold Buffer One via swirling in a 
container o f ice water. Once the pellet was resuspended, the container was buried in ice 
and statically incubated at 4 °C for 90 min. The chilled cells were then collected in a 
previously cooled (4 °C) centrifuge operated at low speed (5 min, 800 x g). After 
centrifugation, the supernatant was again carefully discarded whilst maintaining the 
cells continuously on ice. The cell pellet was carefully resuspended in 8mL o f ice cold 
Buffer Two via swirling in a container o f ice water. Once the pellet is resuspended, the 
cells are quickly and aseptically aliquoted into sterile chilled eppendorffs in 800 fiL 
fractions. The cell fractions are then flash frozen by dipping the eppendorff in ethanol, 
stored at -80 °C overnight, for 1 min. Once frozen, the cells were transferred to the -80 
°C freezer for long term storage. Cells prepared in this manner frequently gave 
transformation efficiencies in the order 107 transformants/jig DNA.
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2.16 Transformation of High Efficiency Competent Cells.
A micro centrifuge tube of high efficiency competent cells prepared according to 2.15 
above was allowed to thaw slowly on ice and 2 \iL of transformation reaction mixture 
was carefully pipetted into 100 |iL of cells. A 1 in 5 dilution of the transformation 
reaction was also added to a separate 100 pL vial o f cells. Finally, positive and 
negative control reactions were also set up, by adding 2 jj.L of restricted vector and 
either 2 (iL of O.Olng.jaL'1 ofpUC 18 vector (positive) or 2 |aL of TE buffer (negative), 
to separate vials (100 pL) o f cells. Once the transformation (or control) additions were 
made, the mixture was gently mixed by flicking the micro centrifuge tube. The tubes 
were then incubated on ice for 30 min. The cells were then heat shocked for 45 s in a 
42°C water bath and immediately placed back on ice. SOC medium (900 jj,L, room 
temperature) was aseptically added to each of the tubes. The cells were then allowed to 
recover for 1 hour by horizontal shaking at 37 °C at 220 rpm. After one hour the cells 
were collected by centrifugation at 10,400 x g and 900 (iL of supernatant was removed. 
The remaining 100 (iL was utilised to resuspend the cells. From each 100 (iL vial, 20 
(iL and 80 pL were aseptically spread onto LB agar plates containing 100 jj-g.mL'1 
ampicillin. The plates were inverted and grown overnight at 37 °C.
2.17 Calculation of Transformation Efficiencies.
Cells prepared as outlined in Section 2.15 were transformed with a known
concentration o f plasmid DNA, to ascertain the transformation efficiency for the batch
of cells. Typically, 2.5 pg of pUC 18 plasmid DNA was utilised in the transformation,
with the transformed cells being plated on LB agar supplemented with 100 |_ig/|iL
ampicillin. The cells were allowed to grow overnight (18 h) and total colonies counted.
The following equation (Maniatis et al., 1989) was utilised to calculate the
transformation efficiency:
CFU x  1000mL y M 0  6pg = C F U s
/uL _ Cells 2.5 pg _  DNA \jjg / MgDNA
Transformation efficiencies in the range of lxlO7 CFU/(ig DNA were regularly 
achieved by the methods outlined in Section 2.15.
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2.18 Screening o f Transformed High Efficiency Com petent Cells.
Following overnight growth, a representative number o f colonies (usually 5-7) was 
picked from each plate. These colonies were inoculated into 10 mL of LB Broth 
supplemented with 100 |j,g/mL ampicillin. The cultures were grown overnight and a 
plasmid preparation was carried out the following day via the 1,2,3 Method. The 
plasmid preparations were then restricted at a unique restriction site, only present if the 
insert had been correctly incorporated into the vector (Not I in the case o f PelB 
Insertion and Pst I in the case o f HRP insertion). This screening methodology was also 
implemented for mutant plasmid screening.
A standard screening digest o f the pQE60pelBHRP vector (with stock concentrations 
noted) was set up as follows:
8 (iL Freshly prepared pQE60pelBHRP vector.
1 fiL 1 Ox Restriction Enzyme Reaction Buffer.
1 (j,L Pst I Restriction Enzyme (10000 U.mL'1)
Once the reaction mixture had been prepared, the contents were gently mixed and 
collected by centrifugation. All digestions were carried out at 37 °C for 1 hour to 
ensure complete restriction. The restricted DNA fragment was then visualised under 
UV light after DNA electrophoresis and suitable staining in ethidium bromide. 
Colonies that produced a suitably digested vector were then chosen for further 
restriction analysis and, ultimately, DNA sequencing.
2.19 Spectrophotometric analysis o f nucleic acids.
DNA concentration was determined by measuring the absorbance at 260 nm, where 
nucleic acids absorb maximally. To calculate the concentration o f DNA the formula 
(Maniatis et al., 1989) below was utilised:
DNAcon{ « / ,  I  = 4«,,„*50xDiI-Factor 
V /  1000
A 50 iJ.g.mL'1 preparation o f pure DNA has an absorbance of 1 unit at 260nm; the 
formula is divided by 1000 to convert to (iL. The purity o f the DNA solution was 
determined by reading the absorbance at 260 nm (kmax for nucleic acids) and the 
absorbance at 280 nm (kmax for proteins) and estimating their ratio. Pure DNA has an 
A 260nm/A280nni of approximately 1.8.
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2.20 DNA Sequencing and Protein Sequence Alignment.
Once a suitable clone had been elucidated from restriction analysis, a fresh plasmid 
preparation was produced. The concentration of the DNA in the preparation was 
calculated as outlined previously (Section 2.19), and was suitably adjusted by dilution 
to 2 for the Value Read and 10 (ig/^L for the Comfort Read, both commercially
available from MWG Biotech, Germany. Fusion Antibodies Ltd, Northern Ireland, 
required 5 |_ig/(J.L concentration of plasmid DNA for sequencing. Standard pQE 
sequencing primers were utilised for the sequencing o f the clones, these primers are 
outlined as follows:
pQE For: GTA TCA CGA GGC CCT TTC GTC T 
pQE Rev: CAT TAC TGG ATC TAT CAA CAG GAG
Sequencing results were obtained via e-mail. Nucleotide sequences were translated to 
amino acid sequences via the Expasy Translate Tool (http://us.expasy.org). The amino 
acid code was aligned with the HRP sequence available in Genbank (PDB Accession 
Number: 1ATJ) utilising the ClustalW bioinformatic program (Thompson et al., 1994). 
Finally, aligned sequences were imported into Genedoc for further sequence 
manipulation.
2.21 Design of mutagenic primers.
Individual primers for each mutagenic PCR were manually designed. Both mutagenic 
primers (forward and reverse) incorporated the desired mutation and also a silent 
mutation that would introduce a new restriction site. The inclusion of a new restriction 
site would allow for cost effective screening o f multiple mutant clones. Both primers in 
a single mutagenic PCR were also designed to have a similar melting temperature. 
Primers were typically between 33 and 41 basepairs in length and had melting 
temperatures greater than 78 °C, estimated utilising the following formula (Boms et al.,
2000):
Tm = 81.5 + 0.41 (%G/C) -  675/N - % mismatch.
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Where N is the primer length and all % are whole numbers. The desired mutation was 
located in the centre of the primer and primers terminated in a G or C base to ensure 
efficient binding to the template DNA.
2.21.1 Mutagenic Primers utilised in this study.
The amino acid substitution sites are emboldened and underlined, whilst silent mutants 
are emboldened. The mutation achieved by each primer is also tabulated. All primers 
were supplied by MWG Biotech, Germany.
Primer Nam e Primer Sequence M utation
pBR I P34A F G A T C C G A T C C C A G G A TC C C A G C T T C A A T A T T A C G T C  P34A
pBR IP34A R g a c g t a a t a t t g a a g c a g c g a t c c t g g g a t c g g a t c  P34A
p B R IK 1 7 4 A F  c t g t c c g g t g g c c a c a c a t t t g g a g c g a a c c a g t g t a g g  K174A
p B R IK 1 7 4 A R  c c t a c a c t g g t t c g c t c c a a a t g t g t g g c c a c c g g a c a g  K174A
pBR IK174E F c t g t c c g g t g g c c a c a c a t t t g g a g a g a a c c a g t g t a g g  K174E
p B R IK 1 7 4 E R  c c t a c a c t g g t t c t c t c c a a a t g t g t g g c c a c c g g a c a g  K174E
pBR IK174N F c t g t c c g g t g g c c a c a c a t t t g g a a a t a a c c a g t g t a g g  K174N
pBR I Kl 74N R c c t a c a c t g g t t a t t t c c a a a t g t g t g g c c a c c g g a c a g  j q  7 4 ^  
pBR IK232A F c c a t c t t c g a t a a c g c g t a c t a t g t g a a t c t c g a g g a g c a g  K232A
pBR IK232A R c t g c t c c t c g a g a t t c a c a t a g t a c g c g t t a t c g a a g a t g g  K232A
pBR IK232E F c c a t c t t c g a t a a c g a g t a c t a t g t g a a t c t c g a g g a g c a g  K232E
pBR IK232E R c t g c t c c t c g a g a t t c a c a t a g t a c t c g t t a t c g a a g a t g g  K232E
pBR IK232N F c c a t c t t c g a t a a c a a t t a c t a t g t g a a t c t c g a g g a g c a g  K232N
pBR IK232N R c t g c t c c t c g a g a t t c a c a t a g t a a t t g t t a t c g a a g a t g g  K232N
pBR IK232F F c c a t c t t c g a t a a c t t t t a c t a t g t g a a t c t c g a g g a g c a g  K232F
pBR IK232F R c t g c t c c t c g a g a t t c a c a t a g t a a a a g t t a t c g a a g a t g g  K232F
pBR IK241A F g t g a a t c t c g a g g a g c a g g c a g g c c t g a t a c a g  K241A
pBR IK241A R c t g t a t c a g g c c t g c c t g c t c c t c g a g a t t c a c  K241A
pBR IK241E F g t g a a t c t c g a g g a g c a g g a a g g c c t g a t a c a g  K241E
pBR IK241E R c t g t a t c a g g c c t t c c t g c t c c t c g a g a t t c a c  K241E
pBR IK241N F g t g a a t c t c g a g g a g c a g a a t g g c c t g a t a c a g  K241N
pBR IK241N R c t g t a t c a g g c c a t t c t g c t c c t c g a g a t t c a c  K241N
pBRIK 241F F g t g a a t c t c g a g g a g c a g t t t g g c c t g a t a c a g  K241F
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Prim er Nam e Primer Sequence M utation
pBR I K241F R C T G T A T C A G G C C A A A C T G C T C C T C G A G A T T C A C K241F
pBR I K232Q_F GA T A A C C A G T A C T A T GT GA A TC T C G A G G A G A A C C A G K232Q
pBR I K232Q_R C T G G T T C T C C T C G A G A T T C A C A T A G T A C T G G T T A T C K232Q
pBR I K241Q_F G TG A A TC TA G A G G A G C A G C A G G G C C TG A TA C A G K241Q
pBR I K241Q_R C T G T A T C A G G C C C T G C T G C T C C T C T A G A T T C A C K241Q
pBR I T102A_F G TC A G TT G TG C A G A TC TG C T G G C G A TA G C TG C G C A A C A G T102A
pBR I T102A R C T G T T G C G C A G C T A T C G C C A G C A G A T C T G C A C A A C T G A C T102A
pBR I Q106R F G C A G A TC T G C TG A C TA TA G C T G C G C G TC A G A G C G T G A C Q106R
pBR I Q106R R G T C A C G C T C TG A C G C G C A G C TA TA G TC A G C A G A T C TG C Q106R
pBR I Q107N_F G C A G A TC T G C TG A C TA TA G C T G C G C A A G A T A G C G TG A C Q107N
pBR I Q107N R G T C A C G C T A T C T T G C G C A G C T A T A G T C A G C A G A T C T G C Q107N
pBR I T110V F G C G C A A C AG A G C G TG G TTC TTG C C G G C G G AC C G TC C TG G T110V
p B R I T l l O V R C C A G G A C G G TC C G C C G G C A AG AA C C AC G C TC TG TTG C G C T110V
pBR I I180F F C C A G T G T A G G T T C T T T A T G G A T C G A T T C T A C A A T T T C I180F
pBR I I180F_R G A A A T T G T A G A A T C G A T C C A T A A A G A A C C T A C A C T GG I180F
pBR_I E238Q_F C A A G TA C  T A T  GT G A A T  C TAC A G G A G C A G A A A G  G C C T G E238Q
pBR I E238Q_R C A G G C C T T T C T G C T C C T G T A G A T T C A C A T A G T A C T T G E238Q
pBR I E239N F C T A T G T G A A T C T C G A G A A C C A G A A A G G C C T G A T A C A G A G E239N
pBR I E239N_R C T C T G T A T C A G G C C T T T C T G G T T C T C G A G A T T C A C A T A G E239N
pBR I R118K_F G AC TC TTG C AG G C C G G C C G TC C TG G A AAG TG C C G C TC G G R118K
pBR I R118K_R C C G AG C G G C A C TTTC C AG G AC G G C C G G C C TG C AA G A G TC R118K
pBR I R159K F C G T G G G T C T G A A T A A A T C G T C A G A T C T T G T G G C T C T G T C R159K
pBR I R159K R GAC AG AG C  C A C A A G A T  C TG AC  GATTTA T  T  C AG AC  C C AC  G R159K
pBR I R283K F C A T G G A C A A A A T G G G T A A C A T T A C C C C G T T A A C G G G T A C R283K
pBR I R283K R G T A C C C G T T A A C G G G G T A A T G T T A C C C A T T T T G T C C A T G R283K
2.22 Site-Directed M utagenic PCR.
Mutagenic PCR was carried out as described by Wang and Malcom (1999) using 
complementary primers. Briefly, this involved two individual mutagenic polymerase 
chain reactions, each using a single primer (forward or reverse). The use o f a single 
primer method increases the mutagenic efficiency, as primer-dimer formations are 
eliminated. Each 50 piL PCR contained 10-100 ng of plasmid template DNA isolated 
from a dam+ (methylating) E. coli strain (typically XL-10 Gold), 0.5 fiM o f each
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mutagenic primer, 200 ¡xM o f each dNTP, 1 unit of pfuTurbo DNA polymerase, 5 fiL 
of specific lOx enzyme buffer and 3 [iL o f Stratagene “Quick-Solutiori”. The 
thermocycling conditions were as follows:
Stage One: Dénaturation.
95 °C 2 min 30 s 1 cycle
Stage Two: Cycling
95 °C 50 s
10 cycles60°C 50 s
68°C 1 min/kb
Stage Three: Final Elongaltion
68 °C 10 min 1 cycle
After primary thermo cycling, the two separate reactions were combined in equal 
amounts to a final volume o f 50 jiL. An additional 1 U of pfuTurbo DNA polymerase 
was added to the mixture and the PCR was repeated as above; however, stage two 
consisted of 18 cycles. After secondary thermocycling, the reaction mixture was cooled 
to <37 °C and the template DNA was removed by digestion with 20 U of Dpn I 
endonuclease at 37 °C for at least 2h. Dpn I selectively digests methylated DNA; 
hence, it will digest the template DNA but not the newly synthesised DNA. The 
remaining DNA was transformed into XL-10 Gold cells, as outlined in Section 2.16. 
These transformed cells were grown on selective LB agar, yielding single colonies. 
Typically, 15 colonies were selected and the plasmids contained within these cells were 
analysed, by endonuclease digestion, for the desired restriction pattern. Potential 
mutants were verified by commercial DNA sequencing: see Section 2.20.
2.23 Selection of Residues for M utagenesis.
2.23.1 Rational Mutation Selection.
Residues for mutation were rationally selected based on prior art that had pinpointed 
key residues influencing the stability o f HRP. Previous cross-linking experiments on 
plant HRP identified Lysines 174, 232 and 241 as important residues (O’ Brien et al.,
2001).
2.23.2 Consensus Mutation Selection.
Sequences were identified utilising a search Boolean, and downloaded from the NCBI 
gene repositoiy (www.ncbi.nlm.nih.gov). These sequences (100) were then aligned 
using the default alignment parameters o f the Clustal W server (Thompson et al.,
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1994). The alignment was saved as a “.aln” file and subsequently processed by the 
“ProteinParser” software. “ProteinParser” is a novel bioinformatic software package 
that allows the user to rapidly elucidate key residues in a protein alignment via a 
frequency counting algorithm. A tolerance level o f “50% Consensus” was set (i.e. > 
50% frequency of occurrence of a particular amino acid) and the consensus sequence 
was subsequently generated (Ryan and Barrett, in press).
2.23.3 Immobilisation Mutation Selection.
Immobilisation, via covalent attachment, to an activated solid phase has been shown to 
improve protein stability. Directional immobilisation, via specific chemically reactive 
amino acid R-groups, offers many potential applications. In this study lysine was 
selected as the amino acid o f choice, since it possesses one o f the most reactive side 
chains o f the twenty proteogenic amino acids. Wild-type arginine residues were 
selected for lysine replacement, as this is a conservative mutation: both size and charge 
are similar, and should result in minimal secondary structure rearrangement. The 
twenty-one arginine residues present in the HRP protein were viewed in Deep View™ 
(Guex and Peitsch, 1997) and analysed based on secondary structure and location. Beta 
sheet-forming residues were preferred over helical ones, and surface-exposed residues 
were selected in preference to buried ones.
2.24 Recombinant Protein Expression Protocols.
2.24.1 Localisation o f recombinant HRP expression.
10 mL o f LB broth supplemented with ampicillin (100 (ig.m l/1), was inoculated with 
200 |jL o f XL-10 Gold cells transformed with pBR_I and the culture grown overnight 
at 37 °C, 220 rpm. This 10 mL overnight culture was utilised to inoculate lOOmL of LB 
broth supplemented with ampicillin (100 (ig.mL-1), to 1% (v/v) inoculum. This 100 mL 
culture was grown until the OD6oonm reached approximately 0.5. At this time, a 1 mi. 
sample was taken and stored at -20 °C. The culture was then either induced with IPTG 
(final concentration of 50 /xM) or no IPTG was added, and a 1 mL sample was taken at 
every time point. Each 1 mL sample was centrifuged at 10,400 x g for 1 min, the 
supernatant removed and saved for later analysis (SI). The pellet was resuspended in 
the 50mM sodium phosphate (pH 7.5). The samples were then sonicated for 30 s, at 
amplitude 40 and wattage output 100, using a microtip Vibra Cell Sonicator. The
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sonicated cell debris was removed via centrifugation at 10,400 x g for 2 min. Fifty 
micro litres each o f the cell lysate supernatant (S2) and the cell culture supernatant (SI) 
was utilised in the TMB peroxidase activity assay to ascertain recombinant HRP 
production and location.
2.24.2 Investigation of IPTG requirement for optimal recombinant HRP production. 
The requirement for IPTG induction was investigated by following a simple time 
course assay over an 18-hour growth time. Cells harbouring the pBR I plasmid were 
cultured to an ODfioonm of approximately 0.5 in the presence of the relevant antibiotics 
and sterilised glucose, at a concentration of 2% w/v. The cells were then centrifuged 
and resuspended in glucose-free LB broth, supplemented with 1 mM ¿-ALA, 2mM 
CaCb and 100 pgmL'1 ampicillin. The cells were then induced with IPTG to final 
concentrations, ranging from 0 mM to 1 mM (0 mM, 0.05 mM, 0.1 mM, 0.5 mM and 1 
mM) and the cells grown for a further 18 hours at 37 °C and 30 °C, each at 220 rpm. At 
0 h, 4 h, and 18 hours post induction, a lmL aliquot was removed and the cells were 
centrifuged at 10,400 x g for 1 min. The cell culture supernatant (SI) was retained for 
further analysis. The cell pellet was resuspended in 200 p,L of 50 mM sodium 
phosphate (pH 7.5) and the suspension sonicated for 30 s, at an amplitude 40 and watt 
output 100, using a microtip Vibra Cell Sonicator. The cell debris was removed and 50 
\iL each o f the cell lysate supernatant (S2) and the cell culture supernatant (SI) was 
utilised in the TMB Peroxidase activity assay to ascertain recombinant HRP production 
and location. Sterilised glucose (final concentration 2% w/v) was added to the negative 
control to block any leaky expression by the lac promotor.
2.24.3 Comparison ofbacterial strains for recombinant HRP production.
Various E. coli derived strains were compared for their ability to express recombinant 
HRP. Competent cells for each strain were produced as per Section 2.15, and each cell 
line was transformed with 1 |ig of pBR I and a single colony bearing this plasmid was 
inoculated into 10 mL of LB broth supplemented with ampicillin (final concentration 
100 (a.g.mL'1). Recombinant HRP expression was carried out as outlined in Section 
2.24.2; however, only repressed, non-induced and 50jiM IPTG conditions were 
investigated.
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2.24.3 Investigation of rHRP expression over time.
A single colony, transformed with pBR_I, was inoculated into 10 mL of LB broth 
supplemented with ampicillin (final concentration 100 pg.mL’1) and was grown 
overnight at 37 °C, 220 rpm. This overnight culture was used to inoculate 10 mL LB 
broth, supplemented with 1 mM 8-ALA, 2 mM CaCfe and 100 (ig/mL ampicillin, to a 
final theoretical optical density o f 0.01 at 600 nm. Replicate 10 mL cultures were set up 
in this manner and one 10 mL sample was taken at the appropriate time-points 
throughout the experiment and centrifuged. Cells were prepared for analysis as 
previously outlined, Section 2.24.1, and assayed for activity via TMB assay (Section
2.30). Absorbances at OD620nm were plotted against time, to determine the optimal 
E.coli growth time.
2.24.4 Optimisation of E. coli culture conditions for maximal HRP production.
An overnight culture was set up as per Section 2.24.1 and 10 mL LB, 1 mM ¿-ALA, 2 
mM CaCl2 and 100 fig.mL'1 ampicillin was inoculated to a final theoretical OD6oonm of 
0.01. The pBR_I-containing cells were grown in the presence of glucose (2% w/v) until 
an OD6oonm o f approximately 0.5 was achieved. The cells were then removed from the 
glucose-containing medium by centrifugation at 2,000 x g for 10 min, and resuspended 
in the same LB minus glucose. Cells were either induced with 50 /¿M IPTG or grown 
non-induced at 30 °C, at 220 rpm for 18 hours. Cells were prepared for analysis as 
previously outlined (Section 2.24.1) and assayed for activity via TMB assay (Section
2.30). Absorbances at 620nm were plotted against time to determine the optimal E.coli 
culture conditions.
2.25 Recombinant HRP Purification
Initially Immobilised Metal Affinity Chromatography (IMAC) was utilised as the 
purification procedure for the recombinant HRP. The Ni-NTA resin was washed 
extensively in running buffer (50 mM sodium phosphate, pH7.5) to remove any traces 
o f storage ethanol. In brief, the method involved the gentle mixing of lmL o f Ni-NTA 
resin with 10 mL o f cleared cell lysate, containing 200 mM Gn HC1 and 1 M NaCl, in a 
sterile universal for at least one hour at 4°C. The resin was collected by a slow (1,000 x 
g/10 min) centrifugation, yielding the “run through” fraction. The resin was then 
washed with 50mM sodium phosphate, pH 7.5, to yield the “wash” fraction. Bound
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recombinant protein was eluted by a pH shift, using 50 mM sodium acetate pH 4.5 to 
reverse the positive charge of the 6 X His tag. Eluted fractions were neutralised via 
dialysis against 50 mM sodium phosphate, pH 7.5. All fractions were analysed for 
peroxidase activity via the TMB assay (Section 2.30) and protein concentration via the 
BCA assay (Section 2.28). Purified fractions containing HRP were concentrated 
(Macrosep™ centrifugal concentrators) and filter sterilised and stored at 4 °C.
The Ni-NTA resin could be regenerated up to five times. Used resin was poured into a 
universal container and washed with 2 column volumes of distilled water followed by 2 
column volumes 50% v/v ethanol. The resin was stripped with 3 column volumes o f 
100 mM EDTA, pH 8.0, then washed with 2 column volumes o f 500 mM NaCl 
followed by 2 column volumes of distilled water. The resin was re-charged with 2 
column volumes of 100 mM NiSC>4, washed with 2 column volumes o f distilled water, 
transferred to a clean sterile container and stored at 4 °C in 20% v/v ethanol.
2.25.1 Osmotic shock and lysozyme treatment for cell lysis.
Proteins were released from the periplasmic envelope by a method similar to that 
described by French et al., (1996). The fractionation buffer (FI) comprised (final 
concentrations) 500 /ig/mL lysozyme, 20% w/v sucrose, 1 mM EDTA (pH 8.0), 200 
mM guanidine hydrochloride and 200 mM Tris-HCl (pH8.0) at room temperature. The 
cells to be disrupted were pelleted by centrifugation at 10,400 x g for 3 min. The pellet 
was resuspended in FI buffer in 20% of the original culture volume. The resuspended 
cells were statically incubated at room temperature for 15 min, after which time an 
equal volume of ice-cold water was added. Once again, the mixture was allowed to 
stand for 15 min at room temperature. The cell debris was then removed by 
centrifugation at 10,400 x g for 10 min. The supernatant was carefully transferred to a 
clean container and prepared for further purification steps.
The recombinant non-His tagged HRP was purified through a three-step purification 
procedure, which utilises the inherent physio-chemical properties o f the enzyme.
2.25.2 Hydrophobic Interaction Chromatography (HIC).
The column was set up by pouring approximately 30 ml Phenyl Sepharose™ into a 
clean, dry column (8 cm x 3 cm). The resin was allowed to settle and the storage 
ethanol was separated from the resin. The resin was then equilibrated with 100 ml (>3
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column volumes) o f 30% w/v (NH^hSCU in 50mM sodium phosphate, pH 7.5. Prior to 
the addition o f cell lysate, an aliquot of t he loading sample (no salt) was saved for 
analysis. The sample was loaded in 30% (NHO2SO4 (w/v; based on original volume 
with no adjustment made for increased volume due to salt addition) and 5mL fractions 
were immediately collected. After loading the sample, the column was washed with 90 
ml o f 30% (w/v) (NH4)2S0 4 , with the fractions collected during this wash being 
labelled as “salt-wash fraction”. A salt gradient of 30%-0% (w/v) (NH^SCU was then 
run, with collected fractions labelled as “salt-gradient fractions”. Finally, the column 
was washed with 50 mM Sodium Phosphate (pH 7.5) and the collected fractions were 
labelled as “buffer-wash fractions The fractions displaying the most peroxidase and 
protein activity were determined by the TMB (Section 2.30) and BCA (Section 2.28) 
assays respectively. The fractions containing the most peroxidase activity were pooled 
and the final volume noted. An aliquot o f post-HIC sample was retained for further 
analysis. The column was cleaned via a 100% ethanol wash (at least 90 ml), and stored 
in 2 0 % v/v ethanol.
2.25.3 Size Exclusion Chromatography.
The column was set up by pouring approximately 100 mL o f Sephacryl S-300-HRrM 
into a clean, dry column (53 cm x 2.5 cm). The resin was allowed to settle and the 
storage ethanol was separated from it. The resin was then equilibrated with 300 ml (>3 
column volumes) 50 mM sodium phosphate (pH 7.5). A maximum of 5 mL sample 
was loaded onto the column; larger volume samples were concentrated via reverse 
osmosis. The sample was loaded in 50 mM sodium phosphate (pH 7.5) and 5 mL 
fractions were collected immediately. The column was washed with 100 mL 50 mM 
sodium phosphate (pH 7.5). The fractions displaying the most peroxidase and protein 
activity was determined by the TMB (Section 2.30) and BCA (Section 2.28) assays 
respectively. The fractions containing the most peroxidase activity were pooled and the 
final volume noted. An aliquot o f post-size exclusion sample was retained for further 
analysis. The column was cleaned using 50 mM sodium phosphate (pH 7.5) wash (at 
least 200 mL), and stored in 20% v/v ethanol.
2.25.4 Anion Exchange Chromatography.
The column was set up by pouring approximately 20 ml DEAE Sepharose into a clean, 
dry glass column (8 cm x 3 cm). The resin was allowed to settle and the storage ethanol
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separated from it. The resin was then equilibrated with 60 ml (>3 column volumes) 50 
mM sodium phosphate (pH 7.5). A maximum of 1 mL was loaded onto the column; 
larger volume samples were concentrated via reverse osmosis. The sample was loaded 
in 50 mM sodium phosphate (pH 7.5) and 5 mL fractions were collected immediately. 
After sample is loading, the column was washed with 20 ml o f 50 mM sodium 
phosphate (pH 7.5), with the fractions collected during this wash being labelled as 
“buffer-wash fraction”. A salt gradient o f 0-1 M NaCl was then run, with collected 
fractions labelled as “salt-gradient fractions”. The fractions displaying the most 
peroxidase and protein activity was determined by the TMB (Section 2.30) and BCA 
(Section 2.28) assays respectively. The fractions containing the most peroxidase 
activity were pooled and the final volume noted. An aliquot o f post-anion exchange 
sample was retained for further analysis. The column was cleaned via 2 M NaCl in 50 
mM sodium phosphate (pH 7.5) wash (at least 80 mL), and stored in 20% v/v ethanol.
2.26 Preparation o f Dialysis Tubing.
Dialysis tubing (1 cm width) was rinsed in dH2 0  and placed in a beaker o f same. One 
small spatula o f Na2-EDTA was added to the dH2 0  and the solution brought to the boil. 
The liquid was allowed to cool and then decanted off. The beaker was refilled with 
dH2 0  and reboiled, this time without EDTA. The water was allowed to cool and was 
poured off. The tubing was rinsed once more with dH2 0  and stored in dH2 0  at 4 °C 
until required.
2.27 Protein Gel Electrophoresis.
2.27.1 SDS-PAGE (Sodium DodecylSulfate PolyAcrylamide Gel Electrophoresis)
SDS PAGE was carried out as described by Laemmli (1970). Typically, the glass plates 
used in the preparation of the gels were washed with detergent, rinsed with dH2 0  and 
wiped with a tissue soaked in 70% v/v ethanol. A gasket was placed about the ridged 
plate and maintained in position by two clamps. The matrix was prepared as follows:
Resolving Gel Stacking Gel
Acrylamide/bis-acrylamide (30/0.8%) 3.3 mL Acrylamide/bis-acrylamide (30/0.8%) 0.7 mL
Buffer A (Section 2.4) 2.5 mL Buffer B (Section 2.4) 1.0 mL
dH20 6.0 ml dH20 3.0 ml
APS (NH4)2S20 8 (10% w/v) 50 nL APS (NH4)2S20 8 (10% w/v) 30 (xL
TEMED 10 nL TEMED 10 nL
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The resolving gel is poured first to within 2 cm of the plate limit, layered with 70% v/v 
ethanol and allowed to set. TEMED is added only when ready to pour the respective 
gel, as it initiates cross-linking o f the acrylamide. Next, the stacking gel is poured and a 
clean comb is inserted into the unpolymerised gel to create wells in which the samples 
will be loaded. The gels were loaded into the gel box at an angle so as to minimise the 
production of air bubbles between the electrode and the gel. The gel box chamber was 
flooded with 1 x Running Buffer (Section 2.4). Samples were prepared by boiling 15 pL 
o f sample in 5 (J.L of 4 X loading buffer for 4 min. The samples were allowed to cool 
and were then loaded into the gel by deposition into the gel wells. Typically, gels were 
run at 200 volts, constant ampage for approximately 40 min or until the dyefront 
reached the end o f the gel. When the power had been switched off, the plates were 
removed and separated and the gel immersed in Coomassie Blue (Section 2.4) stain 
overnight with constant agitation at room temperature. After overnight staining, the gel 
was placed in destain solution, which was changed constantly as it became saturated 
with Coomassie Blue. Once destained, the gel was carefully removed, washed with 
dH2 0 , placed onto a sheet of acetate, scanned and saved in a suitable electronic format.
2.27.2 Western Blotting.
An SDS-PAGE gel was run as described in Section 2.27.1. Coloured molecular weight 
markers (CMr, Amersham Rainbow Markers™, Section 2.4) were included on the gel. 
Six pieces o f 3 mm filter paper (Whatman) and 1 piece o f nitrocellulose membrane 
(Schleicher and Schuell) were cut to the size o f the gel. The filter paper sheets and the 
membrane were soaked in Transfer Buffer for 10 min. Avoiding air bubbles, 3 sheets o f 
filter paper were placed on the cathode of a horizontal semi-dry electro-blotter (Biorad), 
followed by the membrane, the gel, 3 sheets o f filter paper and finally the anode. The 
protein transfer was allowed to take place at a constant 17 V for 30 min. The membrane 
was washed three times for 15 min with TBS buffer (Section 2.4). The membrane was 
then blocked in 30 ml 5% (w/v) Marvel milk powder in TBS buffer for 60 min followed 
by incubation in 20 ml o f murine anti-His antibody solution (prepared in Marvel/TBS 
buffer) overnight at 4°C, with gentle shaking. The membrane was washed 3 times for 15 
min with TBS-T buffer. The secondary antibody, an anti-mouse alkaline phosphatase 
conjugate prepared in Marvel/TBS buffer, was added to the washed membrane and 
incubated for 90 min at room temperature, with gentle shaking. Finally the membrane
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was incubated briefly with the alkaline phosphatase substrate (Sigma (5-Bromo-4- 
chloro-3-indolyl phosphate dipotassium/nitrotetrazolium blue chloride; BCIP/NBT) 
until the signal was clearly visible. Using a flatbed scanner, an image o f the blot was
saved to a PC.
2.27.3 Native Gel Electrophoresis.
Non-denaturing gels, or native gels, allow the electrophoresed protein to remain active 
in the gel matrix. This is due mainly to the absence from the gel o f denaturing 
components, such as SDS and (3-mercaptoethano 1, and also because of the temperature 
used, 4 °C. Samples are separated based on their size and native charge. The gel plates 
were cleaned and assembled as per SDS-PAGE procedure above; however, separate 
running buffer and gel components were utilized, see Section 2.4.
Resolving Gel Stacking Gel
Acrylamide/bis-acrylamide (30/0.8%) 5.4 mL Acrylamide/bis-acrylamide (30/0 .8%) 1.4 mL
Buffer A (Section 2.4) 3.8 mL Buffer B (Section 2.4) 0.6 mL
dH20  11.0 ml dH20  6.0 ml
APS(NH4)2S20 8 (10%w /v ) 100 nL APS (N H ^ O g  (10% w/v) 30 \xL
TEMED 10 nL TEMED10 (iL
Once the separating gel had poured, ethanol was layered over the gel until it had set. 
This layer was then poured off, the stacking gel was poured and the comb inserted to 
create the protein wells. The gel was allowed to polymerise to completion. Non­
denatured molecular weight standards were reconstituted as detailed in the relevant 
product information. Carbonic anhydrase, 29 kDa, chicken egg albumin, 45 kDa, and 
bovine serum albumin, 66 kDa, were used in all gels. Combined standard (15 fiL) was 
applied to each gel, while 20 (iL each of sample mixed with sample buffer were also 
applied. Samples and standards were loaded whilst the gels were submerged in running 
buffer. The gel box was then placed at 4 °C, to maintain enzymatic activity, and a 
constant voltage of 100 V was applied to the gel for 2 hours. The gel was then removed 
and washed exhaustively in cold distilled water. It was then submerged in TMB 
(Section 2.30) reagent overnight at 4 °C with gentle agitation. After overnight 
incubation the gel was rinsed with distilled water to remove any unbound reagent, 
placed onto a sheet o f acetate, scanned and saved in a suitable electronic format.
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2.28 Protein Determ ination using Bicinchoninic Acid Assay (BCA).
This assay was based on the method outlined by Smith and co-workers (1985), and was 
employed as described by the Pierce kit insert. Briefly, fresh bovine serum albumin 
(BSA) was diluted from the stock solution of 2 mg.mL' 1 using a suitable buffer, to 
prepare a standard curve in the range o f 2000-20 (ig.mL'1. The working reagent (WR) 
of the assay was produced by a 1:50 dilution of kit solutions B to A. sample or control 
(25 jiL) was pipetted into the appropriate micro well. To this, 250 pL of WR was added 
and the plate gently shaken for 30 s. The plate was then covered with tinfoil and 
statically incubated at 37 °C for 30 min. The plate was then allowed to cool to room 
temperature for 1 min and the absorbance was measured at 560 nm, Absorbance 
readings for unknown protein concentrations were determined from the standard curve 
previously produced.
2.29 Horseradish Peroxidase UV-Visible spectrum, R einheitzahl N um ber and  
concentration determination.
Broad-scan spectra o f native and recombinant HRP were run from 250-800 nm on a 
UV-VIS spectrophotometer using dedicated PC software (Unicam UV2, with Vision
1.3 software). Smoothing was set to medium. Quartz cuvettes were used throughout and 
the appropriate buffer was used as the blank. Where required the RZ (Reinheitzahl) 
value was determined by utilising the following formula:
The concentration o f HRP could also be determined by measuring the absorbance at 
403nm and applying the millimolar extinction coefficient o f 100 mM^.cm ' 1 (Hiner et 
al., 1995).
2.30 Quantitative HRP Activity Assay, (TMB).
3,3’,5,5’-Tetramethylbenzidine dihydrochloride (TMB; Josephy et al., 1982) was used 
as the reducing substrate in the catalytic activity assay based on that o f Ryan and co­
workers (1994). In brief, 1 mg TMB was dissolved in 200 jiL DMSO. This TMB 
solution was added to 9.8 mL of 100 mM citric acid buffer, pH 5.5, and mixed to 
homogeneity (final DMSO and TMB concentrations 2% v/v and 32 mM respectively). 
To this solution, immediately prior to assay, 3 jiL of H2O2 (30% v/v) was added and
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mixed to give a final concentration of 0.03% v/v (3mM) H2O2 in the reaction solution. 
Sample or blank (50 (J.L) was pipetted into an appropriate well o f  a microplate and 150 
pL of reaction solution was added, mixed and allowed to react for 6.5 min. The 
absorbances o f all samples were read at 620 nm.
2.30.1 Optimisation o f TMB assay.
The optimum HRP concentration, H2O2 concentration and reaction time for the 
standard TMB reaction were determined using a checkerboard experimental design in a 
96 well microplate. HRP concentration was varied on horizontally on the plate, whilst 
simultaneously H2O2 concentration was varied vertically. All reactions were carried out 
in triplicate and the developing colour reaction was measured over time. The sample 
absorbances were plotted against time to determine the linearity o f the reaction and the 
optimum reaction conditions.
2.31 Determ ination o f free amino groups using the TNBS assay.
Free amino groups, such as those on lysine residues, were determined using the 2,4,6- 
trinitrobenzenesulphonic acid (TNBS) assay, (Fields, 1971). Briefly, the reaction was 
carried out in 0.1 M borate buffer at pH 9.5. A standard curve was produced by 
preparing a 10 mM solution of N-a-acetyl-L-Lysine in distilled water and diluting to 
create standards in the range 10 mM to 0.5 mM. To 100 jj.L of enzyme preparation or 
standard, 500 \xL of borate buffer (0.1 M borate buffer in 0.1 M NaOH, pH 9.5) and 
400 |iL of ultra pure water were added. TNBS (20 (iL) was added to the solution and 
mixed. The reaction tubes were covered in tinfoil and left in the dark for 5 min. The 
reaction was terminated by the addition of 2 mL of 1.5 M sodium sulphite in 0.1 M 
NaH2P0 4 . Absorbances were read at 420 nm and unknown samples were determined 
from the standard curve previously constructed.
2.32 Therm al profile o f catalytic activity.
A thermal profile was used to determine the temperature range over which an enzyme 
begins to lose catalytic activity. In short, HRP solutions were exposed to different 
temperatures for 10 min, after which a 50 (iL aliquot was removed to a microplate, 
stored on ice to prevent refolding, and assayed for remaining activity (TMB assay). 
Protein concentration was equalised in all experiments, to allow for the stabilising 
effect o f protein-protein interactions. (Three waterbaths were utilised in the
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experimental setup: as one was being utilised at a determined temperature, the other 
two were being ramped to the next required temperature). Initial temperature was 20 
°C; the temperature was then increased in 10 °C increments over the range 20-40 °C 
and 5 °C increments over the range 40-80 °C. Calculations were carried out on the 
resulting catalytic data to obtain the T5o, the temperature at which 50% catalytic activity 
was noted. All experiments were carried out in triplicate, with the average value used in 
T50 calculations.
2.33 Therm al Inactivation Assay.
Once the thermal profile was completed, and the T50 calculated, a thermal inactivation 
assay was carried out at the T50 (50 °C). Similar to the thermal profile, 50 pL aliquots 
were removed to a microplate on ice; however, in this procedure, time is varied whilst 
temperature remains constant. Aliquots were taken every minute for 10 min. The 
microplate containing the aliquots was then warmed to room temperature and assayed 
for catalytic activity (TMB assay). The optical densities obtained were expressed as 
percent residual activity (where time 0 represented 10 0 % activity) and plotted versus 
time. All experiments were carried out in triplicate, with the average value used in ti/2 
calculations. From this graph the half life (ti/2) can be calculated via data fitting 
utilising the Enzfitter programme (Bio so ft, Cambridge, UK). Only results up to 10 min 
were utilised in modelling as deviations from the first-order model occurred at longer 
incubation times.
2.34 Organic Solvent Tolerance Assay.
This procedure was used to determine the % v/v organic solvent range over which an 
enzyme begins to lose catalytic activity. Recombinant HRP was prepared to a 
concentration o f 100 fig.mL'1 in 50 mM phosphate buffer, pH 7.0. Reaction mixtures 
were set up with 10% increasing volumes o f the solvent o f interest in 50 mM phosphate 
buffer, pH 7.0, in the range 0% - 90% v/v solvent. HRP samples were exposed to the 
relevant solvent concentration for 2 hours at 25 °C in a temperature-controlled 
waterbath. After incubation, 50 /zL aliquots were withdrawn and remaining catalytic 
activity was assayed using standard TMB conditions (Section 2.30). The results were 
expressed as a percent residual activity with respect to the recombinant enzyme in 
aqueous solution. All experiments were carried out in triplicate, with the average value
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used in C50 calculations. The C50 value is the % v/v of organic solvent that reduces 
catalytic activity to half the initial value in aqueous solution. The solvents used were 
dimethyl sulfoxide, methanol and dimethylformamide.
2.35 Tolerance of Excess H2O2.
This procedure was used to determine the mM H2O2 concentration range over which an 
enzyme begins to lose catalytic activity. Recombinant HRP was prepared to a 
concentration of 360 nM in 50 mM phosphate buffer, pH 7.0. Reaction mixtures were 
set up with increasing concentrations o f H2O2 in 50 mM phosphate buffer, pH 7.0, in 
the range 0-50 mM. H2C>2 concentrations were determined spectrophotometrically at 
240 nm using 43.6 M^cm ' 1 as the extinction coefficient (Hemandez-Ruiz et al., 2001). 
HRP samples were exposed to the relevant H2O2 concentration for 30 min at 25 °C in a 
temperature-controlled waterbath. After incubation, 50 ßL aliquots were withdrawn and 
remaining catalytic activity was assayed using standard TMB conditions (Section 2.30). 
The results were expressed as percent residual activity with respect to recombinant 
HRP in aqueous solution. All experiments were carried out in triplicate, with the 
average value used in C50 concentrations. The C50 value is the mM H2O2 that reduces 
catalytic activity to half the initial value in aqueous solution.
2.36 Recombinant HRP Kinetic Analysis.
2,2'-azino-bis(3-ethyl-benzthiazoline-6-sulphonic acid) (ABTS) was utilised as 
substrate for steady state kinetic analysis. The present method was adapted from Childs 
and Bardsley (1975). A 20 mM stock solution of ABTS was prepared in 200 mM 
Na2HP0 4 / 100 mM citric acid pH 4.5 buffer. A 100 mM H2O2 stock solution was also 
prepared separately in the same. For Michaelis-Menten kinetic analysis, a range of 
ABTS from 1.0 mM to 0.05 mM was prepared in buffer by serial dilution o f the ABTS 
stock. Recombinant HRP was prepared to 65 pM in 50 mM phosphate buffer, pH 7.0. 
This concentration of recombinant HRP yielded absorbance readings within the desired 
range o f 0.1-0.9 at 405 nm. Into a microplate well, 2.5 ¡xL o f 100 mM H2O2 and 222.5 
/xL of the desired ABTS substrate dilution were aliquoted, followed by 25 ¿iL of 
recombinant HRP to initiate the reaction. A blank of zero ABTS was included in all 
assays. The microplate was shaken as the initiating enzyme was added and the 
absorbance at 405 nm was recorded every minute for 20 min. The change in absorbance 
per minute (AA/min) was calculated for each substrate calculation. The Enzfitter
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programme fitted the data generated to a Michaelis-Menten equation and calculated 
apparent K ’m values, kj, (Dunford 1999) was calculated by dividing the mol o f ABTS 
product produced per unit time by the number of mol o f rHRP present in the reaction 
mixture.
2.37 Immobilisation M ethods
2.37.1 Cyanogen Bromide-Activated Matrix Immobilisation.
The base form of cyanogen bromide (CNBr) reacts readily with the -OH groups on 
agarose to form cyanate esters or imidocarbonates. These, in turn react with primary 
amines under mild conditions, resulting in the covalent coupling of proteins, to the solid 
phase. HRP (30 pM), plant and recombinant, was immobilised to Sigma CNBr 
activated Sepharose® 4B, as per manufacturer’s instructions. Briefly, the HRP was 
resuspended in the coupling buffer, 0.1 M NaHC0 3  buffer containing 0.5 M NaCl, pH 
8.5. The CNBr-activated Sepharose® 4B was washed and swollen in cold 1 mM HC1 
for at least 30 min. Several washes (>10 column volumes) were required to remove the 
lactose used for storage stabilisation. The resin was then washed with 10 column 
volumes o f distilled water and, finally, with coupling buffer. Immediately, the resin was 
transferred to the solution containing HRP and mixed using an end-over-end rotator for 
at least 2 hours at room temperature. After coupling, any unbound protein was washed 
away using several washes o f coupling buffer. Any unreacted groups were blocked with 
0.2 M glycine, pH 8.0, for 2 hours at room temperature. Extensive washing with high 
(0.1 M NaHCOs buffer containing 0.5 M NaCl, pH8.5) and low (0.1 M acetate buffer, 
pH4) pH buffers removed any remaining glycine and consolidated the HRP-to-resin 
covalent bonds. The resin, with immobilised protein, could be stored at 4 °C or used 
immediately.
2.37.2 Pall UltraBind™ Affinity Membrane Immobilisation.
Pall UltraBind™ affinity membranes comprise a polyethersulfone membrane modified 
with aldehyde surface chemistry, allowing direct protein immobilisation via free amine 
groups. HRP (30 pM), plant and recombinant, was immobilised onto the activated 
membrane as outlined in the manufacturer’s instructions. The protein was resuspended 
in 50 mM sodium phosphate buffer, pH 7.5, and directly spotted onto the activated 
membrane; the latter was allowed to air-dry completely at room temperature for 10 
min. The remaining binding sites were then blocked with 1% non-fat dried skim milk
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(Marvel) in 50 mM sodium phosphate buffer, pH 7.5, for 1 hour at room temperature. 
The membrane was again allowed to air-dry completely at room temperature for 10 
min. Precipitating chromogens such as TMB and DAB (diaminobenzidine) were 
utilised to identify immobilised HRP. Membranes were imaged with a Hewlett Packard 
Scanjet 5590, connected to a Dell Optiplex Computer as follows:
Scanning Variable Setting
Output Type True Colour (24 bit)
Selection Area W: 2.5, H: 1.75
Output Scale 1 0 0 %
Output Resolution 2400 dpi
Sharpen Level Extreme
Scan Form Scanner Glass
Highlights - 1 0 0
Shadows - 1 0 0
Midtones - 1 0 0
2.38 Electrochemical Biosensing Devices.
2.38.1 Screen Printed Electrode.
Screen-printed electrodes (SPE) are small, mass-produced, single-use systems 
comprising a silver conducting track, a carbon working electrode and an insulation 
layer. For this study, screen print electrodes were produced in-house (Dr. Aoife Morrin, 
NCSR, DCU) utilising a semi-automated DEK 247 printing machine (Weymouth, UK). 
Polyester screens, o f varying thickness, were utilised mounted at 45° to the blade 
stroke. All inks were cured in a conventional oven before to use. The electrode was 
subjected to an electrochemical pre-treatment by cycling it in 0.2 M H2SO4 to remove 
any impurities on the electrode surface before any electrochemical deposition. Prior to 
HRP immobilisation, aniline was polymerised onto the SPE surface. In brief, 186 fiL o f 
neat aniline, 7.8 mL 1M HC1 and 2 mL of PVS (polyvinylsulphonate) was 
deoxygenated with nitrogen for lOmin. Aniline was then polymerised from this solution 
onto the surface o f the working electrode by cyclic voltammetry using a platinum mesh 
auxiliary and an Ag/AgCl reference electrode. The potential was cycled between -500 
and +1100 mV at 100 mV s' 1 for the required number o f scans, usually 20. All 
electrochemical protocols were performed on a CH1000 potentiostat with CHI1000 
software. Once the aniline had been deposited, the electrode was transferred to a 2 mL
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batch cell and the chamber flooded with lm L phosphate buffered saline (PBS). 
Electrochemical batch cells were constructed according to Killard and co-workers 
(1999) and were composed of polycarbonate. The cells were designed specifically for 
SPE and incorporated internal Ag/AgCl pseudo-reference and platinum wire auxiliary 
electrodes. The PBS solution in the batch cell was degassed under nitrogen for lOmin; 
afterwards, a layer o f nitrogen was maintained over the reaction vessel and the buffer 
constantly stirred. The polymer surface was then reduced at -500 mV vs Ag/AgCl, with 
a sample interval o f 500 ms over 300 s at a sensitivity o f 1 xlO-4 A.V'1. The protein to 
be immobilised was prepared in PBS also and, immediately upon completion of 
polymer reduction, the PBS buffer was removed from the cell and replaced with the 
protein solution, which was neither degassed nor stirred. Oxidation was performed at 
+700 mV vs Ag/AgCl for 1500 s. During the oxidation step, the protein becomes 
electrostatically attached to the polymer surface. Following oxidation, the protein 
solution was removed and stored at 4 °C for later use. The batch cell was then washed 
with PBS to remove any unbound HRP. PBS (1 mL) was then added to the batch cell 
and the reaction mixture stirred. An amperometric i-t curve was monitored at -100 mV 
vs Ag/AgCl, with a sample interval o f 500 ms over 4000 s at a sensitivity o f 1 x 10“4 
A.V'1. Once a stable baseline of 0 ¡jlA  was achieved, successive additions o f 20 mM 
H2O2 (final concentration) were carried out, with the resulting increase in /¿A recorded 
as part o f the CF1I1000 software. Data points generated were exported and converted to 
Excel™.
2.38.2 Microelectrode Fabrication and Preparation.
Microelectrodes are electrodes with critical dimensions in the micron range. The 
reduced response time o f micro electrodes compared with conventional-sized 
macroelectrodes (millimetre dimensions) enables electrochemical experiments to be 
carried out over extremely short timescales (Andriex et al., 1998). For this study, the 
micro electrode was produced in-house (Dr. Jennifer Brennan, NCSR, DCU) utilising 
soft glass as the external electrode support. A 0.25 (im diameter platinum wire was 
chosen as the conducting material. Platinum is electro chemically inert and compatible 
with biological buffers. In brief, the microelectrode was fabricated by initial partial 
closure o f a glass tube with heat from a Bunsen burner. The tube was rotated to aid 
symmetrical closing. A tin-annealed copper wire was used as the starting wire; to this, a 
hook-up wire was attached by spot soldering. The hook-up wire was kinked to prevent
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fracture during electrode polishing. The platinum wire (0.25 [im diameter) was wrapped 
around the hook-up wire and also carefully spot soldered to ensure correct electrical 
signal transfer. The platinum wire was then passed through the partially closed glass 
tube, and the tube completely sealed by rotation in a Bunsen flame. A plastic cap was 
then glued to the top of the electrode assembly using an epoxy adhesive, both 
stabilising the hook-up wire and preventing contamination o f the electrode interior. To 
confirm electrical signal transfer throughout the fabricated microelectrode, a cyclic 
voltamagram (CV) was carried out in MOPS (50 mM, pH 7.5) buffer. The 
micro electrode tip was then polished to generate a smooth surface, permitting 
electrochemical analysis of electrode surface area. Initially, the tip was polished with
very fine sandpaper to remove any remaining protruding platinum wire. This was
followed by sequential polishing with decreasing sizes o f silica (0.5-0.3 fim) on 
moistened emery polishing paper (ten min at each silica size) with the electrode 
maintained at 90° to the silica. The electrode was rotated in a “figure-of-eight” motion 
to achieve equal polishing over its entire area. The electrode was rinsed with distilled 
water after each polishing and sonicated (240 W)for 5 min in Milli-Q water to remove 
any remaining debris.
Once the electrode was suitably polished, it was placed in a solution o f 1.0 M H2SO4, in 
order to calculate the actual available surface area o f the platinum wire. The potential 
was cycled between limits chosen initially to oxidise and then reduce the surface o f the 
electrode. The area under the reduction peak o f the oxide curve can be converted to the 
actual available surface area by utilising the following equation:
A,
= 420X1 O^C-cm2 Equation I
Where A = real area o f the electrode, Ap = area under the peak and the divisor is the 
charge in coulombs of the reactive species. The geometric area o f the platinum wire, 
assuming that a perfect disc is formed during smoothing, can be calculated as follows:
A = n.r2 Equation II
The ratio o f real area, as calculated by equation I, to geometric area, as calculated by 
equation II, gives an indication of the roughness of the electrode’s surface. A roughness 
ratio between 1.0 and 3.0 is desirable. Continued electrode polishing is required if  the 
roughness ratio falls outside these limits.
The working electrode can also be electro chemically cleaned by cycling in 1.0 M 
H2SO4 between potential limits chosen first to oxidize and then to reduce the surface of
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the platinum electrode. A characteristic curve is achieved, which demonstrates the 
oxidation and reduction peaks o f platinum, and also the evolution and adsorption of 
hydrogen ions at the surface of the electrode. The typical conditions utilised to clean the 
electrode surface are outlined as follows:
Init E (V): 0.0
High E (V): 1.35
Low E (V): -0.2
Initial Scan Polarity: Positive
Scan Rate (V/s): 0.2
Sweep Segments: 10
Sample Interval (V): 0.001
Quiet Time (s): 2
Sensitivity (A/v): 1 x 10'8
2.38.3 Electrochemical Cell preparation and Electrochemical Analysis.
Voltammetry can be defined as the measurement of the current flowing through the 
electrode as a function of the applied potential, with the resulting graph referred to as a 
voltammogram. Amperometry is the measurement of current production when a 
potential is applied between two electrodes, with the resulting graph referred to as an 
amperometric i-t curve. Both cyclic voltammetry and amperometry were performed 
using CH Instruments Model 660a Electrochemical workstation and a conventional 
three-electrode cell. This comprises a working electrode (WE; HRP and Pt wire), a 
reference electrode (RE) and an auxiliary electrode (AE, Pt flag). The reference 
electrode was a Bioanalytical Systems (West Lafayette, USA) Ag/AgCl reference 
electrode, MF2052. A PTFE cap, containing electrode-holding positions, was placed 
over the glass cell. All solutions were deoxygenated thoroughly by sparging with argon 
or nitrogen for at least 15 min prior to experimentation; a blanket o f argon/nitrogen was 
maintained over the solution during all experiments. The system potential was 
maintained by the potentiostat and is quoted with respect to Ag/AgCl reference 
electrode. All experiments were performed at room temperature (22 ± 3 °C). Before 
electrochemical measurements were made, the electrodes were rinsed with Milli-Q 
water and the electrolyte (50 mM MOPS, pH 7.5) to remove unbound material. 
Subsequent measurements were performed in blank electrolyte.
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For cyclic voltammetry the CHI 660a software was set up as follows:
Init E (V): 0.1
High E (V): 0.9
Low E (V): 0.1
Initial Scan Polarity: Positive
Scan Rate (V/s): 0.2
Sweep Segments: 6
Sample Interval (V): 0.001
Quiet Time (s): 2
Sensitivity (AAA): 1 xlO '8
83
For amperometry the CHI 660a software was set up as follows:
Init E (V): 0.1
Sample Interval (s): 
Run Time (s):
0.001
1500
Quiet Time (s): 2
Scales During Run: 
Sensitivity (A/V):
1
1 x 10‘9
2.38.4 Platinum micro electrode etching.
Aqua regia [a fresh mixture o f concentrated nitric acid (specific gravity: 1.42, purity: 
70%) and concentrated hydrochloric acid (specific gravity: 1.18, purity: 37%) in a 1:3 
ratio] was utilised to etch the platinum electrode to form a cavity between the glass 
sides and the recessed platinum wire at the tip o f the electrode. Aqua regia dissolves 
platinum, even though neither constituent acid will do so alone. In combination, each 
acid performs a different task. Nitric acid is a powerful oxidizer, which will dissolve a 
tiny (virtually undetectable) amount o f platinum, forming platinum ions (Pt4+). The 
hydrochloric acid provides a ready supply of chloride ions (Cl'), which react with the 
platinum to produce chloroplatinate ions, also in solution. The reaction with 
hydrochloric acid is an equilibrium reaction which favors formation of chloroplatinate 
ions (PtCl^2). This results in removal o f platinum ions from solution and allows further 
oxidation of platinum to take place; thus, the platinum is dissolved. (Saito et al., 1995). 
The tip o f the 25 fim  diameter platinum electrode was immersed in aqua regia, 
maintained at 75 °C, and the reaction mixture stirred continuously; etching was allowed 
to continue for 3 hours. The extent o f etching was analysed by SEM image analysis 
(Section 2.38.5). Upon sufficient etching, the microelectrode was tested for an electrical 
signal (Section 2.38.3). To determine whether direct electrochemistry was possible, 
BSA, recombinant wildtype and plant HRP were immobilised in the etched cavity and 
the electrochemical signals obtained for each protein were compared.
2.38.5 Scanning Electron Microscopy.
Scanning Electron Microscopy (SEM) was performed to ensure correct cavity 
formation following electrode etching, utilising a Hitachi S 3000N scanning electron 
microscope. The microelectrode was removed from its storage container and sonicated 
in dH20 for 5 min to remove any debris that had collected in the cavity during storage.
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The microelectrode was dried under nitrogen gas and mounted onto the SEM stage, 
held in place by custom SEM contact gel. The stage was retracted into the SEM 
chamber and the vacuum was applied. Once the vacuum was established, the filament 
was saturated and the electron gun aligned. Acceleration voltage was set at 20 kV, the 
working distance was typically 5-8 mm and the spot size was set to 3. The images were 
obtained from the secondary electron detector. To obtain images o f the etched platinum 
wire, the stage was tilted to an angle between 35 and 45°. The images were downloaded 
from the Hitachi S 3000N software to the PC and analysed.
2.38.6 Protein immobilisation onto etched platinum microelectrode.
After successful etching and image confirmation, the electrode was sonicated for 5 min 
and dried under nitrogen. A small hole was introduced into the top of a centrifuge 
microtube and the etched electrode was placed in a vertical position in this hole. Protein 
solution (2 nM each of BSA, recombinant wildtype or plant HRP) was introduced to the 
microtube and allowed to immobilise, via adsorption, overnight at 4 °C. The electrode 
and protein solution were inverted a number o f times to remove from the cavity any air 
pockets that would hinder protein immobilisation. Once immobilised, amperometry was 
carried out on the protein (Section 2.38.3) to determine the direct electrochemical 
properties of the protein.
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Chapter Three.
Cloning, Expression and Purification.
3.0 Introduction.
This chapter describes cloning of the HRP gene into a modified pQE60 vector (Qiagen, 
Figure 3.1), and subsequent development o f a recombinant expression system, capable 
of producing catalytically active recombinant HRP, which could be isolated to a high 
purity. The QIAgen pQE-based vectors contain an optimised promoter-operator region, 
consisting of a strong phage T5 promoter that is recognised by the naturally occurring 
E.coli RNA polymerase. Also contained within the promoter-operator region are two 
lac operator sequences, which bind the lac repressor and ensure efficient repression of 
the powerful T5 promoter. This study utilised E.coli, XL10 Gold (Stratagene) which 
harbours the lacP mutation and, as such, the strain produces enough lac repressor to 
naturally block transcription.
After cloning, the HRP gene was coupled to a PelB leader sequence, which would 
promote translocation o f the resulting polypeptide to the periplasm o f the E. coli cell, 
and a poly histidine tag, that would allow for simple one-step purification via nickel 
affinity chromatography. A schematic o f the cloning process is outlined in Figure 3.2. 
Recombinant expression studies were carried out in a number o f E. coli strains. Growth 
conditions were optimised for maximal production of active HRP; this would also serve 
other purposes, such as HRP mutant characterisation (Chapters 4, 5 and 6). Purified 
wildtype recombinant HRP was characterised in terms o f thermal, solvent and H2O2 
stabilities, along with ABTS steady-state kinetics.
com
Figure 3.1: Schematic diagram of the pQE60 vector, showing T5 promoter, lac operator, synthetic 
Ribsosomal Binding Site (and Shine-Delgamo within), Start codon (ATG), Multiple Cloning Site, Poly 
His Tag and Stop codons. The ampicillin gene and ColEl origin of replication are also noted on the 
vector. The (3-lactamase gene confers resistance to the antibiotic ampicillin and, hence, only plasmid 
containing this gene can be easily selected for. The ColEl origin of replication also permits this high 
copy number plasmid to replicate during cell division.
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Figure 3.2: Cloning overview of the PelB leader (■) and HRP gene (□). The HRP and PelB sequences 
were primarily amplified from the unknown donated vector (F. Arnold, Caltech) via PCR. The PCR 
products were then restricted with the specific endonucleases to allow for directional cloning into the 
intermediate vector. The primers contained the recognition sequences for the endonucleases. The 
deleted His Tag (■) intermediate vector (See section 3.6) was used as the template for cloning into the 
pQE60 vector to form pQE60_PelB_HRP_His (■ denotes correct His Tag incorporation) and 
pQE60_PelB_HRPAHis, depending on the restriction sites utilised for directional cloning.
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Promotor
Figure 3.3: Part (A): Schematic representation of pQE60_PelB_HRP_His. The pQE60 vector contains 
the PelB leader and HRP gene flanked by the initiation codon at the 5’ end and the poly His purification 
tag and stop codon at the 3 ’ end of the multiple cloning site. Part (B): Schematic representation of 
pQE60_PelB_HRPAHis. The pQE60 vector contains the PelB leader and HRP gene flanked by the 
initiation codon at the 5’ end and the stop codon at the 3’ end of the multiple cloning site. Image 
generated using Redasofl: Visual Cloning 3.2 (www.rebase.neb.com)
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3.1 Cloning o f HRP gene sequences into an E. coli expression vector.
Periplasmic localization of the HRP enzyme is fundamental however, as it is in this 
region that the cysteine bonds (four in HRP) are formed and correct protein folding is 
initiated. Thus, the PelB sequence, which aids in protein translocation, was cloned 5’ to 
the HRP gene. Due to the limited nature o f the restriction sites, careful consideration of 
the MCS on the pQE60 vector was required, and cloning of the Pel B leader allowed for 
the introduction of several unique restriction sites into the pQE60 vector. The HRP 
sequences and the Pel B leader sequences cloned are identical to those found in the 
literature (Smith et al., 1990; Welinder, 1979; Lei et al., 1987 andNovagen, 2003).
3.2 Am plification o f PelB Leader and HRP gene sequences by PCR.
The presence of the PelB leader and HRP gene on the unknown plasmid donated by 
Prof F. Arnold (Caltech, USA) was confirmed via di-deoxy sequencing. Primers were 
designed to amplify these sequences separately. Also located on these primers were the 
recognition sequences for the endonucleases required for the directional cloning o f the 
sequences into the pQE60 expression vector. A standard PCR methodology was carried 
out as outlined in Section 2.6. The PCR products and basic cloning strategy are outlined 
diagrammatically in Figures 3.4 and 3.5 on the following page.
His Tag
Nco  I  No tl BamHI
C C A T G G G C A T G A A A T A C C T G C T G C C G A C C G C T G C T G C T G G T C T G C T G C T C C T C G C T G C C C A G G C G G C G A T G G C C g c q q c c g c g g a t C C C g
PelB His Tag
Figure 3.4: Initial amplification of the PelB leader sequence and its inclusion in the pQE60 vector to 
produce the pQE_60_PelB vector. The region surrounding the MCS in pQE60 vector is outlined first; it 
has a MCS containing Nco I, BamHI and Bgl II. The PelB leader sequence was directionally cloned into 
the MCS utilising the Nco I / BamH I cut vector / insert (bottom diagram). Image generated using 
Redasoft Visual Cloning 3.2 (www.rebase.neb.com).
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. ATGCAGTTAACCCCTACATTCTACGACAATAGCTGTCCCAACGTGTCCAACATCGTTCGCGACACAATCGTCAACGAGCTCAGATCCGATC 
CCAGGATCCCTGCTTCAATATTACGTCTGCACTTCCATGACTGCTTCGTGAATGGTTGCGACGCTAGCATATTACTGGACAACACCACCAGTTTCCGCAC 
TGAAAAGGATGCATTCGGGAACGCTAACAGCGCCAGGGGCTTTCCAGTGATCGATCGCATGAAGGCTGCCGTTGAGTCAGCATGCCCACGAACAGTCAGT 
TGTGCAGACCTGCTGACTATAGCTGCGCAACAGAGCGTGACTCTTGCAGGCGGACCGTCCTGGAGAGTGCCGCTCGGTCGACGTGACTCCCTACAGGCAT 
TCCTAGATCTGGCCAACGCCAACTTGCCTGCTCCATTCTTCACCCTGCCCCAGCTGAAGGATAGCTTTAGAAACGTGGGTCTGAATCGCTCGAGTGACCT 
TGTGGCTCTGTCCGGAGGACACACATTTGGAAAGAACCAGTGTAGGTTCATCATGGATAGGCTCTACAATTTCAGCAACACTGGGTTACCTGACCCCACG 
CTGAACACTACGTATCTCCAGACACTGAGAGGCTTGTGCCCACTGAATGGCAACCTCAGTGCACTAGTGGACTTTGATCTGCGGACCCCAACCATCTTCG 
ATAACAAGTACTATGTGAATCTAGAGGAGCAGAAAGGCCTGATACAGAGTGATCAAGAACTGTTTAGCAGTCCAAACGCCACTGACACCATCCCACTGGT 
GAGAAGTTTTGCTAACTCTACTCAAACCTTCTTTAACGCCTTCGTGGAAGCCATGGACCGTATGGGTAACATTACCCCTCTGACGGGTACCCAAGGCCAG 
ATTCGTCTGAACTGCAGAGTGGTCAACAGCAACTCTCATCACCATCACCATCACTAAGCTTGG
Wotl
Hind I I I
PelB HRP His Tag
Figure 3.5: Secondary amplification of the HRP gene and its insertion into the pQE 60_PelB vector. The 
reverse primer of the PelB leader contained a Not I site 5’ to the BamH I site; this introduced a new 
unique restriction site which allowed the cloning of the HRP gene between the Not I and Hind III sites. 
Introduction of the poly Histidine sequence 5’ to the Hind HI site was accomplished by inclusion of that 
sequence on the HRP reverse primer. Image generated using Redasoft Visual Cloning 3.2 
(www.rebase.neb.com).
3.3 Cloning o f Pel B Leader Sequence.
The PCR products generated from Section 3.2 were digested with specific restriction 
endonucleases to allow for directional cloning into the pQE60 vector. PelB was 
restricted with Nco I and BamH I, whilst HRP was restricted with Not I and Hind III. 
Restrictions were carried out as per Section 2.9. The cleaved products were gel purified 
as per Section 2.10 and the restricted and gel purified vector was ligated with the insert 
as per Section 2.14.
1 2 3 4 5 6
1500bp
lOObp
lOOObp
750bp
50bp
Figure 3.6: PCR products of PelB leader, cleaned and uncleaned, lanes 1 and 2. PCR products of HRP 
gene, cleaned and uncleaned, lanes 4 and 5. Sigma size markers are in lanes 3 and 6.
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This cloning allowed for the introduction o f extra unique restriction sites to the MCS to 
aid the cloning of the HRP gene. To confirm the correct insertion of the PelB leader, 
the unique, Not I, restriction site, introduced by PCR, was used in restriction analysis. If  
the sequence was correctly introduced, the vector would be linearised by Not I 
restriction. Digests were carried out as per Section 2.9 and visualised as per Section
1 2 3 4 5
Figure 3.7: A 1% TAE gel depicting the differences in restriction of the pQE60 vector and the pQE 
60_PelB vector. Lane one shows the pQE 60_PelB vector cut with Not I, lane two shows the pQE 
60_PelB vector undigested. Lane four shows pQE60 digested with Not I, and lane five shows pQE60 
undigested. As can be clearly seen, the pQE 60_PelB vector is linearised by the Not I restriction and the 
pQE60 vector is not. Lane three contains Sigma size marker.
3.4 Cloning of HRP gene.
Due to the nature o f the MCS in pQE60 and the presence o f all of the pQE60 MCS 
restriction sites in the HRP gene, judicious introduction o f unique restriction sites was 
required. Primary cloning of the PelB leader allowed for the introduction o f the Not I 
restriction site 5’ to the Hind III site already present in the pQE60 vector. These two 
unique restriction sites were utilised in cloning the HRP gene. As the Hind III site is 3 ’ 
to the polyHistidine tag in the pQE60 vector, the sequence for the Histidine tag needed 
to be inserted into the primer for the HRP PCR, as outlined diagrammatically in Section
A unique restriction site was again used to screen possible clones. The Pst I recognition 
sequence is located only in the HRP gene and, hence, the pQE60_PelB_HRPHis vector 
will be linearised only if the HRP gene has been inserted. Restriction analysis was 
carried out as per Section 2.9 and results were visualised as per Section 2.10. Results 
are outlined in Figure 3.8.
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1 2  3 4
Figure 3.8: A 1% TAE gel depicting the differences in restriction of the pQE 60 vector and the pQE 
60_PelHRP. Lane one shows the pQE 60_PelHRPHis vector undigested. Lane two shows the pQE 
60_PelHRPHis vector cut with Pst I. Lane four shows pQE 60_PelB digested with Pst I. Lane Three is the 
Sigma molecular size marker
3.5 Sequencing of the cloned PelB and HRP vector construct.
A fresh plasmid preparation of the pQE60_PelB_HRPHis vector construct was 
sequenced by MWG-Biotech Ltd (Germany). The concentration of vector and 
sequencing primers utilised are outlined in Section 2.20. Results were obtained in linear 
nucleotide sequence, and several bioinformatic packages were utilised for data analysis.
Due to its size, greater than one kilobase, the cloned construct was sequenced in both 5 ’ 
to 3’ and 3’ to 5’ directions; it was thus necessary to align both result sets to find the 
overlapping sequences in the middle o f the read. This was done by (i) finding the 
reverse complement o f the 3’ to 5’ read (www.bioinformatics.vg) and (ii) aligning this 
reversed sequence to the 5’ to 3’ read (www.prodes.toulouse.inra.fr). The overlapping 
sequences were reduced to a single sequence and, hence, a single linear 5’ to 3’ 
sequence was produced.
The single linear 5’ to 3’ sequence was then translated into amino acid code 
(www.expasy.org), the latter imported into ClustalW multiple alignment program 
(www.ebi.ac.uk) and the sequence aligned with published amino acid sequences for 
HRP (Smith et al., 1990 and Welinder, 1979). Aligned sequences were then imported 
into Genedoc (www.psc.edu), a program utilised for manipulating aligned sequences, 
and similarities compared.
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Figure 3.9: Alignment of the pQE60_PelB_HRP cloned construct with the published literature for the 
Pel B leader (Lei, et al., 1987) and HRP (Welinder, 1979 and Smith et al., 1990). The bioinformatic 
package Genedoc was used to show the alignment of the sequences, with complete agreement indicated 
by a black colouration. As can be seen, complete similarity is noted for the entire clone construct with the 
exception of one mutation at position 34 on the HRP translated protein where an Alanine is replaced by a 
Proline. This mutation was already present in the gene on the donated plasmid and, hence, no mutations 
were introduced by the cloning strategy.
3.6 Out of frame cloning and His tag deletion.
Although sequencing of the pQE60_PelB HRP confirmed that the PelB leader and 
HRP gene were fused in frame to each other, an extra methionine residue had been 
incorporated into the PelB forward primer. Thus, HRP expression was erratic due its 
gene being out o f frame with the correct start codon. Sequencing also revealed that the 
poly His tag, encoded in the reverse primer, was not included in the final construct. To 
counteract these problems, the PelB-HRP gene fusion was subcloned from 
pQE60_PelB_HRP back into pQE60 via a BspH  I / BamH I directional cloning 
strategy, resulting in use o f the correct start codon and the encoding His Tag of the 
vector. A BspH  I site was included on the forward amplification primer for the gene 
fusion, as it is an isoschizomer of Nco I and thus could be utilised in directional cloning 
of the product into an Nco I-cut pQE60. The correct ATG start codon is located within 
its recognition site and, hence, correct expression would be achieved. The reverse 
primer contained a BamH I recognition site, and so the gene fusion would be sub­
cloned in frame with the His tag encoded by the pQE60 vector. The vector was cut with 
Bgl II, which allowed the mutually-compatible BamH  I cut insert to be directionally 
cloned in-frame to the vector encoded His tag. This cloning mechanism also removed 
these two restriction sites and would allow future use o f a designed BamH  I site in 
mutant screening; see Section 4.4.
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T C A T G  A  
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PCR
Insert
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Figure 3.10: Schematic o f Nco I vector digestion and BspH  I insert digestion and in-frame ligation. Also 
outlined is the relationship (eleven basepairs) between the RBS (green lettering) and the primary 
initiation methionine start codon. The reading frame is underlined in the schematic.
The cloning was carried out as per pQE60_PelB_HRP, and similar restriction digest 
gels were produced as outlined in Figures 3.6, 3.7 and 3.8. The new construct, 
pQE60_PelB_HRP_His was sent for sequencing as previously outlined, this time the 
correct reading frame and inclusion of His tag are noted, as outlined in Figure 3.11:
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Figure 3.11: Sequencing results aligned against published sequences for PelB leader (Lei, et al., 1987) 
and HRP (Welinder, 1979 and Smith et al., 1990). Sequencing results are as expected, except for the site 
mutation at position 34 in the HRP amino acid sequence, as described previously. Positions 1-24 
represent the PelB leader, positions 25-28 represent the alanine linker between the leader and the HRP 
gene, whilst positions 30-342 represent the HRP gene. A single mutation (Ala to Pro) is located at 
position 34 (position 60 in the numbering system used in this figure).
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3.7 Expression o f HRP gene in E. coli.
Prior to expression studies, the A34P mutation was reverted to wildtype by site-directed 
mutagenesis as described in Section 4.4. Once reverted expression of the HRP gene was 
optimised for host E. coli strain, induction method, and expression time as outlined in 
Sections 3.7.1, 3.7.2, and 3.7.3 respectively.
3.7.1 E. coli host strain optimisation.
Several commercial E. coli host strains, with different genotypes (Section 2.1.1), were 
examined for optimal expression o f HRP under standard expression conditions.
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Figure 3.12: The optimal host strain for maximal HRP production was initially investigated: ■ glucose 
(2% w/v) repressed cells were used as a negative control, cells induced with ■ 50/iM IPTG or grown ■ 
non-induced overnight, 220 rpm at 30°C.
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Figure 3.13: Investigation of the optimal host strain for maximal HRP production. (R), glucose (2% w/v) 
repressed cells were as a negative control; (N), non-induced or induced (I) with 50/xM IPTG. Cells were 
grown overnight, 220 rpm, at 30°C. Cell contents were lysed by short sonication. No overexpressed 
protein bands are visible in any of the strains; however, the TMB activity assay suggests that XL10 Gold 
cells express functional recombinant protein, although at a low level.
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3.7.2 Determination of optimal culture temperature.
The optimal culture temperature for maximal HRP production was also investigated. 
XL10 Gold cells were grown in the presence o f glucose (2% w/v) as a negative control; 
cells were either induced with 50 ßM  IPTG or grown non-induced at both 30°C and 
37°C, for 18 hours at 220 rpm.
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Figure 3.14: TMB assay of HRP catalytic activity for lOmL XL10 Gold lysate, at both 30°C and 37°C.- 
o — Wildtype repressed 30°C, o - Wildtype repressed 37°C, -  A -  Wildtype noninduced 30°C, A -  
Wildtype noninduced 37°C, -  □ -  Wildtype Induced 30°C, -  □ Wildtype Induced 37°C. The plots for 
repressed growth curves overlap exactly.
The optimal culture conditions for maximal HRP production were also investigated. 
XL10 Gold cells were grown in the presence o f glucose (2% w/v) until an ODgoonm until 
expression was to commence, as outlined in Section 2.24.5.
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Figure 3.15: Investigation of optimal culture conditions. HRP expression was repressed by use of 2% w/v 
glucose. Cells were grown in the absence or presence of glucose until the correct OD6oonm for expression 
was reached. Once OD6oomn reached 0.5, the glucose was removed by exchange of culture media, and the 
cells were allowed to grow non-induced (F) or induced with 50/iM IPTG (C) for 18 hours at 30°C, 220 
rpm. The cells grown in the absence of glucose were also induced with 50/xM IPTG (D) at this OD60onm, or 
allowed to grow non-induced (E). Negative controls, namely empty pQE60 vector (A) and repressed 
pBR_I (B), are included.
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Figure 3.16: Plot of minimal glucose concentration (w/v) to allow cells to reach OD600nm equal to 0.5, 
prior to production of HRP activity.
3.7.3 Investigation o f  HRP expression over time.
XL 10 Gold cells containing pBR_I were grown in Superbroth medium, supplemented 
with 50/5 (Section 2.2.3), over an extended period to ascertain the optimal growth time 
for maximal HRP production.
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Figure 3.17: Plot of HRP activity versus E.coli growth (-o - )  at 30°C, 220 rpm. Individual lOmL 
cultures were taken for each time point to minimise contamination due to extended culturing time. (■) 
Cell periplasmic fractions, (□) Cell supernatant fraction. Endogenous E.coli peroxidase activity has been 
subtracted from the values noted here.
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Figure 3.18: Plot of HRP activity versus E.coli growth (—o —) at 37°C, 220 rpm. Individual lOmL 
cultures were taken for each time point to minimise contamination due to extended culturing time. (■) 
Cell periplasmic fractions, (□) Cell supernatant fraction. Endogenous E.coli peroxidase activity has been 
subtracted from the values noted here.
3.8 Recombinant HRP Purification.
3.8.1 Recombinant HRP N ickel Affinity Purification.
Immobilized nitrilotriacetic acid nickel ion resin was used to purify the expressed 
recombinant HRP to a high degree.
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Figure 3.19: Purification of recombinant HRP via nickel affinity chromatography. Equal amounts of 
enzyme activity were loaded in each case. Various nickel resins were utilised to obtain the optimal 
purification conditions: Qiagen nickel resin, no salt ■; Sigma nickel resin, no salt ; Qiagen nickel resin 
with 1M NaCl ■; Sigma nickel resin with 1M NaCl ■. Total activity for each fraction is noted on Y-axis.
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Figure 3.20: Part (A) shows a 12 % SDS PAGE of a typical rHRP purification (RT, Runthrough; W l, 
wash one; W2, was two; El elute one) with purified rHRP band highlighted. Part (B) compares the crude 
lysate from osmotically lysed cells (CL), XL 10 Gold containing pBR I osmotically shocked, periplasmic 
contents, to the purified and concentrated rHRP (CP). It should be noted that Sigma WideRange™ 
standard markers (M) are utilised in Part (A), whilst Amersham Rainbow Markers™ (M)are utilised in 
Part (B).
Initially, this method was difficult to reproduce (see Section 3.9.5 for reasoning), and so 
conventional purification techniques (hydrophobic interaction chromatography, size 
exclusion chromatography and anion exchange chromatography) were implemented.
3.8.2 Recombinant HRP Classical Purification.
From continual growth curves (see Section 3.7.3) HRP activity was noted in the 
bacterial cell culture supernatant, due to the fusion o f the periplasmic localisation leader 
sequence (PelB) to the HRP gene. To minimise contaminating protein, rHRP was 
precipitated from the cell culture supernatant with 50% w/v ammonium sulphate after 
removal o f cell biomass and conventional protein purification methods were applied to 
this fraction. The optimal ammonium sulphate concentration required to precipitate the 
protein was estimated (Figure 3.21) and the precipitated proteins were subjected to 
sequential hydrophobic interaction, size exclusion and anion exchange purification 
procedures. This conventional purification strategy was also implemented in the 
purification of non-His tagged recombinant HRP (Figures 3.22 to 3.24).
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Figure 3.21: Effect of varying concentrations of ammonium sulphate on rHRP precipitation from the 
bacterial cell culture medium. The TMB assay was used detect rHRP in the culture supernatant (□) or 
precipitated protein pellet (■). Approximately 50% ammonium sulphate precipitates rHRP.
Following its precipitation from the bacterial cell culture supernatant, rHRP was 
dialysed overnight against 50mM sodium phosphate buffer (pH 7.5) to remove the 
precipitating ammonium sulphate salt.
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Figure 3.22: Typical plot of hydrophobic interaction purification of wildtype recombinant HRP. 
Fractions exhibiting the highest peroxidase activity (see boxed area on graph), as denoted by TMB assay 
(O), and protein concentration, denoted by BCA assay (□), were pooled, dialysed overnight and 
concentrated (PEG) prior to application onto size exclusion column.
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Figure 3.23: Typical plot of size exclusion purification of wildtype recombinant HRP. Fractions 
exhibiting the highest peroxidase activity (see boxed area on graph), as denoted by TMB assay (O), and 
protein concentration, denoted by BCA assay (□), were pooled, dialysed overnight and concentrated 
(PEG) prior to application onto DEAE Sepharose column.
Figure 3.24: Typical plot of anion exchange purification of wildtype recombinant HRP. Fractions 
exhibiting the highest peroxidase activity (see boxed area on graph), as denoted by TMB assay (O), and 
protein concentration, denoted by BCA assay (□), were pooled, dialysed overnight and concentrated 
(PEG) prior to further characterisation.
3.8.3 Optimised Recombinant HRP Niekel Affinity Purification.
Studies o f the conventionally purified rHRP (see Figure 3.33) suggested that the rHRP 
molecule formed dimers, which may have obscured the poly-His purification tag. Use 
of the combined osmotic/lysozyme treatment, with the inclusion of 200mM guanidine 
hydrochloride in the purification buffer, dramatically improved IMAC reproducibility 
and enhanced purification factors and yields (see Table 3.2).
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Table 3.1: Typical purification table for lysed cell recombinant A His HRP (non-His tagged HRP), purified via conventional chromatography methods.
Purification
Method
Fraction Vol
(mL)
Protein Conc 
(mg.mL1)
Total
Protein
(mg)
Activity
(/¿mol.inin~1.mI)
Total
Activity
(/anoi.min)
% Recovery Specific
Activity
Q trooI.m in.nig'1)
Purification
Factor
Crude 15 3.486 52.27 1.02x1 O'2 1.53x1 O'1 100 2.9 x 10'J 1.0
Post HIC 6.0 1.525 9.15 2.6 x 10'j 1.56 x 10'2 11 1.7 X  10° .58
Post Cation 0.6 4.805 2.88 4.96 x 10'J 2.9 x 10'3 1.32 1.0 x 10 .59
Post Size Ex 9.5 0.189 1.80 4.28 x 10^ 4.06 x 10_J 1.85 2.3 x 10'j 2.3
Post Anion 10.5 0.133 1.40 3.23 x 10-4 3.39 x 10“J 1.54 2.4 x 10'J 1.1
Table 3.2: Typical purification table for osmotically lysed recombinant His HRP, purified via nickel affinity chromatography.
Purification
Method
Fraction Vol 
(mL)
Protein Conc 
(mg.mL1)
Total
Protein
(mg)
Activity
(/tmol.nUn'.nil)
Total
Activity
(¿tmol.mm)
% Recovery Specific
Activity
(/i mol. min. mg'1)
Purification
Factor
Crude 15 2.24 3.3 x 10" 4.13 x l0 ‘2 6.20 x 10'1 100 1.8 x 10 z 1
Post Ni 15 0.05 0.75 2.55 x 10'2 3.81 x 10'1 62 5.8 x 101 27
3.9 Recombinant HRP Characterisation
3.9.1 Protein Determination
The BCA assay was used to quantify the protein present in a sample. Protein 
concentrations were measured before and after a purification step and also prior to 
characterisation of the native recombinant or mutant forms o f HRP. Bovine serum 
albumin (BSA) was used to construct the standard curve.
Protein Cone (/ig.mL'1)
Figure 3.25: Standard curve of bovine serum albumin (BSA) for the determination of protein, as detailed 
in Section 2.28.
3.9.2 Determination o f amine groups and UV-visible spectrum of rHRP.
The TNBS assay (Section 2.31) can be used to determine the number of free amines, 
and hence the number o f lysines, before and after site directed mutagenesis studies. N- 
a-acetyl-L-Lysine was used to construct the standard curve for this assay: its 
composition has only one available amine group and, hence, an accurate standard curve 
could be developed. HRP has three available lysines under normal physiological 
conditions (O’Brien et al., 2001).
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Figure 3.26: Standard curve o f N-a-acetyl-L-Lysine for the determination of amines by TNBS method.
The UV-visible spectrum o f a concentrated (5piM) recombinant HRP sample in 50mM 
sodium phosphate pH 7.5 was determined. A Soret peak was observed at approximately 
403nm and was attributed to the absorbance o f the iron in the heme group. The 
Reinheitzahl (RZ) purity ratio (A403/A280) can be used to determine the purity o f  a HRP 
mixture, and is particularly useful after purification procedures. It should be noted that 
the absorbance peak at 280nm was attributed to the aromatic amino acid residues, with 
a contribution from the heme moiety (Dunford, 1999). Typical RZ values recorded in 
this study were circa 1.1; however, these varied between 0.3 and 1.5. Arnold and co­
workers also noted poor RZ values for rHRP expression (Arnold and Lin, 2000).
3.9.3 TMB Assay Optimisation.
The HRP in this study was produced via heterologous expression in a prokaryotic cell 
line, and existing catalytic activity assays designed for plant enzyme had to be 
optimised for this form o f the enzyme. TMB assay optimisation was carried out as per 
Section 2.30.1, with the assay based on previous work by Ryan (1992, MSc Thesis, 
DCU). The variables analysed were reaction time, H2O2 concentration and HRP 
concentration (Figs 3.27-3.29). Initially the optimal time was deduced, and the reaction 
is seen to produce product linearly for 8 min, with an R2 of 0.98. From this graph, it 
was concluded that optimal TMB readings should be taken after 6.5 min (Figure 3.27).
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Figure 3.27: Plot of TMB reaction versus time for purified wild type rHRP (10 fig/L). The catalytic 
reaction is linear for 8 min, as indicated by the trend-line and R2 value of 0.98.
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Figure 3.28: Plot of TMB reaction versus time for purified wild type rHRP(10 fig/L), with varying 
concentrations of H20 2. The diagram focuses of the initial phase o f activity, with the final concentrations 
of H20 2 being 0.003% ( -0 - ) ,  0.004 % ( -□ ), 0.005% (-A -)  and 0.006% ( -o ).
Reaction Time (s)
Figure 3.29: Plot of TMB reaction versus time varying concentrations of rHRP: 100//g/L (-□ -), 50/zg/L 
( -o -) ,2 5 /ig ^ (  \ ), 12.5#ig/L( ■ ), 10iig/L( • JandS^g/Li )
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3.9.4 Thermal Stability of wild type recombinant HRP.
3.9.4.1 Thermal profile.
Characterisation of mutants (Chapters 4, 5 and 6) included thermostability analysis, so 
the recombinant wildtype was first compared with commercial plant HRP (Type VI, 
Sigma). This involved constructing a thermal profile o f  the protein, completing from 
this a thermal inactivation at constant temperature and, hence, computing the half-life. 
The thermal profile involves varying temperature at constant incubation time. Residual 
catalytic activity was plotted versus incubation temperature, and the T50 (the 
temperature at which the enzyme displays 50% of its maximal activity) was calculated.
Incubation Temperature (°C)
Figure 3.30: Thermal profile of wildtype plant A- , wildtype recombinant His Tagged , wildtype 
recombinant Non-His Tagged HRP As expected, the recombinant HRP is less stable than plant HRP, 
probably due to lack of posttranslational modifications such as glycosylation (Tams and Welinder, 1998).
T50 of recombinant HRP was estimated, by graphical inspection, to be 50°C, whilst the 
commercially available (Sigma) plant HRP was seen to have a T50 o f approximately 
55°C. The recombinant HRP T50 temperature was used for thermal inactivation. Very 
little difference can be seen between HRP His and HRPAHis.
107
3.9.4.2 Thermal inactivation of wild type recombinant HRP.
A thermal inactivation assay measures activity loss versus time at constant temperature, 
preferably at the enzyme’s T50, which is derived from a thermal profile experiment. The 
T5o suggested by the thermal profile was 50°C; however, at this temperature, complete 
inactivation o f His tagged HRP (conventionally purified from whole cell extract) was 
not achieved. Hence, the thermal inactivation was repeated at higher temperatures, 
55°C and 65°C respectively. Once pure rHRP was obtained, a wildtype lv a lu e  o f 0.056 
min' 1 was noted.
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Figure 3.31: Thermal inactivation of wildtype recombinant His tagged HRP at 50°C. Residual activity 
was measured utilising standard TMB conditions, as outlined in Section 2.30.
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Figure 3.32: Thermal inactivation of wildtype recombinant His tagged, conventionally purified, HRP at 
50°C, -A-55°C, - o -  65°C. Unlike plant enzyme, the recombinant form does not undergo first order 
inactivation. Previous reports cited HRP as following pseudo 1.5 order inactivation (Chang et al, 1988); 
however, pseudo first order inactivation can be achieved by plotting the data from the first 10min of 
inactivation, as outlined in Figure 3.31.
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3.9.5 Native Gel Electrophoresis.
A concentrated wildtype His tagged recombinant sample, conventionally purified from 
whole cell extract, was electrophoresed through a 12% acrylamide native gel, as 
outlined in Section 2.27.3. The gel was then developed in various HRP substrates 
overnight at 4°C, with gentle mixing.
TM B stain ABTS stain DAB stain OPD stain
Figure 3.33: Native gel electrophoresis of concentrated wildtype rHRP. Various HRP substrates were 
utilised to stain the native gel. Each produced two bands of intensity, of approximately 45kDa and 66kDa 
respectively. TMB and ABTS staining yielded the most visible results.
The formation of two bands of peroxidase activity was unexpected; however, it can be 
attributed to the native peroxidase activity o f the host E. coli cell, XL10 Gold 
(Bakalovic et al., 2006). To elucidate which band the E. coli contributes, a native gel 
containing empty vector and rHRP was stained using TMB substrate.
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Figure 3.34: Part (A) shows native gel electrophoresis o f  empty pQE60 vector and wildtype rHRP. The 
empty pQE60 vector displays a single, weak band at approximately 45kDa. Purified His tagged rHRP, 
however, yields a strong activity band at approximately 66kDa. However, this gel (A) was overloaded 
with rWT TMB, as signified by intense staining through resolving section. Gel (B) utilised a lower 
concentration o f  WT rHRP, and single, clear band is evident. TM B was utilised to stain the native gel, at 
4°C overnight with gentle mixing. Coomassie stain was use for marker staining. Markers are for 
illustrative purposes only.
A constant residual activity was noted during thermal inactivation assay (see Section 
3.9.4.2) with an initial rapid decrease in activity followed by a prolonged period, 
greater than one hour, o f residual activity (results not shown). To investigate if the 
native E. coli peroxidase activity contributed to this, a sample o f concentrated rHRP 
was subjected to 55°C for 15 min prior to loading onto the gel.
RT 55°C
Figure 3.35: Native gel electrophoresis o f  concentrated wildtype rHRP incubated at room temperature 
(RT) or 55°C for 15min prior to addition to native gel. TMB was utilised to stain the native gel. Two 
bands were noted in the RT sample; however, only one band, o f  approximately 45kDa, was noted in the 
55°C treated sample.
rHRP samples utilised in Section 3.9.5 were purified by conventional purification 
procedures from lysed E.coli cells via sonication. This method of cell disruption causes 
the entire contents o f the cell to be ejected into the purification buffer. To reduce the 
amount of contaminating protein introduced to the purification buffer, cells were lysed 
via osmotic shock and lysozyme treatment, to release only the proteins secreted to the 
periplasm of the E.coli cell (see Figure 3.36). This, combined with the addition of a 
mildly chaotropic agent, 200mM guanidine hydrochloride, facilitated optimal His Tag
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purification by IMAC (Section 3.8.2). His Tagged purified rHRP was utilised in all 
characterisation assays (see Sections 3.9.3, 3.9.4.2, 3.9.6, 3.9.7, 3.9.8 and 3.9.9).
Figure 3.36: Native gel o f XL10 Gold HRP-producing cells lysed with osmotic shock (O), lysozyme 
treatment (L) and combined osmotic/lysozyme treatment (C). TMB was utilised for staining. A single 
band of TMB activity was noted for all methods utilised. The combined osmotic/lysozyme treatment 
appears to yield the band with greatest peroxidase activity.
3.9.6 Organic Solvent Tolerance.
Organic solvent tolerance assays were carried out as per Section 2.34, with a final 
protein concentration o f 100 /¿g.mL'1 in the reaction solution. Solvent tolerance profiles 
were produced for wildtype recombinant HRP, in triplicate, for each solvent tested. All 
standard errors were within <5% of the triplicate average reading, with the errors bars 
omitted from the graphs for the sake of clarity.
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Figure 3.37: Solvent Tolerance Profile of wildtype recombinant His-tagged HRP, □ MeOH, 0 DMSO, A  
DMF.
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The C50 value was utilised as an indicative value for organo-tolerance; this value is the 
% v/v of organic solvent that causes a 50% decrease in enzymatic activity. DMSO, 
MeOH and DMF yielded C50 values o f 35 % v/v, 53 % v/v, 14 % v/v respectively.
3.9.7 H2O2 Tolerance.
The stability o f recombinant wildtype His tagged HRP to H2O2 was measured as per 
Section 2.35, with a final rHRP concentration o f 360 nM in each reaction. In the 
presence of excess H2O2 and in the absence o f a suitable reducing substrate, HRP 
displays suicide inactivation. Profiles were produced in triplicate, and standard errors 
were noted as less than 1 0  % for all data points.
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3.9.8 ABTS Kinetic Analysis.
ABTS was utilised as reducing substrate for steady state kinetic analysis as per Section 
2.36, with apparent k3 and K’m values calculated by plotting the data generated in the 
software package Enzfitter (see Figure 3.39). Utilising a validated microtitre plate 
approach, the apparent kj for recombinant wildtype was calculated as 333 s' 1 (± 25 s '1), 
whilst the apparent K’mmodelled to be 2.04 mM (±0.06 mM).
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Figure 338: H20 2 tolerance profile for native recombinant His-tagged HRP.
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Figure 3.39: Purified native recombinant IIRP steady state kinetic data, utilising ABTS as reducing 
substrate, plotted using the Enzfitter M programme (Biosoft, Cambridge, UK) modelled to a Michaelis- 
Menten curve. Rate = A405; A405/ €AbW  time = /¿mol.min'1
3.9.9 Western Blot Analysis.
Western Blot analysis o f native recombinant HRP exploited the C-terminal poly 
Histidine purification tag and was carried out as outlined in Section 2.27.2. The results 
confirm the expected size of the denatured recombinant rHRP molecule o f circa 34,000 
Da. This also demonstrates the effect o f denaturing the molecule to reveal the buried 
His-tag, as on a native gel no signal is noted after probing with an anti-(His)6 antibody.
113
A M,[X IcH) B
250 
. 160 
■ 105
75
30kDa
10
Figure 3.40: Western blot analysis of purified wildtype recombinant HRP. Part (A) represents the 
relevant sizes of the Rainbow Markers™. Lane 1 in Part (B) displays the positive control, lane 2 shows 
the standard marker and lane 3 illustrates rHRP. The positive control is the Intemalin protein, 
recombinantly expressed as a His-tag fusion protein in E.coli, which has a molecular weight of 
approximately 68kDa (Leonard P, PhD Thesis, DCU), Initially rHRP, standard markers and positive 
control were electrophoresed though a 12% SDS-PA gel. This was transferred onto a nitrocellulose 
membrane and probed with an anti-His tag murine antibody, which was in turn probed with an anti­
mouse IgG antibody labelled with the reporter protein, alkaline phosphatase. The blot was developed 
with BC'IP/NBT substrate. The blot reveals the size of the rHRP molecule as being circa 34,000 Da, 
similar to that previously reported (Smith et al., 1990)
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Figure 3.41: Western blot analysis of various purified rHRP mutants, to verily correct His tag 
incorporation into rHRP mutant proteins (see Chapter 4 for more information). The blot is arranged as 
follows: (1) wildtype rHRP, (2) Rainbow Markers1, . (3) KI74N, (4) K174E, (5) K.174N, (6) K232N, (7) 
K2324E, (8) K232N, (9) K241N, (10) K241E, (11) K241N. All the mutants display a His tag that is 
recognised by the murine-based anti-His tag antibody, and are of similar size to wildtype rHRP,
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3.10 Discussion.
3.10.1 Choice o f Expression Vector and Host.
The aim of this section of the project was to clone the HRP gene into an appropriate 
expression vector and express this gene construct within a suitable bacterial expression 
host. pQE60 (Qiagen) was chosen as the host vector due to its noted high expression of 
His tagged proteins. It also has several advantageous features, including an optimised 
promoter-operator element consisting of the T5 promoter (recognised by E.coli RNA 
polymerase) and the lac operator sequence (which binds the lac repressor and ensures 
repression of the powerful T5 promoter). The vector also contains a synthetic bacterial 
ribosomal binding site (for high translation rates), a (3-lactamase gene (bla) which 
confers resistance to ampicillin to 1 OOjig.mL"1 (to allow for vector selection; used in 
conjunction with XL 10 Gold’s tetracycline and chloramphenicol resistance) and 
translational stop codons in all reading frames (to prevent read-through transcription 
and ensure stability o f the expression vector). Another key characteristic o f the pQE60 
vector is the presence of C-terminal poly-His tag, which allows for convenient one-step 
purification via IMAC (Qiagen, 2003).
The expression host chosen was E. coli XI-10 Gold cells (Stratagene), as this strain is 
capable o f high expression o f recombinant protein, and is both chloramphenicol and 
tetracycline resistant (Section 2.1.1). This allows for the use o f three antibiotics in the 
production o f the recombinant protein, minimising the chance o f non-transformed cells 
growing in the reaction vessel. It should also be noted that the XL10 Gold strain 
harbours the la c f  mutation which allows the cell to produce naturally enough lac 
repressor to block transcription until an inducer, e.g. IPTG, is added to the reaction 
broth. As such, these cells can be seen to work in tandem with the pQE60 vector and, 
therefore, act as a strong expression system for recombinant proteins (Stratagene, 
2004).
The inclusion o f a suitable leader sequence in-frame with the gene of interest allows for 
translocation o f the expressed protein to the bacterial envelope and the cell culture 
medium. Use o f the PelB leader has increased in popularity, with many cited reports of 
successful translocation o f expressed proteins noted (Mergulhao et al., 2005 and 
references within). Inclusion of the PelB leader has allowed for translocation o f 
recombinant proteins to both the periplasmic space (Barth et al., 2000) and the culture 
supernatant (Zambonelli et al., 2004). Secretion of recombinant proteins to the culture
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medium or periplasm of E. coli has several advantages over intracellular production, 
including simplified downstream processing, enhanced biological activity, higher 
product stability and solubility, and N-terminal authenticity o f the expressed peptide; 
however, the exact mechanism of translocation is not yet fully understood (Comelis, 
2000).
3.10.2 Cloning Difficulties.
As outlined in Section 3.2, the MCS of pQE60 contains the unique restriction sites, Nco 
I, BamH I and Bgl II. These restriction sites, however, were also present in the HRP 
gene sequence (or were proposed as mutagenic screening sites), and so could not be 
utilised in directional cloning. Hence, the vector was engineered to contain additional 
unique restriction sites, primarily introduced via the cloning of the PelB leader 
sequence, as outlined in Section 3.2.
Initially, the PelB leader was cloned Nco I - BamH  I, with the HRP gene cloned second 
via the introduced Not I site and the Hind III site 3’ of the poly His tag. This cloning of 
the HRP gene required the re-introduction of the poly His tag, as the vector His tag had 
been removed. This was achieved by including exactly the same poly-His sequence in 
the reverse HRP primer as was on the original vector. Unfortunately, however, this 
construct was one base pair out o f frame with the initiation methionine included in the 
Nco I site, although the PelB leader and the HRP gene were in-frame with each other. 
This led to erratic HRP production and the requirement to subclone the PelB-HRP 
construct. Thus, the PelB-HRP construct was amplified utilising the “BspH I For” and 
“HRP_ H isR ev” primers outlined in Section 2.1.3. This PCR introduced a BspH I site 
5’ to the PelB sequence and allowed the in-frame PelB-HRP His to be cloned into the 
BspH  I -  Hind III cut vector. The “BspH I For” primer also contained two additional 
bases between the initiation methionine residue and the first base in the PelB Leader 
sequence to maintain the correct reading frame. The bases ‘GC’ were inserted between 
the start ATG in the BspH  I site and the first base of the PelB Leader sequence. This 
introduced a small neutral amino acid, serine, between the initiation methionine and the 
primary alanine of the PelB leader. Also, upon sequencing, it was confirmed that a 
region of the His tag encoded by the primer had been deleted, resulting in poor 
purification yields. To circumvent this problem, the PelB-HRP construct was amplified 
with “BspH I For” and “HRP Rev” primers that allowed BspHI -  BamHI insertion of
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the HRP-PelB construct. Sequencing confirmed the presence of the PelB-HRP-His 
construct, with correct reading frame.
3.10.3 Expression of HRP gene in E. coli.
The HRP gene cloned into the pQE60 expression vector contained a point mutation, 
A34P, which was present prior to cloning. This point mutation was reverted to wildtype 
before any expression or characterisation work was carried out on the recombinant 
protein. Once reverted to wildtype (see Section 4.4) the protein was expressed in 
various cell lines, to select for the optimal host and growth conditions. It was noted that 
XL10 Gold was a superior host to all other E.coli strains investigated. It was also 
discovered that rHRP activity was highest in cell lines that had not been induced with 
IPTG, concurrent with previous work with this gene (Arnold and Lin, 2000). Non­
induced, “leaky” expression has previously been noted in other pQE-based vector 
systems (Liu et al., 1999) and hemoproteins (Vamado and Goodwin, 2004). Indeed, if 
IPTG is added, the cell turbidity begins to drop (data not shown); suggesting that 
overproduction of HRP is somewhat toxic to the cell. Similarly, Jung and co-workers 
(2001) again utilising a pQE-based expression vector, noted an increased ratio of 
holoprotein to apoprotein with decreased addition o f IPTG. Jung suggests that slow 
recombinant hemoprotein production allows for maximal holoprotein production, due 
to the small concentrations of apoprotein acting as heme sinks, binding all available 
heme in the system (Jung et al., 2001). Reduced culture temperatures, limited gene 
induction or utilisation of gentle induction procedures achieves slow recombinant 
protein production. As such, it was noted that rHRP activity was higher in cell lines 
cultured at lower temperature, 30°C as opposed to 37°C. The higher activity could be 
directly attributed to the slower production of the recombinant protein, due to the lower 
growth temperature. Slower production allows for correct folding of the recombinant 
protein and minimises inclusion body formation (Hoffmann et al., 2004), a problem that 
has plagued recombinant HRP production for years (Smith et al., 1990). Use of the 
periplasmic localisation fusion protein, PelB leader, also helps to minimise inclusion 
body formation and the non-reducing environment o f the periplasm is conducive to 
formation o f disulfide bonds, o f which HRP has four. The periplasm is also noted as E. 
coifs  calcium repository, maintaining three times as much free Ca2+ as the cytosol 
(Jones et al., 2002). HRP contains two Ca2+ ions per molecule, and Ca2+ is critical to 
HRP folding and stability (Tams and Welinder, 1998). Overexpression o f HRP is not 
seen after SDS-PAGE analysis o f the cleared cell lysate, although this is probably due
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to the fact that no inducer is utilised in this study. Overexpression of recombinant 
hemoproteins is notoriously difficult, due mainly to the reduced rate o f bacterial heme 
biosynthesis in comparison to recombinant protein production (Vamado and Goodwin, 
2004). Addition of the rate-limiting heme precursor, 5-aminolevulinic acid, may 
increase the bacterial heme biosynthesis; however, this becomes economically unviable 
at large production scales. Repression of HRP expression can be achieved by simple 
addition of 2 % w/v glucose. If the cells are repressed by glucose addition, and 
subsequently transferred to glucose-free medium, increased expression is noted; see 
Figure 3.15. This suggests that initial repression of recombinant protein production 
allows the host cell to grow to a density at which it can later support the production of 
the recombinant protein. Recently, Studier (2005) reported a simple auto-induction 
media, which reduces the “hands-on ” nature of protein expression. The requirement to 
physically remove the cells from the glucose-containing medium, via centrifugation, 
was eliminated by employing the minimal concentration of glucose required to prevent 
HRP expression prior to attainment o f a suitable OD6oonm for cell growth. A final 
glucose concentration between 0.05 and 0.1% w/v resulted in minimal rHRP expression 
at an E. coli cell density (OD6oonm) equal to 0.5. At this point the host cell will consume 
the majority o f the glucose, and it will begin utilising other carbon sources, allowing 
leaky expression o f the HRP gene. Utilising these optimal conditions, an extended 
growth-versus-production study was carried out, which noted maximal HRP activity 
after 24 hours’ growth at 30°C. As the rHRP located in the periplasmic fraction reached 
its maximum production point, rHRP activity was also noted in the cell supernatant. 
With increasing time, the rHRP activity in supernatant fraction began to increase whilst 
the periplasmic fraction showed decreased activity, suggesting a migration of the rHRP 
from the periplasmic space to the cell supernatant. When XLlOGold cells containing 
pBR I were grown at 37°C, an initial burst o f rHRP activity was noted; however, this 
dropped quickly over eight hours. Similar to cells grown at 30°C, a decrease in 
periplasmic activity coincided with an increase in supernatant activity. However, the 
peroxidase activity was much lower for the 37°C production compared with 30°C.
3.10.4 Recombinant HRP Purification.
Immobilized nitrilotriacetic acid was utilised to purify the recombinant HRP. Initially, 
purification results were difficult to reproduce. Instead, conventional purification 
techniques were utilised to purify the protein but these met with limited success due to
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the large concentrations of contaminating proteins in the sonicated cell fraction. To 
reduce this problem, HRP was purified from the cell periplasm and the cell supernatant, 
where it was noted after 24 hours growth. The periplasm is known to contain 
approximately 100 native E. coli proteins, as compared to the 4,000 present within the 
cytoplasm; hence, considerable purification and concentration o f a recombinant protein 
is achieved by targeting a protein to the former (Blattner et al., 1997). Additionally, 
simple osmotic/lysozyme treatment allows release of the recombinant protein from the 
bacterial envelope. Purification from the supernatant is complicated by the dilute nature 
of the recombinant protein; however, protein precipitation can circumvent this problem. 
Secretion removes the recombinant protein from the potentially deleterious action of 
native E. coli proteolytic enzymes and may result in increased expression, although 
many o f these strains are protease-deficient anyway. Gene fusions facilitating protein 
purification, such as His Tags, have developed rapidly in recent years; and can provide 
up to one hundred-fold purification in optimal conditions. Despite the original promise, 
however, several reports have noted the poor performance o f IMAC chromatography. 
IMAC can be seen as a cost effective, high-throughput single step purification 
procedure; however, drawbacks include the poor capture of some proteins (Loughran et 
al., 2006), interference with crystallographic procedures (Lichty et al., 2005) and effect 
of the His tag length on protein termini (Mohanty and Wiener, 2004). In this study, 
poor recombinant protein capture was attributed to protein dimer formation, which in
• '2H- , , ,turn blocked His tag -  Ni interaction. Recombinant HRP is known to form dimers in 
reverse micelles (Gazaryan et al., 1997) and it is plausible that this also occured in this 
study; simple addition o f 200mM guanidine hydrochloride (mildly chaotropic) and 1M 
NaCl (prevents non-specific hydrophobic interaction with the nickel resin) to the 
purification buffer dispels the putative dimer and allows the His Tagged protein to bind 
to the resin. It should be noted, however, that recent research has highlighted the 
inhibitory role o f nickel on HRP. Two nickel molecules bind to a single HRP molecule, 
leading to complete catalytic inactivation (Keyhani et al., 2005). This may cause 
difficulty in the purification o f rHRP utilising nickel affinity chromatography. In this 
study, rHRP / nickel contact times were minimised to reduce the possible protein 
inactivation. Typical yields o f rHRP were 0.65 /¿mol.L'1 fermentation. Although a low 
RZ value, approximately 1.1, was routinely noted for this purified fraction, the presence 
of purified apoprotein can account for increased A280nm without an equal increase in 
A 403nm-
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3.10.5 Recombinant HRP Characterisation.
3.10.5.1 Chromogenic Assay Optimisation.
The TNBS assay can be used to determine the number o f free amines, and hence the 
number of lysines. It was envisaged that this technique would allow quantification of 
the number o f lysines present in the rHRP molecule before and after lysine 
mutagenesis. However, very high concentrations o f rHRP were required to accurately 
carry out this procedure and, due to the non-induced nature o f the expression protocol, 
these concentrations could not be achieved. This remains a very useful technique for 
lysine content characterisation for chemical modification of native proteins.
The TMB assay was optimised for use with recombinant HRP, as it had previously 
been devised for plant HRP (Ryan et al., 1994a). The microplate-based assay was 
optimised for reaction time, H2O2 concentration and HRP concentration. It should be 
noted that Tween 20, to a final concentration of 0.001% (v/v), was added to the reaction 
buffer, as HRP can be inactivated by polystyrene microplates in its absence (Berkowitz 
and Webert, 1981). By using a suitable hydrogen donor, HRP activity can be measured 
indirectly by following the transformation o f the hydrogen donor, which in the case of 
TMB is represented by a change in colour o f the reaction well, from colourless to blue. 
The intensity o f blue colour formation is proportional to the quantity o f HRP present. 
TMB has an absorbance peak of 650nm; however, this particular narrow-band filter 
was not available for microplate readings. A broad scan o f the spectral region 600nm to 
700nm demonstrated that the absorbance peak has a broad shoulder, so readings at 
620nm were adequate. To further increase the sensitivity o f the TMB assay, the 
reaction can be terminated with strong acid, at which point the colouration changes 
from blue to bright yellow due to the loss o f two electrons from the substrate (Josephy 
et al., 1982). The absorbance peak changes to 450nm and a 2-4-fold increase in 
sensitivity is noted (Bos et al., 1981); however, this latter procedure was not 
implemented in this study. The HRP concentration that led to continual linear product 
formation over the experimental timeframe was approximately 12.5 /¿g/L, with the 
optimal concentration of 10M H2O2 stock being 0.003% (v/v; 3mM final concentration) 
and the optimal reaction time being 6.5 minutes. This reaction time is longer than that 
previously reported (Miland, 1996, PhD Thesis, DCU); however, a much smaller 
concentration of HRP was utilised in this study.
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3.10.5.2 Thermal Stability.
Thermal studies formed the basis o f initial rHRP characterisation. Wildtype 
recombinant and plant HRP were both subjected to ramped 10 min incubations at 
increasing temperatures, to plot the enzyme’s thermal profile. It was seen that plant 
HRP is more stable than recombinant HRP; plant HRP displays a T5o of 55°C, while 
rHRP’s is 50°C. The difference could perhaps be attributed to the stabilising effects o f 
the glycan residues on the surface o f the plant HRP molecule (Tams and Welinder,
1998) and possibly the pyroglutamyl blocked N-terminus. Posttranslational 
modifications such as glycosylation cannot be carried out by prokaryotes such as E. 
coli.
The thermal profile suggested that the thermal inactivation assay be carried out at 50°C; 
however, when the rHRP was incubated at this temperature, an initial rapid decrease in 
enzymatic activity was followed by a slow steady decline, suggesting a two phase 
decline in stability. It was attempted to fit the resulting thermal inactivation data to both 
first- and second-order models o f decay; however, the data did not fit. It appeared as 
though two distinct peroxidase populations existed, the first being extremely heat 
sensitive, and the other less so.
Continued investigation into the two-peroxidase hypothesis resulted in native gels 
demonstrating two distinct bands o f peroxidase activity. Peroxidase activity was noted 
utilising TMB, ABTS, DAB and OPD as substrates. The upper band may be a dimer o f 
66 kDa; the latter figure predicted from the size of monomeric recombinant HRP (Smith 
et al., 1990). This size was also confirmed by Western blotting (see Section 3.9.9). It 
was believed that the lower band represents a native E.coli peroxidase-like protein. 
E.coli is known to possess at least two bacterial heme containing “catalase- 
peroxidases”, hydroperoxidase I and II. These molecules are larger (84 kDa; Dunford,
1999) than those noted in Figure 3.33; however, it is plausible that smaller bacterial 
peroxidase-like proteins exist (Bakalovic et al., 2006; Welinder et al., 2002). To confirm 
this, XL10 Gold cells, containing only empty vector, were lysed, electrophoresed and 
TMB-stained. The resultant band confirmed the presence of native E. coli peroxidase. 
To verify if  the second population of peroxidase activity contributed to the heat-stable 
portion o f the thermal inactivation plot, a rHRP sample was subjected to 55°C for 15 
min prior to loading onto the gel. The non heat-treated sample displayed two bands of 
TMB activity, corresponding to previous results; however, the heat-treated sample 
exhibited only a single, smaller band. This indicated that two peroxidase populations
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exist, and a requirement for further purification to remove this contaminating 
peroxidase. The rHRP samples utilised in these initial studies were purified by 
conventional methods; hence, a native E. coli protein with similar physio-chemical 
characteristics could co-purify with the recombinant HRP. To circumvent this problem, 
different cell lysis protocols were analysed in an attempt to release the rHRP protein 
from the cell periplasm without releasing the native E. coli peroxidase protein. 
Combined osmotic/lysozyme treatment released maximal rHRP, with minimal 
contamination. Inclusion of 200mM guanidine hydrochloride in the purification buffer 
also facilitates purification via the His tag, as it presumably disassociates the rHRP 
dimer and allows interaction of the buried hexa-His residue with the nickel resin.
Once a purified rHRP population could be produced consistently, further analysis was 
undertaken. Thermal profiling suggested a T50 of 50°C, for the purified His-Tagged 
rHRP molecule. With further thermal characterisation revealing a £-value o f 0.056 min' 1 
and ti/2 o f approximately 12.5 min at 50°C. The £-value is the rate constant in the single 
exponential decay model (Enzfitter, Biosoft, Cambridge, UK). Previous studies o f rHRP 
report lower /c-values of 0.032 min-1 but the latter was carried out at 65°C (O’Brien, 
PhD Thesis, 1997). Plant HRP is known to have a half-life o f ~ 6  min at 65°C (Miland et 
al., 1996) but the thermal profile (Figure 3.30) demonstrates that recombinant HRP is 
somewhat less stable than plant HRP. The possible role o f glycosylation is highlighted 
by Morawski and co-workers who noted that rHRP, expressed in S. cerevisiae 
demonstrates a T50 o f 67°C identical to the plant HRP utilised for comparison 
(Morawski, et al., 2001).
3.10.5.3 Solvent Stability.
Recombinant HRP’s organic solvent tolerance was also investigated in this study. The 
water miscible solvents investigated were chosen based on their theoretical denaturation 
capacities, methanol (low) and DMF (medium; Khmelnitsky et al., 1991a) and also on 
previous reported peroxidase characterisation (DMSO; Santucci et al., 2003). In all 
cases rHRP catalytic activity decreased with increasing solvent concentration, while the 
C50 value enabled comparison to previously published tolerances for plant HRP.
Previous solvent stability studies have been carried out on free (non-immobilised) and 
immobilised plant HRP. Plant HRP was found to retain almost 100% activity in 30% 
v/v DMSO at 30°C over a two-hour incubation period (Azevedo et al., 2001). Maeda 
and co-workers (2 0 0 2) noted that the microenvironment in the distal heme pocket was
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altered and activity decreased even in the presence of low concentrations o f DMSO. A 
large loss o f secondary structure and the disassociation o f the heme moiety from the 
apoprotein could be attributed to higher concentrations o f DMSO. Santucci and co­
workers (2002) further investigated the denaturation o f plant HRP by DMSO, 
concluding that below 60% v/v DMSO plant HRP retains a compact tertiary structure 
and substantial integrity o f the active site microenvironment; however, above 80% v/v 
DMSO, the heme group disassociates from the apoprotein. As noted in this study, 
recombinant HRP is less stable in DMSO than the plant enzyme, suggesting a role o f 
glycosylation in HRP stability in organic solvents.
The effect o f alcohols on plant HRP has also been investigated. It has been reported that 
ethanol alters the enzyme’s heme group by binding to the sixth coordination site 
(Dunford and Hewson, 1977), although it does not affect the active site or tertiary 
structure o f the protein (Ayyagari et al., 2002). Binding o f ethanol reduces the 
formation of compound I and activity decreases with increasing ethanol concentrations. 
The effect o f ethanol on the heme can be extrapolated to methanol as it is noted that the 
hydroxy group binds to the heme ligand (Sato et al., 1995). Sato and co-workers (1995) 
studied the effects o f methanol on the rate constants in the HRP catalytic cycle (see 
Figure 1.3). They noted that kiapp was moderately reduced by 50% v/v methanol, k2app 
was slightly affected, whereas k3app, the rate-limiting step, was greatly affected. As such, 
assuming that this coordinated ethanol remains bound upon dilution in aqueous buffer, 
increased methanol concentrations affect the rate at which the enzyme can complete its 
catalytic cycle and return to its resting state.
The mechanism o f DMF denaturation of HRP has not been discussed extensively in the 
literature; however, it has been stated that this organic solvent can affect an enzyme in a 
number o f ways, including reduced enzyme-substrate binding, alteration of the enzyme 
conformation, alteration of the reaction rate by changing the dielectric constant and/or 
the viscosity o f the medium, and by reduction of the water content close to the protein 
backbone (Batra et al., 1997). Previous reports of DMF-induced HRP denaturation 
conclude that loss o f activity is due to water stripping by the solvent (Gorman and 
Dordick, 1992) and a C50 o f - 8% v/v for the plant enzyme (Miland, PhD Thesis, DCU, 
1996) is similar to the value for rHRP found in this study.
123
3.10.5.4 H2O2 Stability.
H2O2, although a primary substrate for HRP catalysis, can also function as a suicide 
substrate if no secondary reducing substrate (e.g. TMB, ABTS, etc.) is available. 
Wildtype recombinant HRP yields a H2O2 C5o of 17 ±1 mM, which compares with 
previous published results o f 60% activity in 25 mM (Arnold and Lin, 2000) under the 
same conditions. It should be noted that the H2O2 concentrations and incubation times 
are much smaller for regular rHRP catalytic assays, such as TMB (3 mM, <10 min) and 
ABTS (ImM, 20min) and where a secondary reducing substrate is present. Hence, no 
suicide inactivation occurs during these assays.
3.10.5.5 Kinetic Characterisation.
Recombinant wildtype HRP was analysed for kinetic constants using the traditional 
ABTS chromogenic substrate. ABTS is commonly used to measure steady-state kinetics 
in peroxidases due to the fact that it is a “poor” substrate and, hence, allows a slow 
colorimetric kinetic quantification. However, it should be noted that peroxidases do not 
follow traditional Michaelis-Menten kinetics; instead, apparent k.3 and K’m values are 
recorded (Dunford, 1999). Initially, the experimental protocol was validated by 
comparison of plant HRP values derived from the traditional cuvette-based assay and 
the microtitre plate approach developed in this study. Previous results for plant HRP 
estimated apparent k3 as 321 ± 28 s'1), and an apparent K ’m o f 1.92 ± 0.07 mM (D. 
O’Brien, unpublished). Very similar results were noted with the microtitre plate 
approach: the apparent ks was 333 ± 25 s '1, whilst the apparent K’rawas 2.04 ±0.06 mM. 
Using the same microtitre plate method the apparent fc? for wildtype recombinant His- 
tagged HRP was calculated as 482 ±12 s'1, whilst the apparent K’rawas 0.093 ±0.01mM. 
These results compare well with previously reported apparent kCili and apparent Km 
values o f 670 ±12 s‘l (Smith et al., 1992) and 0.103 ± 0.01 mM (Grigorenko et al.,
1999) respectively. Other reducing substrates were utilised in additional kinetic 
investigations; however, several problems existed. Non-Michaelis-Menten kinetics 
occurred with TMB as the reducing substrate; however, this could be attributed to the 
fact that TMB is a very good peroxidase substrate and is turned over rapidly by the 
enzyme; thus, steady-state kinetics could not be analysed. Iodine was also assessed for 
Michaelis-Menten kinetic activity, however, a sigmoidal, as opposed to a Michaelian
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curve was achieved (data not shown). The use of the iodine reaction with HRP is known 
to be proportional to the concentration of H2O2 and commonly referred to as enzyme- 
catalysed clock reaction (Dunford, 1999). The potassium ferrocyanide assay required 
\ f iM plant HRP per datum point (data not shown). These peroxidase concentrations 
could not be achieved by recombinant HRP expression, so attempts to measure rHRP 
ferrocyanide kinetics were abandoned.
3.10.5.6 Western Blot Analysis.
Western blot analysis was carried out on a purified sample o f rHRP. Correct fusion of 
the His tag to the rHRP protein was confirmed by probing the transfer gel with an anti- 
His antibody. Western blotting also permitted rHRP molecular weight approximation. 
As outlined in Figure 3.40, the approximate size o f rHRP was estimated as 34,000 Da. 
This mirrors the previously published approximation of 33,000 Da (Smith et al., 1990). 
A set o f mutants (see Chapter 4) was also probed in a similar protocol to verify that 
mutagenesis does not interfere with His tag incorporation; all mutants tested generated a 
signal upon anti-His probing. Western blot analysis also verified the non-availability o f 
the rHRP His tag when the protein is suspended a buffer without dénaturants. No 
antibody signal was obtained from a similar experimental procedure utilising a native 
gel (SDS omitted).
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Chapter Four.
Site-Directed Mutagenesis: 
Proximal Lysine Residues.
4.1 Introduction
The aim of the experiments described in this chapter was to identify, create and 
characterise site-specific mutants o f the cloned HRP gene (see Chapter Three). The 
cloned HRP gene was also reverted to wildtype by a Pro to Ala mutation at residue 34. 
Key positions were identified with the aim o f increasing the thermal, solvent and H2O2 
stabilities o f the recombinantly expressed HRP protein. The selection procedure was 
aided by prior knowledge of chemically stabilised plant HRP (O'Brien et al., 2001) and 
suitable replacement amino acids were determined. A simple, two-step mutagenic PCR 
strategy was employed to produce the mutants, which in turn were screened for the 
presence of an indicative altered restriction pattern. Mutants displaying this altered 
pattern were sequenced to confirm mutation and maintenance o f gene integrity.
4.2 Identification of Key Am ino Acid Residues.
The initial residues selected for mutation were all lysine residues, located at positions 
174, 232 and 241. All lie on the outer proximal region of the HRP structure, and have 
previously been chemically modified to yield increased thermal and solvent stabilities. 
O’Brien and co-workers (2001) showed that ethylene-glycol 
^¿v(succinimidylsuccinate), or EG-NHS, crosslinks Lys 232 and Lys 241. Lys 174 was 
also modified, but without any crosslinking, possibly due to its increased distance (>16 
A) from another chemically-modifiable lysine. This lysine modification yielded a four­
fold increase in stability at 65 °C. Note that stabilisation does not require crosslinking 
o f amino acids: neutralisation o f lysine charges (Miland et al., 1996b) or their reversal 
(O’Brien et al., 2003) also stabilised the HRP molecule. These three Lys residues were 
mutated to small, hydrophobic, uncharged alanines; medium sized, hydrophilic, 
uncharged asparagines; medium sized, negatively charged, hydrophilic glutamic acids 
and bulky aromatic, hydrophobic phenylalanines. Introduction of the alanine residue 
was anticipated to develop a cavity whilst simultaneously neutralising the lysine’s 
positive charge. Insertion o f an asparagine was intended to neutralise the lysine charge 
whilst approximately maintaining the space-fill characteristic. Charge reversal, whilst 
maintaining the space-fill, was predicted from a glutamic acid substitution. Another 
indirect role o f charge reversal at positions 232 and 241 could be an increase o f calcium 
ion retention. Based on previous findings, the latter could lead to increased stability 
(Tams and Welinder, 1998). A second round of mutagenesis focussed on double lysine
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and glutamic acid mutations in the same region, as suggested by the outcome o f the 
single lysine replacements.
I
Figure 4.1: Location of key amino acid residues, Lys 174 —, Lys 232 —, Lys 241 — . Also indicated are 
the heme group — and the two calcium ions -
4.1 Optimisation of Mutagenic PCR.
Initially, mutagenic PCR was problematic, with low mutagenic efficiencies achieved. 
This was possibly due to primer-dimer formation between the two highly homologous 
mutagenic primers. This problem was circumvented by employing a two-stage 
mutagenic PCR protocol similar to that described by Wang and Malcom (1999). In 
their approach, the double strands o f the wildtype template vector are treated as two 
separate PCRs (see Figure 4.2).
Figure 4.2: Schematic of alternative mutagenesis approach. In the traditional approach, the wildtype 
vector provides the template for the mutagenic primers, represented by blue and maroon arrows. In the 
alternative approach, however, the double strands of the wildtype template vector are treated as two 
separate PCRs. This approach provides more copies of the mutant strands (signified in blue and purple 
respectively) than the parent wildtype strands. The mutagenic primers will have a higher affinity for the 
newly-synthesised strands than the parent strands, as the primer is completely homologous with the 
newly synthesised strands.
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4.4 W ildtype reversion mutation.
The cloned HRP gene contained a point mutation, A34P that was present in the gene 
prior to cloning (see Figure 3.11). This was reverted to wildtype prior to any further 
mutagenesis studies to allow direct comparison between plant and wildtype 
recombinant HRP. Mutational primers were designed to alter codon 34 from CCA to 
GCT; a silent mutation (GATCC) was also incorporated. The latter introduced a BamH  
I recognition site within thirteen basepairs o f the reversion and, hence, clones subject to 
BamH I restriction would likely contain the desired P34A back mutation.
GGTCCGATCCCAGGATCCCAGCTTCAATATTACGTCTGC.
V  VGATCCGATCCCAGGATCGCTGCTTCAATATTACGTCTGC.
( Pro)
(Ala)
Figure 4.3: Diagrammatic representation of wildtype reversion mutation. Mutation is coloured in red, 
while blue indicates the silent mutation incorporated close to the desired mutants; the latter introduces a 
new selective restriction site. The reading frame is indicated by the underline.
Mutagenesis was carried out on pQE_PelB_HRP_His as outlined in Section 2.21.1. The 
primers utilised were pBR I P34A and the conditions were as per Section 2.22. The 
reversion was confirmed by commercial sequencing.
102 bp
1 2 3 4 5 6 7 8
4331 bp
102 bp
Figure 4.4: Part A represents the expected restriction pattern of pQE_PelB_HRP_His reverted to 
wildtype by a P34A mutation. In silico analysis predicts two bands due to the presence o f the mutant 
BamH I site, one band of approximately 100 basepairs and another o f 4.3 kilobases. Part B is the mutant 
plasmid viewed after restriction and electrophoresis through 1% w/v agarose. The approximate band 
sizes correspond to the predicted pattern. Lanes 1 to 6 contain different clones screened, lane 7 contains 
Sigma size markers and lane 8 contains template DNA.
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4.5 Designed Mutations.
The designed primers (outlined in Section 2.21.1) incorporated the mismatch basepairs 
that would generate the desired mutation upon translation. The codons were altered 
from AAG to GCG, GAG, AAT for the Lys 174 mutations, from AAG to GCG,GAG, 
AAT, TTT for the Lys 232 mutations, from AAA to GCA, GAA, AAT, TTT for the 
Lys 241 mutations and from GAG to CAG and GAG to AAC for Glu 238 and 239 
mutations respectively. A silent mutation was also incorporated into each mutagenic 
primer design: (i) the silent mutation (TGGCCA) introduced a Msc 1 recognition site 
within fourteen basepairs o f the Lys 174 mutations, whilst (ii) the silent mutation 
(CTCGAG) introduced a Xho I recognition site within fifteen basepairs o f the Lys 232, 
241 and Glu238, 239 mutations respectively. Hence, clones could be screened for these 
altered restriction sites, which would indicate the presence of the desired mutation.
4.5.1 Lysine 174 Mutations.
Computer-aided modelling was initially utilised to view the mutations in silico. The 
HRP crystal structure co-ordinates (Accession Number 1ATJ) were downloaded from 
the Protein Data Bank (http://www.rcsb.org/pdb). Computer simulations, using 
Deep View™ mutant modelling, suggested that mutations would still allow the protein to 
fold correctly. Site-directed mutagenesis was carried out on pBR I as outlined in 
Section 2.21.1. The primers utilised were pBR I Kl 74A, pBR I Kl 74E, pBR_I Kl 74N 
respectively and the conditions were as per Section 2.22. Mutants were screened with 
an Msc I / Hind III double digest as outlined in Figure 4.6. Successful inclusion of the 
silent mutation would result in a differential cutting pattern (Figure 4.7) that would 
allow a single clone to be selected for sequence confirmation.
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Figure 4.5: DeepView1M modelling of Lysine 174 mutations. Location of native lysine residue (—) in 
relation to heme group (— )and calcium ion (- -) is depicted in picture A, whilst the various mutants are 
shown in parts B (Ala), C (Asn) and D (Glu). Computer-modelled predicted interactions are shown as 
dotted lines.
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Figure 4.6: Diagrammatical representation of the expected restriction pattern of pBR_I which has been 
mutated at the 174 lysine residue. In silico analysis predicts four bands due to the presence of the silent 
mutant Msc I site. The first band is approximately 3250 basepairs, the second 639 basepairs, the third 438 
basepairs and finally the fourth 106 bp.
1 2 3 4 5 6
3250 bp
639 bp 
438 bp
3250 bp
639 bp 
544 bp
Figure 4.7: The mutant plasmids, pBR_I_174Ala (lane one), pBR_I_174Glu (lane two) and 
pBR_I_174Asn (lane three), viewed after restriction with Msc I and Hind III, and electrophoresis through 
1% w/v agarose. The approximate band sizes correspond to the predicted pattern, although the 106 bp 
fragment is not visible, possibly due to poor ethidum bromide staining. Non-mutated wildtype pBRI,  
digested with Msc I and Hind HI and non-digested non-mutated pBR I, are run in lanes five and six 
respectively as controls. Lane four contains Sigma size markers.
4.5.2 Lysine 232 Mutations.
As previously outlined, computer-generated graphics were used to model the 
prospective Lysine 232 mutations (Figure 4.8). Mutagenesis was performed as outlined 
in Section 2.21.1. The primers utilised were pBR I K232F, pBR_I K232A, pBR_I 
K232E, pBR_I K232N and the conditions used were as per Section 2.22. Mutants were 
screened with an Xho I single digest as outlined in Figure 4.9. Successful inclusion of 
the silent mutation results in a differential cutting pattern, permitting a single clone to 
be selected for sequence confirmation (Figure 4.10).
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Figure 4.8: DeepView™ modelling of Lysine 232 mutations. Location of native lysine residue (A) and 
the various lysine mutant residues (—) in relation to heme group (— ) and calcium ion (- -) are depicted 
in pictures B (Phe), C (Ala), D (Asn) and E (Glu).
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Figure 4.9: Diagrammatical representation of the expected restriction pattern of pBR_I mutated at the 
232 lysine residue. In silico analysis predicts three bands, due to the presence of the silent mutant’s new 
Xho I site. The first band is approximately 3508 basepairs, the second 687 basepairs and the third 238 
basepairs.
3508 bp 3746 bp
687 bp
Figure 4.10: Mutant plasmids pBR_I_232Ala (lane one), pBR_I_232Glu (lane two), pBR_I_232Asn 
(lane three) and pBR_I_232Phe (lane four), viewed after restriction with Xho I and electrophoresis 
through 1% w/v agarose. The approximate band sizes correspond to the predicted pattern. Non-mutated 
wildtype, pBR_I, digested with Xho I, and non-digested non mutated pBRI,  are run in lanes six and 
seven respectively as controls. Lane five contains Sigma size markers.
4.5.3 Lysine 241 Mutations.
Z)eepFz'ew™-assisted modelling o f the Lysine 241 mutants (Figure 4.11) indicated that 
mutation would still produce a fully functional protein. Mutagenesis was carried out on 
pBR I as outlined in Section 2.21.1. The primers utilised were pBR I K241F, pBR I 
K241A, pBR_I K241E and pBR I K241N respectively and the conditions were as per 
Section 2.22. Mutants were screened with an Xho I single digest as outlined in Figure
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4.12. Successful inclusion of the silent mutation results in a differential cutting pattern, 
permitting selection of a single clone for sequence confirmation (Figure 4.13).
Figure 4.11: DeepView™ modelling of Lysine 241 mutations. Location of native lysine residue (A) 
and the various lysine mutant residues (—) in relation to heme group (—) and calcium ion (- -) are 
depicted in pictures B (Phe), C (Ala), D (Asn) and E (Glu).
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Figure 4.12: Diagrammatical representation of the expected restriction pattern ofpBR_I mutated at the 
241 lysine residue. In silico analysis predicts three bands due to the presence of the silent mutant’s new 
Xho I site. The first band is approximately 3508 basepairs, the second 687 basepairs and the third 238 
basepairs.
3508 bp
687 bp
238 bp
3746 bp
687 bp
Figure 4.13: Mutant plasmids pBR_I_241Ala (lane one), pBR_I_241Glu (lane two), pBR_I_241Asn 
(lane three) and pBR_I_241Phe (lane four), viewed after restriction with Xho I and electrophoresis 
through 1% w/v agarose. The approximate band sizes correspond to the predicted pattern. Non­
mutated wildtype pBR_I, digested with Xho I and non-digested non-mutated pBR I are run in lanes six 
and seven respectively as controls. Lane five contains Sigma size markers.
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4.5.4 Glutamic Acid (238/239) Mutations.
Three dimensional in silico analysis of the glutamic acid (238/239) mutations (Figures 
4.14 and 4.15) suggested that mutagenesis would not grossly affect protein tertiary 
structure. Mutagenesis was carried out on pBR I and pBR_I_241E as outlined in 
Section 2.21.1. The primers utilised were pBR I E238Q and pBR_I E239N and 
conditions were as per Section 2.22. Mutants were screened with an Xho I single digest 
(Figure 4.16), with successful inclusion o f the silent mutation resulting in a differential 
cutting pattern (Figure 4.17).
Figure 4.14: DeepView analysis of the Glutamic Acid 238 (A) to Glutamine mutation (B). The mutant is 
visualised in its most energy stable conformation, as calculated by the DeepView™ software. The heme 
group is coloured red, the calcium ion is coloured in yellow whilst the mutation is coloured in purple.
Figure 4.15: DeepView analysis of the Glutamic Acid 239 (A) to Asparagine mutation (B). The mutant 
is visualised in its most energy stable conformation, as calculated by the DeepView1M software. The 
heme group is coloured red, the calcium ion is coloured in yellow whilst the mutation is coloured in 
purple.
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238
Figure 4.16: A diagrammatical representation of the expected restriction pattern of pBRI  mutated at 
position 238 or 239. For the pBR_238 mutation, in silico analysis predicts iwo bands due to removal o f the 
third mutant Xho 1 site: one band of approximately 3746 basepairs and another of 687 basepairs. For the 
pBR_239 mutation, in silico analysis predicts three bands due to the introduction of a third Xho I site, one 
band of approximately 3508 basepairs, another of 687 basepairs and a final band of 238 basepairs.
239 238 M 238 239
Temp Temp
3508 bp
687 bp 
238 bp
3746 bp
687 bp
Figure 4.17: The mutant plasmids (E238Q and E239N) viewed after restriction and electrophoresis through 
1% w/v agarose. In this mutagenesis approach a different plasmid template was used for each mutant, as 
indicated by “Temp”. The approximate band sizes correspond to the predicted patterns.
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4.5.5 Do uble Lysine (232/241) Mutations.
Double lysine (232/241) mutations were modelled utilising DeepView™ (Figure 4.18). 
Mutagenesis was carried out on pBR_I as outlined in Section 2.21.1. The primers 
utilised were pBR I K232/241N, p B R I K232/241Q and pBR I K232F/241N and 
conditions were as per Section 2.22. Mutants were screened with an Xho I single digest 
as outlined in Figure 4.19. Successful inclusion of the silent mutation results in a 
differential cutting pattern permitting selection of a single clone for sequence 
confirmation (Figure 4.20).
Figure 4.18: DeepView"1' modelling of Lysine 232/241 double mutations. Location of native lysine 
residue (232, — and 241, —) in relation to heme group (—) and calcium ion (- -) is depicted in 
picture A, whilst the various mutants are shown in parts B (232/24lAsn), C (232/24lGln) and D 
(232Phe/241Asn).
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Figure 4.19: Diagrammatical representation of the expected restriction pattern of p B R I  mutated at the 
232 and 241 lysine residues. For the intermediate single mutant, in silico analysis predicts three bands 
due to the presence of the silent mutant Xho I site. The first band is 3508 basepairs, the second 687 
basepairs and the third 238 basepairs. The final double mutant construct removes the third diagnostic 
Xho I  site and two bands are predicted, 3746bp and 687bp, similar to pBR_I.
1 2 3 4 5
Figure 4.20: The mutant plasmids pBR_I_232/241Gin (lane one), pBR_I_232Gln (lane two) and 
pBR_I_232/241Asn (lane three) viewed aflcr restriction with Xho I and electrophoresis through 1% 
w/v agarose. The approximate band sizes correspond to the predicted pattern. Non-mutated wildtype 
pBR I, digested with Xho 1 was included in lane five as a control. Lane four contains Sigma size 
markers.
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4.5.6 Sequencing of mutants.
Single mutants were selected for sequencing via a restriction digest screening 
methodology as outlined in Sections 4.5.1 to 4.5.4. Selected plasmids were prepared 
by the Gene Elute™ method, Section 2.8.3, and sent to MWG Biotech or Fusion 
Antibodies Ltd for sequencing by the di-deoxy sequencing method. Results were 
obtained via e-mail and processed through various bioinformatic packages to confirm 
correct reading frame of clone, suitable mutation and maintenance of gene integrity. 
The results are outlined in Figure 4.21.
Figure 4.21: Alignment of lysine mutations with wildtype HRP. The sequences show total identity, 
with the exception of the desired mutation. A depicts K174 mutations; B, K232 mutations; C, K241 
mutations; D, E238 and E239 mutations; and E, K232 and K241 double mutations.
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4.6 Characterisation of Single M utants.
4.6.1 Determination of Single Mutants’ Concentrations.
Single mutants were individually expressed in 500 mL shake culture flasks (as 
previously described, see Section 2.24.4) and were purified via optimised nickel 
affinity chromatography (Section 2.25). Once expressed and purified (typical specific
■5 1 g   _
activity o f -7.5 x 10' /¿mol.min.mg"), the //M concentration o f HRP was calculated as 
per Section 2.29, with the results outlined in Table 4.1.
Table 4.1: Absorbance at 403nm for all lysine mutant forms o f rHRP. rHRP concentrations were then 
calculated using the Beer-Lambert Law, and the rHRP extinction coefficient, lOOmM'cm'1 (Hiner et al., 
1995). Protein concentrations were experimentally determined using the BCA assay.
M utant Abs 403nm rHRP OiM)
Protein Cone 
(mg.ml'1)
H em e/Protein
Ratio
K174N 0.050 1.03 0.645 0.054
K174E 0.026 0.54 0.441 0.042
K174A 0.175 3.62 0.708 0.173
K232N 0.051 1.05 1.182 0.030
K232E 0.182 3.76 1.353 0.094
K232A 0.066 1.36 0.807 0.057
K232F 0.025 0.52 0.165 0.107
E238Q 0.062 1.28 0.320 0.136
E239N 0.013 0.27 0.780 0.012
K2411SJ 0.113 2.33 0.909 0.087
K241E 0.180 3.72 2.163 0.058
K241A 0.089 1.83 1.521 0.041
K241F 0.031 0.64 0.281 0.077
Protein concentrations were equalised for all thermal and organo tolerance assays, 
whilst concentrations o f active rHRP were equalised for all kinetic analysis and H2O2 
stability studies.
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4.6.2 Single Mutant Thermal Tolerance.
All thermal tolerance assays were carried out as per Section 2.31, with a final protein 
concentration of 100 /¿g.mL'1 in the reaction solution. Thermal profiles (Figures 4.22 to 
4.25) and thermal inactivations (Figure 4.26) were produced for each of the mutant 
forms, in triplicate, using recombinant wildtype as a reference. T50 values for each 
mutant are tabulated in Table 4.2
Temperature (°C)
Figure 4.22: Thermal profile of Lysine 174 mutants, A K174A, □ K174E, K174N, o WT.
Temperature (°C)
Figure 4.23: Thermal profile of Lysine 232 mutants, A K232A, □ K232E, K232N, o K232F, and o 
WT.
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Temperature (°C)
Figure 4.24: Thermal profiie of E238Q, E239, -o-WT.
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Figure 4.25: Thermal profile ofLysine 24 linutants, A K241 A, i K241E, K241N, ■ K241F. WT
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Figure 4.26: Semi-log plot of a selection of single lysine mutants’ thermal inactivation at 50°C; A 
K174A, K174N, K232N, o K232F, o Wildtype.
Apparent half-lives for each o f the mutants at 50°C were calculated, as outlined in 
Section 2.33, with the results tabulated in Table 4.2.
Table 4.2: Rate of inactivation at 50°C and calculated apparent half-life (ti/2 ) for each lysine mutant
M utant T50 (°C) Rate Const (min" ) SD (%) ti /2 (min) r z Value
Wildtype 50 5.59 xlO'2 ± 6 12.4 0.98
K174N 47 8.68 xlO'2 ±10 8.0 0.94
K174E 46 1.02 xlO’1 ±3 6.8 0.99
K174A 50 6.77 xlO-2 ± 7 10.2 0.98
K232N 52 3.12x10‘2 ± 7 22.3 0.97
K232E 50 5.95 xlO’2 ± 8 12.0 0.96
K232A 50 9.21 xlO’2 ± 8 7.5 0.96
K232F 52 2.94 xl0‘2 ± 8 23.9 0.92
E238Q 51 9.21 xlO'2 ±11 7.5 0.97
E239N 50 5.74 xlO’2 ±11 12.1 0.95
K241N 53 Not 1st Order
K241E 47 Not I s1 Order ------
K241A 50 1.13 xlO’1 ±10 6.1 0.93
K241F 53 6.10x1 O'2 ± 9 11.3 0.97
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4.6.3 Single Mutant Organic Solvent Tolerance.
All organic solvent tolerance assays were carried out as per Section 2.34, with a final 
protein concentration o f 100 jUg.inL'1 in the reaction solution. Solvent tolerance profiles 
were produced for each of the mutant forms, in triplicate, using recombinant wildtype 
as a reference. All standard errors were within <5% of the triplicate average reading, 
with the errors bars omitted for the sake o f clarity.
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Figure 4.27: Solvent Tolerance Profile o f single lysine mutants; □ K174N, A K174E, o K174A, □ 
K232N, A K232E, o K232A, 0- K232F, ? E238Q, □ E239N, K241N, \  K241E, K241A, K232F,
o Wildtype.
145
120
=r 10 0  o 
¡2*
■I 80
a
3•o
«
£
60
40
20
0
$
*ù
8
ù
8 □
□
□
e-
D
-i---------1-------- 1--------*?---------m---—Q—
10 20 30 40 50 60
DMF (% v/v)
 D------ 0
70 80 90
Figure 4.28: DMF Solvent Tolerance Profile of single lysine mutants; K174N, A K174E, K174A, 
K232N, A K232E, K232A, K232F -o- E238Q, -a- F.239N, K241N, K241E, K241A,
Wildtype.
Apparent Cso values at 25°C for each of the mutants were calculated (Section 2.34), 
with the results are tabulated in Table 4.3.
Table 4.3: Calculated apparent inhibitory concentrations (C50) for each lysine mutant. Standard errors are 
less than 5% in all cases.
M utant OMSO Cso McOH C50 DMF Cs»
Wildtype 35 53 14
K174N 42 45 15
K174E 20 55 13
K174A 30 35 19
K232N 45 45 48
K232E 38 33 15
K232A 40 35 21
K232F 55 67 60
E238Q 30 45 10
E239N 37 53 13
K241N 38 55 18
K241E 30 38 15
K241A 35 38 18
K241F 34 43 20
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4.6.4 Single Mutant H2O2 Tolerance.
All H2O2 Tolerance assays were carried out as per Section 2.35, with a final rHRP 
concentration o f 360 nM in each reaction. H2O2 tolerance profiles were produced for each 
mutant, in triplicate, using recombinant wildtype as a reference. Standard errors o f 
triplicate assays were less than 15 % in all cases.
mM H20 2
Figure 4.29: Hj.02 Tolerance profile of Lysine 174 mutants; A K174A, K174E, K174N, WT.
mM H2O2
Figure 4.30: H2O2 Tolerance profile of Lysine 232 mutants; A K232A, K.232E, K232N, o K232F, and
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mM H2O2
Figure 4.31: H2O2 Tolcrance profile of Lysine 241mutants; A K241A. K241E, K241N, o K241F, WT.
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Figure 4.32: H2O2 Tolerance profile of Glutamic Acid mutants; -o- E238Q, E239N and WT.
Table 4.4: Calculated II20 2 C5o for each single lysine and glutamic acid mutant.
M utant
mM
H2O2 C50
% Error M utant
111M
H2Oj CS(1
% Error
Wildtype 17 ± 4 K232F 1 1 ± 4
K174N 20 ± 8 E238Q 18 + 15
K174E 27 ± 6 E239N 3 ± 5
K.174A 13 ±3 K.241N 1 1 ± 9
K232N 300 ±5 K241E 1 1 ± 4
K232E 36 ± 1 0 K241A 33 ± 6
K232A 19 ± 6 K241F 200 ± 7
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4.6.4 Steady-State Kinetics of Single Lysine Mutants.
All kinetic assays were carried out as per Section 2.35, with a final rHRP concentration 
o f 65 pM in each reaction solution. K’m and k3 values were calculated by plotting the 
kinetic data generated in the software package Enzfitter™. All experiments were 
determined in triplicate, with the average value being used in the kinetic analysis. 
Recombinant wildtype HRP was used as reference.
Table 4.5: Kinetic analysis for all lysine mutants, using ABTS as the reducing substrate. Km and k3 
values, including standard errors, were calculated using the Enzfitter software package.
M utant k3( s'1) SD (s'1) K  m (mM) S D  (mM)
Wildtype 482 ±12 0.093 ±0.013
K174N 624 ± 14 0.142 ±0.013
K174E 354 ± 19 0.142 ± 0.032
K174A 954 ±12 0.096 ± 0.007
K232N 1849 ±103 0.168 ±0.038
K232E 467 ± 18 0.131 ± 0.022
K232A 433 ±10 0.118 ±0.013
K232F 983 ±38 0.126 ± 0.034
E238Q 1298 ±63 0.221 ± 0.033
E239N 526 ±23 0.134 ± 0.026
K241TS1 1141 ±41 0.092 ±0.017
K241E 978 ±64 0.062 ±0.018
K241A 2410 ± 157 0.320 ±0.075
K241F 880 ±20 0.308 ± 0.038
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4.7 Characterisation o f Double Lysine M utants.
4.7.1 Double Lysine Mutant Concentration Determination.
Double lysine mutants were individually expressed in 500 mL shake culture flasks 
(Section 2.24.4). The recombinant HRP mutants were purified via optimised nickel 
affinity chromatography (Section 2.25). Once expressed and purified, the fiM 
concentration of HRP was calculated as per Section 2.29, with the results outlined in 
Table 4.6,
Table 4.6: Absorbance at 403nm for all double lysine mutant forms of rHRP. rHRP concentrations were 
calculated using the Beer-Lambert Law and the rHRP extinction coefficient, 100 mM'cm'1 (Hiner et al., 
1995). Protein concentrations were experimentally determined using the BCA assay.
M utant
Abs
403nm
rHRP (/¿M)
Protein Cone 
(m g .m l1)
H eme/Protein
Ratio
K232/241N 0.059 1.2 0.252 0.161
K232/241Q 0.031 0.6 0.194 0.105
K232F/K241N 0.074 1.5 0.187 0.272
Protein concentrations were equalised for all thermal and organo tolerance assays, 
whilst rHRP concentrations were equalised for all kinetic analysis and H2O2 studies.
4.7.2 Double Lysine Mutant Thermal Tolerance.
All thermal tolerance assays were carried out as per Section 2.31, with a final protein 
concentration of 100 in the reaction solution. Thermal profiles (Figure 4.33)
and thermal inactivations (Figure 4.34) were produced for each of the mutant forms, in 
triplicate, using recombinant wildtype as reference.
Temperature (°C)
Figure 4.33: Thermal profile of Double Lysine 232/241 mutants; A K232/241Q, K232/241N, □
K232F/K241N, < Wildtype.
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Figure 4.34: Linearisation of Double Lysine 232/241 mutants; A K232/241Q, ' K232/241N, □ K232F/K241N, 
o Wildtype.
Apparent half-lives for each of the mutants at 50°C were calculated (Section 2.33) with 
the results tabulated in Table 4.7.
Table 4.7: Rate of inactivation at 50°C and calculated apparent half-life (tic) for lysine double mutants.
M utant Tso (°C) Rate Const (min" ) SD (min) ti/2 (min) r2 Value
Wildtype 50 5.59 xlO'2 ± 6 12.4 0.98
K232/241N 50 3.61 xlO'2 ± 10 19.3 0.91
K232/241Q 48 4.53 xlO’2 ± 8 15.3 0.94
K232F/K241N 52 2.53 xlO’2 ± 6 27.4 0.95
4.7.3 Double Lysine Mutant Organic Solvent Tolerance.
All solvent tolerance assays were carried out as per Section 2.34, with a final protein 
concentration of 100/ig.mL'1 in the reaction solution. Solvent tolerance profiles were 
produced for each of the mutant forms, in triplicate, using recombinant wildtype as 
reference. All standard errors were within <5% of the triplicate average reading, with 
the errors bars being omitted for the sake of clarity.
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Figure 4.35: Solvent Tolerance profile of Double Lysine 232/241 mutants; A K232/241Q, 
K232/241N, > K232F/K241N, Wildtype.
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Apparent C50 values at 25°C for each of the mutants were estimated (Section 2.34); the 
results are tabulated in Table 4.8.
Table 4.8: Estimated apparent inhibitory concentrations (C50) for each double lysine mutant
M utant DM SO Cs0 MeOH C50 DMF Cso
Wildtype 35 53 14
K232/241N 35 48 20
K232/241Q 32 48 9
K232F/K241N 62 65 62
4.6.4 Double Lysine Mutant H2O2 Tolerance.
All H2O2 tolerance assays were carried out as per Section 2.35. Triplicate standard 
errors were less than 10 % in all cases.
mM H2Oj
Figure 4.36: HjOj Tolerance Profile of Double Lysine 232/241 mutants; A K232/24 IQ, K232/241N, - 
u- K232F/K241N,'- o-Wildtype.
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Table 4.4: Calculated H20 2 C3o for double lysine mutants.
M utant
niM 
M2O2 Cso
% Error
Wildtype 17 4
K232/241Q 17 3
K232/241N 65 5
K232F/K241N 70 8
4.7.4 Steady-State Kinetics o f Double Lysine Mutants.
All kinetic assays were carried out as per Section 2.36, with a final rHRP concentration 
of 65 pM in each reaction solution. All experiments were repeated in triplicate, with the 
average value being used in Enzfitter1M analysis to estimate apparent K’m and ks. 
Again, recombinant wildtype HRP was used as a reference.
Table 4.9: Steady-state kinetic analysis for all double lysine mutants, using ABTS as the reducing 
substrate. K’m and k_i values, including standard errors, were calculated using the EnzfitterlM software 
package.
M utant fe (s ') SD (s'1) K,m (mM) SD (mM)
Wildtype 482 ± 12 0.093 ±0.013
K232/241N 378 ±30 0.114 ± 0.036
K232/241Q 1549 ±61 0.197 ±0.068
K232F/K241N 1008 ±39 0.114 ±0.018
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4.8 Discussion.
4.8.1 Mutation Selection and Generation.
The aim of these experiments was to produce, verify and characterise site-directed 
mutants o f the HRP gene situated in the pBR I plasmid. A rational design approach 
was used to select key residues for substitution. Prior knowledge from chemical 
modifications that stabilised plant HRP suggested that exposed lysine residues play an 
important role in HRP stability. Ethylene-glycol Ms'(succinimidylsuccinate) 
modification o f three of HRP’s six lysines led to an increased thermal stability (O’Brien 
et al., 2001), whilst neutralisation o f lysine’s positive charge also afforded increased 
thermal and solvent stability (Miland et al., 1996b). Charge reversal, via chemical 
modification with compounds such as phthalic anhydride (O’Brien, et al., 2003) and 
carboxylic acid anhydrides (Ugarova et al., 1979), has also been shown to affect 
stability. However, the basis of stabilisation is not known for these latter chemical 
modifications and, therefore, there is scope for mutational studies to ascertain the 
effect(s) of simply neutralising and reversing the lysines positive charge without the 
inclusion of chemical compounds. Phthalic anhydride, for example, contains a benzene 
ring in its structure: it is not known if the observed stabilisation is due to charge 
reversal, the spread of electrons around the benzene ring, the hydrophobic interaction 
between the aromatic benzene ring and a particular hydrophobic patch of the HRP 
molecule, or some other interaction with the benzene group.
Replacement amino acids were chosen for a variety o f reasons. Initially, they were 
chosen based on size, hydrophilicity and charge. It was attempted to maintain the 
space-fill and hydrophilicity characteristics o f a lysine residue when mutating to 
another amino acid, but charges were either neutralised (Asn) or reversed (Glu). The 
effect of a space-creating, hydrophobic, charge-neutralising substitution was 
investigated by replacing a lysine with an alanine residue and the effect of a bulky 
aromatic, hydrophobic substitution was examined by the introduction o f a 
phenylalanine.
From initial results, two additional residues, Glu 238 and Glu 239, were also subjected 
to mutation and analysis. Both residues are negatively charged and mutation of the 
positively-charged lysines nearby highlighted the important role o f charge in this 
region. An uncharged amino acid was chosen as the substitute residue acid in both 
cases, glutamine (238) and asparagine (239), mirroring the rationale o f the lysine 
mutagenesis studies.
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Initial results o f mutagenic PCR were disappointing, with few colonies observed after 
transformation o f the amplified vector into highly competent cells (see traditional 
method, Figure 4.2). The low yield o f amplified mutant vector could possibly have 
been caused by primer dimer formation, as the two mutagenic primers are 10 0% 
homologous to each other. Use of a two-stage mutagenic PCR protocol similar to that 
described by Wang and Malcom (1999), however, circumvented this problem.
Initially, the mutation present prior to cloning, Ala 34 Pro, was reverted to wildtype. 
This would allow direct comparison between wildtype and mutant recombinant HRPs 
and plant HRP. Wildtype and mutant clones were screened via a silent mutation 
incorporated into the mutagenic primer, which permitted easier identification of 
positive clones for the desired mutation. By co-introduction of diagnostic restriction 
sites, using silent mutations, each mutant construct could be verified prior to 
commercial DNA sequencing. It must be noted, however, that silent mutations may 
change mRNA conformation, perhaps leading to altered mRNA stability and/or 
translation efficiency. Although no such problems were noted in this study (due to the 
use o f preferred E. coli codons) there are alternative approaches to screening and 
identifying mutations prior to DNA sequencing, such as a gradient PCR screening 
strategy (Padmakumar and Varadarajan, 2003). After screening, a single clone was 
selected; sequencing confirmed the reversion o f the gene to wildtype, and henceforth 
this plasmid was named pBR_I.
Site-directed mutagenesis was then carried out on pBR I to introduce the desired lysine 
mutations. Single mutants were made; however, characterisation of these single 
mutants prompted the development of double lysine and glutamic acid mutants. Again, 
restriction analysis allowed for economical selection o f the desired clones for 
confirmation sequencing. All clones were synthesised and screened and the mutations 
confirmed by sequencing. Results were then aligned using GeneDoc™ bioinformatic 
software to demonstrate the precise nature and the location of the mutations.
4.8.2 Thermal Stability.
Initially, single lysine mutants were analysed for thermal tolerance, using a thermal 
profile as a guide to select a standard temperature for thermal inactivation. Wildtype 
recombinant displayed 50% activity (T50) at approximately 50°C; most mutants had a 
similar T50 value except for K174E, K174N and K241E, which displayed a slightly 
lower T50 (~8%), and K232F, FC232N, K241F, K241A and K241N, which had a slightly
156
higher T50 (~6%). Double mutant K232/241N displayed a similar T50 to wildtype, while 
T50 o f K232/241Q was slightly decreased T50 (-4%). All thermal inactivations were 
performed at 50°C to allow direct comparison with the reference wildtype recombinant 
HRP across the mutant matrix. The resulting data were modelled by Enzfltter™ 
(Bioso ft, Cambridge, UK) to a first order exponential decay (Mozhaev, 1993) to give 
the rate constant, k, from the equation:
Where No is the initial activity and N(t) equals activity at time (t). This equation can be 
rearranged to yield:
At 50% activity ln(N/N0) becomes ln2; thus, dividing ln2 (0.693) by (~k) yields the t\n, 
or half-life o f the enzyme. It has previously been demonstrated that peroxidases do not 
follow first-order thermal denaturation kinetics; instead, they tend to display 1.5-order 
(Chang et al., 1998). Therefore, the values described here may not represent true half- 
lives. First-order decay models were applied to the thermal inactivation data. The 
majority of the mutants obeyed the model for the first 10 min o f inactivation, but some 
(K174N and K232A for example) gave poor fits, indicated by low correlation 
coefficients. The tin values reported here are for comparison purposes only: increases 
or decreases over wildtype recombinant are assumed to indicate increased or decreased 
thermal stability.
Many of the single mutants (6 out o f 11) displayed decreased ¿1/2, with the largest 
decrease (28%) noted for K232A. Although proteins are surprisingly robust to site 
directed mutations (Tavema and Goldstein, 2002b), this is not apparent in the present 
study, despite the implementation of a rational mutational approach. All positions 
mutated led to an altered tin compared with wildtype: see Table 4.2. It is clear that 
certain regions are more important than others for thermostabilisation o f the HRP 
molecule. All lysine 174 mutants display an 18% - 21% decrease in stability (as 
deduced from the ¿1/2). Hence, it can be seen that lysine 174 is an important contributor 
to HRP thermostability. DeepView  analysis o f the protein crystal structure, and 
previous homology modelling, suggests an interaction (possibly hydrogen bond) 
between Lysl 74 and the heme group. Therefore, substitution o f this residue will disrupt 
this presumably-stabilising interaction, allowing more freedom for the heme moiety 
and, ultimately, unfolding o f the protein backbone, heme group disassociation and a
N(t )  = N 0e-kl
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decrease in enzyme activity at elevated temperatures. Previous stabilising chemical 
modifications only changed the properties o f this residue, but the residue itself 
remained. In these earlier reports Lys 174 was not analysed in isolation as a 
thermostabilising residue; however, this work clearly demonstrates the important 
thermostabilising role o f wildtype Lys 174.
An opposite trend is evident at Lys 232, where most mutations appear to be 
thermostabilising, with the exception o f K232A. Previous chemical modification results 
suggested that charge neutralisation, charge reversal and crosslinking in this area can 
effect moderate thermostabilisation of HRP. Charge-neutralising modification o f the 
lysine residues (Miland et al., 1996b) was mimicked by introduction of asparagine, 
whilst charge reversal (O’Brien et al., 2003) was implemented by the introduction o f 
glutamic acid, and a phenylalanine was introduced to assess the effect o f a benzene ring 
in the region. The rational mutational approach proved successful for position 232, as 
all mutations yielded increased thermal stability as judged by ti/2; Phe, 200%; Asn, 
70%; and Glu, 10%. Lys 232 is located in a region of negative electrostatic potential, as 
determined from crystal structure analysis, and charge neutralisation may help to 
alleviate some non-optimal charge-charge interactions. Also, Lys 232 is located in a 
hydrophobic region; so neutralisation of the positive lysine charge may affect 
thermostability and organo-tolerance, see Sections 4.6.2 and 4.6.3. Substitution by a 
phenylalanine residue could increase the region’s hydrophobicity and aid stabilisation. 
Mutation of Lys 232 to the neutral, small, alanine yields the largest decrease in 
thermostability (28%) of all the lysine mutants, from which the importance o f the 
space-fill characteristics o f the Asn residue can be inferred. Both Lys to Asn and Lys to 
Ala mutations neutralise the lysine charge; however, the Asn mutation maintains 
similar (but not identical) space-fill characteristics to the Lys. Although Lys 232 is 
situated on the periphery of the enzyme structure, correct protein packing in this outer 
region is paramount in maintaining enzyme structure, and ultimately function, at 
elevated temperatures. Thus, at position 232 on the HRP backbone, maintenance of 
space-fill characteristics is more important than charge in protein thermal stabilisation. 
DeepView™  investigation suggests that the side chain o f K232 hydrogen bonds with 
the side chain o f Asp 230 and Asn 236, whilst K241 bonds with Asn236. K232 
substitution may improve hydrogen bonding in this region. For example, K232N 
increases hydrogen bonding (introduction of an additional Asn 231 bond), whilst
1 • • '?4-maintaining pre-existing bonds. Asn 236 bonds directly to the proximal Ca whilst Asp
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230 forms part of the extended Ca2+ binding pocket (Howes et al., 2001a). 
Consolidation of this pocket may delay proximal calcium ion disassociation which is 
known to play a pivotal role in HRP stabilisation (Coates et al., 1998). This is reflected 
in this study, as K232N displays increased thermal (1.8-fold), solvent (DMSO and 
DMF; see Section 4.8.3) and even H2O2 (17.6-fold; although this is probably not Ca2+ 
related, see Section 4.8.4) stabilities. A space-fill substitution (Phe) removes some 
hydrogen bonds in this region, yet still yields increased thermal (2-fold) and solvent 
stabilities, probably as part as a result of compensatory packing. Only two mutations at 
position 241 (K241F and K241 A) could be analysed using first order kinetics. A trend 
similar to K232A is noted, indicated by a 50% (K241 A) and a 20% (K241F) decrease 
in t\a. K241 occurs close to K232, so destabilisation by introduction of a small, neutral 
amino acid may be due to (i) poor space-fill characteristics afforded by the alanine 
residue or (ii) increased strain, and/or (iii) electron distribution properties due to 
incorporation of a phenylalanine. K241A, through Deep View™ mutational analysis 
clearly exemplifies the critical combined role o f space-fill and hydrogen bonding. Here 
all hydrogen bonds are broken and a cavity is created, resulting in dramatic decrease in 
thermal stability. The other substitutions (K241E and K241N) display differing thermal 
profiles. K241N shows a significant stabilised plateau between 55°C and 70°C. Thermal 
inactivation was carried out at temperatures between 50°C and 80°C, with K241N 
displaying 30% activity after 30 min incubation at 70°C, far superior to wildtype 
recombinant HRP. The increased thermostability of the K241N mutant may again be 
attributed to optimised charge interaction and hydrophobic core packing, as noted with 
K232N. DeepView' M predicts increased hydrogen bonding after the introduction o f Glu 
or Asn at position 241 (introduction o f a Glu 239 and Gin 240 bond respectively). 
K241E displays a slightly lower T50 than wildtype, and it could be assumed that this 
mutation would not increase the thermostability o f the enzyme.
The single-mutant thermal characterisation and earlier chemical cross-linking suggested 
the development o f glutamic acid (E238 and E239) and double lysine mutant (K232 
and K241). Both Glu residues were mutated to non-charged glutamine (238) and 
asparagine (239). The lysines were mutated to asparagine (K232/241N), glutamine 
(K232/241Q) or phenylalanine and asparagine (K232F/K241N). Both glutamic acid 
mutants displayed a decreased thermal stability (¿1/2), ranging from 3% (E239N) to 60% 
(E238Q) compared with the wildtype. Surprisingly, neutralisation o f residues 238 and 
239 close to the important 232/241-stabilisation axis did not improve the thermal
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stability. Although neutralisation of Glu 239, the one closer to the important Lys 241, 
yielded a mutant with only slightly decreased thermal stability, it is clear that a complex 
charge-transfer mechanism exists in this region, and that careful selection o f any 
potential charge neutralisation mutation is paramount. This is evident from the fact that 
neutralisation of Glu 238, with the similarly sized glutamine, causes a 60% decrease in 
thermal stability. It is clear that the Glu 238 plays an important role in HRP thermal 
stability, possibly by charge-charge interactions, and that mutation o f helix-favouring 
residues within the enzyme core to residues without helical propensities can have 
detrimental effects on HRP thermal stability (see Chapter 5).
Individually, Lys to Asn mutations at positions 232 and 241, or Lys to Phe at position 
232, generated mutant proteins with greater thermostability than wildtype recombinant; 
however, these mutations appear to be mutually incompatible, i.e. their stabilising 
effects are not additive. Although an increase in thermostability is noted for the double 
asparagine mutant, it is not as stable as the individual K232N (21% increase in t \a for 
K232/241N as compared with 70% for K232N). Also, the thermostable plateau noted 
between 50°C and 70°C in K241N is absent from the double mutant. Thus, 
neutralisation of two lysine charges in this region does not increase protein 
thermostability further than a single mutation. Because of the importance of space fill 
characteristics noted above (exemplified by the Lys to Ala mutation), a double 
glutamine mutation was effected. This would neutralise the positive charges on the 
wildtype lysine and increase the space fill capacity at this position, compared with Asn. 
However, K232/K241Q displays an 8% decrease in t\a compared to the wildtype 
recombinant HRP. The inclusion of an extra -CH2- entity in the amino acid’s R-group, 
thus extending its space fill characteristics, appears to be counter productive, and 
decreases the protein’s thermostability, possibly by increased backbone strain. 
Understanding the factors underlying protein thermal stability is very complex, due 
mainly to the numerous parameters that combine to stabilise a protein. For example, 
plant HRP thermal stability has been shown to be a function of calcium content 
(Haschke and Friedhoff, 1978), pH (Lemos et al., 2000), solution environment 
(Machado and Saraiva, 2005) and chaotrophic reagents (GnHCl; Huddleston et al., 
1995). In this study, thermal stability o f glycan-free recombinant HRP and mutants was 
investigated, and any stabilising effect o f protein glycosylation was not evident. Tams 
and Welinder (1998) demonstrated that deglycosylated plant HRP displays little 
alteration in thermal stability; however, the deglycosylated form does show a 2-3 fold
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decrease in folding stability in guanidium chloride. This contradicted previous reports 
suggesting that deglycosylation thermally destabilised HRP (Bonnaffe et al., 1993). The 
present study showed a difference in thermal profile between His-tagged recombinant 
wildtype HRP and plant HRP, which is comparable to previous studies between plant 
and recombinant forms of HRP (Orlaova et al., 2003). Although the process o f HRP 
thermal dénaturation is not yet fully understood, recent experimentation suggests that it 
is irreversible and under kinetic control (Pina et al., 2001).
Several chemical modification procedures have been used to stabilise HRP in recent 
years, ranging from attachment of PEG (Garcia et al., 1998), attachment of bis- 
succinimides to the lysine groups (Ryan et al., 1994 and Miland et al., 1996a), 
acétylation of the lysine groups (Miland et al., 1996b), phthalic anhydride modification 
(O’Brien, 1997 and 2003) and glucosamine modification (Liu, et al., 2002). A common 
trend is evident in all these chemical modification procedures: the overall positive 
charge of the HRP molecule, which has a pi o f 9.0, is reduced and the exposed lysine 
residues are often the target for charge alteration. As outlined in this study, substitutions 
o f these lysine residues (K241N and K232N) increase the thermostability (although not 
to the same extent as chemical modification). The present results also suggest an 
important thermostabilising role for the wildtype Lys K174.
Matthews (1993) noted that “the process o f thermal unfolding disrupts the non- 
covalent interactions involved in maintaining the native structure and thereby provides 
a means o f detecting changes in this network due to amino acid replacement”'. 
Traditionally, site-directed mutants probing molecular thermostability focussed on 
internal regions o f the protein structure (the hydrophobic core area) and often 
highlighted core packing (Gromhina, 2003). Proteins such as lysozyme (Funashashi, et 
al., 2003) and barnase (Machicado, et al., 2002) were intensely mutated and studied in 
this way. However, several reports suggest that single amino acid changes, not 
necessarily located in the protein core, can affect thermostability in recombinant 
proteins (Kwon et al., 1994; Numata et al., 2001; Krowarsch and Otlewski, 2001; and 
Hakamada et al., 2001).
4.8.3 Organic Solvent Stability.
The effects of different organic solvents on the lysine / glutamic acid mutants were also 
analysed. Solvents were chosen based on their theoretical dénaturation capacities 
(Methanol, low and DMF, medium; Khmelnitsky et al., 1991a), and on previous plant
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peroxidase studies (DMSO; Santucci et al., 2003; N. Carolan, PhD Thesis, Dublin City 
University, 2004). The C50, the % v/v o f solvent that causes a 50% decrease in 
enzymatic activity, was utilised to compare organo-tolerance across the mutant matrix. 
In all cases, native HRP and single lysine mutants were inactivated as the percentage 
volume of organic solvent increased. Overall increases in organo-tolerance were noted 
for DMSO with K174N, K232F, K232N, K232E, K232A and K241N; for DMF with 
K174A, K232F, K232N, K232A, K241N, and K241A, and for MeOH with K232F, as 
compared to wildtype recombinant HRP. This indicates that removal o f  lysines’ 
positive charge benefits solvent stability.
No apparent trend was evident for the K174 mutants: K174E and K174A showed a 
decrease in C50, whilst K174N showed a 1/5 increase in DMSO. K174E displayed a 
similar C50 to wildtype in MeOH; however, both K174A and K174N showed decreases 
in C50 in the same solvent. No significant change in C50 was noted for DMF. All K232 
mutants exhibit an increase in C50 in DMSO, with K232F displaying the largest increase 
(3/5). In contrast, however, the majority o f 232 mutants displayed decreased MeOH 
tolerance, with the exception of K232F (1/4). The largest single gain in solvent stability 
was displayed by K232F in DMF, with a greater than 4-fold increase in C5o. K232A 
and K232N also exhibited increased stability in DMF, whilst K232E showed similar 
DMF stability to wildtype. It is clear from Figures 4.27 and 4.28 that an activation 
process occurs in low concentrations o f DMF and MeOH. K232N and K232F display a 
>1/4 increase in activity in 10% v/v DMF compared with aqueous solution, and with 
K232F in MeOH 1/2 activation is noted at 40% v/v. Many examples o f enzyme 
activation in low-to-moderate concentrations o f organic solvents have been reported 
(Khmelnitsky et al., 1991a), with 1/5 activation of HRP noted in 10% v/v acetonitrile 
and tetrahydrofuran, accompanied by a notable reduction o f Km for the substrate o- 
dianisdine (Batra et al., 1997). This activation process was attributed to an altered 
conformational form of HRP structure in the presence o f an organic solvent. The HRP 
mutants may adopt a more active, less stable, form o f the enzyme in a mixed organic 
solvent-aqueous system (Ryu and Dordick, 1989). With the exception o f K241E, which 
showed a slight decrease in stability, the K241 mutations displayed similar DMSO 
tolerance to wildtype. K241N stability in MeOH was similar to wildtype; however, the 
Phe, Glu and Ala mutants exhibited decreased in C50S (20% v/v, K241F and 38% v/v, 
K241E and K241A, compared to a wildtype value of 50% v/v). K241F, K241N and
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K241A displayed an increase in DMF stability, (C5o of 18-20% v/v compared to a 
wildtype value 14% v/v) whilst K241E showed a similar stability to wildtype.
Glu 238Q displayed at least a 1/8 decrease in organo-tolerance in all solvents tested. 
Mutation of Glu 238 may cause minor destabilisation of the protein backbone, which in 
turn promotes unfolding and loss o f activity in non-natural environments. Glu 238 is 
part o f Helix G (Gajhede et al, 1997), and mutations within helical secondary structures 
can be detrimental to peroxidase stability (see Chapter 5). Glu is the most common 
residue in helical secondary structure and replacement with a residue with lower helical 
propensity may reduce overall helical strength (by increased tension) and lower 
stability (Costantini et al., 2006). Conversely, Glu 239 is not part o f Helix G and 
displays similar stability characteristics as wildtype HRP. The effect o f charge 
neutralisation (E238Q) may also explain drastic loss of thermal and moderate loss o f 
solvent stability for both Glu mutants, possibly due to long-range structural 
perturbations induced by the single amino acid substitutions (Vendruscolo, 2002). It 
should be noted that both display an activation in 10% v/v MeOH, with E239N 
displaying a 1.6-fold increase in activity in 20% v/v MeOH; however; no overall 
stability gain is afforded by either Glu mutation as all C50 values are equal to, or less 
than; wildtype. No other enzyme activation processes are noted in the two remaining 
solvents tested. The effects o f each individual solvent on HRP and methods of 
stabilisation have been previously discussed (Section 4.8.2 and 4.8.3) but the present 
results indicate that certain residues are important for the solvent stability o f 
recombinant HRP. The stabilising interaction that E238 maintains within the 
recombinant HRP molecule may be space-fill, charge- or secondary structure-related, 
or a combination of all; however, from the results outlined its presence in the protein 
backbone is essential to the solvent stability of recombinant HRP. DeepView™  analysis 
shows Glu238 hydrogen bonds with Tyr 234 and Val235, whilst E239 bonds with Arg 
224 and Asn236. Deep View1 M mutational modelling suggests that E238Q may form 
putative hydrogen bonds with Glu239 or Arg 264 and Phe 251. Stabilising interactions 
with the proximal Ca2+ ion may be improved by introduction of new hydrogen bonding 
patterns in this region. Additionally, E239 may bond with Lys 241. Bonding to the 
stabilising K241 residue may explain why E239N displayed similar thermal and solvent 
stabilities (in all solvents tested) to wildtype.
The double lysine mutants were also analysed for stability in the same solvents, under 
the same conditions. Again, both double-lysine mutants inactivated as the percentage
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volume o f organic solvent increased. The double mutants showed similar tolerance in 
DMSO as wildtype recombinant HRP, although K232/241Q did display a very small 
decrease in C5o, (32% v/v, wildtype 35% v/v). Both double mutants displayed a 
decreased C50 in MeOH (48% v/v, wildtype 53 % v/v) despite the single K241N mutant 
having similar C50 as wildtype. The single K232N mutant displays a 1/8 decrease in C50 
in MeOH, and so the stabilising effect of K241N in the same solvent may be negated by 
the presence of the destabilising K232N in this instance. The double glutamine mutant 
displays a large activation (1.4-fold increase in activity) in low concentrations o f 
MeOH (<20% v/v). As outlined previously, enzyme activation in low concentrations o f 
organic solvent is common; however, the C50 value indicates that the mutation does not 
afford any major stability gains in higher concentrations o f organic solvent. The largest 
increase in solvent stability was noted for single mutant K232N (2.5-fold); however, 
the double asparagine mutation yields only a 1.4-fold increase in C50. Again, the 
concerted effect of a small stability gain (K241N, 28%) in conjunction with a large 
stability gain (K232N, 250%) may result in only a modest stability gain for the double 
mutant. It is clear from these results that the double mutations are non-synergistic and 
non-additive in relation to recombinant HRP organo-stability. Although the double 
glutamine mutant displays a similar solvent tolerance profile to wildtype HRP, it also 
yields a slightly decreased C50 value, indicating that this mutation does not increase 
organotolerance.
Other enzymes have been subjected to site-directed mutagenesis in order to increase 
their stability in organic solvents. Yang and co-workers (2000) individually mutated 
two lysine residues o f Pencillin G acylase enzyme, resulting in increased stability in 
acidic and organic solvent environments. Martinez and Arnold (1991) systematically 
altered charged surface residues of ce-lytic protease to more hydrophobic amino acids; 
this resulted in a double mutant that displayed increased stability in 84% v/v DMF 
compared to the wildtype. Arnold’s research group have also utilised random 
mutagenesis techniques in order to increase the stability and activity o f various 
enzymes in organic solvents, including cytochrome P450 BM-3 monooxygenase 
(Wong et al., 2004), para-nitrobenzyl esterase (Moore and Arnold, 1996) and subtilisin 
E (Chen and Arnold, 1993). Arnold has reviewed the area of engineering enzymes for 
organic solvent applications (Arnold, 1990). Several other methods exist for stabilising 
enzymes for use in organic solvents, including immobilisation, where the enzyme is
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immobilised to, or entrapped within, a protective solid support matrix (Batra et al., 
1997) and chemical modification (Miland et al., 1996b). Dai and Klibanov (1999) also 
demonstrated that the phenomenon of ‘‘’molecular memory''’ is applicable to 
peroxidases. Here, enzymes are lyophilised in the presence of certain stabilising 
excipients, which eliminate lyophilization-induced activity losses when the peroxidase 
is suspended in non-aqueous media. Solvent extraction and reactivation o f HRP also 
utilises the enzyme’s ability to “remember” its solvent-exposed history, and increase its 
stability once it has been reactivated (Kim et al., 2000). It should also be noted that 
stabilisation o f HRP in water-immiscible solvents, such as toluene and benzene, can be 
achieved by increasing its hydrophobicity, via attachment o f PEG, and this also aids in 
increasing activity (Vazquez-Duhalt et al., 1992).
As outlined in Section 4.1, previous chemical modifications on the lysine residues both 
neutralising (Miland et al., 1996b) and charge reversal (O’Brien et al., 2003) exert a 
stabilising effect on the molecule in organic solvents. In this present study, one o f the 
largest stability gains was exhibited by K232N, which compares well with previous 
chemical modification results, namely the demonstration that alteration o f the charge on 
lysines 232/241 by succinimides resulted in significant improvement in peroxidase 
stability in DMF (Miland, 1996c). Khmelnitsky and co-workers (1991b) also 
demonstrated that surface hydrophilicity is important for protein stability in organic 
solvents. It is well known that many enzymes can function in organic solvents (Ogino 
and Ishikawa, 2001); however, protein denaturation often occurs in water-miscible 
solvents, by a process referred to as “water-stripping” (Gorman and Dordick, 1992). 
Gorman and Dordick describe how T2O (tritiated water) is desorbed from HRP by 
organic solvents such as MeOH and DMF. DMF desorbed significantly less T2O than 
MeOH, despite displaying a higher theoretical denaturation capacity. This could be due 
to the similar structure of MeOH and H2O, allowing MeOH to strip and replace water 
molecules close to the protein surface. HRP was also shown to retain less T2O than 
other enzymes such as chymotrypsin; however, there is a major requirement for water 
for HRP activity and, therefore, any water removal will have a detrimental effect on 
enzyme activity. The mutations carried out in this section removed a positively charged 
amino acid (Lys) and replaced it with a neutral Asn and negatively charged Glu; thus an 
increase in solvent stability could be attributed to the ability o f the mutant (K232N for 
example) to retain its bound water molecules in higher concentrations o f organic 
solvent. Although water-stripping may be a cause of protein denaturation, it cannot be
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the only reason, as substantial inactivation is noted for all solvents at concentrations 
less than 50% v/v, i.e. where there is equal volumes of water and solvent, and, hence, 
adequate water available to the HRP molecule.
4.8.4 H2O2 Stability.
The stability o f wildtype and mutant HRPs in the presence o f excess concentrations o f 
H2O2 was also examined. In the absence of a reducing substrate (TMB, ABTS, DAB 
etc.), and with excess H2O2 present, HRP undergoes suicide inactivation. Wildtype 
recombinant HRP yields a H2O2 C50 of 17 ±1 mM, which compares with previous 
published results of 60% activity in 25 mM H2O2 (Arnold and Lin, 2000) under similar 
conditions. Arnolds and Lin’s (2000) HRP was expressed in Saccharomyces cerevisiae 
with glycosylation possibly increasing H2O2 stability. H2O2 stability o f most Lys and 
Glu mutations is equal to or less than wildtype; however, K232E and K241A display a 
2-fold increase in H2O2 C50. Surprisingly, K174A displayed the poorest thermal and 
DMSO stabilities, yet it displays a 1.5-fold increase in H2O2 C50. Two mutations, 
K232N and K241F, yielded a large increase in H2O2 C50 (18- and 12-fold respectively) 
under the conditions used. Both of these mutants also exhibit increased thermal and 
solvent stabilities. This is also evident in the double lysine mutants’ C50 values for 
H2O2, where K232/241N and K232F/K241N retain 75% and 100% activity in 50mM 
H2O2 respectively.
H202-mediated HRP inactivation has been the subject o f much research, with several 
theories forwarded as to the inactivation pathway. In recent years, however, Hemandez- 
Ruiz and co-workers’ (2001) “three-pathway modeF  has gained support. In this model, 
catalytic competition exists in the presence of excess H2O2, with three possible 
outcomes. These are: (a) formation of the dead-end Compound III (See Figure 1.3), (b) 
a catalase-type reaction, and (c) total enzyme inactivation. The first and second 
outcomes are enzyme survival routes and selection of one over the other depends on 
several parameters, including pH (Hemandez-Ruiz et al., 2001). In following either 
survival pathway, the strong oxidising power o f HRP’s Compound I reacts with H2O2 
as an electron donor (i.e. reductant; H2O2 normally acts as a oxidant or electron 
acceptor) in a complex set of reactions. These result in (i) a single electron transfer, 
leading to Compound II and peroxide anion formation (HO2') or (ii) a two-electron 
process forming molecular oxygen (pseudo-catalase activity) (Amao et al., 1990). 
Catalases are found in most aerobic systems where they decompose H2O2 to water and
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oxygen. The major difference between catalase and peroxidase is that the former 
generates water and oxygen, while the latter generates water and two free radicals (see 
Figure 1.3; Dunford, 1999). If excess H2O2 persists, the survival pathway is abandoned 
and progressive enzyme inactivation is noted, resulting in the formation o f inactive 
verdohaemochrome P670 (Hiner et al., 2001). The pivotal point of abandonment has 
been identified as the Compound I - peroxide complex (Hiner et al., 2002). A transient 
intermediate (P965) has been shown to complex Compound I and the peroxide 
substrate. Decay of this intermediate, via two competing reactions (survival or 
inactivation), determines the fate o f the enzyme. On a mechanistic level, H2O2 
inactivation has been shown to effect structural changes, typically affecting the heme 
moiety, as indicated by an altered Soret band (Schmidt et al., 2002).
Catalase-like activity has been noted for HRP, with possible in vivo HRP pseudo- 
catalase roles involved in plant-pathogen interactions (Baker et al., 2000). Typically, 
HRP can scavenge H2O2 effectively in the presence o f a suitable phenolic reducing 
substrate, e.g. lignin. Indeed, the properties o f HRPC (high affinity for H2O2, rapid 
formation of Compound I and high activity at low substrate concentrations) suggest that 
it could offer an efficient detoxification mechanism for the plant, a role normally 
associatated with catalases (Yamasaki et al., 1997). Under oxidative stress, however, or 
during a protective H2O2 burst (in response to pathogenic attack), HRP alone can 
scavenge H2O2 with concurrent molecular oxygen production (Hemandez-Ruiz et al., 
2001).
HRP pseudo-catalase activity, although somewhat weaker than bacterial catalase- 
peroxidases and chloroperoxidases, is much stronger than that o f some Class II 
peroxidases (e.g. Arthromyces ramosus peroxidase; Hiner et al., 2002a). Therefore, 
HRP is ranked “intermediate” in H2O2 protection within the peroxidase superfamily. 
(Hiner et al., 2001). HRP A2 demonstrates increased H2O2 tolerance compared to 
HRPC. This has been attributed to the presence of a modified Compound III in HRP 
A2-mediated H2O2 catalysis in the absence of a reducing substrate. Normally, a water 
molecule is weakly bound to Compound III; however, the altered Compound III 
replaces this H2O molecule with a tightly bound O2* radical, affording increased 
stability. The alternative Compound III may be kinetically disfavoured during the 
HRPC catalytic cycle (Hiner et al., 2001).
Hiner and co-workers (2001) defined the ‘partition ra tio ’ as a mechanism for 
comparing H2O2 stability o f HRP variants. This ratio yields the number o f H2O2
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turnovers occuring prior to enzyme inactivation. Glycosylation was shown to increase 
HRPC H2O2 stability (2-fold), whilst mutations to the active site (Arg 38 and His 42) 
caused a 10-fold loss. Mutations outside the active site have also reduced susceptibility 
to H2O2 inactivation: F I43A, for example, yields in a 15% increase in H2O2 stability. 
Continued mutagenesis studies on other peroxidases highlight the potential for 
increasing H2O2 stability (Valderrama at al., 2002). Miyazaki and Takahashi (2001) 
engineered a stabilised H2O2 binding pocket in a recombinant manganese peroxidase 
(Class II peroxidase) by Asn81 and multiple Met substitutions. Additionally, a single 
substitution, H52Q, alters yeast cytochrome c peroxidase (Class I peroxidase) H2O2 
catalysis from reduction to oxidation (Bateman et al., 2001). Arnold and Lin (2000) 
improved HRP’s H2O2 stability by directional evolution (65% increase; L131P and 
L371I mutations). These mutations also resulted in increased thermal and solvent 
stabilities (although this may be coincidental, as two different phenotypes are in 
question).
Therefore, the stabilisation of HRP against H2O2 inactivation is complex, with many 
possible outcomes dictating the enzyme’s fate. In this study, by altering the charge of 
the protein (but maintaining the space-fill characteristics in this region) the catalase- 
type reaction may have been selected over Compound III formation (Hemandez-Ruiz et 
al., 2001). This hypothesis is supported by the stabilising K232N, but not K232A, 
mutation. This could perhaps lead to a HRP-based catalase-type reaction, which allows 
HRP to maintain catalytic activity in elevated concentrations o f H2O2.
4.8.5 Kinetic Characterisation.
The effect of lysine substitutions on the steady-state kinetics o f recombinant HRP was 
investigated with ABTS as the reducing substrate. Peroxidase kinetics do not follow the 
traditional Michaelis-Menten model, with the steady state rate constants, ki and k3 (see 
Figure 1.3), governing the catalytic cycle, ki is typically too rapid for accurate 
measurement by steady state kinetics. is often referred to as the rate-limiting step in 
HRP kinetics and is the rate constant described in this study; the use o f “steady state 
parameters, kcat and Km, is inappropriate fo r  peroxidase kinetics” (Dunford, 1999). 
Hence, experimentally determined steady-state values are often referred to as kj app, or 
the apparent catalytic constant.
Six of the nine single lysine mutants display an increase in k3, whilst o f the remaining 
three, one shows kj value similar to wildtype, while the other two show decreased
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values (K232A, 8% and K174E, 25% decrease). The largest increase in k3 was noted for 
K241A, which displayed a four-fold increase. Only one mutant (K241E) showed a 
decreased K ’m (33% reduction in ABTS binding capability). All the other mutants 
displayed a similar (K174A and K241N) or increased K ’m, (K232A, 27%; K232E, 
40%; K174N, 50%; and K174E, 50%; and K232N, 80%). However, similar to the k3, 
the largest increase in K’m was noted for K241 A, which displayed a 240% decrease in 
binding affinity for ABTS under the experimental conditions used. The explanation for 
the significantly increased k3 and K ’m for K241A may be the reorientation of the 
protein backbone due to the inclusion of a smaller amino acid at this position. This 
hypothetical molecular rearrangement may affect the overall HRP structure, reducing 
access to the binding region for the bulky ABTS substrate (K’M), which may also result 
in easier product disassociation, thus increasing the k3. A similar rationale can be 
applied to the other mutants displaying increased k3 or K ’M, with the converse applying 
to those mutants with decreased kinetic values. However, this hypothesis would have to 
be confirmed by crystallisation studies and use o f additional substrates.
E238Q displayed a 1.7-fold increase in k3\ this mirrors previous increases in k3 
following charge neutralisation in that region. A 30% increase in K’m was noted for 
E239N; however, only a small increase (<10%) in k3 was observed.
The kinetic values obtained for the double lysine mutants appear somewhat 
contradictory to those for the single mutants. The double glutamine mutant, with 
decreased space fill capacity, displays a 2.3-fold increase in k3 accompanied by a 1.1- 
fold increase in K ’m- Although less pronounced an improvement as the single lysine 
mutant, K241A, it appears that alteration of the protein backbone has occurred, by 
decreased space fill in this region and that mutant proteins’ binding capacity for ABTS 
has been decreased. Surprisingly, however, use of the other amide, Asn, in a double 
substitution yields a 1/5 decrease in k3, accompanied by a 1/4 increase in K ’M-
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4.9 Conclusions.
In this chapter a mutant matrix was generated, focussing on rationally selected lysine 
and glutamic residues indicated by prior art (O’Brien et al., 2001). The “best” single 
mutants, those yielding improved thermal, solvent and H2O2 stability, were substitutions 
whereby the positively-charged lysine was neutralised (most notably by asparagine) at 
positions 232 and 241 in the HRP backbone. Improved space-fill, or hydrogen-bonding, 
characteristics resulted in improved stability, possibly by delaying proximal calcium ion 
disassociation. Mutation of lysine 174 and glutamic acid 238 led to decreased thermal 
and solvent stabilities and suggests important stabilising roles for these residues in 
wildtype HRP. Double mutations, incorporating the best single mutants, yielded further 
improvements (K232/K241N, K232/K241Q and K232F/K241N); however, the effects 
were non-synergistic or additive; also, overpacking resulted in decreased stability. 
Many o f the mutants displayed increased ¿3 , although without a concurrent K ’m  change, 
suggesting alteration to catalytic steps rather than substrate binding.
Thermal stability in bio catalysts is a major factor in decreasing process costs, as 
reactions can be carried out more efficiently, reactants are often more soluble, and 
microbial contamination is minimised at higher temperatures (van den Burg and Eijsink, 
2002). Thermostabilised HRP will find many potential applications, including 
wastewater treatment, enzymatic synthesis at elevated temperatures, and in “time- 
temperature integrators” (Lemos et al., 2000). Solvent-stabilised rHRP will similarly 
find many applications including phenolic polymerisation, as an analytical reagent in 
monophasic organic media and in organic solvent based biosensors (Dordick, 1991). 
Improved H2O2 stability will increase the applicability of HRP in wastewater treatment, 
where currently it suffers from intolerance o f high concentrations o f the primary 
substrate H2O2, low enzymatic reusability, and financial costs (Ryan et al., 2006).
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Chapter Five.
Site-Directed Mutagenesis: 
Consensus Approach.
5.1 Introduction.
Comparison is one o f the most basic procedures in biology. Measuring similarities 
and differences between organisms allows scientists to generate groups and clusters, 
from which we can infer such things as evolutionary relationships (Levitt and 
Gerstein, 1998). The alignment o f nucleotide or amino acid sequences is an essential 
tool in molecular biology as it allows rapid detection o f “relatedness” between 
seemingly unrelated proteins and can act as an essential prelude to molecular 
evolutionary analysis. As such, development of bioinformatic software capable o f 
processing vast data sets is paramount (Chenna et al., 2003; Thompson et al., 1994). 
One application of such alignment procedures is in the identification of key stabilising 
residues in a protein structure (Lehmann and Wyss, 2001). This methodology is often 
referred to as the Consensus Approach, or semi-rational protein design, with several 
successful reports o f protein stabilisation using this approach available (Miyazaki et 
al., 2001, Lehmann et al., 2002, Flores and Ellington, 2005). The consensus approach 
is based on the assumption that conserved residues, as detailed in the sequence 
alignments o f related proteins, contribute more to the protein’s stability than non­
conserved residues (van den Burg and Eijsink, 2002). It has been proven that a set of 
amino acid sequences o f homologous, mesophilic enzymes contains sufficient 
information to allow rapid design o f a thermostabilised, fully functional enzyme 
(Lehmann et al., 2000).
Based on these assumptions, a consensus peroxidase protein was developed “in 
silico", utilising newly constructed bioinformatic software (Section 5.3) capable of 
analysing an aligned set o f peroxidase sequences. By inspecting the consensus 
peroxidase protein together with that o f the crystal structure o f HRP, certain HRP 
residues were selected and mutated to the corresponding peroxidase consensus 
residue. The mutant protein was expressed and purified and its stability characteristics 
were measured to ascertain the effects o f mutation.
Stability gains for the consensus mutants were disappointing, however. A rigorous 
bioinformatic approach was implemented which, through the generation o f an 
archetype peroxidase, suggested the importance of the helical secondary structure 
within the protein backbone. As such, mutation of these residues failed to increase the 
stability o f the protein, and leads to the conclusion that the consensus approach may 
not be globally applicable.
171
5.2 Generation of Peroxidase Consensus Gene.
One hundred unique peroxidase sequences were downloaded from the NCBI gene 
repository (www.ncbi.nlm.nih. gov/entrez/query.fcgi?db=Protein), utilising the 
following search boolean:
“((((((Peroxidase) AND (plant))) NOT (precursor)) NOT (putative)) NOT  
(Segment)) NOT (catalase)”
These sequences were then aligned via the Clustal W (Thompson et al., 1994) 
alignment package, using the default alignment parameters for the Clustal W server 
(http://www.ebi.ac.uk/clustalw). The alignment was saved as a “.aln” file and 
subsequently processed by the “ProteinParser” software (see Section 5.3) to generate 
the consensus sequence. A baseline level o f “50% Frequency” was set with the 
following amino acids returned as being more frequent within “peroxidase consensus 
protein
Table 5.1: Consensus amino acids calculated utilising a 50% tolerance threshold. The first amino acid 
listed is the residue present in the HRP gene, the number is the position in the sequence, and the second  
letter is the most frequent amino acid. The % frequency is also reported.
Amino Acid % Frequency
T102A 58
Q106R 57
Q107D 57
T110V 75
I180F 73
5.3 Generation of the “ProteinParser” Bioinformatic Software.
“ProteinParser'’ is a Java based programme that interrogates aligned sequences at 
individual residue positions and calculates the percentage amino acid at a particular 
position. A tolerance level can be defined whereby the programme output will contain 
only residues over a certain consensus level, e.g. the amino acid occurs at that position 
in > 50% of the aligned sequences. This novel software was generated in conjunction 
with Ronan Barrett, School o f Computing, Dublin City University, and is freely 
available for download at www.computing.dcu.ie/~rbarrett/software.html.
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Figure 5.1: GeneDoc™  representation o f  aligned HRP and consensus peroxidase gene sequence. Black shading is representative o f  conservation, whilst green 
colouration signifies the consensus amino acids substituted and analysed in this study. It should be noted that at positions 38 and 102 a difference in sequence is 
present; however, the amino acids in question are leucine and isoleucine, a very conservative replacement, and so this region is shaded in black. Leu is predicted at 
position 222; however, a baseline (50% frequency) was noted for this substitution, and was not considered for further analysis.
5.4 M utational Primer Design.
As previously described in Section 2.21, mutational primers were designed to 
introduce the “consensus” desired mutation. The primers incorporated mismatch 
basepairs that would generate the desired mutation, once translated. A silent mutation 
was also incorporated into each primer to insert a novel restriction site close to the 
desired mutation. Hence, screening of clones for the new restriction sites would 
indicate the presence of the desired mutation.
5.5 Designed M utations and Computer Simulations.
Initially, computer aided modelling was utilised to view mutations in silico. The HRP 
crystal structure co-ordinates (Accession Number 1ATJ) were downloaded from the 
Protein Data Bank (http://www.rcsb.org/pdb). Computer simulations, using 
DeepView™ modelling (Figure 5.2 to 5.6), suggested that the mutations would still 
allow the protein to fold correctly. Site directed mutagenesis was carried out on 
pBR_I as outlined in Section 2.21. The primers utilised were pBR_I T102A, pBR_I 
Q106R, pBR_I Q107D, pBR I T110V, and pBR I I180F respectively, and the 
conditions were as per Section 2.22. Mutants were screened with a Bgl II digest 
(T102A, Q106R, Q107D), a Nae I digest (T110V), and a Cla I digest (I180F), as 
outlined in Figures 5.7 to 5.9. Successful inclusion of the silent mutation would, in 
turn, result in a differential cutting pattern that would allow a single clone to be 
selected for sequence confirmation.
Figure 5.2: DeepView™  analysis of the Threonine 102 to Alanine mutation. The mutant is visualised 
in its most energy stable confirmation, as calculated by the DeepView™  software. The heme group is 
red, the calcium ion in yellow and the mutation is in dark purple.
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Figure 5.3: Deep View™ analysis of the Glutamine 106 to Arginine mutation. The mutant is visualised 
in its most energy stable conformation, as calculated by the DeepViewm  software. The heme group is 
red, whilst the mutation is in green.
Figure 5.4: DeepView'M analysis of the Glutamine 107 to Asparagine mutation. The mutant is 
visualised in its most energy stable conformation, as calculated by the DeepViewrM software. The heme 
group is red, whilst the mutation is in light purple.
Figure 5.5: DeepView™ analysis of the Threonine 110 to Valine mutation. The mutant is visualised in 
its most energy stable conformation, as calculated by the DeepView™  software. The heme group is red, 
the calcium ion is coloured in yellow, whilst the mutation is in orange.
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Figure 5.6: DeepView analysis of the Isoleucine 180 to Phenylalanine mutation. The mutant is 
visualised in its most energy stable conformation, as calculated by the Deep View™ software. The heme 
group is red, whilst the mutation is in black.
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Figure 5.7: Part A represents the expected restriction pattern of pBR I mutated at either position 102, 
106 or 107. In silico analysis predicts three bands due to the presence o f the mutant Bgl II site, one 
band of approximately 3918 basepairs, another of 440 basepairs, and a final band of 75 basepairs. Part 
B is the mutant plasmid viewed after restriction and electrophoresis through 1% w/v agarose. The 
approximate band sizes correspond to the predicted pattern.
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Figure 5.8: Part A represents the expected restriction pattern of pBR_I mutated at position 110. In 
silico analysis predicts two bands due to the presence of the mutant Nae I site, one band of 
approximately 4083 basepairs and another of 350 basepairs. Part B is the mutant plasmid viewed after 
restriction and electrophoresis through 1% w/v agarose. The approximate band sizes correspond to the 
predicted pattern.
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Figure 5.9: Part A represents the expected restriction pattern of pBR I mutated at position 180. In 
silico analysis predicts two bands due to the presence of the mutant Cla I site, one band of 
approximately 4207 basepairs and another of 226 basepairs. Part B is the mutant plasmid viewed after 
restriction and electrophoresis through 1% w/v agarose. The approximate band sizes correspond to the 
predicted pattern. Cla I will only restrict Dam- DNA, hence, this plasmid was prepared from a Dam- 
strain, ER2925 (New England Biolabs, Boston, USA).
177
5.6 Sequencing of mutants.
Single mutants were selected for sequencing via a restriction digest screening 
methodology as outlined in Figures 5.7 to 5.9. Selected plasmids were prepared by the 
Gene Elute™ method, Section 2.8.3, and sent to MWG or Fusion Antibodies Ltd for 
sequencing using the di-deoxy sequencing method. Results were obtained via e-mail 
and processed through various bioinformatic packages to confirm correct reading 
frame o f clone, desired mutation and maintenance of gene integrity. The results are 
outlined in Figure 5.10.
Figure 5.10: Segments of a GeneDoc™ alignment of Consensus Mutants at positions 102-, 106% 107", 
110 (A), and 180- (B), with wildtype PelB_HRP. The sequences show complete identity, with the 
exception of the mutated residues, which have been altered to the desired amino acid.
5.7 Characterisation of Consensus Mutants.
5.7.1 Determination o f Consensus Mutants Concentration.
Consensus mutants were individually expressed in 500 mL shake culture flasks as 
previously described, see Section 2.24.4. The recombinant HRP mutants were purified
via optimised nickel affinity chromatography, as outlined in Section 2.25. Once
-> 1
expressed and purified (typical specific activity o f -7.5 x 10' ^mol.min.mg'), the ¡¿M 
concentration of HRP was calculated as per Section 2.29, with the results outlined in 
Table 5.2. RZ values o f ~1.0 were regularly achieved.
Table 5.2: Absorbance at 403nm for all consensus mutant forms of rHRP. rHRP concentrations were 
calculated using the Beer-Lambert Law, and the rHRP extinction coefficient, 100mM'1cm'1 (Hiner et 
al., 1995). Protein concentrations were experimentally determined using the BCA assay. 
“Combination” is a pentuple mutant comprising: T102A, Q106R, Q107N, T110V and I180F.
Mutant
Abs
403nm
rHRP 
(/* M)
Protein Cone 
(mg.mL'1)
Heme/Protein
Ratio
T102A 0.074 1.52 0.187 0.276
Q1106R 0.074 1.52 0.216 0.239
Q107D 0.110 2.26 0.239 0.320
T110V 0.041 0.85 0.265 0.109
I180F 0.021 0.43 0.157 0.093
Combination 0.130 2.68 903 0.101
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Protein concentrations were equalised for all thermal and organo tolerance assays, 
whilst active rHRP concentrations were equalised for all kinetic studies.
5.7.2 Consensus Mutant Thermal Tolerance.
All thermal tolerance assays were carried out as per Section 2.32 for each o f the 
mutant forms, in triplicate, using recombinant wildtype as a reference, with a final 
protein concentration of 100 /xg.mL^in the reaction solutions.
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Figure 5.11: Thermal profile of Consensus Mutants □, T102A; A, Q106R; , Q107D; , T110V; o, I80F; 
, Combination; o, WT. T50 values for each mutant are tabulated in Table 5.3.
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Figure 5.12: Semi-log plot of Consensus Mutants thermal inactivation at 50°C □, T102A; A, Q106R;
, Q107D; , T110V; o, I80F; , Combination; o, WT. ti/2 values for each mutant were modelled using 
Enzfitter™ and are tabulated in Table 5.3.
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Apparent half-lives for each of the mutants at 50°C were calculated, as outlined in 
Section 2.33, and are tabulated in Table 5.2.
Table 5.3: T50 value, modelled ¿-value (rate of inactivation) and calculated apparent half-life (ti/2) for 
each consensus mutant at 50°C.
Mutant
T50
(°C)
Rate Constant 
(m in1)
%SD
tl/2
(mins)
r*
Value
Wildtype 50 5.59 xlO" ±6.6 12.4 0.98
T102A 51 5.39x1 O'2 ±7.5 12.9 0.97
Q106R 49 8.52 xlO’2 ±7.7 8.1 0.96
Q107D 51 6.76 xl O'2 ±11.0 10.3 0.96
T110V 51 5.07 xlO'2 ± 10.0 13.7 0.93
I180F 50 6.48 xlO'2 ± 10.0 10.7 0.94
Combination 49 7.83 xlO"2 ±9.4 8.8 0.92
5.7.3 Consensus Mutant Organic Solvent Tolerance.
All solvent tolerances were estimated as per Section 2.34, in triplicate, using 
recombinant wildtype as a reference at a final protein concentration o f 100 /xg.mL"1. 
Solvent tolerance profiles were produced for each o f the mutant forms. All standard 
errors were within <5% o f the triplicate average reading, so errors bars have been 
omitted for the sake o f clarity.
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Figure 5.13: DMF Tolerance of Consensus Mutants □, T102A; À, Q106R; □, Q107D; , T110V; o, I80F; 
, Combination; o, WT.
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Figure 5.14: Solvent Tolerance (DMSO and MeOH) of Consensus Mutants □, T102A; A, Q106R; , 
Q107D; , Tl 10V; o, I80F; , Combination; o, WT.
C50 values for each o f the mutants at 25°C were calculated, as outlined in Section 2.34, 
with the results tabulated in Table 5.4 .
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ITabic 5.4: Calculated C50 for each Consensus Mutant. Standard Errors were less than 5% in all cases.
M utant
DMSO
C50
MeOH
C50
DMF
C50
Wildtype 35 53 14
T102A 35 54 12
Q016R 30 45 11
Q107D 35 48 11
T110V 34 45 20
I180F 34 43 14
Combination 35 40 20
5.7.4 Consensus Mutant H2O2 Tolerance.
All H2O2 tolerance assays were carried out as per Section 2.35 for each mutant in 
triplicate using recombinant wildtype as a reference. Final rHRP concentration o f  360 
nM in each reaction. H2O2 tolerance profiles were produced for each mutant. Standard 
errors were less than 15 % in all cases.
M H20 2
Figure 5.15: H20 2 Tolerance Profile of Consensus Mutants □, T102A; A, Q106R; □, Q107D; 0, T110V; 
o, I80F; _, Combination; o, WT.
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Table 5.5: Calculated H20 2 C50 for consensus mutants.
M utant
mM 
H2O2 C50
% Error
Wildtype 17 ± 4
T102A 17 ± 13
Q106R 7 ± 6
Q107D 18 ±3
T110V 425 ±11
I180F 17 ± 4
Combination 8 ± 1
5.7.5 Consensus Mutant Steady-State Kinetics.
All kinetic assays were carried out as per Section 2.36, with a final rHRP 
concentration o f 30 pM in each reaction solution. Apparent K’m and k3 values were 
calculated by the software package Enzfitter™. All experiments were performed in 
triplicate, with the average value being used in the analysis. Again, recombinant 
wildtype HRP was used as a reference.
Table 5.6: Steady-state kinetic of consensus mutants, with ABTS as reducing substrate. Apparent K’m 
and A:? values, including standard errors, were calculated using Enzfitter™.
M utant k3 (s'1) SD (S'1) K ’m (jlM) SD (jiM)
Wildtype 482 ±12 0.093 ±0.013
T102A 605 ±37 0.200 ±0.30
Q106R 359 ± 7 0.541 ±0.25
Q107D 486 ±33 0.885 ±0.09
T110V 374 ± 4 0.170 ±0.02
I180F 497 ±3 0.308 ±0.02
Combination 491 ± 10 0.062 ± 0.007
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5.8 Discussion.
The aim o f these experiments was to identify, produce, verify and characterise semi- 
rational site-directed mutants of the HRP gene situated in the pBR I plasmid. A semi- 
rational mutational stratagy, based on the consensus approach, was utilised in the 
identification of key residues for mutation in this study. The consensus approach, in 
its simplest application, is a comparative methodology. Different relations o f a 
particular protein are aligned against each other and the consensus, or most common, 
amino acid at a particular position is estimated (Lehmann et al., 2000). In recent years, 
however, variations o f this simple methodology have been implemented to stabilise j8- 
lactamase (Amin et al., 2004) and to alter the cofactor specificity o f a lactate 
dehydrogenase (Flores and Ellington, 2005). In vivo, proteins are under no selective 
pressure to form optimally stable structures; instead, they tend to form structures of 
adequate stability, i.e. the protein is just stable enough not to limit the host organism’s 
viability (Magliery and Regan, 2004). As such, there is a wide scope for stabilisation 
of mesophilic proteins, with the substitution of non-consensus amino acids by 
consensus ones offering a feasible approach to improve the stability o f  a protein.
5.8.1 Consensus Mutation Selection and Generation.
In this study, 100 peroxidase sequences were downloaded from the freely available 
gene bank, hosted by the National Centre for Biotechnology (www.ncbi.nlm.nih.gov). 
The search (carried out on the 5th August, 2005) was restricted to full length, 
confirmed plant peroxidase proteins, using a variety o f limit Booleans in the search. 
The results yielded 548 protein entries; however, about 1/5 were repeat sequences and 
were not used as part of the consensus generation. The sequences were aligned 
utilising the alignment tool, Clustal W (www.ebi.ac.uk/clustalw), employing the 
programme’s default settings. The output “.a/«” file was used as the entry data in the 
novel Java-based “ProteinParser” programme. This software interrogated each 
residue at each position in the peroxidase sequence, and, given a tolerance threshold 
of 50% identity, generated a consensus amino acid for each position. The “Consensus 
Plant Peroxidase Protein” was then aligned with the HRP protein sequence and 
similarities and differences were noted. The HRP protein demonstrates a 49% 
similarity the Consensus Protein. More significant for this study, however, the HRP 
protein differs from the Consensus Protein at five positions, four of which are within a
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conserved region, residues 94-111, and these residues were therefore selected for 
mutation to the consensus residue.
As previously outlined in Section 4.8.1, the consensus mutants were synthesised using 
the optimised two-stage mutagenic PCR strategy (Wang and Malcom, 1999). Also, a 
silent diagnostic restriction site was included in the mutagenic primer to allow for 
rapid, economical screening of several potential clones. Once all clones were 
synthesised, screened and the mutations confirmed by commercial sequencing, the 
results were aligned using GeneDoc™ bioinformatic software to demonstrate the 
identity and the location of the mutations. One of the key results from this chapter is 
the generation of a suite of site-specific, semi-rationally designed, HRP mutants based 
in the modified pQE60 expression vector (see Chapter 3). These clones permitted the 
expression, purification and characterisation of the desired mutant proteins with the 
aims o f (i) generating a stabilised form o f recombinant HRP, and also o f (ii) 
ascertaining the applicability o f the consensus approach to stabilising rHRP.
5.8.2 Thermal Stability.
Initial characterisation of the consensus mutants comprised thermal profiles and 
thermal inactivation. As stated previously, all thermal studies were carried out at a 
constant protein concentration, in order to normalise any possible effects o f protein 
concentration on stability. Thermal profiles o f the consensus mutants suggested that 
50°C was a suitable standard temperature at which to carry out thermal inactivation. 
Although the consensus mutants did not display any increase in T50 in comparison 
over wildtype, the lowest T50 noted (Q106R and Combination Consensus; this latter 
pentuple mutant comprises T102A, Q106R, Q107N, T110V and I180F) was within 
4% of the wildtype value. This corresponds closely to previous results (see Table 4.2). 
Enzfitter™ modelling of thermal inactivation data permitted the calculation o f the 
apparent half-life, tm, of the mutant enzymes at 50°C and direct comparison with the 
recombinant wildtype form o f HRP. Only two mutants displayed increased thermal 
stability as judged by the tm  value, namely T102A and T110V. These displayed a 
marginal 4% and 11 % increase in tm  respectively, whilst the remaining mutants all 
showed decreased thermal stability, ranging from a 17% (Q107D) to 35% (Q106R) 
decrease in tm  versus wildtype. T102A is located in Helix D (Gajhede et al., 1997) at 
the back o f the substrate-binding site and, as such, incorporation o f an alanine residue 
in the helical secondary structure is acceptable. Ala, a small non-charged amino acid,
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may lead to improved helical structure (Fersht and Serrano, 1993, and Nosoh and 
Sekiguchi, 1990) resulting in decreased protein entropy and, hence, improved 
thermostability. Rojkova and co-workers (1999) recently described a 24% increase in 
thermal stability by a single serine-to-alanine helical substitution. They utilised a 
consensus-based approach together with rational stabilisation logic (hydrophobization 
of the a-helix structure) to select the helical residues for mutation, and thus confirmed 
the important role o f alanine residues in helical structure stabilisation. T110V is 
located on the last turn of the same helix, (D; Gajhede et al, 1997) as T102A. Recent 
reports suggest that incorporation o f valine into helices can be destabilising (Brosnan 
and Brosnan, 2006), although several studies concluded that helical valines may 
instead stabilise proteins (Gregoret and Sauer, 1998): Val’s conformational rigidity 
lowers the entropic cost of forming favourable side-chain van der Waals interactions 
(Cornish et al., 1994).
In comparison, substitution o f the glutamine residues at positions 106 and 107, with 
aspartic acid and bulky arginine could place increased torque on the helix, leading to 
destabilisation and, hence, to the observed decrease in thermal stability. Recently, 
however, arginine residues have been demonstrated to occur at high frequency in a- 
helical structures in thermophilic enzymes, with the propensity towards a central 
location within the helix structure (Kumar et al., 2000). Conversely, in this study, the 
introduction o f an arginine residue at the centre of a helix results in the least thermal 
stable HRP mutant. Additionally, the H-bonding side chain of aspartic acid is known 
to compete directly with backbone H-bonds o f the helix structure; this disrupts the 
secondary structure and leads to protein destabilisation (Chou and Fasman, 1978). 
Also, due to the buried nature o f these mutations, re-orientation of the core packing 
may cause decreased thermal stability. Previous studies have demonstrated that, in 
most proteins, the core is exquisitely packed and stabilisation by mutation is generally 
difficult to achieve; as a result, any mutation will probably result in suboptimal 
packing (Lee and Vasmatzis, 1997). Another possible reason for destabilisation 
resulting from the substitution of Gin 106 and 107 with charged amino acids, Arg 
(106) and Asp (107), is the introduction of an unpaired charge in the protein core. 
Ladbury and co-workers (1995) demonstrated that an unpaired charge in the core of 
an E. coli thioredoxin protein results in reduced heat stability and unfolding of the 
protein. The I180F mutation, located close to a helix, gave no significant alteration in 
thermal stability over wildtype. Although not noted for helical propensity, Phe can
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serve as a helical amino acid, as the helix-forming tendency o f a particular amino acid 
depends on the sequence context in which it occurs (Padmanabhan et al., 1990). The 
combined mutant, (T102A/Q106R/Q107D/T110V/I80F), displayed a 30% decrease in 
thermal stability, indicating that thermally stabilising mutants cannot offset the 
negative effects o f destabilising substitutions (in HRP at least). Indeed, the mutations 
could be seen to be ‘subtractive \  as the decreased stability for the combination mutant 
matches the least thermostable mutant, Q106R.
As outlined previously, thermal stabilisation of proteins is both complex and 
challenging. The exact mechanisms of protein stability remain unclear, with several 
phenomena playing important roles, often in a concerted fashion. Hence, slight 
adjustment o f one of these factors may have a knock-on effect onto other stabilising 
interactions, as discussed for amino acid charge interactions (Vendruscolo, 2002). 
Although previous consensus-based approaches have yielded proteins with increased 
thermal stability (Lehmann et al. 2000, and references within, Lehmann et al 2002, 
and Lett et al., 1999), it has also allowed for identification of particular residues that 
influence thermal stability (Hakamada et al., 2001, Clemente and Marquez, 2000). 
From the present data, it is clear that mutation of helix-favouring residues to residues 
within the enzyme core without helical propensities can have detrimental effects on 
HRP thermal stability.
5.8.3 Organic Solvent Stability.
The effects of different organic solvents on the consensus mutants were also analysed. 
As before, solvents were chosen based on their denaturation capacities (Methanol, 
low; and DMF, medium; Khmelnitsky et al 1991a), and from previous heme plant 
peroxidase solvent studies (DMSO, Santucci et al., 2003; and N. Carolan, PhD Thesis, 
Dublin City University, 2004). In all cases, consensus mutants were inactivated as the 
percentage volume o f organic solvent increased. Overall, no increases in organo- 
tolerance were noted for any of the solvents tested compared with wildtype. As 
previously described, solvents can effect protein denaturation in a number o f ways, 
including removal o f the hydration shell close to the protein backbone. In an aqueous 
environment, an enzyme can be visualised as comprising two regions. The first, of 
high polarity, is in contact with the aqueous solution, while the second region is 
concealed from the aqueous environment. When, however, the polarity o f the 
hydration shell is decreased by sequential removal o f aqueous solvent and
187
replacement by non-aqueous solvent, the previously-sequestered hydrophobic region 
begins to disperse, resulting in disorganisation and destabilisation o f the protein 
(Butler, 1979). The C50 value (Section 2.34) was again utilised to compare organo- 
tolerance across the mutant matrix. The largest decrease in C50 was 25%, for the 
combination mutant in MeOH. Q106R displayed at least a 12% decrease in organo- 
tolerance in all solvents tested. Versus wildtype, T110V and the combined mutant 
showed increased stability in DMF, decreased stability in MeOH and comparable 
stability in DMSO. I180F displayed similar stability to wildtype in DMSO and DMF, 
but lower stability MeOH. T102A and Q107D displayed similar stabilities to wildtype 
in all solvents tested.
Previous computational analysis o f protein mutation suggests that most mutations 
within the protein backbone will have neutral effects on protein stability, due to the 
flexibility o f the protein structure (Palma and Curmi, 1999). Also, conservative 
substitutions that maintain protein polarity do not cause a notable loss o f solvent 
tolerance compared to wildtype. Mutation o f the Gin 106 may cause minor 
destabilisation of the protein backbone, which in turn promotes unfolding and loss o f 
activity in non-natural environments, although this would have to be confirmed by 
crystallisation studies. The effect of charge introduction (e.g. Q106R) may explain the 
drastic loss o f thermal and medium loss o f organo-stability for both Gin mutants, 
possibly due to long-range structural perturbations induced by single amino acid 
substitutions (Vendruscolo, 2002). Interactions between closely situated amino acids 
are known to influence secondary structure, which in turn contributes to overall 
protein stability (Munoz et al., 1996). Note that all mutants display an activation in 
10% v/v MeOH, with T102A displaying a 35% increase in activity in 20% v/v 
MeOH; however, no overall stability gain is afforded by any mutation, as all C50 
values are equal to, or less than, wildtype’s. Peroxidase activation in MeOH has 
previously been reported, with the activation process being attributed to an altered 
form o f the peroxidase conformational structure in the presence of an organic solvent 
(Carolan N, PhD Thesis, Dublin City University, 2004). No activations are noted in 
the other two solvents tested. The effects o f each solvent on HRP and methods of 
stabilisation have been previously discussed (Section 4.8.3). The present results do 
indicate, however, that certain residues are important for the organo-stability o f 
recombinant HRP. Q106 clearly maintains a stabilising interaction within the HRP 
molecule. This maybe charge- or space-fill related, or a combination o f both;
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however, from the results outlined in this chapter, its presence is essential to the 
solvent-stability of the recombinant HRP molecule.
5.8.4 H2O2 Stability.
The H2O2 tolerance of consensus mutants was also investigated, with the results 
mirroring the thermal stability characterisation. Three mutants (T102A, Q107D and 
I180F) displayed almost identical C50 values to wildtype. Q106R, the least stable 
mutant under all conditions tested, demonstrated a 58% decrease in H2O2 tolerance, 
compared to wildtype. Interestingly, T110V stabilises the protein against high H2O2 
concentrations; this may be due to the removal o f the -O H  moiety o f Threonine, 
which could oxidise to an aldehyde or acid carboxyl in the presence o f the reactive 
oxygen species generated during H2O2 catalysis. Valine, although a similar amino 
acid, contains only an aliphatic side chain (Creighton, 1993). The ''subtractive ’ nature 
o f this set of mutations is again noted as, similar to the thermal characterisation, a 
significantly destabilising mutation (Q106R) cannot be “rescued” by inclusion o f a 
stabilising mutation (T110V).
5.8.5 Kinetic Characterisation.
The effect o f consensus mutations on the kinetics o f recombinant HRP was 
investigated under steady-state conditions with ABTS as reducing substrate. As 
discussed previously (Section 4.8.5), peroxidase kinetics do not follow the traditional 
Michaelis Menten model; instead k3 and K ’m , or the apparent catalytic constants, are 
routinely used to describe peroxidase reaction rates. Two of the consensus mutants, 
Q106R and T110V, displayed a decrease (-25%) in k3, with the remaining mutants all 
displaying a value equal to or greater than wildtype. The largest increase in k3, 25%, 
was noted for T102A; typically however, k3 varies between 0% to 25% of the 
wildtype value. The importance of charge and suitable space-fill characteristics are 
noted for mutations in this region: those located at the back o f the substrate-binding 
site (T102A, Q106R, Q107D) display a similar k3 app to wildtype. In contrast, these 
mutations notably affect the K ’m for ABTS, with increases o f 9.5-fold noted for 
Q107D, almost six-fold for Q106R, and over two-fold for T102A. These increases in 
K ’m  can be attributed to mutation-induced alterations within the substrate-binding 
domain.
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5.8.6 Failure o f Consensus Approach: Bioinformatic Analysis.
As outlined, only two mutants (T102A and T110V) registered marginal stability gains 
over wild type, in sharp contrast to previous consensus studies with other enzymes 
(Miyazaki et al., 2001, Lehmann et al., 2000 and 2002, Amin et al., 2004; Flores and 
Ellington, 2005). This unexpected outcome prompted further investigation, utilising 
bioinformatic analysis o f the Class III peroxidases and comparison of wildtype rHRP 
to a novel hypothetical archetypal peroxidase sequence, as a means to explain the 
apparent failure o f this approach to stabilise rHRP. This section o f the study was 
undertaken in conjunction with Dr. Mary J. O’Connell, School o f Biotechnology, 
Dublin City University. All o f the following bioinformatic analysis was carried out by 
Dr. O’Connell at “The Bio informatics and Pharmacogenomics Laboratory”, NUI 
Maynooth, Ireland.
5.8.6.1 Consensus Methodology Validation.
The Consensus Approach outlined in Section 5.2 ignores phylogenetic relationships 
among the sequences and so may be biased towards those clades (sub-groups) where 
there are more sequences available, due to redundancy of GenBank. For this reason, 
and to validate the consensus sequence generated in this study, a phylogenetic 
approach based on a recently published phylogenetic tree for the Class III plant 
peroxidases (Duroux and Welinder, 2003) was applied to produce a second consensus 
sequence. This tree was “pruned” by selecting a single representative from each clade. 
The resulting sequences were aligned and a phylogenetic consensus peroxidase was 
generated, as previously outlined in Section 5.2. Comparison o f the original consensus 
sequence, based on a frequency counting algorithm, with the phylogenetic one 
revealed 90% identity, validating the original consensus methodology.
Further investigation of Class III peroxidases resulted in the generation of a 
hypothetical archetypal peroxidase sequence. Reconstructed ancestral protein 
sequences have rapidly developed as an important way to infer information about a 
protein’s evolutionary history (Hall, 2006). The ancient peroxidase sequence was 
formulated utilising powerful bioinformatic software in which a model-based 
statistical algorithm for maximum likelihood (ML) reconstructs the complete set o f all 
ancestral nodes on the phylogenetic tree. This algorithm for marginal reconstruction 
applies Bayesian statistics to define the most probable character state for each 
ancestral character, given a set o f extant sequences and their phylogenetic
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relationships. This statistical approach has previously been shown to yield very high 
confidence intervals (91-99% accuracy for Lysozyme c sequences; Yang et al., 1995) 
and was recently validated by Hall (2006), see Figure 5.16.
0 .1 substitutions per site
Figure 5.16: Part (A) depicts a ribbon 3-D structure of modem day HRP, as depositied in PDB (1ATJ). 
The active site residues conserved throughout the evolution of the peroxidase phylogeny are 
highlighted in red. Part (B) is the Reduced Phylogenetic tree adapted from Duroux and Welinder 
(2003). A sequence representing each of the 24 clades identified for the peroxidase family (one 
unavailable due to sequence mis-annotation) were taken at random from the published and fully 
resolved peroxidase phylogenetic tree (Duroux and Welinder 2003). The phylogenetic tree above was 
generated using a Maximum likelihood method implemented in PAML (Yang, 1997). Branch lengths 
represent the degree of sequence divergence, the scale in number of substitutions per site is given 
below the tree. The leaves of the phylogeny represent the following species names before the Aru, 
Armoracia rusticana; Pba, Populus balsamifera; Gma, Glycine max; Pvu, Phaseolus vulgaris; Nta, 
Nicotiana tabacum; Ath, Arabidopsis thaliana; Sol, Spinacia oleracea; Les, Lycopersicon esculentum; 
Ghi, Gossypium hirsutum; Lus, Linum usitatissimum; Tre, Trifolium repens; and Ama, ¿Lvicennia 
marina. The number following the is the Genbank Accession number. The clade representing HRP 
and HRP A2 is denoted by (-4-), whilst the SBP representative is depicted by (3£). The closest 
branchpoint between HRP and SBP is denoted by “Grandparent”, whilst the hypothetical archetypal 
peroxidase sequence is defined as “Archetype”. Image generated by Dr. M.J. O’Connell.
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Figure 5.17: DeepView™ modelling of the hypothetical archetypal peroxidase (A) compared to the modem day HRP (B). Archetypal sequence was submitted to the 
SWISS-MODEL web server, ■which provides an automated protein homology-modelling service (Guex and Peitsch, 1997; Schwede et al., 2003). The heme group is 
highlighted in red and the calcium ions are highlighted in yellow in part (B).
The most ancient reconstructed peroxidase pre-dates all other peroxidases and 
represents the first or “archetype” peroxidase. The second peroxidase used in the 
comparison represents the most recent common ancestor (MRCA) o f the SBP and 
HRP enzymes, the “grandparent”. SBP is known to be a more stable plant peroxidase 
than HRP (McEldoon and Dordick, 1996) and, hence, elucidation o f key stabilising 
differences between SBP and HRP would be advantageous. The “archetype” and 
“grandparent” full-length sequences should agree closely with the consensus 
sequences generated by Protein Parser. Comparison o f these ancestral sequences with 
the consensus sequences generated from both the frequency counting and 
phylogenetic approaches reveals agreement across most o f the alignment (grandparent 
97%, archetype 85%). All three approaches identified T102A, Q106R and Q107D. 
Furthermore, two of the three methods (frequency counting and ancestral protein 
generation) revealed T110V and II80F. Again, these correspondences confirm that the 
initial consensus-identification approach was valid.
5.8.6.2 Class III peroxidase Bioinformatic Analysis.
Only one mutation, T102A (4% increase in thermal stability, Table 5.3), was 
predicted by all three consensus methods applied. This substitution is also present in 
the notably more stable SBP, and was generated (together with other mutations) in 
Morawski and co-worker’s (2001) directed evolution study o f HRP; however, T102A 
was not studied alone and was included among mutants with enhanced activity rather 
than increased stability. It is also interesting to note that only one other o f Morawski 
and co-workers mutations (2001), at position F221L, was predicted by consensus 
methodology (specifically, by the ProteinParser programme and the “Archetype” 
sequence), although previous reports have shown that this position can influence HRP 
stability (Morimoto et al., 1998; and Howes et al., 2001b). Alignment o f the relevant 
sequences reveals that HRPC consensus substitution T110V actually occurs in the 
more stable SBP but, curiously, the T102A and I180F substitutions occur in both SBP 
and in the less stable HRP A2. These coincidences suggest that the consensus 
approach is not a fruitful one for plant peroxidases, irrespective o f its success with 
other proteins. Further, four o f the five consensus positions lie within a very short, 
nine-residue cluster spanning T102 - T110 in helix D (Figures 5.2 -  5.5), with only 
1180 occurring outside this region (between helices F and F’). This narrow focus of 
the peroxidase consensus positions may explain the lack o f stability gains in the
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present instance. No such clustering is apparent in previous reports o f consensus 
protein stabilization, where the various consensus positions are distributed more 
evenly throughout the entire sequence (Lehmann et al., 2000). In contrast, this study 
indicates that the peroxidases are not a suitable case for consensus building. Figure 
5.18 displays the clusters o f consecutive columns in the constructed consensus 
sequence. From previous studies on peroxidases within A. thaliana, these enzymes 
share on average 75% identity in their primary structure (Welinder, 2002). This 
indicates that within the A. thaliana clade there is strong selective pressure to retain 
the structural confirmation. It is known that there is close similarity between 
Horseradish Peroxidases and their equivalent A. thaliana peroxidase, for example 
HRP A2 is 95% similar to A. thaliana A2 peroxidase (Nielsen et al., 2001).
The ancestral peroxidase generated in this study (Dr. M.J. O’Connell) permits the 
peroxidase structural form to be traced. It appears that the Class III peroxidases have 
evolved to retain their structural helices and active site, suggesting that structure and 
function are tightly associated in this family (see Figure 5.18). There is some slight 
sliding o f helices throughout evolution but this is acceptable over longer periods of 
time (Lesk, 2004). Alternatively, peripheral regions o f a protein outside the helices are 
free to change their folding pattern entirely (Lesk, 2004). Retention o f such structures 
suggests that these enzymes have a very ancient function consistent with their modem 
day one. From this study it is clear that identification o f the key residues giving rise to 
HRP stability must rely on some methodology other than the consensus approach. 
Finally, several researchers have noted that stability differences between homologous 
proteins may be due to a very few naturally occurring sequence variations (Eijsink et 
al., 2004 and references within). Previous published reports o f consensus mutations 
have also noted low, 33%, success rates (i.e. mutants with increased stability as a 
percentage of the total mutants generated; Lehmann et al., 2000). Magliery and Regan 
(2004) have recently developed a more advanced consensus model, which accounts 
for some of the inadequacies o f the basic consensus approach (Lehmann et al 2000), 
including: accounting for (i) regions o f poor consensus and (ii) regions o f high 
homology that mask subfamilies. A collection of subfamilies may also negatively 
affect the basic consensus result, and this is rationally integrated into the statistical 
free energy model (Magliery and Regan, 2004). This present study, however, aimed to 
refine a simple, easy to implement, frequency-counting methodology, as opposed to 
the more complex simulation of the covariation of amino acid residues.
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Figure 5.18: Location of helices within HRP, the hypothetical archetypal peroxidase and Protein Parser-generated consensus protein (BRCon). The defined 
“blocld’ nature of the consensus residues is also clear. Residues selected for mutation as part of this study are highlighted in green, whilst the catalytic residues are 
coloured in red. Numbering above the sequences is based on the larger hypothetical archetypal peroxidase. Image generated in GeneDoc™ as outlined in Section 
2.20
5.9 Conclusion
This chapter describes the application of a semi-rational consensus approach to 
protein stabilisation. Residues were selected for substitution based on direct 
comparison with the ProteinParser “Consensus Peroxidase Protein The 
ProteinParser frequency counting algorithm is valid, as confirmed by two separate 
approaches (phylogenetic and archetype generation procedures). It was noted that 
certain residues were important for rHRP stability. Mutation o f Gin 106 results in 
decreased thermal and solvent stabilities. Saturation mutagenesis, however, is required 
to confirm the potentially important role o f Gin 106 in HRP stability. Disappointingly, 
many o f the mutants displayed similar (or inferior) thermal and solvent stabilities as 
wildtype rHRP. Surprisingly, T110V displayed dramatic H2O2 stability, and requires 
further study to elucidate the key interactions causing this stabilisation. A possible 
pseudo-catalase activity may be attributed to this mutant’s ability to function at high 
concentrations o f H2O2. Major differences are noted, however, between the mutants 
and wildtype in apparent binding coefficient, K’m, the opposite o f  what was observed 
for the Lys-Glu substitutions (Chapter4). This is possibly due to the location of the 
mutations, close to the binding site, and not the mutation itself. A subtractive, 
destabilising affect was noted upon combination of all the individual mutations. 
Sequence comparison o f the modern-day HRP with the hypothetical archetypal 
peroxidase sequence generated in this study suggested the important role o f conserved 
helices within the Class III peroxidases. The determinants o f the different thermal 
stabilities seen among plant peroxidases (e.g. HRP A2, HRP C and SBP) evidently lie 
in the unstructured loops linking the conserved helices. Unfortunately, these loops 
show a low incidence of consensus amino acids, so rational or semi-rational design o f 
stabilizing mutations within these loops remains a challenging task.
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Immobilisation and Sensor Dcvelopment.
6.0 Introduction.
Protein immobilisation has been studied for many years, mainly focussing on the 
simplest immobilisation technique, adsorption. This methodology, although 
simple to implement, suffers from several drawbacks, including the removal o f 
adsorbed protein by stringent washing, high contamination (due to non-specific 
protein binding) and denaturation of proteins adsorbed onto hydrophobic surfaces 
(Cretich et al., 2006). Covalent immobilisation of proteins offers a more robust 
approach and, in recent years, this technology has developed rapidly, primarily 
due to the increase in number and range o f activated solid supports, and the ability 
to engineer or chemically modify biomolecules to allow for easier covalent 
attachment. Protein chemistry is now commonly utilised to covalently bind 
biomolecules to an activated solid phase via reactive amino acid side groups. In 
recent years, several protein-engineering strategies have introduced reactive amino 
acids to promote directed protein immobilisation. Lysine is the most commonly 
utilised amino acid in this instance, due to the fact that it can be incorporated into 
most secondary structures with minimal distortion o f the protein backbone. This 
compares to the more reactive cysteine, which can cause misfolded proteins due to 
unpaired disulphide bridges (Allard et al., 2002). While site-directed thiol-based 
immobilisation has been achieved (Zhen et al., 2004), employing a cysteine-free 
wildtype protein reduces the risk o f protein misfolding (Huang et al., 1997). 
Although generic approaches to orientated protein immobilisation are rapidly 
developing (His tags, Leucine zippers, etc.), there still remains a need for the 
development o f site-directed, directionally immobilised proteins.
Peroxidase application spans the bioscience and biotechnology spectra, ranging 
from bioremediation (Wanger and Nicell, 2002) and biocatalysis (van de Velde, et 
al., 2001) through diagnostics (Dotsikas and Loukas, 2004) to recombinant protein 
expression (Jung et al., 2001), transgenics (Veitch, 2004), bio informatics (Duroux 
and Welinder, 2003), protein engineering (Morawski. et al., 2000) and even to 
therapeutics (Tupper et al., 2004). However, one of the most common uses o f 
HRP is in biosensors. A biosensor is "an analytical device that brings together an 
immobilised biological sensing material [often HRP] and a transducer to produce 
an electronic signal that is proportional to the concentration o f the target 
chemical substance” (Luong et al., 1995). HRP dominates peroxidase-based 
sensor research and has continued to develop through many forms, from the
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traditional voltammetric- and amperometric-based methods o f detection, to nano- 
sized devices. Real-time quantification o f hydrogen peroxide continues to be one 
of the main reasons for sensor development (Tonning et al., 2005), although other 
diverse applications include the detection of glucose (Alonso Lomillo et al., 2005), 
ethanol (Azevedo et al., 2005) and tumour markers in vivo (Lin and Ju, 2005). 
Enzyme-based biosensors require rapid and uniform transfer o f  electrons 
generated at the enzyme active site to the transducer. The distance between the 
active site and the transducer can hinder electron transfer; often, posttranslational 
modifications such as glycosylation increase this distance. Recombinant HRP, 
devoid of glycans, offers a shorter path for electron transfer and numerous reports 
o f rHRP-based sensors have appeared (Ferapontova, 2004a). The typical 
bioelectrocatalytic reduction of H2O2 at the surface o f the electrode configurations 
utilised in this study, screen-printed and etched electrodes, is outlined in Figure 
6.1.
h 2o h2o
PANI’ PANI“ PANI* PANI0
B
h 2o h 2o
ELECTRODE ELECTRODE
Figure 6.1: Schematic representation of bioelectrocatalytic reduction of H20 2 at a peroxidase-modified 
electrode. Part A depicts a screen-printed electrode configuration, with a polyaniline mediator (PANI) 
shuttling electrons from the active site to the electrode surface. Part B illustrates a non-mediated etched 
electrodc configuration, in which the electrons ‘jum p’ between the active site and the electrode surface.
198
6.1 Identification o f K ey Amino Acid Residues for Immobilisation.
This study focussed on the introduction of extra lysine residues to allow for orientated 
rHRP multipoint attachment to a cyanate ester activated solid phase, e.g. cyanogen 
bromide activated matrix. Previous reports o f this methodology selected asparagine, 
glutamic acid or arginine residues for replacement by lysine (Abian et al., 2004); 
however, only arginine residues were considered in this study, as Arg to Lys is a 
conservative mutation: both size and charge are similar, and should result in minimal 
secondary structure rearrangement. There are twenty-one arginine residues in the HRP 
protein; these were viewed via Deep ViewlM (see Figure 6.2) and analysed based on 
secondary structure and location. Residues located in (8-sheets were preferred over 
helical residues, and surface-exposed residues were selected in preference to buried 
ones. Only residues on the opposite side to the active site entrance were considered, as 
attachment via the “bactf' o f the molecule would allow an orientated “molecular 
velcro” approach to rHRP immobilisation. This resulted in a selection o f A rg il8, 
Argl59 and Arg283 for mutation as outlined in the flow diagram (Figure 6.3).
Figure 6.2: Part A displays the location of the arginine residues ( • ) in HRP. The arrow highlights the 
active site entrance in both cases. The purple residues ( • ) highlighted in Part B show the location of the 
three arginine residues (R118, R159, R283) selected for mutation to lysine, to allow for orientated rHRP 
immobilisation.
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Possible Argmine Residues.
19, 27,31,38, 62, 75,82,93,118,123,124,153,159,178,183, 206,224, 264,283, 298,302.
Arginine Residues Selected for Mutation.
118 ,159  and 283
Figure 6.3: Rationale and selection flowchart for arginine to lysine mutations. Initially, arginine residues 
were analysed based on secondary structure, helix, beta sheet or turn. Those residues that were not part of 
a helix (or first amino acid of a helix) were then evaluated based on location. Residues buried within the 
protein core were eliminated, as immobilisation would not be possible with these residues. Any residue 
close to the active site entrance was also eliminated, as immobilisation with such residues would not 
allow orientated immobilisation.
6.1.1 Visualisation and Generation o f Immobilisation Amino Acids.
Any alterations to the tertiary protein structure were predicted by the “mutation” 
function in the DeepView™ software; these were subsequently analysed and visualised 
(Guex and Peitsch, 1997). The individual mutagenic PCR was carried out as described 
in Section 2.22, and the primers utilised were p B R I  R118K, pBR I R159K and pBR I 
R283K. R118K was synthesised initially, followed by R159K and, finally, R283K. The 
existing, chemically-modifiable lysine residues (232 and 241) were substituted, by Phe 
(K232) and Asn (K241) as outlined in Sections 4.5.2 and 4.5.3.
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W ildtype Residue M utant Residue
Figure 6.4: Location of arginine to lysine mutations (—) and predicted tertiary structure alterations. 
R118K is depicted in pictures A and B, R159K in C and D and R283K in E and F. The heme group (■—) 
and calcium ions ( ) are also highlighted.
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Figure 6.5: Parts A, B, and C are, respectively, diagrammatical representations of the expected 
restriction pattern for the mutant plasmids, pBR_I_118Lys, pBR_I_159Lys and pBR_I_283Lys. Part D 
shows these mutants viewed after restriction with the relevant restriction enzyme and electrophoresed 
through 1% w/v agarose. The approximate band sizes correspond to the predicted pattern, p B R I l  18Lys 
(lane two), pBR_I_159Lys (lane four) and pBR_I_283Lys (lane six). Non mutated wildtype, 
pBR_I,digested with the relevant restriction enzyme (WT) is run as comparison in each case (Lanes 1, 3 
and 5). Lanes “M” contain Sigma size markers. The additional bands observed in lane one are the 
different forms of a plasmid: open circular, covalently closed-circular and nicked.
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6.1.2 Sequencing of mutants.
Individual immobilisation mutant clones, “Velcro Plus” (R118K, R159K, R283K) and 
“Velcro Minus” (R118K, R159K, K232F, K241N, R283K), were selected for 
sequencing via a restriction digest screening methodology as outlined in Figure 6.5. 
Selected plasmids were prepared by the Gene Elute™ method, Section 2.8.3, and sent 
to Fusion Antibodies Ltd (Belfast) for sequencing using the di-deoxy sequencing 
method. Results were obtained via e-mail and processed through various bioinformatic 
packages (Section 2.20) to confirm correct reading frame of clone, suitable mutation 
and maintenance of gene integrity. The results are outlined in Figure 6.6.
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Figure 6.6: Alignment “Velcro Plus” and “Velcro Minus’'’ sequencing results with wildtype PelB_HRP. 
The sequences show total identity, with the exception of the 118, 159, 283 residues in “ Velcro Plus” and 
the 118, 159, 232, 241, 283 in “Velcro Minus”, which have been mutated to the desired amino acid.
6.2 Expression, Purification and Immobilisation o f “Velcro” M utants. 
Immobilisation mutants were individually expressed in 500 mL shake culture flasks and 
purified via optimised nickel affinity chromatography as previously described; see 
Section 2.24.4 and Section 2.25. Once expressed and purified, the fiM concentration of 
rHRP mutants were calculated as per Section 2.29, with the results outlined in Table
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Table 6.1: Absorbance at 403nm for immobilisation mutants. rHRP concentrations were calculated using 
the Beer-Lambert Law, and the rHRP extinction coefficient, lOOmM'cm'1 (Hiner et al., 1995). Protein 
concentrations were experimentally determined using the BCA assay. K283R revertant Velcro is 
indicated by “/
M utant Abs 403nm rHRP (/¿M)
Protein Cone
(mg/ml)
H em e/Protein
Ratio
Velcro Plus 0.015 0.3 0.258 0.039
1 Velcro Plus 0.045 0.9 0.538 0.057
Velcro Minus 0.159 3.2 1.418 0.077
* Velcro Minus 0.047 0.9 0.521 0.059
6.2.1 Immobilisation on Cyanogen Bromide Activated Matrix.
Initially, all immobilisation mutants and wildtype rHRP were immobilised to CNBr- 
activated Sepharose, see Section 2.37.1. The % immobilisation was calculated as 
outlined in Table 6.2.
Table 6.2: Immobilisation rate for wildtype, Velcro Plus and Velcro Minus mutants. Calculation is based 
on activity before and after immobilisation, assuming that no protein inactivation occurs during the 
immobilisation process. K283R revertant Velcro is indicated by “/  ”.
M utant
Name
Pre Immobilisation  
Units o f A ctivity  
(/imol.min" )
Post Immobilisation  
Units o f Activity  
(/imoLmin'1)
Im m obilisation
(%)
Wildtype 5.25 2.67 50%
Velcro Plus 1.54 1.32 86%
* Velcro Plus 0.43 0.33 69%
Velcro Minus 2.14 1.22 57%
t  Velcro Minus 1.02 0.49 42%
Each form o f immobilised rHRP was then characterised as to its thermal, solvent and 
H2O2 stabilities, as outlined in Section 6.3.
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6.3 Characterisation o f Free and Immobilised Im m obilisation M utants.
6.3.1 CNBr-Immobilised HRP Thermal Tolerance.
Thermal inactivation was carried out as per Section 2.32. Preliminary assays suggested 
50°C as the T50 for free Velcro Plus, Velcro Plus(K283R), Velcro Minus, Velcro 
Minus(K283R) and wildtype rHRP, and this was the temperature used for both free and 
immobilised rHRP forms. Thermal inactivation curves were produced for each mutant 
triplicate (i) in free solution and (ii) CNBr-immobilised, using recombinant wildtype as 
a reference.
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Figure 6.7: Thermal inactivation curve of Wildtype rHRP (O) Velcro Plus (A ) and Velcro Plus(K283R) 
(□) rHRP carried out at 50°C. The solid lines indicate the free solution activities; the dashed lines, 
immobilised activities.
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Figure 6.8 Thermal inactivation curve of Velcro Minus (A) and Velcro Minus(K283R) (□) rHRP carried 
out at 50°C. The solid lines indicate the free solution activities; the dashed lines, immobilised activities.
Table 6.3: Rate of inactivation at 50°C and calculated apparent half-life (ti/2) for immobilisation mutants 
in both free and immobilised (*) forms. K283Rrevertant Velcro is indicated by
M utant T 5o ( ° C ) k-value ( - ) SD ( % ) ti /2 (min) vl Value
Wildtype 50 5.59 xlO^ ± 6 12.4 0.98
Wildtype* - 2.55 xlO'2 ± 9 27.2 0.91
Velcro Plus 50 5.35 xlO’2 ± 9 12.5 0.91
Velcro Plus * - 2.23 xlO'1 ± 9 3.1 0.90
^Velcro Plus 50 5.68 xlO'2 ± 10 12.2 0.91
^Velcro Plus* - 5.44 xlO'2 ±8 12.8 0.92
Velcro Minus 50 1.09 xl 0'1 ± 7 6.3 0.93
Velcro Minus * - 1.52 xl 0'1 ±11 4.6 0.90
^Velcro Minus 50 4.45 xl O'2 ± 6 16.5 0.98
^Velcro Minus* - 4.91 xl O'2 ± 10 14.2 0.91
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6.3.2 CNBr-Immobilised Organic Solvent Tolerance.
All organic solvent tolerance assays were carried out as per Section 2.33, with a final 
protein concentration of 100 /xg/mL in the reaction solution. Solvent tolerance profiles 
were produced for each mutant form, in triplicate, using recombinant wildtype as a 
reference. All standard errors were within <5% of the triplicate average reading. These 
results were then compared to the CNBr-immobilised forms o f the enzyme under the 
same conditions. Larger standard errors (5-15%) were noted for the immobilised forms; 
however, this could be attributed to the non-homogenous suspensions generated during 
individual triplicate sampling.
% v/v Solvent
Figure 6.9: Solvent Tolerance Profile of (o) rWT HRP in DMSO and MeOH. The solid lines indicate the 
free solution activities; the dashed lines, immobilised activities.
207
% v/v Solvent
Figure 6.10: Solvent Tolerance Profile of ( ) rWT HRP (in DMF), Velcro Plus (A) and Velcro 
Plus(K283R) (□) rHRP in DMSO and MeOH. The solid lines indicate the free solution activities; the 
dashed lines, immobilised activities.
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% v/v Solvent
Figure 6.11 Solvent Tolerance Profile of Velcro Plus (A ) and Velcro Plus(K283R) (L i) rHRP in DMF 
and Velcro Minus (A )  and Velcro Minus(K283R) (□ ) rHRP in DMSO and MeoH. The solid lines 
indicate the free solution activities; the dashed lines, immobilised activities.
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%  v/v DM F
Figure 6.12: DMF Solvent Tolerance Profile of Velcro Minus (A) and Velcro Minus(K283R) (□) rHRP. 
The solid lines indicate the free solution activities, whilst the dashed lines represent immobilised 
activities
Apparent C50 (% v/v solvent that causes half inactivation) concentrations for each of the 
mutants at 25°C were calculated, as outlined in Section 2.33, with the results tabulated 
in Table 4.3.
Table 6.4: Half-inactivation concentrations (C50) for each Velcro mutant. K283R revertant Velcro is 
indicated by “/  ”.
M utant
DMSO MeOH DMF
Free Immob Free Immob Free Immob
Wildtype 35 32 53 40 14 14
Velcro Plus 35 24 44 32 1 2 17
* Velcro Plus 30 28 35 38 16 10
Velcro Minus 35 42 45 43 25 29
î  Velcro Minus 30 28 35 38 16 15
2 1 0
6.3.3 H2O2 Tolerance o f CNBr Immobilised HRP mutants.
H2O2 Tolerance assays were carried out as per Sections 2.34. H2O2 tolerance profiles 
were produced for each mutant, in triplicate, using recombinant wildtype as a reference. 
These results were then compared to the CNBr-immobilised forms o f the enzyme under 
the same conditions. Triplicate standard errors were less than 12 % in all cases.
mM H20 2
Figure 6.13: H2O2 inactivation curves of Wildtype (O), Velcro Plus ( ), Velcro PlusK283R ( ), Velcro 
Minus (□) and Velcro Minus K283R (A) rHRP carried out at 25°C. The solid lines indicate the free 
solution activities; the dashed lines, immobilised activities.
Table 6.5: Calculated half inactivation concentrations (C50) for each free and CNBr-immobilised mutant. 
K283R revertant Velcro is indicated by “/  ’’.Immobilised forms are highlighted with ‘
M utant
C50 H2O2 
(mM )
% Error M utant
C50 H2O2 
(mM )
% Error
Wildtype 17 ± 4 * Velcro Plus* 5 ± 9
Wildtype* 6 ± 7 Velcro Minus 17 ± 9
Velcro Plus 38 ± 12 Velcro Minus * 5 ± 7
Velcro Plus * 5 ± 8 t  Velcro Minus 33 ± 9
* Velcro Plus 44 ± 4 t  Velcro Minus * 5 ± 5
2 1 1
6.3.4 UltraBind™ Affinity Membrane Immobilised Activity.
Velcro Plus, Velcro Plus(K283R), Velcro Minus, Velcro Minus(K283R) and wildtype 
rHRP were also immobilised to an activated, modified polyethersulfone (PES) 
membrane to demonstrate proof of the principle o f an orientated immobilised rHRP 
molecule on a planar surface.
Velcro Minus M utant
Figure 6.14: Diagrammatical representation of proposed UltraBind™ Affinity Membrane
Immobilisation strategy. The Velcro Minus mutant should immobilise in an orientated fashion, with the 
active site facing away from the membrane. The Wildtype rHRP can immobilise with only K232, K241 
and K174, and many do so in a random mode; thus, the active site entrance may be blocked or sterically 
hindered, leading to reduced catalytic activity.
Equimolar concentrations o f rHRP, Velcro Plus and Velcro Minus mutants were 
spotted onto the UltraBind™ Affinity Membrane, as outlined in Section 2.37.2.
A B C  D E
Figure 6.15: Scanned images of spotted immobilised overnight (24 hours) DAB stained rHRP activity. 
Image A represents BSA blank, image B wildtype rHRP, image C Velcro Plus, image D Velcro Minus 
and image E the reverse membrane side of image D.
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Velcro + Velcro -
Plant W ildtype Velcro + V elcro- K 283R  K 283R
Figure 6.16: Scanned images o f DAB stained, spotted immobilised rHRP activity. Images were scanned 
as outlined in 2.37.2, and converted to greyscale utilising Hewlett Packard Scanjet 5590 image software. 
Time points indicated on the left are in hours. Increased DAB colouration was indicative o f peroxidase 
activity; this was noted within minutes for the Velcro mutants, whereas wildtype and plant HRP required 
a longer time period to develop any colouration.
213
6.4 Electrochem ical Biosensors.
6.4.1 Plotting convention for this study.
The American convention for electrochemical data is used throughout this study. A 
typical current-potential plot is outlined in Figure 6.17, with cathodic currents related to 
reduction processes plotted in an upward direction and anodic currents related to 
oxidation processes plotted in downward direction.
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Figure 6.17: Current-potential plotting convention utilised in this study.
6.4.2 Screen Printed Electrode.
Recombinant HRP offers the possibility o f direct electron transfer from the active site 
to the sensing device, since it lacks the bulky sugar chains o f the plant enzyme. This is 
currently a vibrant area o f research. In this study, the electron transfer rate o f 
recombinant wildtype and plant HRP were investigated on screen-printed electrodes. 
Screen-printed electrodes are small, mass-produced, single use devices comprising a 
silver-conducting track, a carbon working electrode and an insulation layer (see Figure 
6.18). Initially, a conducting layer o f aniline was deposited onto the carbon working 
electrode via cyclic voltammetry. BSA, recombinant and plant HRP were then 
electro chemically immobilised onto the polyaniline surface via “time-based” 
Amperometry (Section 2.38.1). The CHI 1000 software then recorded the response o f 
each protein to the addition of H2O2.
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Figure 6.18: Components of the in-house screen-printed electrode: (A) Plastic electrode backing, (B) 
Ag/AgCl conducting path, (C) carbon working electrode, (D) Insulation layer. Working area: 7.07mm2, 
(A Morrin, PhD Thesis, Dublin City University, 2003).
Stainless steal 
locking plila j ]
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Figure 6.19: Batch Cell configuration. The polycarbonate batch cell comprised an upper reaction vessel 
and a lower base, between which the screen print electrode was clamped. Platinum wire auxiliary and 
pseudo silver/silver chloride wire reference electrodes were incorporated into the reaction vessel with 
external connections, as shown in diagram (Adapted from Killard et al., 1999)
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Figure 6.20: Electro-deposition of polyaniline in 1M HC1 onto the surface o f the screen printed 
electrode. Successive polymerisation cycles are shown which correspond to increase in thickness o f the 
film during aniline deposition. The oxidation peaks were assigned to the [A] oxidation of 
leucoemeraldine (LM) to leucoemeraldine radical cation (LM*1), and the [B] oxidation of LM*+ to 
emeraldine (EM). The reduction peaks are assigned to the [C] reduction of EM to emeraldine radical 
cation (EM*+) and [D] EM*+ back to LM (Wallace et al., 2003).
u
Time (s)
Figure 6.21: Current response plot of immobilised rHRP (—), plant HRP (—) and immobilised Bovine 
Serum Albumin (—), BSA was used as a blocking, non-reactive protein to account for any background 
noise. After 1 hour equilibration and 200 seconds constant current, 0.025 mol.L"1 H20 2 (final 
concentration) was added at 50 second intervals to a 1 mL mixing reaction vessel containing the screen- 
printed electrode with immobilised HRP; the electrode was connected to a CHI 600A Potentiostat.
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6.4.3 Etched Micro-Electrode.
6.4.3.1 Schematic of a microelectrode.
Plastic Cap and 
Adhesive
Hook-up wire
Tapered end
Tin annealed Copper wire
Soft glass tubing
Soldered connection
Soldered connection
Platinum micro wire
Figure 6.22: Schematic cross-section of an in-house fabricated microelectrode. Typical tip diameter: 
2mm
6.4.3.2 Characterisation o f fabricated platinum microelectrode in H2SO4.
When a platinum electrode is cycled over a certain potential range in 1.0 M H2SO4, a 
characteristic curve is noted. This curve consists of several peaks, which can be 
attributed to various forms of platinum, oxygen and hydrogen at the surface o f the 
electrode. In Figure 6.23 these forms are labelled as: Oa -  formation o f adsorbed 
oxygen and platinum oxide layers, Oc -  reduction of oxide layers, Ha - oxidation of 
adsorbed hydrogen, Hc -  reduction of adsorbed hydrogen. The voltammogram displays 
two distinct peaks for adsorbed and desorbed hydrogen; these have been attributed to 
strongly and weakly adsorbed (or desorbed) hydrogen. The strongly adsorbed hydrogen 
is more positive, due to the fact that a higher free energy of adsorption is needed for a 
larger shift in potential (Lambrechts and Sansen, 1999).
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Figure 6.23: Cyclic voltamagram of a platinum microelectrode (25//M radius) in 1.0 M H2SO4, at a scan 
rate of 0.2 V/s. Oa -  formation of adsorbed oxygen and platinum oxide layers, Oc -  reduction o f oxide 
layers, Ha - oxidation of adsorbed hydrogen, He -  reduction of adsorbed hydrogen.
Due to the well-characterised formation of oxide monolayers on platinum, the charge 
passed in removal o f these adsorbed layers (labelled Oc in Figure 6.23) is routinely used 
to determine the real or microscopic surface area of these electrodes. In the case o f 
platinum, hydrogen adsorption or desorption on its surface may also be used to 
determine the microscopic area. The method of oxide reduction for the determination o f 
the real surface areas o f platinum microelectrodes assumes that oxygen is adsorbed at 
the surface in a monomolecular layer and also that one oxygen atom is attached to one 
metal atom (Carolan N, PhD Thesis, DCU, 2004). The surface roughness o f the 
micro electrodes was calculated by dividing the microscopic surface area by the 
geometric area. The surface roughness value for the micro electrode was calculated as 
1.25 (see Table 6 .6).
Table 6.6: Calculation of geometric area, electrochemical surface area and surface roughness factor for 
in-house fabricated 25 /¿m radius platinum electrode.
M icroelectrode Radius Geometric Actual surface Surface
Type (Jim) Area (cm2) Area (cm2) Roughness
Platinum 25 1.96 x 10's 2.46 x 1 O'5 1.25
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6.4.3.3 Cyclic Voltammetry o f a bare platinum electrode.
Cyclic voltammetry was carried out initially in phosphate buffer (50 mM Sodium 
Phosphate, pH 7.0) and subsequently in MOPS buffer (50 mM MOPS, pH 7.0), to 
verify that no oxidation or reduction events took place over the given potential window 
of +0.1 to +0.9 Volts. This indicates that the electrode is clean and was polished 
sufficiently. Biological buffer interference was assessed and measures taken to 
eliminate it over the potential window studied. The buffers were deoxygenated 
thoroughly prior to, and an inert gas atmosphere maintained over the buffer during, any 
electrochemical analysis. Lithium perchlorate was used as a standard, non­
electro chemically active solution.
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Figure 6.24: Cyclic voltammogram depicting the electrochemical response of a 25/mi platinum 
microelectrode in (—) 50mM Sodium Phosphate Buffer pH 7.0, (—) 50mM MOPS Buffer pH 7.0. and 
(—) 50mM lithium perchlorate standard. The scan rate was 0.2 V/s.
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6.4.3.4 Direct Electroxidation of H2O2 at the platinum microelectrode.
It is known that direct electro-oxidation o f H2O2 can occur in the vicinity o f a platinum 
electrode at high potentials, e.g close +0.80V (N. Carolan, PhD Thesis, DCU, 2004). 
As the aim of these experiments was to demonstrate direct electron transfer from the 
HRP active site to the surface of the electrode, via H2O2 catalysis; it was imperative 
that spontaneous H2O2 breakdown was characterised and taken into consideration.
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Figure 6.25: Cyclic voltainmagram depicting the electrochemical response of a 25fim platinum 
microelectrode in the presence o f (— ) 0/^M H2 O2 in 50mM MOPS buffer, pH 7.0pH, (—) 2.5 x 10'1 
mol.L'1 H2 O2 in 50mM MOPS Buffer and (—) 1 x 10'3 raol.L1 H2 O2  in 50mM MOPS buffer. The scan 
rate was 0.2 V/s.
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6.4.3.5 Etching of the platinum microwire in the microelectrode.
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Figure 6.26: Scanning Electron Microscope (SEM) images of non-etched and etched microelectrodes. A 
and B depict low magnification (3 Ox and 80x respectively) images of the platinum microwire at the tip of 
the electrode. C shows a high magnification (2,000x) image of the polished, non-etched electrode. The 
black ellipse surrounding the platinum wire is due to electron charge build-up. Image D is a low 
magnification (30x) of the etched microelectrode. A hollow is present (darkened shadowed area indicated 
by the arrow) where the microwire was present in Images A and B. Picture E is a high magnification 
(l,200x) image o f the etched depression in the electrode, whilst picture F is a high magnification 
(3,000x) illustration of the lower region of the etched microwire, depicting the recessed nature of the 
platinum in relation to the glass surround.
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6.4.3.6 Time-current response following addition o f H2O2.
Upon addition o f H2O2 substrate to the electrochemical cell, as outlined in Section 
2.38.3, electrons are generated at the active site o f the HRP molecule, immobilised 
w ithin the etched cavity o f the platinum microelectrode. These electrons can be shuttled 
from the active site to the platinum microwire, which in turn causes a change in the 
potential o f the system, resulting in an increase in charge. Sequential additions o f H2O2 
substrate will result in a ‘staircase’ like graph as outlined in Figure 6.27.
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Figure 6.27: Typical amperometric time course curve depicting the electrochemical response of an 
etched platinum microelectrode with recombinant HRP immobilised within the cavity. 2.5 x 10*4 mol.L'1 
H20 2 (final concentration) was injected sequentially every 20 s to the rapidly mixed, degassed, 
electrochemical cell.
The amperometric time course can be linearised by plotting the plateau current value 
after each substrate injection versus substrate concentration. Any potential plant HRP 
direct electrochemistry was also investigated by carrying out the same experimental 
procedure as outlined for recombinant HRP, with an equal initial peroxidase activity 
available for immobilisation. As adsorption is a non-specific method of en2yme 
immobilisation, each enzyme was immobilised in triplicate and the average 
amperometric response recorded for each H2O2 concentration. BSA was utilised as a 
negative control: this provides an immobilised protein surface but one lacking in 
peroxidase activity. This procedure took any direct, non-enzymatic, electro-oxidation of 
H2O2 at the platinum microelectrode into consideration.
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Figure 6.28: Linearised amperomctric time curve, with sequential additions o f 5.0 x 10'5 mol.L'1 H2 O2 at 
20 s intervals. Recombinant HRP ( ), Plant HRP (A ) and BSA (□ ) (2nM final concentration) were 
immobilised within the etched cavity, via adsorption, overnight at 4°C.
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Figure 6.29: Linearised amperomctric time curve, with sequential additions of 2.5 x 10  ^ mol.L'1 H2 O2 at 
20 s intervals. Recombinant HRP ( ), Plant HRP (A ) and BSA (□ ) (2nM final concentration) were 
immobilised within the etched cavity, via adsorption, overnight at4°C.
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Figure 6.30: Linearised amperometric time curve, with sequential additions of 5.0 x 10"4 mol.L"1 H20 2 at 
20 s intervals. Recombinant HRP (o), Plant HRP (A ) and BSA (□ ) (2nM final concentration) were 
immobilised within the etched cavity, via adsorption, overnight at 4°C.
6.4.3.7 Electrochemical kinetic analysis, Eadie-Hofstee Plot.
The data generated for the amperometric response to H2O2 catalysis by recombinant 
HRP can also be utilised to calculate apparent K’m value for HRP towards H2O2. The 
Eadie-Hofstee plot is a commonly utilised method to determine the kinetic parameters 
o f biosensors (Kamin and Wilson, 1980).
H 202 (mM)
Figure 6.31: Enzfitter™  MichaelisMenten kinetic modelling of the linearised recombinant HRP H20 2 
catalysis data in Figure 6.30.
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When the rHRP electrochemical data from Figure 6.29 was plotted with the Eadie- 
Hofstee methodology an pseudo-sigmoidal curve was noted. The upward curvature was 
attributed to H2O2 diffusional limitations. However, when a higher H2O2 concentration 
was utilised (2.5 x  10"* mol.L'1), the data fitted very well to a Michaelis-Menten kinetic 
model (see Figure 6.31), and an Eadie-Hofstee plot resulted in an apparent K’m 
calculation o f 17.2 x  103 M for H2O2. This apparent K ’m was calculated in the absence 
of a reducing substrate (e.g. ABTS), with the electrode providing the electron 
source/sink.
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Figure 6.32: The electrochemical Eadie-Hofstee plot for a recombinant HRP etched electrode biosensor. 
The slope of the line was used to calculate the apparent K’m of recombinant HRP for H20 2.
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6.5 Discussion.
Protein immobilisation can be simply defined as the limitation o f protein molecule 
mobility in space, or relative to another molecule (Martinek and Mozhaev, 1985). Four 
basic immobilisation techniques exist: physical adsorption, covalent attachment, 
copolymerisation, and microencapsulation. “Immobilisation can result in increased 
protein stability; however, this may not be the primary reason for immobilisation. 
Enzymes are often immobilised because o f the economic costs involved in their 
isolation and purification, to allow their reuse, or use in bio reactors, and to prevent 
contamination of the end product” (O'Fagain, 1997).
6.5.1 Immobilisation Mutants’ Free Solution Stability.
In this study, arginine residues were selected for substitution to lysine residues, to allow 
directed immobilisation of rHRP to an activated matrix. Of the twenty-one arginine 
residues in rHRP, only three were deemed suitable for the proposed mutagenesis: 
Argl 18, Argl59 and Arg283. Lysines are often chosen as the amino acid o f choice for 
covalent immobilisation as they occur frequently in proteins and are active nucleophiles 
when unprotonated, i.e. at alkaline pH. They are also routinely located on surface- 
exposed regions of proteins, due to their charged/polar nature. This characteristic also 
allows for simple immobilisation reactions, as lysine residues do not require activation 
prior to immobilisation (O'Fagain, 1997). Arg to Lys is a conservative mutation and 
should result in minimal disruption to the protein tertiary structure (Betts and Russell, 
2003). Important hydrogen bonds between an arginine and a phosphate moiety have 
previously been noted, however, and replacement of such an Arg with a Lys can be 
disastrous. This is due to lysine possessing only a single amino group and, hence, 
hydrogen bonding is limited (Betts and Russell, 2003). This problem is not evident 
here, however, as Velcro Plus (where the Arg residues are replaced by Lys), displayed 
almost identical thermal and solvent stabilities (with the exception of MeOH) to 
wildtype rHRP in free solution studies. It should be noted that additional mutagenesis 
o f Velcro Plus to Velcro Minus (by removal o f the chemically modifiable Lys 232 and 
Lys241) results in a dramatic decrease in stability. This is somewhat surprising, as the 
modifiable residues were mutated to the most stabilising residues, K232F and K241N, 
described in Chapter 4. Addition of the bulky aromatic Phe residue may have combined 
with the impaired hydrogen bonding introduced by additional Lys residues, resulting in 
a destabilised molecule. In free solution studies, Velcro Minus displays a 50% decrease
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in thermal stability and a 20% decrease in MeOH stability. However, Velcro Minus also 
displays equal H2O2 stability and two-fold greater stability to DMF at room 
temperature, although these latter stabilities do not match those of K232F/K241N 
double mutation in free solution (see Section 4.6.3 and 4.6.4). As such, free solution 
analysis indicates that inclusion of K232/K241N is not advantageous to the Velcro 
molecule in terms of stability, but is necessary to ensure directed immobilisation. One 
of the Arg residues (283) is located on the last turn of Helix J (Gajadhe et al., 1997). 
Previous results (see Chapter Five) demonstrated the key role o f the helix within the 
HRP structure scaffold. As such, both Velcro Plus and Velcro Minus were back- 
mutated at this position to yield Velcro Plus(K283R) and Velcro Minus(K283R) 
revertants respectively. Although this reduced the number of potential immobilisation 
sites, it was noted to have an effect on free solution stability. For example, Velcro 
Minus(K283R) displayed a 2.6-fold increase in thermal stability over Velcro Minus as 
judged by in Ua at 50°C. This mutant also showed a 1.3-fold increase in thermal 
stability over wildtype. However, Velcro Plus and Velcro Plus(K283R) displayed very 
similar thermal stabilities. Solvent stability was also affected by re-introduction o f the 
Arg residue at position 283, with Velcro Plus(K283R) exhibiting a decrease in DMSO 
(1/6) and MeOH (1/5) tolerance compared to Velcro Plus, although Velcro 
Plus(K283R) did show a 1/3 increase in C50 in DMF. Velcro Minus(K283R) displayed 
decreased solvent stabilities in all solvents tested (DMSO: 1/7, MeOH: 1/5 and DMF: 
1/3, respectively) in free solution studies. Interestingly, both reversion mutants 
displayed an increased H2O2 stability in free solution, (14% for Velcro Plus(K283R) 
and 94% for Velcro Minus(K283R). As such, the thermal and H202-stabilising effect of 
the Lys232 and 241 mutations (Phe and Asn respectively) are only noticeable when the 
helical properties are maintained within the protein backbone.
6.5.2 Immobilisation on CNBr-Activated Sepharose.
Another disadvantage of K232 and K241 removal is evident during immobilisation to 
CNBr-Activated Sepharose. Wildtype rHRP, with three potential immobilisation sites 
(Lys 174, 232, 241), displays 50% immobilisation. Velcro Minus(K283R) with three 
potential immobilisation sites (K174, K118 and K159), yields only 42% 
immobilisation. Velcro Minus, with four potential immobilisation residues (K174, 118, 
159, 283), achieves 57% immobilisation. However, Velcro Plus(K283R) with five 
potential immobilisation sites (K118, 174, 159, 232, and 241), yields 69%
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immobilisation. Velcro Plus, with six possible immobilisation sites (K118, 174, 159, 
232, 241, 283) yields 86% immobilisation. These calculations were based on units of 
activity available for immobilisation and units o f activity immobilised, making the 
assumption that no inactivation occurred during the immobilisation process. rHRP has 
previously demonstrated its stability in all conditions utilised during immobilisation, 
e.g. low pH during the elution step of nickel affinity protein purification. The total 
duration o f low pH conditions for rHRP coupling was minimised and was much shorter 
than that used in protein purification. Cyanide inactivation of HRP is known to occur 
(Dunford, 1999); however, cyanide release would be minimal and quickly diluted and 
removed due to the high number of washes during the immobilisation procedure. 
Fuentes and colleagues (2006) noted that the rate of HRP immobilisation depended 
exponentially on the concentration of reactive groups on the protein and the support. 
Therefore, protein immobilisation occurs at regions exhibiting the highest density o f 
reactive groups.
Wilcheck and Miron (2002) noted that lysine is the key amino acid responsible for 
protein immobilisation onto CNBr-Activated Sepharose. However, they noted that 
random immobilisation of the proteins examined did not cause any loss o f activity, and 
they argue that random immobilisation is similar to orientated, as immobilisation 
occurs through one to two bonds. It should be noted that all proteins investigated in that 
publication were native, glycosylated proteins, with no indication given as to the total 
number or location of available lysine residues. Conversely, Cha and co-workers (2005) 
demonstrated that orientated immobilisation of enzymes is critical, particularly as 
applied to protein chips. Ultimately, the future of immobilised protein chips in 
biomedical diagnostics is orientation dependent. Cha and co-workers (2005) noted that 
random immobilisation on an activated silicon chip is seen to drastically alter protein 
function, as compared to free solution activity.
6.5.3 Cyanogen Bromide Activated Matrix Immobilised Enzyme Characteristics.
6.5.3.1 Thermal Stability.
Following successful immobilisation onto activated CNBr, the four Velcro mutants 
were characterised as to their thermal, solvent and H2O2 stabilities, utilising 
immobilised wildtype rHRP as a reference. Free-solution thermal profiling suggested 
50°C as standard temperature to carry out thermal inactivation analysis on the 
immobilised forms. At this temperature, immobilised wildtype rHRP demonstrated
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more than two-fold stabilisation, as indicated by Un- However, the only Velcro mutant 
to display an increase in immobilised thermal stability was Velcro Plus(K283R), with a 
marginal 5% increase in Ua at 50°C. Velcro Plus (4-fold), Velcro Minus (1.25-fold) and 
Velcro Minus(K283R) (1.25-fold) all displayed a notable decrease in thermal stability. 
It appears that multipoint attachment, most evident in the case o f Velcro Plus, increases 
strain on the rHRP molecule. This, in conjunction with restricted movement, causes a 
dramatic decrease in thermal stability. Previous reports o f destabilising multipoint 
immobilisation of glucoamylase also point to increased protein strain as reason for 
decreased thermal stability (Gerasimas et al., 1980), while the type of immobilisation 
resin can also destabilise the immobilised protein (Nys et al., 1977). These results 
contradict previous reports o f increased thermal stability, due to multipoint attachment 
(Abian et al., 2004). However, Abian and co-workers (2004) focused their mutations on 
a lysine-rich area of Pencillin G Acylase, which previous chemical modification studies 
had proven not to be critical for protein stability, and so minimised the chance of a 
deleterious mutation (or interaction from other mutations) in this area. This group also 
utilised a glyoxyl-agarose activated solid phase for protein immobilisation. Plant HRP 
has previously been immobilised onto a variety o f solid phases, by a range of different 
techniques, to increase thermal stability. For example, Lai and Lin (2005) covalently 
immobilised plant HRP onto porous aminopropyl glass beads. Upon immobilisation, 
the operational pH range was broadened in the acidic range by one pH unit and optimal 
operating temperature was increased by 10%, with the thermal stability o f the 
immobilised molecule increased by 20% compared to free solution plant HRP. The 
immobilised HRP was utilised in the removal of ¿»-chlorophenol from wastewater; 
however, the removal efficiency did not match that o f free HRP due to substrate 
diffusion limitations (Lai and Lin, 2005). Rojas-Melgarejo and co-workers (2004) also 
noted increased thermal stability (30%) for plant HRP absorbed onto cinnamic 
carbohydrate esters, similar to that noted in this present study for wildtype rHRP (27%), 
covalently immobilised onto CNBr.
6.5.3.2 Solvent Stability.
Immobilised wildtype rHRP shows no alteration in DMSO and DMF stability; 
however, it displays decreased (25%) MeOH tolerance. Velcro Plus displays a 40% 
decrease in DMSO, 30% decrease in MeOH, but a 40% increase in DMF stabilities. 
CNBr-immobilised Velcro Plus(K283R) displays similar solvent stabilitites to the non­
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immobilised form; however, DMF incubation results in a 38% stability decrease. 
Surprisingly, Velcro Minus CNBr immobilisation yields increased (20% in DMSO, 
16% in DMF) or equal stability (MeOH) in all solvents tested. CNBr-immobilised 
Velcro Minus(K283R) displays almost identical solvent stabilities to free solution 
Velcro Minus(K283R). The reduced tolerance o f Velcro Plus can again be ascribed to 
increased strain and lack of protein flexibility. Organic solvent molecules, that have 
stripped and replaced water molecules, are maintained in close proximity to the protein 
surface due to the confined nature o f the immobilised protein, leading to protein 
denaturation. Increased catalytic stability, as demonstrated by Velcro Minus, can be 
attributed to orientated immobilisation. The immobilisation is not as rigid as Velcro 
Plus, as demonstrated by the smaller thermal stability loss, yet it maintains the 
molecule’s active site correctly orientated for optimal catalytic activity.
Protein immobilisation for use in organic solvents is a rapidly developing area o f 
research; recently Temino and co-workers (2005) demonstrated that encapsulation of an 
alcohol dehydrogenase and its NADPH cofactor within a polyvinyl alcohol hydrogel 
protected the enzyme from organic solvents and thermal denaturation. This allowed the 
enzyme to effectively catalyse the conversion o f prochiral ketones to chiral alcohols in 
the presence of organic solvents. Encapsulation is one o f the simplest immobilisation 
strategies to execute; however, it is critical that there is rapid diffusion o f substrates and 
products in and out of the encapsulating material (Hudson et al., 2005). The possible 
role o f HRP in organic solvent catalysis has been previously outlined (Section 1.1.6) 
and so any increase in stability in this area will be o f great benefit.
6 .5.3.3 H2O2 Stability.
An unexpected result was noted for Wildtype and Velcro mutants’ stability in H2O2. 
Despite a large variation in H2O2 stability (Velcro Plus(K283R), Velcro Plus and 
Velcro Mmws(K283R) display a 2.6, 2.2 and 2-fold increase in stability respectively 
compared to wildtype and Velcro Minus), all four mutants and wildtype show a 
dramatically decreased H2O2 stability after CNBr immobilisation. For example, Velcro 
Plus exhibits a 7-fold decrease, whilst wildtype and Velcro Minus displays a 3.4-fold 
reduction. All immobilised forms demonstrate an apparent basal C50 value o f 5 mM 
H2O2. A possible reason for this may be the immobilised rHRP favouring the 
Compound III or inactivation pathways of the peroxidase H2O2 catalytic cycle 
(Hemandez-Ruiz et al., 2001). Immobilisation-induced strain may interfere with the
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necessary enzyme flexibility, leading to inappropriate H2O2 turnover and, ultimately, 
enzyme inactivation. Previous immobilised HRP H2O2 tolerance results appear to 
depend on the type and reactivity o f the activated solid phase. Rojas-Melgarejo and co­
workers (2004) report increased H2O2 tolerance with HRP adsorbed onto cinnamic 
carbohydrate esters when the stability analysis was carried out at pH 7.0; however, 
when the experiment was repeated at pH 4.5, there was a dramatic loss o f H2O2 
stability. The authors believe that reactive oxygen species such as superoxide, 
generated during H2O2 catalysis, may have been absorbed by the cinnamic support 
instead of attacking the essential enzyme residues. Alternatively, at lower pH, carbonyl 
groups are oxidised and do not provide a sink for oxidising reactive oxygen species, 
leading to dramatic enzyme destabilisation (Rojas-Melgarejo et al., 2004).
Although covalent immobilisation was utilised in this study, many methods o f 
immobilisation exist; however, the selection of the optimal procedure is critical to 
maximising immobilisation efficiency and potential stability gains. Azevedo and co­
workers (2004), for example, utilised immobilised plant HRP in a mini-packed bed 
reactor flow-injection analysis system. HRP was immobilised onto alkylamine 
controlled pore glass by two methods: adsorption and covalent linkage (using 
glutaraldehyde and EDC coupling methodologies). High operational stabilities were 
noted for glutaraldehyde-immobilised HRP; whilst EDC coupled HRP demonstrated 
poor stability. Adsorbed HRP simply desorbed upon reactor washing, and required 
cross-linking after adsorption to promote correct immobilisation. The immobilised HRP 
permitted the monitoring and quantification of H2O2 (up to 1.1 x 10' mol.L' ) in a 
continuous on-line bioprocess set-up.
Nahar and Bora (2004) recently outlined an interesting immobilisation method utilising 
microwaves to covalently immobilise HRP to light-activated inert polymers. This 
technique is rapid, simple and maintains enzyme catalytic activity. Non-specific protein 
absorption is minimised due to short reaction time (less than 60 s) and this technique 
may prove useful in protein micro-array production.
There are very few reports of either direct or random immobilisation o f recombinant 
HRP in the literature. Rojas-Melgarejo and colleagues (2006) noted the difficulty in 
immobilising recombinant HRP to traditional adsorbent solid phases, as the 
recombinant protein lacks the carbohydrate residues commonly used for this type of 
immobilisation. Instead, cinnamic esters were successfully employed (63% 
immobilisation rate) as an immobilisation platform. This platform utilises physical
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adsorption in conjunction with glycosylation-independent hydrophobic interaction. 
Wildtype recombinant HRP immobilised in such a fashion yielded an 8% increase in 
thermal stability. Abad and co-workers (2005) recently described directed recombinant 
HRP immobilisation via an N-terminal His tag-cobalt (Il)-terminated gold nanoparticle 
interaction. Although no stability data were available for this method, its potential 
application in orientated immobilised rHRP onto gold electrodes for biosensing is 
obvious. Allard and colleagues (2002) utilised a poly-His/poly-Lys double-tagged 
recombinant protein expression procedure, which permitted the inclusion of various 
combinations o f the His/Lys tags for directed immobilisation. Similar methods for 
directed immobilisation include the use of a poly-Arginine tag, as demonstrated by 
Stempfer and colleagues (1996). In this case an (Arg)6 tag was genetically engineered 
as a C-terminal fusion peptide, permitting orientated adsorption onto polyanionic 
adsorbents under low-salt conditions. The mutant’s stability closely resembled the 
wildtype’s under heat and urea denaturing conditions; however, there was a slight 
alkaline shift in pH optimum.
6.5.4 UltraBind™ Orientated Proof o f Principle.
Lopez-Gallego and co-workers (2005) recently illustrated an alternative to traditional 
protein chemical modification for stabilisation. In their communication, chemical 
modification o f an enzyme was proposed, not to increase stability, but to enrich the 
protein surface with reactive groups. This should facilitate multipoint covalent 
attachment during protein immobilisation. The present work has further advanced this 
idea by alteration of the amino acid composition of rHRP to increase the number o f 
lysine residues, and also to focus these lysines to a specific region of the 3-dimensional 
structure. This study proposes directed, multipoint immobilisation o f rHRP onto a 
commercially available, modified polyethersulfone (PES) membrane. The additional 
lysine residues are located on the opposite side o f the molecule to the active site (Velcro 
Minus)', hence, immobilisation via these lysines forces the protein to orientate its active 
site away from the membrane and towards the bulk solution phase. Figure 6.16 
demonstrates increased catalytic activity for the Velcro Minus immobilised rHRP 
compared with Wildtype, over a five-hour period. Equal concentrations o f Velcro 
Minus, Velcro Plus and wildtype rHRP were applied; however, increased catalytic 
activity towards DAB substrate is directly attributed to optimal orientation o f the rHRP 
molecule (Velcro Minus), as compared to the random orientation o f wildtype rHRP,
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(see Figure 6.16). Velcro Plus mutants displayed a similar trend to wildtype rHRP; 
however, poor coloration was noted over the four-hour initial incubation period. If  the 
catalytic reaction is allowed to proceed overnight at room temperature (Figure 6.15), it 
is clear that the colour development is more intense for the Velcro Minus, compared to 
Wildtype and Velcro Plus. The initial poor colouration of Velcro Plus is augmented by 
increased reaction time, and reaches a threshold similar to wildtype. As outlined 
previously, conformational changes due to multipoint attachment may have caused the 
suboptimal catalytic activity o f Velcro Plus. No simple adsorption is noted in the 
immobilisation procedure, as the reverse side o f the membrane displays no catalytic 
colouration (see Figure 6.15, part E). Activated membranes are typically single-side 
activation; hence, if correct covalent immobilisation is achieved, as demonstrated here, 
only one side will capture enzyme. Furthermore, this experimental setup also 
demonstrated reusability. Immobilised Velcro Minus, was stained repeatedly (up to 
three times, data not shown) with TMB, non-precipitating substrate, over a period of 
several hours, with appreciable catalytic activity noted each time.
The immobilisation of enzymes can increase protein stability (Mateo et al., 2000); 
however, by implementing orientation-dependent protein immobilisation, researchers 
may not only stabilise a protein, but may also promote superior performance in 
applications such as biosensors. Recent developments in this area focus on the type of 
bio-recognition involved in immobilisation. Traditionally, lysines (as in this study) or 
cysteines can be engineered into a protein backbone to allow for immobilisation. 
However, as the field of proteomics enlarges, protein micro arrays require vast 
concentrations of immobilised protein, which cannot be easily achieved by site-specific 
immobilisation. More generic methods of immobilisation have developed in recent 
years, from His-tag chelation to biotin-avidin interaction. Polypeptide scaffolds 
comprise a topical generic immobilisation method, employing a hydrophobic anchor 
attached to a leucine-zipper protein capture domain utilised to directionally immobilise 
several different proteins to a hydrophobic solid phase (Zhang et al., 2005).
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6.5.5 Electrochemical Biosensing Devices.
6.5.5.1 Screen Print Electrode.
Screen-printed electrodes are commonly utilised in the mass production of disposable 
electrochemical sensors. The practical utility o f screen-printed electrodes has long been 
exploited, despite the limited knowledge on the actual electrode reactions (Wang et al., 
1998). In this study the different electrochemical properties ofwildtype and plant HRP 
were investigated, utilising an in-house produced screen-printed electrode. Prior to any 
enzyme immobilisation, the screen-print electrode was electro chemically cleaned by 
the pre-treatment method of Killard and co-workers (1999). In this method, cycling o f 
the screen-printed electrode in sulphuric acid is believed to strip the carbon electrode 
surface, removing any insulating materials present on that surface. Once the pre­
treatment was completed, a polyaniline:polyvinylsulphonate (PANI/PVS) layer was 
deposited on the bare screen-print electrode, via cyclic voltammetry. The voltage was 
cycled until the leucoemeraldine radical cation peak reached an anodic current o f 
approximately 2.8mA (see peak A, Figure 6.20). This typically required 10 cyclic 
sweeps, and mirrors well previous work in this area (Iwuoha et al., 1997). However, 
this was difficult to reproduce accurately and, as such, the layer depth demonstrates 
some variability. PANI can fulfil many roles in biosensor configuration, including 
extension of the linear range of the sensor, as an immobilisation platform for 
biocomponents and as the electron mediator (Grennan et al., 2005). The inclusion o f 
PVS in the polymer synthesis maintains electrical neutrality once the polymer is 
oxidised and results in increased polymer structural stability and conductivity over a 
broader range of pH values (A. Morrin, PhD Thesis, DCU, 2003). The conducting 
polymer is capable o f penetrating the insulating exterior o f proteins and can provide a 
direct electrochemical communication between the redox centre o f the protein and the 
electrode surface. This is achieved by delocalisation of redox charges over a series o f 
conducting polymer groups, thereby acting as self-contained electron-transfer mediators 
(Grennan et al., 2006). Once the PANI/PVS conducting layer had been deposited, the 
protein o f choice; in this study BSA, recombinant or plant HRP, was immobilised onto 
the surface of the PANI/PVP layer via time-based amperometry. A long (~1 hr) 
equilibration period was required to allow the electrode to reach steady state prior to 
amperometric analysis. This extended equilibration period was required to allow the 
polymer charge, built up during PANI/PVP oxidation in previous preparatory steps, to 
dissipate. This charging current is common in polymer-modified screen-printed
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electrodes (Iwuoha et al., 1997). Previous non-biosensor PANI-based HRP 
immobilisation studies have demonstrated increased thermal and solvent stabilities, in 
conjunction with improved kinetic values (Fernandes et al., 2004). Steady-state 
amperometric analysis o f BSA, recombinant and plant HRP was then carried out. 
Protein molecules are too large to permeate the polyaniline layer and, as such, catalytic 
activities occur on the surface o f the polymer (A. Morrin, PhD Thesis, DCU). There are 
very few reports o f recombinant HRP utilised in screen print electrodes, with none 
incorporating polyaniline. Schumacher and co-workers (2001) employed a graphite 
electrode with adsorption and entrapment used as the immobilisation techniques.
In the present study, equimolar concentrations of each protein (2 nm) were individually 
electrostatically immobilised onto the polyaniline layer. Once immobilised and a steady
2 i
state condition achieved, successive additions o f 2.0 x 10' mol.L' H2O2 were carried 
out, with the resulting increase in fiA  recorded. Figure 6.21 demonstrates the increased 
fiA  output for recombinant HRP as compared to plant HRP. This can be attributed to 
rHRP’s lack of glycosylation, allowing a more rapid transfer o f  electrons from the 
enzyme’s active site to the sensing electrode surface. Plant HRP displays 20% 
glycosylation (Ryan et al., 2006), which is known to hinder efficient electron transfer 
(Presnova et al., 2000). BSA was utilised as a non-reactive blocking protein, to account 
for any direct electro-oxidation of H2O2 at the polymer surface. Figure 6.21 
demonstrates that there is some direct electro-oxidation of H2O2; however, both forms 
of the peroxidase yield results above this basal value. When lower concentrations o f 
H2O2 were employed, very small A f i A  were observed (data not shown), possibly due 
to H2O2 diffusion problems. However, use of high concentrations o f H2O2 led to rapid 
peroxidase denaturation. Wildtype recombinant HRP has a free-solution H2O2 C50 of 
-1 .7  x 10'2 mol-L'1, during a 30 min incubation (see Chapter 3); the value is just 5mM 
for CNBr-immobilised rHRP (see Chapter 6). As such, 2.0 x 10'2 mol.L'1 injections 
would rapidly denature the enzyme. This is observed by the initial rise, followed by a 
drop in A/zA as H2O2 concentration increases within the electrochemical cell. Previous 
SEM and AFM image analysis o f screen-printed electrodes with HRP immobilised 
suggested that the protein is immobilised in a non-orientated fashion, and often in 
aggregates (Grennan et al., 2006). This may have resulted in steric hindrance for H2O2 
access to the active site o f the protein. A possible method to overcome aggregate 
formation was recently suggested by Lori and co-workers (2006), in which N- 
nitrilotriacetic acid (NTA) was co-doped into the electropolymerised PANI/PVS
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polymer. The NT A could efficiently chelate recombinant proteins incorporating a His- 
tag to the electrode surface. Further to this, incorporation of HRP into the screen print 
“ink” prior to deposition may provide an alternative approach. Direct electron transfer 
is achieved by plant HRP inclusion in this “biocomposite ink”. However, several 
difficulties exist in mass production of such screen print electrodes, mainly involving 
the optimisation o f the “biocomposite ink” (Ledru et al., 2006). Morrin and co-workers
(2002) previously demonstrated that the optimum plant HRP concentration was 0.75 
mg.mL'1 for polyaniline-modified screen-printed electrodes. This concentration 
achieved a theoretical monolayer distribution on the electrode surface. However, a 
similar concentration o f active recombinant HRP could not be achieved, as detailed 
previously (Section 3.10.4). The maximal production o f rHRP dictated the working 
concentration o f peroxidase within this arrangement, which was typically 0.65/iM.L'1. 
To overcome this problem, a more sensitive method of amperometric analysis was 
investigated, namely etched microelectrodes.
6.5.5.2 Etched Microelectrode.
Microelectrodes are defined as electrodes o f critical dimensions in the micron range. 
Microelectrodes possess many advantages over the traditional macro electrode 
(millimetre dimensions) including a reduced response time, which enables 
electrochemical experiments to be carried out over extremely short timescales (Andriex 
et al., 1998). Also, current measurement can be carried out in the pico- and nano-Amp 
range, which permits more sensitive analysis. The micro electrode utilised in this study 
was produced in-house in collaboration with Dr. Jennifer Brennan, NCSR, DCU, and is 
outlined diagrammatically in Figure 6.22. The microelectrode was polished, to achieve 
a smooth surface, and then electro chemically characterised.
Cyclic voltammetry on a platinum electrode, in 1.0 M H2SO4, yields a characteristic 
curve. The oxide monolayer peak was utilised to calculate the “electrochemical area” 
which, in conjunction with the geometric area, allowed an estimation of the surface 
roughness. Typical values for the microelectrode surface roughness ratio are between
1.0 and 3.0, with the microelectrode generated in this study achieving 1.25. A cyclic 
voltammagram over the potential window of +0.1 to +0.9 Volts illustrated the 
importance of biological buffer choice. Sodium phosphate (50 mM, pH 7.0) buffer 
demonstrated a curve similar to that o f H2SO4 cycling. This was attributed to the HC1
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utilised  to adjust the buffer solution’s pH  acting lik e  the H 2 SO4 , and electro chem ically 
cleaning the electrode. A s such, M OPS (50 mM, p H 7.0) buffer was u tilised  as the 
b io lo g ical buffer o f choice. T h is buffer was pH-adjusted only w ith N aO H, and had 
previously demonstrated its electrochem ical com patibility (N . Carolan, PhD Thesis, 
D C U , 2004). The cy clic voltam m etry curve generated in  M OPS (50 mM, pH  7.0 ) was 
very sim ilar to that o f a non-electrochem ically active solution, lithium  perchlorate. The 
potential w indow  was extended for M OPS (50 mM, p H 7.0 ) to ensure that no peaks 
were observed at more positive potentials, as noted in  Figure 6.24.
Possible direct electro-oxidation o f H 2 O2 in  the v icin ity  o f a platinum  electrode was 
investigated by injection o f various concentrations (0, 2.5, and 10 x  10^ m o l.L '1) o f 
H 2 O2  into rapidly-m ixing M OPS (50 mM, pH 7.0) buffer solution. A  sm all curve-shift 
was recorded for 2.5 x  10-4 m ol.L ' 1 H2 O2 injection; however, upon the addition o f 1.0 x 
10 ' 3 m ol.L ’ 1 H 2 O2 , an anodic peak at 0.6 V o lts was noted. This was ascribed to the 
direct electro-oxidation o f H 2O2 in  the electrolyte solution, M OPS (50 mM, pH  7.0). 
Therefore, a negative control was critica l for a ll subsequent am perom etric 
electrochem ical analysis.
The platinum  w ire o f the electrode was then etched, v ia  subm ersion into hot (75  °C) 
aqua regia, for 3 hours. The m icrow ire was im aged using scanning electron m icroscopy 
before and after etching. P rio r to etching, the w ire was cle arly v isib le  at the tip  o f the 
electrode; however, after 3 hours etching, it was no longer v isib le  and a recess was 
noted, as indicated by shadowing, upon visualisatio n o f the m icrow ire region at high 
m agnification. The dark ellipse surrounding the platinum  w ire in  some o f the im ages is 
due to electron charge build-up. Platinum  conducts electrons, glass does not: where the 
two meet, there is a difference in  electron concentration, resulting in  a darkened ring 
around the platinum  w ire. The roughness o f the etched electrode was not calculated, as 
the exact depth o f the etched cavity could not be determined.
Equim olar concentrations (2 nM ) o f recom binant H RP, plant H RP and B S A  were 
im m obilised into the cavity generated and a current—tim e assay w as perform ed to 
analyse the response o f the etched electrode to successive additions o f H 2 O2 . A ll 
experim ents were carried out in  triplicate, as protein im m obilisation v ia  adsorption is 
d ifficu lt to reproduce. The average values were plotted in  Figures 6.28 to 6.30, w ith 
error bars noted for each. Upon successive additions o f H 2 O2 , a sharp increase in  the 
reduction current was recorded for recom binant H RP; w hich reached steady state 
w ithin 20 s o f H2 O2 injection, resulting in  the typical “staircase” shape curve. A
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shallower curve was noted for plant HRP, which was very similar to the negative 
control, BSA. Various concentrations o f H2O2 were investigated, with increasing 
substrate concentration resulting in increased reduction currents. A linearised 
calibration curve was constructed from the current-time response assay data, utilising 
the current value at the steady-state region for each H2O2 addition. The correlation 
coefficients for the linearised graphs were all S0.99, with the exception o f 5.0 x 10'5 
moLL'1 H2O2 injection curve (correlation coefficient = 0.92, Figure 6.28); the latter was 
possibly caused by substrate diffusional limitations. A common trend was noted 
throughout: steeper curves were recorded for recombinant HRP as compared to plant 
HRP, indicating that a recombinant HRP-based etched electrode sensor is more 
responsive to successive additions of H2O2. The electrochemical Eadie-Hofstee plot can 
be utilised to demonstrate the effect o f internal diffusion as well as approximate K’m 
value. A sigmoidal curve was obtained for 5.0 x 10'5 mol.L_1 H2O2 injection data, 
indicating diffusional limitations within the system. This reinstates previous 
assumptions on diffusional problems at low H2O2 concentrations indicated by the poor 
correlation coefficient of the calibration curves for this data set. However, with 
increased substrate concentration, data were obtained that fitted the Michaelis-Menten 
kinetic model, resulting in the calculation of 17.2 x 10'3 M as K’m for H2O2. This
"X
compares with the published K’m o f 12.8 x 10' M for the closely related, but 
glycosylated, soybean peroxidase (SBP; Wang et al., 2001). Other, recently published, 
peroxidase H2O2 K’m values include: 1.27 mM (Korean radish peroxidase; Kim and 
Lee, 2005) and 1.77 mM respectively (Marula fruit; Mdluli, 2005).
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6.6 Conclusion.
In this study, extra lysines were utilised to directionally immobilise rHRP onto both a 
CNBr-Activated Sepharose solid phase and an activated, modified polyethersulfone 
(PES) membrane. The key element to achieve controlled enzyme orientation is to 
selectively attach the biomolecule at a predetermined site(s) on the protein surface 
(Zhen et al., 2004). Therefore, additional lysine residues were genetically introduced to 
the wildtype HRP molecule (Velcro Plus) and those chemically modifiable lysines 
present in rHRP (K232 and K241) were removed ( Velcro Minus). Subsequent 
bioinformatic analysis indicated that restoration of one o f the arginine residues (R283) 
to both Velcro Plus and Velcro Minus would be beneficial. These substitutions 
generated a suite o f rHRP mutants tailored for immobilisation. Mutants showed 
decreased CNBr-immobilisation rates with decreasing lysine content. Following CNBr- 
immobilisation, only wildtype rHRP displayed an increased thermal stability 
(approximately 2.2-fold). Frustratingly, the Velcro mutants displayed a notable 
decrease in thermal stability. Velcro Minus yielded the best solvent stabilities o f the 
immobilised rHRP forms. All the immobilised rHRP forms exhibited very poor H2O2 
stabilities, with an apparent common basal C50 noted. Directional immobilisation onto 
an activated, modified polyethersulfone (PES) membrane permitting maximal catalytic 
activity was achieved.
Recombinant and plant HRP immobilised onto screen-printed electrodes resulted in fiA  
differences in reduction current upon H2O2 addition. However, the concentration of 
substrate required to produce this AfxA  caused rapid enzyme inactivation. Additionally, 
the optimal peroxidase concentration required could not be achieved by the current 
prokaryotic host organism. To overcome this effect, a more sensitive sensor, namely the 
etched micro electrode, was utilised. This configuration confirmed that rHRP could 
achieve direct electron transfer, generating a series of calibration curves ranging from 0 
to 10 mM. An Eadie-Hofstee replot o f the data allowed for an estimation o f the K’m
17.2 x 10‘3 M of recombinant HRP towards H2O2, similar to other plant peroxidases. 
Diffusional limitations were noted at lower concentrations o f H2O2, attributed to the 
external and internal diffusional resistance (Limoges and Savéant, 2003). This 
preliminary work provides much scope for mutants to be applied in these and other 
biosensor configurations,
239
Chapter Seven. 
Overall Conclusions.
7.0 Overall Conclusions.
This work has shown that a N-terminal PelB leader and C-terminal (His)6 is compatible 
with functional HRP. Culture optimisation permitted expression o f functional HRP as a 
fusion protein with PelB leader sequence to 0.65 ¿iM.L"1, without the need for protein 
refolding. Attempts to use conventional purification methodologies (HIC, Size 
Exclusion and Anion Exchange chromatography) resulted in the co-purification of a 
native E. coli peroxidase; however, nickel affinity chromatography achieved 30-fold 
increase iii purification values and 70% recovery rates once the protocol had been 
optimised.
Stability characterisation of purified rHRP demonstrated that catalytic activity was 
maintained up to 55°C, with a graphically determined T50 value o f 50°C. The apparent 
half-life (t\a) at 50°C (k=0.0559) was subsequently calculated as 12.4 min. 
Organotolerance studies indicated that rHRP was most stable in MeOH (C50 53 % v/v), 
followed by DMSO (C50 35 % v/v). DMF was the most deleterious solvent, exhibiting a 
C50 o f 14 % v/v. No activation was noted in any solvent tested. rHRP yielded a C50 o f 
17 mM H2O2, after 30 min static incubation. Characterisation also revealed the apparent 
k3 for recombinant wildtype to be 333 ± 25s'1, whilst the K’m was 2.04 + 0.06 mM.
Initially, solvent-exposed lysine residues (K174, K232 and K241) were selected for 
substitution to increase overall stability. Single mutations (Ala, Glu, Asn and Phe) were 
introduced by an adapted mutagenic PCR strategy. A similar characterisation protocol 
to wildtype rHRP followed protein expression and purification, which concluded that 
mutations to Lysines 232 and 241 can positively influence stability, whilst Lys 174 
substitutions have a negative effect. The outocome of these single mutations suggested 
the development o f additional single and double mutations. The double mutations 
combined the two best individual lysine mutations. All double mutations yielded 
increased thermal tolerance as judged by t\a. K232F/K241N was the most stabilising 
mutation; however, stabilising single mutations were not additive. The important 
stabilising role o f Glu238 was noted. All lysine mutants displayed altered kinetic 
constants, k3 in particular.
Five potentially stabilising mutations (T102A, Q106R, Q107D, T110V and I180F) were 
predicted by novel validated bioinformatic software (ProteinParser) and developed in
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the third section o f this study. Overall, the stability characteristics o f these mutants were 
disappointing. Marginal gains in thermal stability were noted, whilst only one mutant 
displayed increased solvent or H2O2 stability, the latter significantly so; however, this 
unexpected outcome prompted further investigation. The original frequency-counting 
algorithm was independently validated, which suggested the pivotal stabilising role 
played by the helical structures in HRP. The location o f the mutations analysed in this 
study (in or close to a helix) highlighted the fact that the Consensus Concept is not 
globally applicable. This study does suggest, however, the important stabilising role o f 
Q106 and, that a single residue substitution can significantly alter the stability o f HRP 
to H2O2.
Judicious introduction of modifiable groups (lysine residues) to the outer surface of 
rHRP permitted simple orientated immobilisation, although at a cost to stability in the 
case o f CNBr-Activated Sepharose immobilisation. This study also demonstrated that 
even conservative substitutions (Lys to Arg) can compromise both free-solution and 
immobilised stability. The important stabilising role o f helical secondary structure is 
evidenced again.
Recombinant HRP functionality in two sensor configurations was explored. Electron 
transfer was evident in the screen-printed electrode; however, the optimal concentration 
of HRP required for this sensor configuration was beyond this study’s current E. coli 
production rate and, as such, further investigation was abandoned. Use o f an etched 
microelectrode permitted use of low-concentration rHRP. A clear difference between 
the recombinant and plant HRPs’ direct electron transfer is apparent using an etched Pt 
microelectrode. The resulting rHRP data fitted a Michaelis-Menten kinetic model, and 
subsequent Eadie-Hofstee analysis yielded a K’m calculation o f 17.2 x 10'3 M for H2O2. 
The mutants generated in this study remain to be analysed in terms o f biosensor 
performance.
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7.1 Summary and Future Work.
The work described in this thesis has achieved the following successes:
• Directional cloning of PelB and HRP gene, with C-terminal HiS(6) tag, into pQE60.
• Optimal expression of functional rHRP using XL10 Gold E. coli strain.
• IMAC purification of rHRP to single-band homogeneity, as judged by SDS-PAGE.
• Characterisation (thermal, solvent, H2O2 tolerance and kinetic analysis) o f rHRP.
• Generation of a number o f rational lysine mutants based on prior experimentation.
• Characterisation o f lysine mutants and comparison to wildtype.
• Further elucidation of the stabilising roles o f K174, K232, E23 8 and K241.
• Development o f ProteinParser programme for amino acid frequency counting.
• Creation of a number of rational consensus mutants based on ProteinParser predictions.
• Characterisation of consensus mutants and comparison to wildtype.
• Validation of frequency counting algorithm and development o f archetype peroxidase.
• Elucidation o f the key stabilising role of the helical secondary structure with HRP.
• Establishment o f orientatable HRP immobilisation via additional lysine incorporation.
• Stability investigation of both free and CNBr-immobilised HRP mutants
• Application o f rHRP to screen-print electrodes and Pt micro electrodes for H2O2 
detection.
Future work in this area should address:
• Expression of HRP in eukaryotic host or use of co-expression systems (Vamado and 
Goodwin, 2004) to increase yield (particularly important for sensor development).
• Chemical modification o f rHRP and introduction of chemically modifiable groups (e.g. 
lysine) to allow for selectable chemical modification.
• Use of phage display techniques to directionally evolve HRP towards increased stability.
• Synthesis and expression of archetype peroxidase protein, comparison with modem day 
HRP.
• Rapid reaction kinetics for rHRP and mutants.
• Physical characterisation studies: NMR, Raman spectroscopy, crystallisation o f notable 
mutants.
• Incorporation into H2O2 sensors and catalase studies for H202-tolerant T110V mutant.
• Continued development of rHRP in etched platinum electrode, mutant investigation.
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